data_1lmj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1lmj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 1.6 tp -89.94 179.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 29.1 t0 -85.63 93.58 8.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 30.7 mp0 -76.27 -19.25 58.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.357 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.5 t -83.56 -26.09 30.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.462 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -71.29 -25.95 62.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.24 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.5 mm -45.41 -39.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.693 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.9 t -165.99 156.19 11.24 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 4.9 Cg_endo -86.37 -19.89 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.356 2.704 . . . . 0.0 111.749 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -109.21 21.9 16.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.484 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -42.8 -46.51 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.168 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -88.05 3.76 47.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 57.94 12.49 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.851 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 173.21 -50.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -70.11 -144.03 0.22 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.088 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 5.4 mt-30 -137.2 124.93 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 0.0 110.993 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.25 132.12 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.7 t -109.2 163.79 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.42 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.567 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.6 t-20 -111.29 143.08 42.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.354 . . . . 0.0 111.299 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -151.97 154.87 33.19 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 14.5 Cg_endo -57.16 116.61 3.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.746 2.297 . . . . 0.0 111.858 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.45 42.87 57.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.916 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.6 OUTLIER 167.3 -178.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.763 0.316 . . . . 0.0 110.547 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.563 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 11.2 p90 -159.54 176.15 12.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.544 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.517 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -145.51 -172.35 3.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.529 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -147.91 158.73 44.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 0.0 111.38 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.88 74.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.152 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -46.06 -179.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLU . 9.8 t0 -106.62 -141.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.225 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -23.1 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -124.87 23.48 6.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.618 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 23.2 m-85 -75.42 131.04 39.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 111.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.543 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.6 pt-20 -109.86 130.17 55.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -33.96 114.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.038 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' HA3' ' ND2' ' A' ' 44' ' ' ASN . . . -75.59 55.25 2.92 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.491 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 4.0 p90 -56.97 -25.96 59.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.491 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 3.7 mtt -66.59 -19.05 65.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.105 0.479 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.463 ' C ' ' CG ' ' A' ' 42' ' ' MET . 1.8 mmm -119.36 -32.18 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.578 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.463 ' CG ' ' C ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 178.73 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.433 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 178.01 33.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.14 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.474 ' ND2' ' HA3' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -85.21 -157.97 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.669 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.1 m -107.43 116.5 32.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.061 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.475 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -136.15 95.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.633 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -10.91 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.703 0.801 . . . . 0.0 113.028 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.543 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.2 pt -70.37 -173.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.313 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.3 t0 -99.2 74.03 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 9.2 mp0 -48.28 -22.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 65' ' ' ASN . 34.3 m -76.72 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.697 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -117.65 -23.87 7.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.51 -28.46 67.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -128.38 137.97 32.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.117 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.11 -6.44 12.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.964 2.443 . . . . 0.0 112.043 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -111.78 -17.9 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.147 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -46.94 118.93 2.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.965 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 47.0 m 44.01 26.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.2 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.01 -31.93 19.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.836 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.9 25.47 6.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.095 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.15 -125.59 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.626 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 31.5 t -139.29 135.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 43.5 t -108.92 97.05 6.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.366 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 62.2 m80 -88.87 63.5 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.135 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.458 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.7 t-20 -45.71 122.42 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.514 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -120.01 -165.55 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.994 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 68' ' ' GLY . 9.0 mt-10 -73.65 140.38 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.16 36.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 169.95 -178.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.644 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 3.5 p90 -153.14 148.41 26.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.92 135.85 50.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.36 131.84 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.059 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.42 127.34 37.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.301 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.753 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.49 -31.92 0.89 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.099 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.753 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.6 Cg_exo -71.85 -169.3 6.03 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.641 1.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 75' ' ' PRO . 98.2 Cg_exo -43.22 178.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.904 2.403 . . . . 0.0 112.856 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.55 -18.26 50.53 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 7.5 t-160 -104.23 -127.95 0.24 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.53 59.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.013 0.435 . . . . 0.0 110.056 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -86.26 129.53 34.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.52 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.534 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.36 133.0 88.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.682 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.14 -48.4 19.71 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.675 2.25 . . . . 0.0 112.011 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -146.95 21.21 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.12 -23.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.768 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.584 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 75.57 91.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.928 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 150.61 103.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.97 148.21 48.25 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.226 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 t0 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.874 0.369 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.94 169.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.526 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 10.6 t0 -75.08 -49.14 20.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.073 0.463 . . . . 0.0 109.823 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.4 mp0 68.53 -52.91 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.757 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 47.5 t -63.74 -37.11 86.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.531 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -66.77 -25.8 66.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HB ' HD12 ' A' ' 14' ' ' LEU . 7.1 mm -39.92 -37.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.148 0.499 . . . . 0.0 110.397 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.85 151.68 8.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.696 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.74 -17.53 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.999 2.466 . . . . 0.0 111.49 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -113.69 21.92 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.988 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -38.25 -61.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.339 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 45' ' ' CYS . 1.6 m -73.26 -3.39 26.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.65 11.13 27.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 178.42 -50.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.87 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.44 -150.97 2.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.638 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -132.93 110.42 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.303 . . . . 0.0 110.963 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.6 p -52.54 131.27 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 28' ' ' GLU . 4.0 p -106.82 167.05 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.413 ' ND2' ' OE1' ' A' ' 7' ' ' GLU . 8.7 t-20 -112.94 140.71 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.367 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.462 HG22 ' CG ' ' A' ' 28' ' ' GLU . 1.9 p -147.29 148.62 32.3 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.109 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HA ' ' OD2' ' A' ' 4' ' ' ASP . 4.0 Cg_endo -46.88 116.38 1.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.021 2.481 . . . . 0.0 111.973 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.73 45.71 39.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.998 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 169.13 -167.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.583 0.23 . . . . 0.0 110.479 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 5.9 p90 -169.66 176.2 5.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 111.465 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -144.74 -145.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.456 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.48 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 1.1 m -163.12 154.43 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.414 . . . . 0.0 111.333 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -105.82 67.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.254 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -45.4 175.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.488 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -141.95 -39.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -122.14 14.44 8.92 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.016 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.541 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 3.1 m-30 -94.99 161.17 14.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.829 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -118.25 131.24 56.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.55 102.69 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.652 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.71 64.66 0.85 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.719 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' A' ' 40' ' ' MET . 4.2 t80 -83.56 -11.59 57.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.7 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.518 ' HG3' ' N ' ' A' ' 41' ' ' MET . 3.3 ptm 176.69 -31.79 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -83.0 -20.17 35.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.08 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 104.62 -21.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.058 0.849 . . . . 0.0 110.626 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 42' ' ' MET . 14.9 mmtm -171.38 100.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.518 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -158.98 33.72 0.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 15' ' ' CYS . 2.8 t 9.52 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.901 0.75 . . . . 0.0 112.406 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -150.59 110.32 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.1 p-10 -2.1 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.947 0.779 . . . . 0.0 112.576 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -50.55 174.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 51.9 t0 -93.7 75.47 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mp0 -51.64 -21.66 2.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.976 0.417 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.46 ' HA ' HD23 ' A' ' 57' ' ' LEU . 78.9 m -76.75 -9.67 58.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.618 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.79 -23.51 6.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -29.82 64.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -125.1 137.2 29.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.86 -8.13 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.014 2.476 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -119.17 -3.51 10.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -53.36 122.17 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.7 m 48.97 24.66 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.515 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -65.22 61.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.474 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 150.06 -16.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.881 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.22 -124.29 4.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.24 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.572 HG13 ' CE1' ' A' ' 64' ' ' HIS . 75.0 t -136.24 132.91 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.315 . . . . 0.0 110.957 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 25.0 t -104.79 94.58 5.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.572 ' CE1' HG13 ' A' ' 62' ' ' VAL . 42.3 m80 -89.96 59.91 4.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.2 t-20 -47.83 109.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.555 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -108.77 178.02 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.019 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER -71.95 121.82 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 68.12 32.91 77.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.2 t 158.06 178.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.637 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -146.92 142.95 28.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.469 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 3.3 mmm180 -109.42 116.64 32.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.683 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -94.87 128.0 41.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.579 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.0 tt0 -128.37 123.29 33.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.693 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.29 -32.24 0.94 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.998 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.693 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 29.5 Cg_exo -64.85 170.93 32.43 Favored 'Cis proline' 0 C--N 1.356 0.926 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.7 1.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 73.8 Cg_exo -35.37 -28.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.992 2.461 . . . . 0.0 113.029 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.37 -31.2 0.04 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.434 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.2 t-80 -91.85 -129.2 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.525 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -140.03 66.34 1.4 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.105 0.479 . . . . 0.0 109.726 179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.95 93.44 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.154 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 33.4 t -43.24 137.79 2.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.477 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 76.1 Cg_endo -79.17 111.94 2.97 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.931 2.421 . . . . 0.0 113.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.4 m120 72.62 -1.24 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.6 mp -81.63 -18.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.77 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.947 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.59 98.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.497 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -59.01 150.75 23.84 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.5 t0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 1.4 tp -89.77 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.529 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 34.0 t0 -86.76 101.14 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -81.11 -24.34 37.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.131 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.2 t -71.09 -41.92 70.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.745 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 1.4 ttt180 -57.44 -32.92 67.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.01 -38.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.473 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -165.22 146.76 6.32 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.687 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 -16.51 8.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.938 2.426 . . . . 0.0 111.799 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.88 16.92 21.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.486 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -44.81 -43.44 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.797 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 55.1 m -74.57 -14.13 60.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 66.61 6.3 34.84 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.137 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 1.9 tpt180 174.11 -29.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -94.65 -151.04 27.87 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.083 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.439 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 1.8 mm100 -127.09 115.34 19.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.289 . . . . 0.0 110.993 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.2 p -57.92 132.71 54.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.027 0.441 . . . . 0.0 111.676 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -116.6 164.25 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.241 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.6 t-20 -107.31 147.21 30.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.479 ' CG2' ' CD ' ' A' ' 28' ' ' GLU . 2.5 p -154.29 154.12 29.17 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.81 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.82 117.74 4.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 111.903 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.13 43.7 41.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER 167.42 -174.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.327 . . . . 0.0 110.482 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.564 ' CE2' HD23 ' A' ' 14' ' ' LEU . 18.9 p90 -157.21 165.94 34.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.025 0.44 . . . . 0.0 111.552 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.522 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -130.39 -171.2 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.006 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.522 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -145.83 168.8 19.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.872 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -128.06 65.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.104 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' LYS . 62.5 m -39.29 166.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.251 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 14.3 t0 -55.73 -96.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.387 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -138.31 0.92 2.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.812 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -173.01 22.94 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.422 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.0 m-30 -100.02 138.96 36.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.422 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.4 120.1 30.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.525 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.35 99.16 11.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.546 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.91 84.89 1.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.894 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 26.1 t80 -131.57 -46.1 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 41' ' ' MET . 1.9 mtp -106.76 5.52 28.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.15 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.7 OUTLIER 84.91 37.04 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' LYS . 4.5 mtp -145.36 15.38 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 37' ' ' SER . 0.8 OUTLIER 34.75 45.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.937 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -88.22 35.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.626 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 69.4 m 22.5 102.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.583 0.552 . . . . 0.0 111.962 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.55 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -126.31 100.41 6.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.044 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.56 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.5 p-10 11.86 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.929 0.768 . . . . 0.0 112.702 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -33.45 155.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.601 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 54.0 t0 -89.54 74.43 7.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.851 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 19.6 mp0 -49.62 -27.87 5.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.733 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -70.31 -9.26 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.48 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.8 mt-30 -121.78 -31.09 4.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 52' ' ' GLN . 11.8 ttt85 -36.61 -42.53 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.205 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.19 154.32 58.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.437 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.444 ' O ' HD21 ' A' ' 56' ' ' LEU . 74.5 Cg_endo -91.41 -2.06 4.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.454 2.769 . . . . 0.0 112.093 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -126.42 10.94 7.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.128 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -58.11 129.24 41.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.2 m 40.21 30.13 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.283 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -60.96 71.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 137.33 -6.1 3.59 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.39 -127.15 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 38.4 t -140.46 117.09 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.406 ' HB2' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.07 101.56 14.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 66.1 m80 -90.47 60.36 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.049 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' A' ' 50' ' ' GLU . 1.7 t-20 -43.68 112.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 64' ' ' HIS . 1.6 p -115.84 -161.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.051 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.35 140.08 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 56.31 19.7 26.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.768 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.4 t 156.32 -175.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.643 0.258 . . . . 0.0 110.724 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.8 p90 -142.19 159.31 42.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.946 0.403 . . . . 0.0 111.317 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.457 ' NE ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -115.54 112.25 21.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.075 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.5 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.86 131.73 35.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.265 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -132.33 121.0 22.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.807 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.697 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.62 -32.61 1.07 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.873 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.697 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 26.2 Cg_exo -65.32 171.4 33.19 Favored 'Cis proline' 0 C--N 1.356 0.96 0 C-N-CA 123.918 -1.284 . . . . 0.0 112.715 1.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.538 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 65.8 Cg_exo -33.65 -28.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.151 2.567 . . . . 0.0 113.264 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -35.0 -31.87 0.02 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.695 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -89.4 -125.42 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -144.69 60.56 1.33 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' ' SG ' ' A' ' 87' ' ' CYS . 0.3 OUTLIER -90.47 98.7 11.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.029 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.542 ' HB3' ' HB ' ' A' ' 84' ' ' ILE . 1.4 t -51.75 137.29 34.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.327 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 64.9 Cg_endo -75.07 115.49 4.29 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.917 2.411 . . . . 0.0 113.588 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 21.1 m120 72.89 24.13 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.169 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' A' ' 81' ' ' SER . 1.4 mp -102.06 -27.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.251 0.548 . . . . 0.0 109.858 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.556 ' CA ' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER 74.08 69.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.499 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 85' ' ' SER . . . 166.4 100.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.22 145.84 30.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.11 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.572 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.477 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.328 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.583 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -91.42 -164.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.583 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 12.2 t0 -87.01 -48.18 8.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.851 0.357 . . . . 0.0 111.286 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.6 mp0 72.99 -56.94 0.65 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 8.4 t -63.84 -14.56 54.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.567 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.461 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.2 -33.21 56.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HB ' HD13 ' A' ' 14' ' ' LEU . 12.4 mm -41.86 -37.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.73 163.71 9.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.36 -22.5 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.145 2.564 . . . . 0.0 111.809 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.75 15.94 27.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.621 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -45.79 -49.42 15.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.766 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -59.96 -13.11 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.74 -10.76 37.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.035 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 7.3 tpt180 177.35 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.98 -129.88 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.608 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LYS . 3.3 mt-30 -144.97 118.27 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 111.388 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -69.18 146.35 52.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.879 0.371 . . . . 0.0 110.982 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 43.9 t -128.67 152.79 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 7' ' ' GLU . 3.2 t-20 -77.75 153.36 33.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.971 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 27' ' ' PHE . 16.3 p -157.46 155.7 27.79 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.605 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.6 Cg_endo -51.46 110.37 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.746 2.297 . . . . 0.0 112.07 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.17 44.17 74.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.118 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.75 -160.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.766 0.317 . . . . 0.0 110.286 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.621 ' CZ ' ' CD2' ' A' ' 14' ' ' LEU . 6.5 p90 -165.08 145.0 6.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -104.77 -146.88 0.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.45 171.43 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.537 0.685 . . . . 0.0 112.793 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLN . 3.1 tmtm? -131.49 65.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.364 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 95.0 m -50.04 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.549 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -136.74 -151.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.263 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 32' ' ' ASP . 26.9 mm-40 -0.71 -86.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.949 0.781 . . . . 0.0 112.871 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.77 9.57 2.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 18.6 m-85 -69.9 106.88 3.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.638 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -89.58 136.02 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -28.54 113.98 0.08 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -38.03 -85.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 88.17 -24.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE ' ' A' ' 46' ' ' MET . 2.8 mtm -72.21 -24.44 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.435 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.5 mmm -124.66 -35.75 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.641 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 164.4 -51.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CE ' ' HB2' ' A' ' 37' ' ' SER . 5.9 mmtp 174.38 104.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -159.66 49.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.131 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 84.7 m 15.65 110.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.669 0.788 . . . . 0.0 112.937 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.516 ' CE ' ' SD ' ' A' ' 40' ' ' MET . 26.2 ptm -124.93 120.06 30.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.9 p30 -25.45 126.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.405 0.621 . . . . 0.0 111.707 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.531 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -54.68 -174.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.455 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 58.3 t0 -101.55 73.05 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.271 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 2.5 mp0 -49.07 -22.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.475 ' HA ' HD22 ' A' ' 57' ' ' LEU . 60.1 m -75.45 -13.22 60.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.676 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 1.8 mt-30 -111.46 -20.3 12.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -60.52 -30.04 69.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.982 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -123.62 138.28 30.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.51 -6.47 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 112.195 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -121.32 -4.27 9.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.535 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.89 119.98 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.839 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 65.0 m 46.71 25.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.519 . . . . 0.0 109.991 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' CB ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.1 -27.01 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.92 30.5 3.71 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.04 -126.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.572 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.62 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 42.7 t -135.68 135.48 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.9 t -109.33 96.94 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.949 0.404 . . . . 0.0 111.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.62 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 57.6 m80 -89.69 62.39 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.454 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.2 t-20 -47.07 118.61 2.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.518 HG23 ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -115.09 -170.15 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 10.1 mp0 -73.11 131.16 41.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 44.11 33.5 2.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.359 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 172.78 168.73 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.681 0.277 . . . . 0.0 110.772 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.0 p90 -144.72 145.97 31.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.518 ' CD ' HG23 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.0 137.19 48.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.522 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.93 127.73 56.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.061 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.531 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.2 tt0 -126.97 123.97 38.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.787 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.722 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.83 -31.34 0.72 Allowed Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.973 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.722 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 43.3 Cg_endo -67.05 174.22 31.08 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 123.828 -1.321 . . . . 0.0 112.827 1.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 71.5 Cg_exo -35.4 -28.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.006 2.471 . . . . 0.0 113.073 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.25 -30.63 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.469 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 3.3 t-160 -93.72 -130.44 0.13 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.71 65.46 1.43 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.522 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.8 101.43 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.192 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.533 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 32.9 t -50.43 137.48 22.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 85.1 Cg_endo -79.96 112.76 2.9 Favored 'Trans proline' 0 CA--C 1.526 0.121 0 C-N-CA 122.909 2.406 . . . . 0.0 113.59 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 23.4 m120 73.39 -3.21 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.265 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.5 mp -80.68 -25.09 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.156 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.23 87.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 153.78 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.877 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.494 ' HA ' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -60.7 150.95 30.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.197 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.266 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -108.18 153.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 32.0 t0 -61.31 84.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.036 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 27.3 mp0 -70.9 -11.92 61.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.1 t -83.22 -43.24 16.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -67.5 -23.62 65.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.738 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.465 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.6 mm -42.97 -39.7 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.36 140.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.16 -18.45 18.38 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 111.388 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -116.6 20.96 13.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.245 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.587 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -37.06 -61.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.307 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -80.27 7.67 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.381 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 78.99 -45.78 2.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.947 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -134.9 -46.74 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -59.25 -177.61 1.08 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.825 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.07 102.63 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.484 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 13.8 p -40.22 150.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.246 0.546 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 16.2 t -130.32 164.39 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.771 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 t-20 -114.31 138.93 49.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.418 . . . . 0.0 111.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 1.5 p -148.8 157.55 40.57 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.63 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 19.0 Cg_endo -59.17 121.0 9.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.598 2.199 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 46.81 44.19 17.43 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.625 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.68 -179.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.358 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CE2' HD22 ' A' ' 14' ' ' LEU . 21.4 p90 -164.04 -177.69 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 111.995 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.0 pt-20 -162.56 -147.52 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.851 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.484 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 13.6 p -170.4 -176.83 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.214 0.53 . . . . 0.0 111.59 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -121.76 73.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.727 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 66.7 m -40.61 167.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 16.4 t0 -60.24 -99.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.258 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -129.9 -32.08 1.89 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' CA ' ' HA2' ' A' ' 68' ' ' GLY . . . -134.84 14.82 4.37 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.507 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.1 m-85 -90.74 125.89 35.83 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.563 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.77 131.72 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.882 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.53 ' OG ' ' CE ' ' A' ' 43' ' ' LYS . 1.6 t -95.34 106.36 18.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.447 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.14 76.19 1.02 Allowed Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.227 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 70.7 t80 -109.1 -51.49 2.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.0 110.009 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -98.98 -3.32 35.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.578 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.8 OUTLIER 86.53 38.11 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.857 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtt -134.84 5.45 3.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.974 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CE ' ' OG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 51.93 96.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.451 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -157.2 44.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.242 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 44' ' ' ASN . 67.1 m 5.2 107.82 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.934 0.771 . . . . 0.0 112.133 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.57 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 24.0 ptm -130.59 111.69 12.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.521 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.4 p-10 -21.81 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.371 0.605 . . . . 0.0 111.987 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -46.91 -178.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.111 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 59.2 t0 -106.82 71.04 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.849 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 29.4 mp0 -48.86 -25.13 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.474 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 40.8 t -73.85 -8.76 57.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.681 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 3.9 mt-30 -118.06 -28.84 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -40.94 -42.2 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.001 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.4 152.14 77.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.473 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.518 ' HG2' ' CD1' ' A' ' 56' ' ' LEU . 96.5 Cg_endo -86.56 -6.6 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.285 2.657 . . . . 0.0 112.086 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.1 mp -104.45 -15.93 15.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.179 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.578 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -51.12 114.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.599 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 76.8 m 53.34 20.96 2.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.176 0.512 . . . . 0.0 109.994 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -36.95 -36.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.691 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.7 -8.55 9.81 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.028 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.14 -150.34 15.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.546 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 38.7 t -116.78 129.6 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.475 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.4 p -94.28 98.9 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.984 0.421 . . . . 0.0 111.081 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 66' ' ' THR . 0.5 OUTLIER -96.18 65.18 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.206 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.7 t-20 -47.12 116.47 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -103.45 -175.59 2.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 4.5 pt-20 -49.84 -102.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.441 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 34' ' ' GLY . . . -85.73 55.24 4.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.363 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 28.9 t 170.44 -161.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.578 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.7 p90 -167.15 146.05 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 3.4 mtp180 -110.38 159.06 17.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -135.65 136.54 41.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.066 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 18.0 tt0 -130.52 118.13 20.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.904 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.69 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -79.53 -33.7 0.84 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.839 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.69 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.03 171.25 37.18 Favored 'Cis proline' 0 C--N 1.354 0.85 0 C-N-CA 123.92 -1.283 . . . . 0.0 112.699 1.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 78' ' ' HIS . 61.7 Cg_exo -37.32 -29.74 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.932 2.421 . . . . 0.0 112.881 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -38.5 -30.38 0.09 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.218 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 6.1 t-160 -87.01 -127.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -142.01 63.55 1.41 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.38 129.01 36.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.288 -178.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.553 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -59.57 131.74 88.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.84 -49.24 18.26 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.846 2.364 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -149.76 33.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.462 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -102.01 -24.87 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.352 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.8 OUTLIER 82.73 84.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.803 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 158.63 102.68 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.531 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.68 152.29 35.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.21 178.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.306 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 t0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -89.9 167.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.5 t0 -69.89 -50.06 46.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 111.056 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.0 mp0 72.07 -55.89 0.66 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.444 ' HA ' HD13 ' A' ' 14' ' ' LEU . 97.9 m -64.62 -18.23 64.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.385 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -72.18 -33.52 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.465 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HB ' HD12 ' A' ' 14' ' ' LEU . 10.9 mm -40.84 -36.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -165.48 155.67 11.72 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.679 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -85.75 -19.31 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.3 2.666 . . . . 0.0 111.457 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.52 25.06 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -46.44 -40.06 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.863 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -78.74 4.34 14.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.177 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 34.69 29.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.101 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.615 ' NE ' ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER 153.63 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.834 0.35 . . . . 0.0 110.763 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 15' ' ' CYS . . . -86.18 -140.85 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.562 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.496 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.7 mt-30 -142.98 102.73 4.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 0.0 111.019 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.449 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 29.2 t -56.31 146.61 23.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 37.7 t -131.47 162.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.3 t-20 -97.13 150.33 20.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 27' ' ' PHE . 4.6 p -154.76 146.26 16.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.81 112.16 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.897 2.398 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.93 44.38 82.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.92 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.43 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.78 0.324 . . . . 0.0 110.639 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 7.7 p90 -164.83 144.99 7.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 29' ' ' CYS . 2.1 pp20? -117.65 -171.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.605 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.1 166.57 24.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 111.887 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.493 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -123.61 84.05 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.662 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 163.0 12.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.305 0.574 . . . . 0.0 112.386 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.63 -91.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -119.92 16.09 10.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.99 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.615 ' CE2' ' NE ' ' A' ' 17' ' ' ARG . 2.5 m-30 -103.01 166.92 10.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.524 ' CB ' HG21 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.62 139.86 53.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.502 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 83.0 p -87.88 94.7 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.034 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 86.48 71.01 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.43 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 33.0 t80 -67.53 -21.01 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.52 -27.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.4 OUTLIER -65.08 -36.16 83.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 179.1 -87.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.748 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.531 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -162.13 37.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.863 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -86.45 173.03 9.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.585 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' ' CB ' ' A' ' 35' ' ' TYR . 49.3 t -111.05 110.07 20.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.598 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 ppp? -145.5 119.99 9.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.54 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 2.2 p-10 -6.5 109.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.97 0.793 . . . . 0.0 112.375 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.524 HG21 ' CB ' ' A' ' 36' ' ' GLU . 1.1 pt -53.85 -177.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.406 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 54.7 t0 -99.58 74.03 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.552 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 3.6 mp0 -48.35 -26.0 1.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.474 ' HA ' HD23 ' A' ' 57' ' ' LEU . 63.4 m -73.51 -12.55 60.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 7.9 mt-30 -115.17 -23.52 8.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.481 ' NH1' ' CG ' ' A' ' 54' ' ' ASP . 1.1 ttt-85 -53.73 -31.51 48.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.024 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' CG ' ' NH1' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -132.19 142.58 45.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.4 -6.26 10.95 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.137 2.558 . . . . 0.0 111.908 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -112.4 -10.13 13.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.258 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.627 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -51.88 121.87 7.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.8 m 47.83 24.61 0.6 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -55.59 -18.19 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.699 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.74 22.91 5.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.69 -125.34 0.97 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.683 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' CG1' ' NE2' ' A' ' 64' ' ' HIS . 41.8 t -138.62 136.72 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.782 0.325 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.2 t -105.7 96.86 6.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.29 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.557 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 29.4 m80 -89.76 61.21 5.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -46.04 118.87 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.525 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 5.0 p -111.89 -162.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 118.08 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 71.92 24.11 77.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.446 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 166.0 178.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 0.0 110.614 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.9 p90 -142.6 147.18 35.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.525 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.54 112.25 24.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.464 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.76 138.18 31.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.843 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tt0 -143.13 122.11 12.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.704 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -79.86 -29.91 0.59 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.704 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 23.5 Cg_exo -67.3 178.09 20.18 Favored 'Cis proline' 0 C--N 1.358 1.04 0 C-N-CA 124.188 -1.171 . . . . 0.0 112.649 1.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.535 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 78.7 Cg_exo -36.45 -26.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.953 2.436 . . . . 0.0 113.087 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -34.58 -32.33 0.02 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.579 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 10.6 t-160 -90.06 -127.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 24.2 mt-30 -140.73 68.63 1.35 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.4 OUTLIER -90.0 125.55 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.181 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.538 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 1.1 p -59.67 134.08 89.18 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.831 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.89 -46.49 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -158.24 32.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.534 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.37 -12.81 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.62 85.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.046 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 150.45 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.276 0.36 . . . . 0.0 111.633 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 t -69.33 158.24 35.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.922 0.392 . . . . 0.0 111.007 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.576 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.9 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.4 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.819 0.343 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.96 -176.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.749 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 t0 -92.26 107.81 19.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.972 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 17.9 mp0 -91.28 -22.81 20.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.086 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 41.5 t -78.88 -31.2 45.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.4 ttt85 -64.02 -30.26 71.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.274 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.468 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.6 mm -40.87 -37.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.469 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.1 t -164.79 155.78 12.95 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.968 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.4 Cg_endo -84.33 -21.69 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 0.0 111.477 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -114.41 27.19 9.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.003 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.47 -59.59 0.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.342 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.0 m -88.95 27.43 1.35 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.641 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 43.91 22.23 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.908 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 166.04 -59.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.134 0.467 . . . . 0.0 110.993 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' SG ' ' A' ' 45' ' ' CYS . . . -54.28 -163.69 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.683 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 mm-40 -125.74 109.69 12.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.773 0.321 . . . . 0.0 110.96 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -63.09 125.87 25.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.49 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.4 t -109.05 164.1 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.133 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.559 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.4 t-20 -102.68 148.53 25.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 26' ' ' ASP . 2.5 p -155.42 156.45 30.93 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.862 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 12.4 Cg_endo -56.26 117.93 4.66 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.74 2.293 . . . . 0.0 111.904 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . 49.28 44.41 34.83 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.859 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 166.55 -178.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.741 0.305 . . . . 0.0 110.459 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 7.1 p90 -155.25 155.08 33.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.522 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 pt-20 -123.32 -167.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.03 -177.38 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 112.193 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 1.1 tmtm? -141.74 79.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.567 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 21.8 m -60.15 -179.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.775 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.3 t70 -90.66 -151.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.415 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.3 mt-10 -33.13 -74.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.732 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -135.4 40.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.057 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 3.0 m-30 -88.43 133.72 34.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.58 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.58 121.89 32.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.305 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.521 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.57 98.2 11.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 110.48 76.14 0.85 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.797 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 65.3 t80 -111.94 -76.69 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.564 ' HB3' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -123.16 -12.84 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.193 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 42' ' ' MET . 13.5 mmm -90.89 -22.57 20.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.697 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.7 mmt 123.27 -43.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.402 1.064 . . . . 0.0 110.911 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -158.72 20.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.585 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -67.26 149.86 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.5 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 15.9 m -95.64 102.21 13.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.458 . . . . 0.0 110.34 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 25.5 ptm -127.83 116.59 20.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.087 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -21.36 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.929 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.58 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -46.52 -177.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.441 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.8 t0 -96.8 72.42 2.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.714 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 70' ' ' TYR . 1.6 mp0 -50.86 -22.19 2.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.476 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.4 t -76.01 -8.95 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.705 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.416 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 3.4 mt-30 -119.12 -24.12 6.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -23.74 9.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.52 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 2.1 m-20 -124.99 139.45 33.62 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.041 0.448 . . . . 0.0 111.166 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.79 -9.38 15.74 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.029 2.486 . . . . 0.0 112.279 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -119.13 -6.62 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.53 112.58 0.67 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.582 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 39.6 m 52.69 22.16 2.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.0 109.864 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -38.49 -38.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.51 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.62 24.06 6.2 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.806 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -136.27 -130.88 2.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.531 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 73' ' ' GLU . 70.0 t -137.82 128.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.777 0.322 . . . . 0.0 111.001 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.466 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -98.15 95.02 7.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.57 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 41.0 m80 -88.53 60.45 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 8.3 t-20 -45.93 112.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.514 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.35 -161.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.66 127.03 34.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 56.81 29.86 59.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 168.2 -172.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' CE2' HD21 ' A' ' 57' ' ' LEU . 9.6 p90 -156.97 147.56 21.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.71 116.48 31.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.322 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.5 t -98.42 134.91 40.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.305 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.3 tt0 -150.19 126.2 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.518 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.711 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -49.65 -45.91 79.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.456 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.711 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 3.3 Cg_exo -75.56 -60.21 0.09 OUTLIER 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.669 -1.388 . . . . 0.0 113.193 1.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.672 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.9 Cg_endo -84.39 -155.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.87 2.38 . . . . 0.0 113.155 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.0 37.44 9.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.874 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.516 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 161.0 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.235 0.54 . . . . 0.0 111.255 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -139.22 78.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.105 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -56.98 107.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.463 0.649 . . . . 0.0 111.784 -178.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.52 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 55.4 p -52.03 124.62 29.72 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.526 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -76.42 111.75 3.32 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.796 2.331 . . . . 0.0 113.221 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 23.4 m120 73.66 13.68 4.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.336 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' SER . 3.8 mp -101.24 -44.92 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 5.7 p 91.75 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 154.18 102.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -50.27 130.27 22.73 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.864 0.364 . . . . 0.0 110.901 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.516 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 1.1 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.175 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.3 t0 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.87 -165.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 9.4 t0 -87.56 -50.1 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 111.103 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.5 mp0 73.11 -55.49 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 20' ' ' CYS . 91.1 m -63.22 -24.31 67.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.95 -32.58 69.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.463 ' HB ' HD13 ' A' ' 14' ' ' LEU . 11.4 mm -44.04 -39.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 110.281 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.0 t -163.17 153.28 13.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.712 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_endo -85.54 -19.42 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.169 2.58 . . . . 0.0 111.093 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -112.2 26.89 10.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.994 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.585 ' CD2' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.69 -47.73 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -83.2 11.02 7.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.402 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 60.89 9.95 16.73 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.159 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 162.15 -37.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -68.47 -153.49 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.805 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.05 101.59 5.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.1 t -57.15 150.16 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 28' ' ' GLU . 7.1 p -132.06 154.0 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 21' ' ' VAL . 6.4 t-20 -91.55 142.34 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.229 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 27' ' ' PHE . 13.4 p -147.89 151.09 37.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.51 103.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.853 2.368 . . . . 0.0 111.992 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.12 98.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.117 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.2 OUTLIER 178.8 -166.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CE2' ' CD2' ' A' ' 14' ' ' LEU . 4.7 p90 -172.45 139.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.671 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' HG3' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -105.97 -147.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.684 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.2 m -170.08 159.49 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -122.6 71.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.473 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.9 OUTLIER -49.59 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.06 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -125.96 -156.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.109 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER 8.32 -75.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.009 0.818 . . . . 0.0 112.636 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -157.72 29.61 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.136 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 22.9 m-85 -79.24 151.15 31.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 2.1 pt-20 -112.02 128.16 56.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -83.42 92.78 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 114.32 56.86 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 58.4 t80 -77.12 -24.83 51.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.845 0.355 . . . . 0.0 110.787 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.14 -25.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.465 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 42.0 mmm -72.68 -33.36 66.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.421 ' HG2' ' C ' ' A' ' 41' ' ' MET . 1.8 ptm 166.0 -63.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 12.9 tptt -177.01 29.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.451 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -76.91 179.51 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.44 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.572 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.4 m -92.16 106.58 18.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 mmt -124.0 101.01 7.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.045 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.3 p-10 -21.83 101.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.984 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -48.42 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.094 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 56.3 t0 -94.69 71.7 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.564 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 1.3 mp0 -48.3 -24.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.27 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 18.1 t -76.92 -8.97 58.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.0 mt-30 -116.38 -21.29 9.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 54' ' ' ASP . 7.8 ttt-85 -58.75 -33.25 70.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -115.89 140.58 26.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.091 0.472 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 90.3 Cg_endo -80.83 -5.03 13.02 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.085 2.523 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -128.37 1.22 5.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.56 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.6 HD23 ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.41 115.56 1.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.123 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.516 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER 49.22 21.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.643 -179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.29 87.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.2 -24.4 0.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.098 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -129.15 -98.16 0.87 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.944 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.591 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 19.2 t -150.32 125.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 111.572 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -89.55 99.27 12.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.591 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 71.2 m80 -89.62 59.79 4.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 1.4 t-20 -46.0 117.98 1.71 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.4 p -117.69 -171.05 1.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.089 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.6 pt-20 -73.25 143.2 47.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.9 32.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.612 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER 164.69 174.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.61 0.243 . . . . 0.0 110.43 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.6 ' CD2' HD23 ' A' ' 57' ' ' LEU . 8.7 p90 -146.8 166.44 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.142 0.496 . . . . 0.0 111.783 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HD3' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -122.54 108.15 12.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 19.0 m -89.59 116.33 27.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.152 0.501 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.547 ' CD ' ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -100.75 141.7 33.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.495 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.756 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -78.05 -35.63 1.24 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.026 -178.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.756 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 9.6 Cg_exo -73.74 -168.54 6.18 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.454 0.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 65.0 Cg_exo -40.57 172.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 113.04 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.92 86.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.154 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.592 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -139.74 -136.86 0.12 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.08 84.5 1.39 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.275 0.489 . . . . 0.0 111.254 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.04 123.82 34.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.085 0.469 . . . . 0.0 111.677 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.55 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -49.95 122.22 13.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.264 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 73.2 Cg_exo -37.32 -44.98 1.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.869 2.38 . . . . 0.0 112.713 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 82' ' ' PRO . 32.2 m120 -163.24 24.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -86.91 -27.34 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.427 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 4.9 p 87.15 87.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.347 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 153.48 84.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 9.6 t -38.34 152.9 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.592 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 24' ' ' PRO . 2.8 t70 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 tp -89.75 159.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.525 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 59.5 t0 -75.21 90.04 2.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 0.0 111.041 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.1 mp0 -74.08 -21.86 59.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.054 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -46.74 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.511 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.525 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 1.2 mmt-85 -50.63 -31.95 17.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 15.0 mm -53.31 -55.08 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.504 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 14' ' ' LEU . 1.4 t -143.06 121.95 7.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.84 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.7 -19.56 47.47 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.756 2.304 . . . . 0.0 110.753 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -118.88 25.57 10.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.717 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.652 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.53 -44.43 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.862 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -84.37 15.69 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.459 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.55 5.83 7.39 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.811 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 174.39 -60.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.758 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 31' ' ' CYS . . . -48.71 164.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.749 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.93 84.53 5.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.81 0.338 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -44.46 148.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.161 0.505 . . . . 0.0 111.165 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 39.3 t -135.52 163.45 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.425 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.545 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -91.41 146.25 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.025 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 3.6 p -151.56 156.02 34.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.5 Cg_endo -55.24 107.53 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.239 . . . . 0.0 111.888 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.34 41.79 95.26 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.017 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 173.75 -167.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.652 ' CZ ' ' CD2' ' A' ' 14' ' ' LEU . 2.5 p90 -164.85 145.27 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 5.9 pt-20 -117.21 -167.41 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 2.9 p -167.52 154.4 8.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.192 0.52 . . . . 0.0 111.718 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -101.58 76.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.266 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.52 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . 60.0 m -41.23 169.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.849 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -91.78 -151.23 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.318 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' ASP . 67.1 mm-40 -33.12 -95.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -114.96 36.48 3.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.588 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.8 m-85 -89.8 121.59 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.754 0.311 . . . . 0.0 110.429 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.581 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -94.81 128.1 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 7.7 p -84.07 95.05 8.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.59 34.72 0.68 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 2.3 t80 -55.87 -17.36 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.316 . . . . 0.0 110.913 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.65 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.987 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' MET . 29.2 mmm -75.9 -29.68 58.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.593 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.3 mmt 131.69 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.281 0.988 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 7.8 tptt 177.98 104.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 0.0 111.281 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -166.97 50.52 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.966 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 15' ' ' CYS . 74.6 m 5.93 100.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.154 0.909 . . . . 0.0 112.235 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.484 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.8 mmt -125.95 113.67 17.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.827 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 46' ' ' MET . 9.9 p-10 -20.89 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 O-C-N 123.667 0.604 . . . . 0.0 112.04 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -42.13 176.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.544 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 45.4 t0 -92.97 76.18 4.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.75 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 32.2 mp0 -48.8 -25.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.865 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 45.2 t -74.69 -8.8 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.71 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -117.98 -26.37 6.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.637 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -30.23 61.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB2' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.24 138.05 25.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.98 -4.7 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.99 2.46 . . . . 0.0 112.05 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -119.49 -11.54 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.516 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.49 113.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 75.4 m 51.84 21.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 110.247 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.44 -28.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.649 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.24 -7.83 6.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.101 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.15 -152.43 11.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 64' ' ' HIS . 47.4 t -112.74 129.87 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.325 . . . . 0.0 111.067 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 7.3 p -95.41 101.59 13.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.562 ' CD2' HG11 ' A' ' 62' ' ' VAL . 28.3 m80 -90.19 62.26 5.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 7.9 t-20 -44.53 109.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -108.51 -178.61 3.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.97 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.3 129.32 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 41.15 29.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -167.72 -169.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.574 ' CE1' HD21 ' A' ' 57' ' ' LEU . 1.6 p90 -171.47 139.76 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.766 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.465 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 1.3 mtp180 -109.83 158.98 17.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.235 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -131.92 143.93 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.258 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 21.6 tt0 -139.79 118.13 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 111.799 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.704 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.93 -32.8 0.93 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.869 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.704 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.35 172.38 34.6 Favored 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.594 1.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.517 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 49.9 Cg_exo -35.36 -27.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.055 2.503 . . . . 0.0 113.162 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.66 -31.08 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.45 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.569 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -89.65 -126.47 0.07 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.19 58.08 1.4 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -81.99 109.04 15.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.624 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.548 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -43.8 133.63 3.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.44 -68.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.54 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -127.35 29.54 5.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.689 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -96.28 -14.76 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.801 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.563 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.7 87.74 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.966 178.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 154.36 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.78 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.511 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.569 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.457 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 57.2 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.0 OUTLIER -118.33 164.69 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 47.8 t0 -81.23 109.19 15.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.539 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 14.1 mp0 -92.47 -23.85 19.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.941 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -70.87 -45.64 64.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.566 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.463 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.1 ttt180 -51.9 -35.3 44.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 10.7 mm -41.51 -39.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.338 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.77 150.03 11.11 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.678 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 -16.64 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.135 2.556 . . . . 0.0 111.541 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -108.62 20.21 18.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.328 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.65 -50.58 4.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.206 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -63.86 -10.07 18.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.7 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 62.74 6.93 13.18 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.883 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.638 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 13.9 tpt180 172.58 -44.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.876 0.369 . . . . 0.0 110.706 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.68 -139.05 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.622 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.1 mt-30 -136.69 111.39 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 110.995 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -68.82 155.36 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 36.8 t -140.76 161.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.736 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.3 t-20 -90.63 155.93 18.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.508 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 27' ' ' PHE . 11.9 p -156.87 155.73 28.8 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.833 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.0 Cg_endo -54.61 110.26 0.5 Allowed 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.71 2.274 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.01 41.92 94.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.96 -162.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.536 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 14' ' ' LEU . 6.3 p90 -163.58 141.44 7.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.029 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -101.61 -150.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -165.86 177.43 7.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.148 0.499 . . . . 0.0 111.78 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' CD ' ' A' ' 30' ' ' LYS . 5.6 tmtm? -145.43 76.24 1.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.192 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 5.8 m -44.83 177.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.694 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.87 -73.44 0.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.313 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.95 -74.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.148 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 48' ' ' ILE . . . -101.09 -0.61 54.65 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.158 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.9 m-85 -71.05 118.15 13.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 tp10 -89.96 141.02 29.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.416 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 37' ' ' SER . 13.0 p -45.49 81.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.154 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' HA3' ' N ' ' A' ' 43' ' ' LYS . . . 82.14 -12.09 45.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.169 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 40' ' ' MET . 0.0 OUTLIER 72.17 4.1 4.9 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.579 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 107.97 -22.41 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.758 0.823 . . . . 0.0 110.97 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 42' ' ' MET . 3.1 ptm -66.63 -32.98 74.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 41' ' ' MET . 21.5 mmt -162.31 -75.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 110.467 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 12.2 tptt 179.97 -24.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.04 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.56 ' ND2' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -46.0 90.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' CYS . 25.2 m -36.15 103.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.393 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.532 ' HA ' ' CD2' ' A' ' 35' ' ' TYR . 3.2 ptp -132.14 135.55 46.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 p-10 -22.39 118.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.34 0.591 . . . . 0.0 111.95 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 36' ' ' GLU . 8.1 pt -58.47 -170.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.475 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 57.4 t0 -97.76 71.98 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.453 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.2 mp0 -50.72 -21.51 1.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.462 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 9.1 t -77.39 -10.03 59.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.441 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.2 mt-30 -117.65 -22.39 8.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HD3' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.45 -24.03 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.095 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.457 ' OD1' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -126.57 138.02 31.59 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.965 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.94 -7.88 13.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.942 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -115.65 -7.94 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.597 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.562 HD23 ' CE1' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -52.07 114.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.7 m 52.53 22.29 2.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.223 0.535 . . . . 0.0 109.955 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 3.4 ttt180 -40.25 -30.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.56 22.22 4.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.021 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -138.76 -131.11 2.83 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.466 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.572 ' CG1' ' NE2' ' A' ' 64' ' ' HIS . 39.4 t -135.37 129.7 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.763 0.316 . . . . 0.0 110.733 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.457 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.8 p -97.99 95.88 7.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.572 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 38.6 m80 -88.98 60.41 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.679 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.9 t-20 -43.0 117.03 0.98 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.265 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.535 HG22 ' CD ' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -117.58 -179.65 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' N ' ' OG1' ' A' ' 66' ' ' THR . 10.5 pt-20 -64.65 135.4 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.02 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 37.12 31.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.594 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER 172.9 158.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' A' ' 50' ' ' GLU . 4.1 p90 -136.49 147.38 47.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.194 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.535 ' CD ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.18 119.23 38.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.326 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.532 ' CB ' HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -92.07 142.51 27.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.866 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -133.55 122.46 23.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.743 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.99 -34.49 2.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.98 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.743 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.2 Cg_exo -71.96 -174.07 11.15 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.61 1.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 78.5 Cg_exo -39.94 173.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.028 2.485 . . . . 0.0 113.011 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.37 56.54 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -101.12 -126.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.961 179.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 35.2 tt0 -151.3 64.64 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.383 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 72' ' ' CYS . 0.6 OUTLIER -90.9 109.97 21.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.848 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.7 t -58.44 136.79 85.61 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 4.9 Cg_exo -74.15 109.94 2.99 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 113.809 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 22.0 m120 71.1 -1.18 2.8 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.553 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -77.42 -35.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.239 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 3.9 p 85.03 84.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.373 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 151.34 96.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.52 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -55.56 160.89 2.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.282 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.8 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.218 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 24' ' ' PRO . 37.4 t70 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 1.6 tp -89.85 165.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 14.2 t0 -77.29 92.06 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.063 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 31.8 mp0 -73.93 -17.33 61.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 55.6 m -83.77 -27.58 28.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.14 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -46.11 -44.07 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.295 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -156.2 146.46 15.88 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.586 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.48 -15.92 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.998 2.465 . . . . 0.0 111.626 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.35 19.0 18.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.397 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.19 -49.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 18' ' ' GLY . 8.0 t -89.51 36.84 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.654 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . -14.37 80.38 0.0 OUTLIER Glycine 0 C--N 1.335 0.485 0 O-C-N 123.978 0.799 . . . . 0.0 113.771 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.619 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 116.53 13.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . -148.14 -149.65 5.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.11 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -133.72 106.75 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 37.5 t -56.07 155.59 6.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 20.5 t -136.26 164.91 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.597 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.578 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 9.2 t-20 -115.96 141.78 47.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.211 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 27' ' ' PHE . 9.5 p -146.25 155.46 50.37 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 32.2 Cg_endo -64.06 112.35 1.83 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . 70.52 31.76 68.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER 165.31 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.696 0.284 . . . . 0.0 110.472 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -164.43 -176.01 4.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.215 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' A' ' 27' ' ' PHE . 8.3 pt-20 -167.88 -155.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.284 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 6.2 p -168.15 179.15 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 111.969 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -117.32 80.35 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.607 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -54.67 163.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.081 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 -88.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.088 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -122.61 -80.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.29 -3.92 64.78 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.356 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.53 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 14.5 m-85 -68.63 123.82 21.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.958 0.408 . . . . 0.0 110.218 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -93.59 136.75 33.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.046 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.466 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -92.54 96.83 10.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.944 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 100.67 44.75 2.06 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' MET . 5.8 t80 -40.03 -30.25 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.074 0.464 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.47 -38.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.548 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.517 ' N ' ' HE2' ' A' ' 40' ' ' MET . 4.5 ptm -57.64 -47.99 80.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.818 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 41' ' ' MET . 46.9 mmm -163.09 -94.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -168.47 96.92 0.4 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.474 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -165.21 134.25 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.184 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -42.72 121.91 2.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.355 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -149.77 86.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.53 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 7.9 p-10 -15.77 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.744 0.653 . . . . 0.0 112.142 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -45.04 179.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.451 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 61.0 t0 -95.88 73.63 3.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.9 mp0 -50.07 -24.35 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.995 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 7.3 t -75.83 -9.43 58.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.721 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.441 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -119.34 -23.33 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -52.86 -34.8 56.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 139.02 28.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.07 0.462 . . . . 0.0 111.019 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.08 -7.91 13.08 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.036 2.49 . . . . 0.0 111.931 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -108.81 -14.24 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.117 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.534 ' CG ' ' HB3' ' A' ' 85' ' ' SER . 0.3 OUTLIER -50.52 120.35 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.666 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.4 m 47.64 24.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.425 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.14 -21.46 3.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.216 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.51 13.02 5.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.049 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.41 -132.46 3.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.628 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 64' ' ' HIS . 34.0 t -133.16 127.53 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 111.089 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.9 p -94.1 106.74 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.033 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.564 ' CE1' HG11 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.45 67.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.519 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.537 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -48.03 110.24 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.517 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -104.93 -170.97 1.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.018 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.62 126.79 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.1 28.54 1.94 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -169.74 -168.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.898 0.38 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.538 ' CD2' ' HB3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -167.68 140.55 3.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.517 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.6 OUTLIER -110.98 156.07 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.53 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.54 137.32 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 31.5 tt0 -138.59 116.48 11.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.803 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.723 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -80.67 -30.18 0.56 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.723 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 21.9 Cg_exo -67.95 176.79 25.78 Favored 'Cis proline' 0 C--N 1.357 0.978 0 C-N-CA 123.988 -1.255 . . . . 0.0 112.767 1.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 78' ' ' HIS . 76.9 Cg_exo -39.86 -24.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.908 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -35.58 -31.81 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.337 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -83.39 -121.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.503 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 39.5 tt0 -148.73 65.6 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -90.46 111.51 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.9 -178.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.0 t -62.07 137.1 95.55 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.719 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 63.6 Cg_endo -76.57 108.88 2.75 Favored 'Trans proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.052 2.501 . . . . 0.0 114.063 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 20.4 m120 72.51 14.25 5.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.259 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.55 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 2.0 mp -95.75 -19.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 110.201 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.57 86.0 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.11 178.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 147.64 98.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.487 0.492 . . . . 0.0 111.428 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.9 t -63.77 161.7 14.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.591 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.186 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.4 t0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.945 0.402 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.475 HD11 ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -95.06 153.38 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.367 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 41.1 t0 -69.58 90.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -73.85 -20.52 60.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.68 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.0 t -79.31 -36.26 39.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.491 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.0 ttt85 -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 14' ' ' LEU . 13.3 mm -52.24 -46.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.91 154.14 14.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -87.2 -18.84 2.61 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.29 2.66 . . . . 0.0 111.722 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -108.12 21.35 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.378 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.06 -51.66 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.981 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 45' ' ' CYS . 12.4 m -95.13 17.26 14.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 67.93 3.34 28.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.969 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 175.09 -52.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.988 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 30' ' ' LYS . . . -48.11 176.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.804 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 10.7 mt-30 -105.96 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.809 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 2.9 p -52.27 134.91 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 111.558 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -118.38 164.05 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.21 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.3 t-20 -106.34 142.96 35.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 111.644 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 1.6 p -149.87 157.06 38.36 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 15.9 Cg_endo -57.61 111.84 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.256 . . . . 0.0 111.849 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.55 44.28 67.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.695 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 171.11 -175.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.738 0.304 . . . . 0.0 110.516 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.56 ' CE2' HD23 ' A' ' 14' ' ' LEU . 28.0 p90 -160.23 167.38 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.254 0.549 . . . . 0.0 111.716 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.7 pt-20 -143.51 -165.18 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.583 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.8 p -170.7 168.09 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -114.17 82.19 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.16 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -39.03 165.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.514 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 2.7 t70 -77.15 -144.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.17 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.8 mt-10 -28.15 -93.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.859 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -123.51 32.67 4.21 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.22 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 21.2 m-85 -81.6 143.8 31.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.001 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -117.49 132.96 56.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.64 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -42.31 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.353 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -47.25 -76.64 0.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 87.39 -22.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.663 0.268 . . . . 0.0 111.04 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 mtm -59.5 -32.08 69.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.21 0.529 . . . . 0.0 109.884 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.0 mmm -117.42 -23.23 7.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.516 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 179.31 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.224 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' MET . 1.2 tptt 173.31 34.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.994 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -62.44 -177.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.779 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -100.39 105.84 17.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.207 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.544 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 2.2 ptp -123.83 99.87 6.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.302 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -9.14 125.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.846 0.716 . . . . 0.0 112.732 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -64.94 -174.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.256 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -100.44 73.54 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.301 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.561 ' HG2' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp0 -50.09 -21.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 51.1 m -77.7 -9.83 59.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.45 -22.27 8.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.637 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 33.9 ttt-85 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.105 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.494 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -100.97 156.12 35.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.027 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.448 ' O ' HD23 ' A' ' 56' ' ' LEU . 20.8 Cg_endo -90.2 -2.61 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.344 2.696 . . . . 0.0 112.364 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -132.06 14.57 4.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.404 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.546 ' HA ' ' CA ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -62.81 129.16 39.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.7 m 45.93 25.89 0.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.351 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -62.31 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.239 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 129.6 0.46 5.73 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.806 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -122.55 -139.06 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.562 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.578 ' CG1' ' NE2' ' A' ' 64' ' ' HIS . 55.8 t -127.58 117.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 6.3 t -84.1 94.33 8.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 47.8 m80 -89.43 53.73 2.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 17.6 t-20 -49.66 111.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.718 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.52 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -112.7 -161.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.316 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.4 pt-20 -75.53 138.93 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 34.59 46.6 0.58 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.721 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.1 t 157.61 -176.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.561 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 1.8 p90 -154.81 156.13 35.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -122.92 117.19 24.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.01 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.54 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -100.07 135.37 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 62' ' ' VAL . 3.4 tt0 -150.22 120.59 7.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.112 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.691 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -45.68 -47.53 38.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.691 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.4 Cg_exo -76.3 -60.41 0.08 OUTLIER 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.771 -1.345 . . . . 0.0 113.264 0.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.676 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.7 Cg_endo -83.38 -154.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.823 2.349 . . . . 0.0 113.111 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 78' ' ' HIS . . . 45.88 39.36 8.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.917 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.564 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.51 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.0 111.041 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -141.78 73.03 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.54 ' CG ' ' HB3' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -63.83 91.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.211 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.557 ' HB3' ' CG1' ' A' ' 84' ' ' ILE . 0.3 OUTLIER -46.68 130.7 8.38 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 59.2 Cg_endo -74.51 112.58 3.59 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.965 2.444 . . . . 0.0 113.253 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 70' ' ' TYR . 22.9 m120 75.97 34.26 0.55 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.985 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -115.0 -39.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.111 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 4.7 p 88.74 69.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.041 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.03 116.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -62.46 128.49 36.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.564 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.0 t0 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.457 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 1.6 tp -89.86 173.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.516 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 51.5 t0 -84.49 97.81 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.931 0.396 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.8 mp0 -76.75 -25.93 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 11' ' ' SER . 92.3 m -69.51 -45.43 68.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.353 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -50.5 -35.58 29.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.034 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 11.1 mm -42.37 -40.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -161.94 147.88 10.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.578 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.8 Cg_endo -85.24 -17.05 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.038 2.492 . . . . 0.0 111.256 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -112.13 23.76 13.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.059 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.572 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -38.96 -54.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.421 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -77.39 -10.84 59.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.067 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.31 -1.82 48.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.775 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.568 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 6.8 tpt180 -173.57 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.971 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -71.72 -151.61 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.628 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -133.74 99.3 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.7 t -50.77 153.52 1.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.188 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 31.6 t -136.86 161.72 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.724 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 3.7 t-20 -95.69 143.65 26.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -149.18 155.82 39.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.9 Cg_endo -55.59 105.88 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.717 2.278 . . . . 0.0 111.952 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.43 41.51 97.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.906 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 175.57 -168.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.697 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.572 ' CE2' HD23 ' A' ' 14' ' ' LEU . 13.6 p90 -165.82 148.12 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.534 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.0 pt-20 -118.46 -170.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.434 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -147.34 155.78 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 111.531 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -113.36 71.66 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.967 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -50.74 -175.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.856 -178.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.62 -158.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.049 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 32' ' ' ASP . 3.9 mm-40 19.88 -82.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.181 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ASP . . . -152.62 22.45 0.82 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.61 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 28.3 m-85 -79.79 134.38 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.52 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 4.6 pt-20 -99.66 134.83 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.52 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -86.49 88.2 7.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.528 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 125.58 79.87 0.37 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.273 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 22.0 t80 -122.18 -3.07 9.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.72 0.295 . . . . 0.0 111.238 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 159.7 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.091 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -89.88 -24.34 21.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.6 OUTLIER 124.26 -19.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.256 0.972 . . . . 0.0 109.988 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.528 ' HA ' ' N ' ' A' ' 38' ' ' GLY . 1.7 tptt -164.8 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.912 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 21.94 102.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.885 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 1.3 m -39.21 95.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.18 0.514 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -119.74 91.88 3.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.147 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.5 p30 -5.51 123.24 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.087 0.867 . . . . 0.0 112.958 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -63.2 -171.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.606 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 54.3 t0 -94.83 72.82 3.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.814 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.547 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.4 mp0 -51.01 -21.59 1.86 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.458 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.2 t -78.28 -9.01 59.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.748 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.4 mt-30 -116.74 -22.22 8.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.713 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -59.95 -32.71 71.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.138 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -116.15 137.48 23.47 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.037 0.446 . . . . 0.0 110.979 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.77 -4.16 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.193 2.595 . . . . 0.0 112.147 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -118.88 -9.43 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.285 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD1' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.96 114.15 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.575 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 35.5 m 50.78 23.54 1.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.271 0.557 . . . . 0.0 109.959 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -39.42 -31.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.689 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.38 21.65 5.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -137.99 -129.76 2.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.573 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' GLU . 28.3 t -136.19 129.67 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 24.6 p -97.4 96.33 8.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.506 ' NE2' HG11 ' A' ' 62' ' ' VAL . 52.0 m80 -88.67 59.85 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.731 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 3.7 t-20 -44.1 119.48 1.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.871 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 64' ' ' HIS . 1.4 p -119.43 -162.07 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 69' ' ' SER . 2.7 mt-10 -77.47 142.61 39.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 69' ' ' SER . . . 33.98 34.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.753 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 65.1 p 172.89 -169.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.628 ' CZ ' ' CD1' ' A' ' 57' ' ' LEU . 1.5 p90 -162.1 147.92 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HG2' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.93 146.39 35.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.963 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -119.19 138.7 52.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.931 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -131.77 123.45 27.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.744 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.72 -34.1 1.71 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.989 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.744 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 15.1 Cg_exo -70.99 -176.06 13.65 Favored 'Cis proline' 0 C--N 1.356 0.945 0 C-N-CA 124.154 -1.186 . . . . 0.0 112.616 0.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.8 Cg_exo -39.29 172.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.015 2.476 . . . . 0.0 112.928 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.77 48.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.7 t-160 -99.48 -126.12 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.751 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -151.67 64.52 0.86 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.122 0.486 . . . . 0.0 110.011 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.524 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.94 107.52 19.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.247 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 31.3 t -55.3 136.77 68.76 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -77.52 110.49 2.98 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.904 2.403 . . . . 0.0 113.845 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.3 m120 71.83 -0.61 3.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.344 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.541 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -79.33 -35.12 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.251 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 4.4 p 85.98 81.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.181 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 155.02 101.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' HD13 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.4 148.95 30.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.319 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.295 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.434 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 28.7 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -120.69 161.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 23.9 t0 -42.39 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.618 ' HB3' ' CG ' ' A' ' 27' ' ' PHE . 1.5 mt-10 95.37 -52.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.121 0.569 . . . . 0.0 110.805 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 5.5 t -66.68 -36.01 81.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.497 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -76.89 -26.24 53.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.77 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ARG . 9.2 mm -38.18 -36.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.74 154.02 8.67 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -89.7 -18.58 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 111.471 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -104.97 17.5 24.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.065 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD23 ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.84 -55.39 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -85.73 15.19 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 43.72 24.59 0.47 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.381 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.558 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER 163.29 -59.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.3 -150.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 2.4 mt-30 -137.92 113.08 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 24.6 p -53.49 155.31 3.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.8 t -133.55 163.79 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.565 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -107.06 142.45 36.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.965 0.412 . . . . 0.0 111.64 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 26' ' ' ASP . 2.0 p -152.28 153.59 31.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.55 116.55 2.93 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 111.713 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . 46.42 46.92 17.1 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.576 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 171.41 177.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -157.98 161.27 38.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.431 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.517 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -133.57 -172.25 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.459 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 1.1 m -140.83 159.09 42.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 19' ' ' GLN . 1.6 tmtm? -112.76 75.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.5 m -45.87 155.78 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.334 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.465 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 30.9 t70 -57.3 -81.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 6.2 mt-10 -145.11 -40.19 0.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.48 17.52 6.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.391 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 3.8 m-30 -89.61 158.16 17.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -122.08 124.73 44.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.471 ' HB3' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -88.49 105.41 17.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.72 69.83 0.66 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.389 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 91.5 t80 -104.28 -15.02 15.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.445 ' SD ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 168.32 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.198 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.556 ' O ' ' CB ' ' A' ' 42' ' ' MET . 30.7 mmm -75.53 -16.26 60.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.479 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.556 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.5 mtm 99.17 -15.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.524 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.596 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 1.6 mmtp 172.87 99.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.885 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -168.14 72.53 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.347 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 57.1 m -28.65 108.88 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.722 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 8.6 ptm -138.87 113.17 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.5 p-10 0.08 106.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.982 0.802 . . . . 0.0 112.809 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -56.53 -175.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.66 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.452 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.9 t0 -94.6 76.13 3.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.421 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 70' ' ' TYR . 1.8 mp0 -49.68 -21.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.142 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.524 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 44.1 t -77.69 -11.11 59.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -111.59 -23.86 10.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -20.92 40.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.829 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -132.76 142.61 45.41 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 -5.63 11.76 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.94 2.427 . . . . 0.0 112.354 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -122.5 -8.37 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.821 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.575 HD22 ' CE2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -53.12 114.35 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 74.1 m 58.0 16.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.47 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -42.73 -27.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.425 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.23 29.4 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.073 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.59 -132.83 2.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.955 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 73' ' ' GLU . 52.1 t -132.54 136.15 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 88.4 m -93.01 89.94 6.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.572 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 31.7 m80 -89.03 47.78 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 110.041 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 19.5 t-20 -44.61 116.06 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.276 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.505 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -115.39 -162.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLY . 1.3 mt-10 -75.66 135.87 40.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.91 37.83 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.58 168.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.727 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.575 ' CE2' HD22 ' A' ' 57' ' ' LEU . 15.1 p90 -140.98 149.57 41.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.505 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.63 106.25 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.512 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.8 t -90.19 132.85 35.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.741 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.7 tt0 -145.81 128.09 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.717 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -50.59 -45.49 85.27 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.558 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.717 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 2.7 Cg_exo -75.08 -60.32 0.08 OUTLIER 'Cis proline' 0 C--N 1.352 0.732 0 C-N-CA 123.664 -1.39 . . . . 0.0 113.183 1.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.8 Cg_endo -85.13 -156.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.884 2.389 . . . . 0.0 113.59 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.05 37.25 9.76 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.0 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 160.52 -165.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 111.342 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.22 86.26 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.637 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -65.73 124.12 21.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.348 0.595 . . . . 0.0 111.932 -178.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -53.34 123.09 34.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.879 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.28 -44.81 43.72 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.578 2.185 . . . . 0.0 112.032 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -145.36 13.81 1.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.554 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -89.93 -20.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.622 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.34 103.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.0 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.622 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 127.55 106.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.904 0.752 . . . . 0.0 111.276 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.81 139.14 58.73 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 111.328 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.562 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.821 0.343 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -89.85 165.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 61.7 t0 -71.9 91.93 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 48.9 mp0 -72.56 -24.83 61.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.518 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 20.3 t -70.41 -45.7 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.464 ' HG2' ' OD2' ' A' ' 6' ' ' ASP . 6.8 mmt180 -55.18 -31.25 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 9.5 mm -37.97 -37.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.305 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.86 153.57 8.2 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.642 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.72 -22.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.854 2.37 . . . . 0.0 111.495 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -108.02 18.99 20.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.939 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -29.68 -57.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.516 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -93.29 -18.52 22.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.426 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 84.03 -47.2 3.8 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.033 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 31.5 tpt85 -116.68 -9.69 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 0.0 111.268 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -118.46 -171.96 15.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.615 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -118.29 108.9 15.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -50.58 134.67 23.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.064 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 28' ' ' GLU . 2.1 p -119.43 146.16 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.5 t-20 -84.89 141.25 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.41 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -148.6 155.12 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.754 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.3 Cg_endo -53.0 104.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.79 42.77 94.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.752 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.429 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER 178.62 -168.68 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CE1' HD22 ' A' ' 14' ' ' LEU . 5.9 p90 -173.61 139.5 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.52 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -106.48 -148.75 0.42 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.284 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 m -163.09 148.35 11.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 0.0 111.493 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' CD ' ' A' ' 30' ' ' LYS . 6.6 tmtm? -100.87 67.3 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.098 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 93.4 m -52.52 171.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.842 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 11.1 t70 -68.58 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.522 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.418 ' HG2' ' C ' ' A' ' 68' ' ' GLY . 1.6 tt0 -128.07 -65.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.506 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.71 5.07 32.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.456 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.576 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 m-85 -69.58 112.64 6.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.023 0.44 . . . . 0.0 110.395 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.46 117.07 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.467 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -81.99 103.13 11.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.585 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . . . 126.86 69.47 0.17 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 77.9 t80 -123.61 11.23 9.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.89 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 0.0 111.431 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.597 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.5 mmt -94.96 -27.96 15.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.597 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.5 OUTLIER 127.45 -20.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.443 1.089 . . . . 0.0 110.101 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 5.6 mptt -148.75 -89.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.772 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 36.27 67.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 15' ' ' CYS . 27.6 m -29.7 96.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.154 0.502 . . . . 0.0 110.889 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -125.85 115.35 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.868 -178.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -20.87 138.92 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.584 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.3 pt -82.94 -174.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.134 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.504 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 41.6 t0 -104.07 72.98 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 6.0 mp0 -47.34 -26.04 1.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.391 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.53 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 48.8 t -75.31 -11.93 60.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.038 0.447 . . . . 0.0 110.833 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.0 mt-30 -111.47 -25.3 9.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.353 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HD3' ' OD2' ' A' ' 54' ' ' ASP . 5.0 ttt180 -51.03 -32.89 22.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.594 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 60.2 m-20 -129.78 150.59 76.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.777 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.48 -3.89 6.62 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.238 2.625 . . . . 0.0 112.491 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -113.89 -10.59 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.576 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -53.17 119.57 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.793 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 61.7 m 46.8 26.1 0.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.499 . . . . 0.0 109.968 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 1.3 ttt85 -41.4 -28.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.535 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.68 21.32 3.4 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.891 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -127.57 -139.98 5.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.716 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 73' ' ' GLU . 79.7 t -121.7 137.13 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 25.9 m -96.08 89.13 5.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.496 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 56.7 m80 -89.99 49.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.447 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 13.2 t-20 -45.73 113.76 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.519 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.5 p -105.06 -173.82 2.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.956 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 1.6 mp0 -50.5 -98.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . -88.8 57.71 4.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.415 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 10.8 t 156.8 -173.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.285 . . . . 0.0 110.67 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.576 ' CE2' HD21 ' A' ' 57' ' ' LEU . 7.5 p90 -148.55 149.9 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.519 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -113.62 118.21 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.051 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.07 142.39 27.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.334 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 62' ' ' VAL . 2.2 tt0 -136.19 122.41 20.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.592 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.75 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.07 -34.55 1.71 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.005 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.75 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 11.8 Cg_exo -72.89 -172.15 9.28 Favored 'Cis proline' 0 C--N 1.356 0.943 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.521 0.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 89.2 Cg_exo -41.0 176.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.943 2.429 . . . . 0.0 113.006 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.28 48.76 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.577 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.3 t-160 -101.68 -126.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.506 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 30.2 tt0 -151.22 64.8 0.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.113 0.482 . . . . 0.0 109.894 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.46 129.22 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.576 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -58.79 134.29 86.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.563 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.83 -50.56 12.08 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.595 2.197 . . . . 0.0 111.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -147.15 28.52 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -96.65 -23.65 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.56 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 74.98 89.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.142 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 151.87 99.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.527 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.25 157.15 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.348 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.577 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -93.04 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.0 t0 -84.61 -50.81 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.0 mp0 73.6 -56.9 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.616 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 28.3 t -64.68 -18.18 64.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.62 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.508 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -76.89 -34.22 57.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.552 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.458 ' HB ' HD11 ' A' ' 14' ' ' LEU . 24.3 mt -43.3 -37.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.615 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 t -162.25 152.19 13.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.671 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -85.53 -17.8 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.114 2.543 . . . . 0.0 111.466 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.53 22.41 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.216 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.577 HD21 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -43.72 -44.25 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.163 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.8 m -83.91 11.47 7.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 52.73 11.1 1.16 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.942 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 tpm_? 172.81 -55.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.338 0.569 . . . . 0.0 110.877 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -64.98 -145.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.969 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 mt-30 -131.48 124.41 30.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.016 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 2.2 p -75.09 130.43 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 111.252 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 41.5 t -117.34 162.02 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.645 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.63 148.54 22.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.499 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 27' ' ' PHE . 6.4 p -152.72 149.12 21.58 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.59 111.45 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.805 2.337 . . . . 0.0 111.953 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.68 43.7 86.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.888 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 170.01 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.869 0.366 . . . . 0.0 110.671 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.577 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 16.2 p90 -166.51 144.41 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.6 pt-20 -109.98 -168.12 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.5 m -152.31 165.31 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 111.69 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -124.94 72.26 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.564 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.469 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 98.7 m -41.84 170.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.55 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -80.83 -73.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -131.21 -85.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.646 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 33' ' ' GLU . . . -93.33 -7.6 61.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.639 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.515 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 19.1 m-30 -68.57 127.15 31.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 pt-20 -100.24 128.06 46.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -86.94 105.73 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.21 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 117.13 24.17 3.64 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.798 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 40' ' ' MET . 84.9 t80 -44.6 -26.71 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.557 ' CG ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.14 -34.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.574 ' CG ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -54.14 -44.44 71.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.749 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.75 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 8.8 tptt -167.82 23.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.548 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.574 ' ND2' ' CG ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -76.33 143.26 40.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 86.5 m -85.13 108.84 17.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 22.8 ptm -136.6 113.46 10.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.95 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 2.0 p30 2.57 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 124.028 0.83 . . . . 0.0 112.973 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -53.31 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.163 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 46.0 t0 -97.19 73.47 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.937 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 1.7 mp0 -49.47 -23.19 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 110.763 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 24.3 t -76.38 -11.22 59.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.9 mt-30 -114.45 -23.96 9.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -57.79 -31.44 66.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' HB2' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -116.02 137.81 23.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.833 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.01 -2.12 10.1 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.061 2.507 . . . . 0.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -122.93 -5.62 8.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.596 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.562 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -53.05 116.67 2.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.957 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.1 m 52.08 21.49 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.17 -26.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.272 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.57 21.63 6.31 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.95 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -147.48 -129.83 1.97 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.683 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 64' ' ' HIS . 38.7 t -137.16 133.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.825 0.345 . . . . 0.0 110.569 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.0 p -99.95 96.88 7.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.496 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.576 ' CD2' HG11 ' A' ' 62' ' ' VAL . 16.9 m80 -88.4 61.14 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.4 t-20 -41.96 120.45 1.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.902 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.527 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -121.17 172.7 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.3 pt-20 -59.99 139.19 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 67' ' ' GLU . . . 38.08 33.77 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.48 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 179.3 -166.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.131 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -173.63 144.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.446 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.5 OUTLIER -109.36 152.09 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -132.17 135.55 46.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.089 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' VAL . 6.7 tt0 -142.9 124.97 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.977 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.783 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -63.71 -38.57 39.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.783 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.0 Cg_exo -80.16 -172.51 11.19 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.291 -1.129 . . . . 0.0 112.587 1.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 8.9 Cg_exo -28.39 152.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.16 2.573 . . . . 0.0 113.56 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.09 -12.77 16.94 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.574 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.4 t60 -120.53 -131.93 0.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.522 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.32 72.42 1.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 110.16 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -84.16 125.81 32.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.269 0.556 . . . . 0.0 111.861 -179.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.543 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 1.1 p -62.89 132.68 94.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.854 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.29 -48.21 13.65 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.656 2.237 . . . . 0.0 112.395 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -153.69 33.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.61 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -101.96 -12.31 8.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.41 86.88 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.305 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 150.73 104.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.2 t -71.21 145.93 49.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.716 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 2.3 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.24 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.9 t0 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.813 0.34 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -90.5 -165.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 17.8 t0 -91.77 -49.27 6.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.997 0.427 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 16.1 mp0 71.71 -55.32 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 67.4 m -61.37 -27.1 68.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.855 0.359 . . . . 0.0 110.344 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.9 -32.62 73.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.169 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.45 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.4 mm -45.51 -39.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' HD2' ' A' ' 12' ' ' PRO . 17.7 t -168.13 154.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.205 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 76.1 Cg_endo -89.31 -20.12 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.234 2.623 . . . . 0.0 111.289 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.32 22.0 16.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.6 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.541 HD23 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.87 -46.44 5.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.272 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -82.35 2.4 32.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.364 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 65.19 4.24 15.41 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.668 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 175.95 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.109 0.455 . . . . 0.0 111.362 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 30' ' ' LYS . . . -65.05 -131.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.163 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 5.1 mt-30 -148.28 122.0 9.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.39 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -67.95 160.85 27.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.7 t -141.43 164.1 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.746 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 6.3 t-20 -105.25 151.21 24.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.457 HG23 ' OE2' ' A' ' 28' ' ' GLU . 5.7 p -153.77 146.82 17.86 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.876 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.77 111.51 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.904 2.403 . . . . 0.0 112.059 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.8 42.08 96.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.996 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.05 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.481 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 4.1 p90 -165.32 171.75 13.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.971 0.415 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 pt-20 -142.62 175.14 10.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -139.91 153.35 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 111.379 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.512 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.21 162.84 12.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.907 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 1.3 m -139.74 153.66 47.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.071 0.463 . . . . 0.0 111.341 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -89.89 -157.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.657 -179.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 32' ' ' ASP . 4.4 mt-10 9.42 -77.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -154.28 31.02 0.71 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.176 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 21.9 m-85 -81.12 155.58 26.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -132.68 133.41 43.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -42.96 100.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' HA2' ' CE ' ' A' ' 46' ' ' MET . . . -51.04 -76.22 0.18 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.695 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 84.48 -12.35 0.77 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.45 ' SD ' ' HE3' ' A' ' 46' ' ' MET . 1.0 OUTLIER -88.85 -16.8 31.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.337 179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -33.15 2.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.22 36.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HD3' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER 51.17 36.62 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -77.21 -152.45 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.2 m -115.73 113.68 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.526 ' CE ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -130.54 103.72 6.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.088 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.0 p-10 -12.57 110.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.062 0.851 . . . . 0.0 112.654 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -48.76 -173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.116 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 60.5 t0 -101.51 72.92 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.378 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' CG ' ' HB3' ' A' ' 70' ' ' TYR . 5.1 mp0 -51.96 -22.01 3.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 110.149 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -11.27 60.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.488 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.443 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -115.27 -29.04 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.643 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -49.35 -38.0 26.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -113.12 130.55 23.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.797 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' C ' HD11 ' A' ' 56' ' ' LEU . 73.0 Cg_endo -77.52 -5.73 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.829 2.353 . . . . 0.0 112.156 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -126.64 -6.73 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 85' ' ' SER . 0.5 OUTLIER -30.39 134.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 1.3 m 38.49 36.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.47 -40.8 0.89 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 21.6 7.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.889 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -136.02 -157.0 7.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.951 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.58 HG12 ' CE1' ' A' ' 64' ' ' HIS . 35.3 t -113.96 123.33 69.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.897 0.38 . . . . 0.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -88.84 98.41 11.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.821 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.58 ' CE1' HG12 ' A' ' 62' ' ' VAL . 47.6 m80 -93.37 61.02 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.252 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 12.9 t-20 -49.04 114.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -116.08 -163.47 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -76.03 144.86 40.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.17 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 33.87 35.03 0.04 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.831 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 166.55 177.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.369 . . . . 0.0 111.263 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.539 ' HB3' ' CG ' ' A' ' 50' ' ' GLU . 1.8 p90 -148.84 147.38 28.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 64' ' ' HIS . 3.5 mmm180 -109.66 148.73 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -130.17 133.35 46.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 4.1 tt0 -125.83 119.12 27.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.697 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -64.29 -40.09 48.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.697 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 17.4 Cg_exo -69.26 174.21 39.75 Favored 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.616 1.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 67.1 Cg_exo -30.85 -32.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.057 2.504 . . . . 0.0 113.096 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.61 -30.62 0.06 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.279 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -103.03 -134.92 0.32 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -137.32 82.61 1.94 Allowed 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.323 0.51 . . . . 0.0 110.992 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -90.28 113.48 25.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 82' ' ' PRO . 18.1 t -67.6 135.77 92.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.903 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 Cg_exo -32.96 -115.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.031 3.154 . . . . 0.0 114.157 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.42 39.74 0.96 Allowed 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.957 -0.464 . . . . 0.0 111.062 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -95.93 -31.01 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER 72.04 89.23 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 179.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 157.37 74.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.463 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.0 t -35.89 146.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.585 0.231 . . . . 0.0 110.431 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.537 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.189 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 23' ' ' THR . 22.0 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.837 0.351 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.61 155.42 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 8' ' ' CYS . 50.7 t0 -76.31 67.66 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.639 ' CB ' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 -45.33 -25.02 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.417 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HA ' HD13 ' A' ' 14' ' ' LEU . 37.3 m -74.48 -39.24 62.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' ASP . 13.6 ttt-85 -55.41 -34.2 64.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.786 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.456 ' HB ' HD12 ' A' ' 14' ' ' LEU . 10.9 mm -42.91 -40.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -160.48 145.88 11.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.484 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -83.08 -17.13 6.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.032 2.488 . . . . 0.0 111.279 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -113.57 24.08 12.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.91 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.62 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.34 -48.67 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.436 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -81.21 0.28 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.205 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 82.69 -44.33 3.21 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.507 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 1.6 tpt180 -142.34 -40.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -63.83 178.46 7.34 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.669 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.5 mt-30 -100.76 95.91 6.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.624 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.475 ' CA ' ' SG ' ' A' ' 15' ' ' CYS . 50.9 t -47.42 130.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.528 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -116.5 154.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.974 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.495 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -107.1 163.4 13.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 112.069 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 1.1 p -161.4 158.9 23.5 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.478 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 7.1 Cg_endo -49.84 110.39 0.37 Allowed 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.728 2.285 . . . . 0.0 112.192 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.09 89.48 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.354 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CA ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.53 176.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.639 ' CD1' ' CB ' ' A' ' 7' ' ' GLU . 7.1 p90 -155.87 148.99 24.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.331 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.528 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 pt-20 -114.46 -144.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.973 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.9 m -167.84 159.86 11.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.468 . . . . 0.0 111.702 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -120.16 72.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.319 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 94.7 m -42.09 171.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.7 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 25.6 t0 -85.66 -92.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.554 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 56.4 mt-10 -111.95 -69.86 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.374 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.37 -2.03 35.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 13.7 m-85 -69.32 125.31 26.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.721 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -106.05 127.44 53.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.503 ' CB ' ' HD2' ' A' ' 43' ' ' LYS . 1.3 p -91.05 116.5 28.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.92 37.8 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.79 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 79.4 t80 -77.79 -20.81 52.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 110.808 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.493 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.74 -24.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -72.6 -23.14 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 109.67 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.195 0.934 . . . . 0.0 109.953 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 163.25 104.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.766 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -170.01 47.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.396 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' CYS . 94.4 m -1.6 116.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.365 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.567 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 9.8 ptm -143.02 128.93 19.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.2 p-10 -20.93 113.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -58.48 -173.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.545 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 53.9 t0 -101.67 72.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' CG ' ' HB3' ' A' ' 70' ' ' TYR . 19.9 mp0 -50.22 -22.31 1.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.458 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 70.0 m -75.25 -9.63 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.542 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.06 -20.84 9.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.761 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.57 -31.37 70.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.134 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.56 141.49 41.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.465 ' O ' HD13 ' A' ' 56' ' ' LEU . 91.8 Cg_endo -84.82 -5.76 9.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.134 2.556 . . . . 0.0 112.156 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -119.51 0.38 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -53.65 114.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.508 ' HB3' ' N ' ' A' ' 62' ' ' VAL . 56.7 m 54.4 22.31 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.766 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.19 -35.19 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.458 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.26 18.09 25.95 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.923 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 62' ' ' VAL . . . -148.08 -122.64 1.29 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.76 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 73' ' ' GLU . 19.0 t -150.01 135.36 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.794 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.7 p -102.64 100.98 11.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.141 0.496 . . . . 0.0 110.938 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.511 ' NE2' HG13 ' A' ' 62' ' ' VAL . 37.7 m80 -88.98 64.16 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 16.4 t-20 -46.49 120.15 2.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.181 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.461 HG23 ' HD3' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -117.33 -162.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.991 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 7.3 mt-10 -80.51 133.88 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 46.01 42.85 12.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 3.0 p 159.39 -172.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.793 0.33 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.3 p90 -159.3 150.27 19.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 64' ' ' HIS . 4.2 mmm180 -109.84 146.47 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.7 t -125.79 127.47 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.45 127.94 36.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.472 -178.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.793 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.24 -37.73 14.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.793 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.3 Cg_exo -80.12 -172.61 11.33 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.456 1.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 20.8 Cg_exo -28.08 150.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.148 2.565 . . . . 0.0 113.406 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.12 -16.51 11.9 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -115.76 -131.09 0.31 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.105 -0.548 . . . . 0.0 109.686 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -150.97 71.39 1.02 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.277 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -85.72 105.41 16.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.408 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.553 ' HB3' ' CG1' ' A' ' 84' ' ' ILE . 0.3 OUTLIER -61.15 134.42 93.07 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.911 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 56.1 Cg_endo -72.27 109.34 2.7 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.869 2.379 . . . . 0.0 113.568 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 20.0 m120 73.68 33.29 1.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.533 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -110.82 -32.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.567 ' CA ' ' HA ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER 77.4 72.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.793 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 155.4 99.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.508 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 t -59.76 151.56 25.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 110.7 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.19 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.92 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.578 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 15.1 t0 -88.02 -49.31 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.6 mp0 72.45 -55.46 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 66.4 m -62.03 -23.89 66.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -66.19 -35.5 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.153 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.452 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -41.6 -37.41 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.327 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' CYS . 1.6 t -164.74 153.54 11.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.605 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.1 Cg_endo -83.28 -20.31 5.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.156 2.571 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -114.26 25.89 10.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.146 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD23 ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.08 -50.16 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.266 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 6.9 t -60.18 -14.06 15.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.71 -3.23 44.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.778 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 10.9 tpt180 176.82 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.052 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -85.85 -139.92 5.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.889 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -132.97 106.73 7.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 111.029 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 40.8 t -59.96 152.17 24.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 111.299 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 39.8 t -138.89 163.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.561 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.2 t-20 -100.27 146.78 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 27' ' ' PHE . 4.9 p -150.54 146.31 19.55 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.77 107.89 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.864 2.376 . . . . 0.0 112.008 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.02 40.6 99.12 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.128 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 171.99 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.573 ' CZ ' HD23 ' A' ' 14' ' ' LEU . 6.3 p90 -169.15 151.81 4.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.4 pt-20 -131.26 -170.97 2.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.152 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -165.49 150.87 9.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 111.681 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -97.23 81.69 3.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.143 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -44.09 174.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.61 -95.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.377 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 9.6 tt0 -114.21 -77.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -103.91 4.13 45.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.83 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 21.8 m-30 -69.94 133.07 46.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.286 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' OE2' ' CD1' ' A' ' 39' ' ' PHE . 1.4 pt-20 -89.29 128.52 35.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 33.5 p -84.1 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 95.64 76.78 1.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.786 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' ' OE2' ' A' ' 36' ' ' GLU . 4.0 t80 -85.64 -18.01 34.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 110.547 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.37 -35.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -60.17 -42.89 95.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.518 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.67 -87.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.013 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -161.2 32.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.25 -174.97 3.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.176 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.585 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 1.5 m -111.02 107.82 17.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' C ' ' A' ' 47' ' ' ASP . 18.1 ptm -141.48 110.57 6.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.518 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.09 124.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.985 0.803 . . . . 0.0 112.752 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -78.0 -174.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.209 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.6 t0 -98.52 72.97 2.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 11.8 mp0 -52.74 -21.85 4.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.475 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -74.83 -10.57 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.458 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 7.2 mt-30 -119.63 -25.98 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -28.26 14.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.239 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 5.9 m-20 -133.32 144.4 52.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 111.259 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.11 -5.32 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.157 2.571 . . . . 0.0 112.045 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.04 2.45 10.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -56.9 122.69 12.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' GLY . 76.0 m 49.76 25.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.18 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.72 61.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 151.91 -16.82 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.199 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.51 -120.78 3.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.573 HG13 ' CE1' ' A' ' 64' ' ' HIS . 71.6 t -137.55 135.72 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 0.5 OUTLIER -106.59 92.38 4.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.12 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.573 ' CE1' HG13 ' A' ' 62' ' ' VAL . 37.6 m80 -89.73 60.24 4.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.741 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 22.2 t-20 -51.3 111.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -108.27 -161.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.042 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' HA ' ' CB ' ' A' ' 47' ' ' ASP . 4.1 mt-10 -89.75 128.68 36.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 67.01 26.46 73.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.646 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.0 t 158.14 -176.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.1 p90 -146.82 147.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.451 ' HD3' HG22 ' A' ' 66' ' ' THR . 1.0 OUTLIER -109.79 121.36 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -99.58 131.69 45.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.964 179.372 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -130.33 120.13 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 111.884 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.707 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.0 -31.95 0.85 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.938 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.707 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 40.8 Cg_endo -66.47 173.0 32.82 Favored 'Cis proline' 0 C--N 1.356 0.94 0 C-N-CA 123.802 -1.332 . . . . 0.0 112.76 1.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 72.1 Cg_exo -36.74 -29.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.943 2.428 . . . . 0.0 112.88 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.96 -30.45 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.377 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 5.6 t-160 -89.74 -129.34 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.56 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 20.0 mt-30 -138.55 61.16 1.59 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.523 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -87.19 125.55 34.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.408 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.532 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -56.66 134.12 78.08 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.819 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.97 -57.1 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.746 2.297 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -143.98 27.92 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.38 -13.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.669 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.93 91.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.786 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.53 99.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -63.65 148.84 47.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 4.1 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.892 0.377 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.526 ' CG2' ' HG3' ' A' ' 7' ' ' GLU . 1.5 tp -89.54 176.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -74.07 -49.0 25.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.289 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.3 mp0 72.06 -56.38 0.65 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.62 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 90.1 m -62.42 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -69.14 -30.2 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.582 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.478 ' HB ' HD13 ' A' ' 14' ' ' LEU . 13.5 mm -48.73 -41.68 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -161.65 156.51 19.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.125 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.4 -18.17 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 111.597 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -107.09 20.94 18.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.309 179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.578 HD23 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -45.84 -39.44 8.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 45' ' ' CYS . 91.5 m -82.23 -3.88 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.263 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 57.0 13.76 9.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.57 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.561 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 2.7 tpt85 173.61 -54.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.69 -151.38 6.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.69 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.0 mt-30 -123.93 121.43 35.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.968 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.5 t -65.58 154.7 37.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 41.4 t -135.93 160.25 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.918 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.524 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.13 147.84 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.362 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.459 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.2 p -152.68 146.17 17.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.07 111.63 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.889 2.392 . . . . 0.0 111.884 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.47 43.61 90.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.94 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 169.17 -165.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 0.0 110.602 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.578 ' CZ ' HD23 ' A' ' 14' ' ' LEU . 13.3 p90 -164.61 141.72 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 6.9 pt-20 -108.72 -172.38 2.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.06 163.67 27.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.527 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -121.11 55.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.211 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 72.8 m -31.66 152.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.634 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 26.6 t70 -61.03 -72.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 7.7 mt-10 -155.78 -34.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.868 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.18 6.26 8.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.628 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.3 m-85 -92.77 141.78 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.384 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.3 120.19 25.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.379 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.526 ' C ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -8.1 120.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.885 0.741 . . . . 0.0 112.42 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.61 57.74 2.96 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 2.0 p90 -52.42 -24.02 7.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.177 -0.512 . . . . 0.0 111.154 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.522 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 2.1 mtt -66.96 -24.77 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.166 0.508 . . . . 0.0 110.013 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.464 ' HE2' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -107.6 -35.57 6.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.55 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 166.95 -61.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.7 tptt 172.47 65.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.85 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.538 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -131.88 87.95 2.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.268 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 44' ' ' ASN . 66.9 m -10.61 117.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.997 0.811 . . . . 0.0 111.846 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.498 ' O ' ' C ' ' A' ' 47' ' ' ASP . 21.5 mtp -140.11 104.98 4.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.849 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.504 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.9 p-10 7.7 112.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -48.59 -175.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.331 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 57.4 t0 -102.32 72.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.46 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.2 mp0 -49.86 -23.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.468 ' HA ' HD21 ' A' ' 57' ' ' LEU . 59.8 m -76.21 -10.18 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.649 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.465 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.4 mt-30 -116.87 -23.83 7.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.68 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -54.12 -33.53 58.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.044 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 4.9 m-20 -127.52 141.69 41.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.15 -8.35 11.9 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.058 2.506 . . . . 0.0 112.06 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -112.8 -8.71 13.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.507 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.633 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.23 120.57 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 58.9 m 45.98 26.12 0.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.182 0.515 . . . . 0.0 110.086 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.78 -30.24 22.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.745 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.28 18.79 7.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.23 -130.32 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 73' ' ' GLU . 48.7 t -134.21 136.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 50.9 t -106.81 99.08 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.26 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.508 ' NE2' HG12 ' A' ' 62' ' ' VAL . 54.1 m80 -90.81 61.03 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.572 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.473 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 8.3 t-20 -47.42 112.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.914 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.522 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -111.85 -163.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 4.2 mt-10 -72.19 134.39 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.73 36.49 0.12 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 171.52 163.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.744 0.307 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.0 p90 -138.03 145.41 41.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.7 115.71 30.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.55 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.68 132.75 35.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.019 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.43 120.81 22.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.825 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.699 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.01 -32.42 0.99 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.926 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.699 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 25.8 Cg_exo -65.33 171.84 31.78 Favored 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 123.883 -1.299 . . . . 0.0 112.67 1.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 71.0 Cg_exo -36.33 -27.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.939 2.426 . . . . 0.0 112.95 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.33 -30.78 0.06 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.272 -0.965 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -91.03 -128.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.517 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -140.42 65.16 1.42 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.194 0.521 . . . . 0.0 109.614 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.88 130.33 36.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.408 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.544 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -61.05 134.91 93.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.895 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.9 -53.8 6.49 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.712 2.275 . . . . 0.0 112.47 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -148.06 24.46 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.245 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -91.74 -17.55 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.964 0.411 . . . . 0.0 110.542 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.92 89.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.025 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.8 98.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.516 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.33 151.61 31.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.154 178.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.26 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.7 t0 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.7 mp -104.09 165.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 62.6 t0 -77.38 97.21 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 29.0 mp0 -81.68 -21.32 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.4 t -70.57 -49.84 43.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.59 -22.58 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 7' ' ' GLU . 27.7 mt -45.5 -40.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -164.56 140.11 4.7 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -76.02 -17.07 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.571 2.181 . . . . 0.0 111.651 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.76 13.93 22.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.559 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.25 -56.36 2.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.3 t -62.56 -11.76 18.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.022 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.46 -2.12 47.92 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.63 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 11.6 tpt180 177.53 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -87.46 -143.88 8.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.948 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -130.45 112.54 13.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.658 0.266 . . . . 0.0 110.961 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 21.2 p -53.95 154.17 4.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 111.195 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 14.2 t -134.79 164.62 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.106 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.0 t-20 -110.29 139.54 45.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 111.595 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 27' ' ' PHE . 2.1 p -147.36 153.9 44.82 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.752 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.22 119.91 7.31 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.794 2.329 . . . . 0.0 111.846 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.11 43.77 25.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.847 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.41 -169.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.363 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE2' HD23 ' A' ' 14' ' ' LEU . 20.5 p90 -166.26 176.6 7.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.185 0.517 . . . . 0.0 111.755 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -153.37 -165.47 2.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.892 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 9.3 p -170.32 151.12 3.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 111.576 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -94.36 78.75 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.267 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -42.29 170.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.493 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 13.6 t0 -63.87 -96.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.536 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.94 -74.55 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -99.77 -6.35 54.51 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.086 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 17.6 m-30 -69.14 128.84 38.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.11 149.56 21.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.686 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 69.3 p -59.64 77.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . 102.73 -64.49 0.42 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.882 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 62.6 t80 97.66 -14.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.075 0.55 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.12 -24.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.061 -179.828 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -73.75 -39.32 64.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.309 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 155.02 -59.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.35 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CD ' ' HB2' ' A' ' 37' ' ' SER . 1.8 tptt 179.35 105.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.732 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -161.21 27.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.899 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' CYS . 2.9 m 42.72 106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.589 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' ASP . 10.2 mmm -148.57 103.4 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.098 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.1 p-10 0.27 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.809 . . . . 0.0 112.763 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.488 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -65.64 -173.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.521 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -91.0 74.24 6.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.939 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.578 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -51.64 -23.83 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.718 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 40.5 t -74.67 -11.87 60.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.52 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.4 mt-30 -116.99 -25.66 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -50.82 -37.99 46.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.506 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -113.11 137.93 22.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 -5.07 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.075 2.517 . . . . 0.0 111.982 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.69 -6.67 9.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.42 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -52.72 124.71 14.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.3 m 45.02 26.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.331 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.89 62.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.431 179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 146.35 -15.43 1.66 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.627 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.52 -116.65 3.6 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.177 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 49.9 t -150.05 130.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.935 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.0 p -100.25 100.91 11.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.043 0.449 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.516 ' O ' ' CG2' ' A' ' 66' ' ' THR . 73.4 m80 -89.93 57.22 3.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -42.28 110.53 0.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.345 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -114.26 -161.63 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.028 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' SER . 6.7 mt-10 -75.47 139.89 42.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.16 32.83 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.795 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER 171.68 177.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.6 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -147.86 148.32 30.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.89 114.63 28.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.569 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.78 136.87 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.007 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 31.3 tt0 -134.48 120.82 20.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.811 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.727 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -81.06 -32.99 0.67 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.856 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.727 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 45.7 Cg_endo -67.74 173.69 35.74 Favored 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.641 0.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 77.1 Cg_exo -36.26 -30.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.994 2.463 . . . . 0.0 112.723 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.51 -30.93 0.06 OUTLIER Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.262 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 5.4 t-160 -88.7 -127.62 0.06 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.98 62.85 1.43 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.76 131.12 35.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.438 -178.901 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.543 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -62.12 134.85 94.65 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.759 179.727 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.14 -55.39 4.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.567 2.178 . . . . 0.0 112.307 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -145.51 25.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.347 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -93.42 -17.62 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.324 179.454 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER 73.79 90.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.979 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.25 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.72 148.73 50.51 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.292 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.2 t0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.8 -179.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.711 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -90.31 -48.27 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.587 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.2 mp0 67.43 -53.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.907 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 78.5 m -67.13 -22.47 65.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.865 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.1 ttt85 -72.69 -30.77 64.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.273 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -45.29 -40.77 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.483 179.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -159.02 152.93 19.45 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.616 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -83.48 -23.03 3.57 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.119 2.546 . . . . 0.0 111.14 179.519 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -114.85 31.25 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.709 179.382 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.89 -54.28 0.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.518 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.5 m -88.42 26.61 1.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 32.99 34.68 0.02 OUTLIER Glycine 0 C--O 1.229 -0.18 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.194 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 157.33 -60.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.96 0.409 . . . . 0.0 110.393 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.89 178.27 1.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.097 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.31 102.39 11.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.82 0.343 . . . . 0.0 110.811 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 38.8 t -57.9 142.46 46.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.5 t -129.22 162.52 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.563 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.5 t-20 -96.81 142.13 29.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.373 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -146.42 151.79 44.45 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.872 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.69 117.08 2.98 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.9 2.4 . . . . 0.0 111.923 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.35 44.73 44.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.829 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 168.81 -164.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.705 0.288 . . . . 0.0 110.462 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 9.6 p90 -164.2 142.83 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.353 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 5.2 pt-20 -111.45 -167.64 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.201 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -153.29 -177.61 6.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.419 0.628 . . . . 0.0 111.76 -179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 4.9 tmtt? -138.42 69.27 1.38 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.797 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 93.8 m -42.41 169.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -64.82 -93.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.257 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.13 -35.47 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.12 27.34 2.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.367 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 4.5 m-30 -94.09 139.01 31.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.573 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -90.09 120.44 31.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 15.7 p -79.21 91.28 4.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 103.13 72.56 0.92 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.557 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 18.4 t80 -87.52 -8.03 56.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.93 -32.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.717 -179.871 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.8 mmm -71.8 -36.44 70.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.4 OUTLIER 156.27 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 1.9 mmtm -158.13 22.63 0.25 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -63.62 76.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 111.381 -179.681 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 16.0 m -37.48 100.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -126.39 121.72 33.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 -179.47 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.7 p-10 -21.2 100.23 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.985 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.573 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -47.55 -176.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.282 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.5 t0 -97.62 72.17 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.583 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HB3' ' CD1' ' A' ' 70' ' ' TYR . 2.0 mp0 -51.21 -21.61 2.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.451 ' HA ' HD23 ' A' ' 57' ' ' LEU . 7.1 t -77.72 -8.68 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 6.0 mt-30 -118.92 -22.06 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -53.66 -23.04 10.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.34 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -124.38 140.64 35.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.058 0.456 . . . . 0.0 110.971 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -78.35 -10.3 16.18 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.011 2.474 . . . . 0.0 112.364 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.69 -2.72 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.581 179.702 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.562 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -50.9 111.64 0.58 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.691 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HA ' HD22 ' A' ' 80' ' ' LEU . 61.3 m 56.3 18.59 3.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.91 -35.98 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.47 179.507 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.7 22.72 8.11 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.957 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.0 -131.16 2.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.827 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 73' ' ' GLU . 71.6 t -137.14 129.6 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.878 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.7 p -98.71 94.22 6.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.553 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 18.8 m80 -88.37 60.6 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.266 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -44.58 115.15 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.3 p -111.38 -161.61 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -85.72 127.46 34.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 55.52 27.22 47.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.11 174.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.743 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 29.5 p90 -141.64 151.22 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.7 112.29 24.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.189 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.5 t -96.45 135.44 38.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 62' ' ' VAL . 2.9 tt0 -150.06 127.52 11.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.388 -178.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.725 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -49.26 -45.36 76.07 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.443 179.569 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.725 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.1 Cg_exo -76.07 -61.42 0.05 OUTLIER 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.676 -1.385 . . . . 0.0 113.121 0.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.693 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.7 Cg_endo -85.37 -155.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.932 2.421 . . . . 0.0 113.02 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 78' ' ' HIS . . . 51.73 20.48 5.92 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.836 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.59 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 1.1 m-70 168.43 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.218 0.533 . . . . 0.0 111.499 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.36 95.86 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.823 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -73.23 120.53 18.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 -178.931 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.552 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.3 OUTLIER -48.4 123.79 11.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.09 -42.0 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.975 2.45 . . . . 0.0 112.881 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -154.3 19.42 0.49 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -91.28 -11.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.744 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.618 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 63.94 90.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.892 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.618 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 137.38 112.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.714 0.634 . . . . 0.0 111.252 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -68.11 158.67 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 110.697 179.572 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.59 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 21.0 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.028 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 10.8 t0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 1.4 tp -89.61 177.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.8 t0 -71.88 -48.02 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 71.73 -56.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.743 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 87.5 m -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -64.49 -34.77 78.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.678 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.465 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.8 mm -42.24 -39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.25 179.368 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.28 151.88 13.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.62 -179.917 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.71 -19.08 3.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.189 2.593 . . . . 0.0 111.041 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -111.97 26.93 10.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.969 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.601 ' CD2' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.86 -48.34 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.352 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -84.64 8.58 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.312 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 39.66 25.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.491 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' CB ' ' HB2' ' A' ' 45' ' ' CYS . 1.1 tpt180 173.24 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -88.4 -156.08 30.42 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.999 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -125.68 110.45 13.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.791 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.3 t -60.74 154.13 22.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.324 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 40.6 t -139.9 161.41 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.721 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.537 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -91.51 142.35 27.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.315 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 27' ' ' PHE . 4.7 p -147.5 150.81 38.22 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.932 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.83 109.25 0.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.788 2.325 . . . . 0.0 111.906 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.06 43.18 93.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.909 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.65 -163.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 0.0 110.727 -179.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.601 ' CE2' ' CD2' ' A' ' 14' ' ' LEU . 11.7 p90 -167.76 139.89 3.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.99 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.7 pt-20 -108.18 -172.65 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.638 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -145.57 157.92 43.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.458 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -109.55 64.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.196 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -50.46 154.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.488 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 22.9 t70 -37.69 -90.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.304 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 27.0 mt-10 -140.03 -37.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -132.15 20.07 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.342 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.7 m-30 -89.23 155.51 19.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 111.212 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.575 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -112.87 122.41 47.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.656 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -78.47 82.52 4.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 126.63 49.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' MET . 12.1 t80 -66.28 -13.78 60.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.8 -31.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.707 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 42' ' ' MET . 8.9 mmt -66.81 -36.24 81.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.613 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 159.13 -56.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 17.6 tptt -160.68 21.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.992 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -70.51 129.51 39.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.796 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 17' ' ' ARG . 55.8 m -65.69 107.08 1.65 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.643 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 47' ' ' ASP . 6.6 mmt -135.24 103.25 5.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.468 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.1 p-10 -1.21 105.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.967 0.792 . . . . 0.0 112.897 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.575 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.8 pt -63.58 176.11 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 47.6 t0 -91.58 77.36 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 7.1 mp0 -47.97 -30.61 4.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 57' ' ' LEU . 77.9 m -71.11 -10.94 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -118.48 -16.01 9.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -61.22 -36.68 80.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.377 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -129.09 124.43 22.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.402 -179.629 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.7 -8.27 15.02 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.198 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.512 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -111.23 -13.05 14.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.071 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -47.66 114.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.869 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 64.2 m 51.05 21.58 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.358 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.06 -31.42 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.45 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 20.8 5.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.713 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -135.33 -143.43 4.75 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.85 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.614 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 50.8 t -119.39 128.02 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.317 . . . . 0.0 110.913 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 16.1 t -99.36 90.84 4.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 111.483 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.614 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 43.0 m80 -89.63 57.64 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.394 179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -48.64 108.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.483 ' OG1' ' N ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.87 -161.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.953 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' N ' ' OG1' ' A' ' 66' ' ' THR . 2.5 mt-10 -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 75.86 23.24 72.74 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 1.3 p 156.52 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.703 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.635 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 5.9 p90 -148.62 152.82 37.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 2.5 mmm180 -109.53 106.63 16.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.01 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.4 t -92.56 125.17 37.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.4 tt0 -143.19 116.5 9.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.623 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -38.2 -65.05 0.4 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.008 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.747 ' HD2' ' HD3' ' A' ' 76' ' ' PRO . 84.9 Cg_endo -104.94 14.63 10.76 Favored 'Cis proline' 0 N--CA 1.441 -1.563 0 C-N-CA 123.775 -1.344 . . . . 0.0 113.126 1.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.747 ' HD3' ' HD2' ' A' ' 75' ' ' PRO . 69.9 Cg_exo -41.7 171.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.357 2.038 . . . . 0.0 112.227 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.32 81.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.586 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.83 -159.91 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.0 110.861 -178.946 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.59 80.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -68.88 120.19 14.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.569 . . . . 0.0 111.487 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.5 OUTLIER -46.87 127.95 8.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.089 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.39 -52.43 7.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.763 2.309 . . . . 0.0 112.422 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -138.45 20.62 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.95 -28.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.781 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.63 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 82.34 100.81 0.05 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.92 179.015 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 129.33 133.99 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.898 0.749 . . . . 0.0 111.308 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 40.5 t -73.28 140.53 46.87 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 5.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.315 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.936 0.398 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -94.99 166.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.761 179.783 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.5 t0 -72.95 -51.44 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 109.974 179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 6.5 mp0 69.69 -53.32 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.512 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 86.3 m -63.82 -27.04 68.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.4 mmt180 -68.14 -33.47 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.442 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.5 mt -44.42 -39.9 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.092 0.473 . . . . 0.0 110.445 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.417 ' O ' HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -162.03 150.83 12.8 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.456 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.8 -19.72 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.127 2.552 . . . . 0.0 111.342 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -111.91 25.43 11.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.134 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.563 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.92 -36.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.331 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -85.66 15.63 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.314 -179.435 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 52.1 16.94 3.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.281 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 153.65 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.524 ' N ' ' HB2' ' A' ' 15' ' ' CYS . . . -67.77 -162.6 2.03 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.034 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.4 mt-30 -121.02 112.04 18.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -70.59 149.6 46.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.327 0.584 . . . . 0.0 112.471 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.8 t -135.35 163.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.343 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -99.63 142.41 31.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.219 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.431 ' CG2' ' HG2' ' A' ' 28' ' ' GLU . 4.3 p -146.05 145.67 25.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.22 111.75 0.17 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.965 2.443 . . . . 0.0 112.003 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.56 47.47 44.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.919 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 172.01 -172.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.822 -179.596 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 17.3 p90 -163.05 146.76 10.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 15.5 pt-20 -124.16 -177.4 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.155 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.3 m -141.41 163.98 31.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' GLN . 1.4 tmtt? -110.83 69.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' LYS . 72.7 m -33.0 144.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.58 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 14.7 t70 -51.59 -71.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 4.2 tt0 -153.51 -62.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.575 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.47 28.63 11.26 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.596 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.505 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 4.8 m-30 -98.08 159.91 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.668 0.275 . . . . 0.0 110.783 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.551 ' CB ' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.67 131.23 55.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.547 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -83.0 94.57 7.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 106.58 43.25 1.47 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.432 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 25.0 t80 -46.04 -32.33 2.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 110.347 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.75 -30.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.051 179.67 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.507 ' HG2' ' ND2' ' A' ' 44' ' ' ASN . 4.8 ppp? -55.97 -43.91 77.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.558 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER 171.37 -40.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.0 OUTLIER 156.96 87.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.568 -179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -149.36 93.99 2.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.227 0.537 . . . . 0.0 110.415 179.651 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 40.4 m -36.2 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.073 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 39' ' ' PHE . 3.3 ptm -133.13 131.39 40.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.9 p-10 -18.29 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.544 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' CB ' ' A' ' 36' ' ' GLU . 3.7 pt -49.67 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.328 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 58.3 t0 -101.05 72.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.375 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 70' ' ' TYR . 3.1 mp0 -48.86 -24.94 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.223 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 37.2 t -75.43 -10.16 59.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.422 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 2.4 mt-30 -118.77 -23.3 7.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.879 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -21.04 18.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -128.96 139.2 34.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.998 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.58 -5.32 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.923 2.415 . . . . 0.0 112.072 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.519 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.2 -8.37 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.614 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -51.78 117.12 2.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.871 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 60.7 m 49.28 23.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.041 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 2.4 tmt_? -45.91 -33.68 3.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.741 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.31 11.42 10.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.065 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.89 -138.54 4.09 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 50.4 t -126.48 135.32 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.463 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 14.0 p -103.08 99.48 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 66' ' ' THR . 48.1 m80 -90.01 60.23 4.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -44.5 110.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.352 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -109.69 -178.5 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.667 179.553 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 4.4 pt-20 -79.39 119.35 22.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 73.59 26.54 69.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.7 t 158.4 177.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.727 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.581 ' CE2' HD23 ' A' ' 57' ' ' LEU . 15.0 p90 -144.35 149.51 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.73 114.28 27.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.444 -179.508 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.03 135.59 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 20.7 tt0 -132.16 117.75 18.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.697 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.73 -33.09 0.98 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.822 179.399 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.697 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.13 171.86 35.47 Favored 'Cis proline' 0 C--N 1.355 0.907 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.634 1.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 61.5 Cg_exo -36.61 -29.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.022 2.481 . . . . 0.0 112.833 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.8 -30.63 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.328 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.583 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 4.8 t-160 -88.45 -127.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.47 62.88 1.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.151 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.6 130.95 35.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.375 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.538 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -61.38 134.79 93.53 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.45 -53.26 7.41 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.674 2.25 . . . . 0.0 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -148.75 26.25 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.299 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -94.03 -17.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.434 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.6 90.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 179.105 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.2 100.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.27 149.26 48.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.101 178.787 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.583 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.353 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 t0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.812 0.339 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -104.87 153.58 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.905 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 44.2 t0 -62.39 74.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 111.068 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.538 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 37.5 mp0 -56.67 -17.04 7.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 13.8 t -81.35 -35.05 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.676 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.47 -27.75 64.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.523 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -45.57 -41.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -164.79 127.36 1.57 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.919 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 11.2 Cg_exo -68.19 -18.27 45.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.659 2.239 . . . . 0.0 111.034 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.28 11.27 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.484 179.633 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.585 HD21 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -43.24 -47.98 6.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.2 t -72.9 -14.35 61.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 76.23 -2.36 57.03 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.1 tpt85 177.35 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.035 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -82.47 -139.16 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.99 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 7.8 mt-30 -140.3 107.5 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.642 0.258 . . . . 0.0 110.916 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 5.2 p -52.37 149.72 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -131.26 163.99 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.555 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -110.27 141.89 42.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.007 0.432 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.449 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.7 p -148.51 157.01 42.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 16.2 Cg_endo -57.86 113.03 1.34 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.658 2.239 . . . . 0.0 111.726 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.43 44.88 59.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.541 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 171.58 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.366 -179.502 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CE2' HD21 ' A' ' 14' ' ' LEU . 27.3 p90 -166.75 175.91 7.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 111.852 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 10.3 pt-20 -153.59 -164.88 2.0 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 10.4 p -170.09 150.4 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 111.638 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.93 83.54 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.396 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -48.68 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.418 -179.355 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.7 t0 -104.33 -144.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.983 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 32' ' ' ASP . 2.6 mm-40 -29.61 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.83 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -120.0 25.93 7.32 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.663 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 20.9 m-30 -79.91 135.07 36.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 5.0 pt-20 -108.07 131.89 54.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.845 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.442 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.6 99.06 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.914 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.97 44.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.558 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 17.7 t80 -86.46 -6.6 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.775 0.322 . . . . 0.0 111.035 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 158.98 -23.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.643 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.4 OUTLIER -90.72 -20.38 22.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.781 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.3 OUTLIER 100.51 -13.88 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.917 0.76 . . . . 0.0 110.413 -179.528 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 42' ' ' MET . 7.0 tptt 168.35 100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.002 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -166.72 34.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.442 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.7 m 34.66 98.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.429 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.6 mmt -132.83 102.19 5.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.53 179.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.24 123.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.017 0.823 . . . . 0.0 112.796 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -66.84 -173.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.137 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 43.2 t0 -95.13 76.57 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.026 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.3 mp0 -46.58 -27.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.393 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 34.7 t -75.07 -16.83 60.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.003 0.43 . . . . 0.0 110.605 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.462 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -103.02 -23.31 13.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.216 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -43.98 92.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -100.63 155.92 35.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -93.3 3.77 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.432 2.755 . . . . 0.0 112.733 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.01 11.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.335 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -57.33 118.23 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 34.6 m 50.2 24.14 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.392 0.615 . . . . 0.0 109.653 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.52 -29.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.818 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . -134.18 27.25 3.31 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.961 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.68 -126.36 2.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.83 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 73' ' ' GLU . 43.0 t -137.39 135.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 110.818 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 61.9 m -96.92 92.59 6.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.493 ' CE1' ' CD ' ' A' ' 73' ' ' GLU . 58.2 m80 -88.98 48.84 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.038 0.447 . . . . 0.0 110.27 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 9.1 t-20 -42.42 116.93 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.522 HG23 ' CD ' ' A' ' 71' ' ' ARG . 2.5 p -119.53 -176.44 3.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 5.2 pt-20 -64.0 134.59 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.45 36.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.489 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 171.78 156.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' CE1' HD23 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -133.57 145.61 50.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' CD ' HG23 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.86 114.11 27.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.503 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -89.78 134.13 34.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.863 179.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -131.57 127.06 36.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.749 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.73 -33.68 1.6 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.437 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.749 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 14.6 Cg_exo -71.25 -173.3 9.44 Favored 'Cis proline' 0 C--N 1.356 0.964 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.568 1.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 81.3 Cg_exo -40.92 173.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.938 2.425 . . . . 0.0 112.812 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.51 53.25 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 1.1 t60 -101.08 -125.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.509 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 30.4 tt0 -151.05 65.85 0.91 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.001 0.429 . . . . 0.0 110.296 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.91 123.08 34.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.47 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.538 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 79.8 p -60.41 136.44 91.9 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.756 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.19 -66.0 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.787 2.325 . . . . 0.0 112.541 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -137.48 41.07 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.224 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -106.06 -14.74 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.413 . . . . 0.0 110.47 179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.35 89.12 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.12 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 155.18 93.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.521 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -54.58 159.93 1.97 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.766 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.576 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 39.2 68.52 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 1.6 tp -89.94 179.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 29.1 t0 -85.63 93.58 8.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 30.7 mp0 -76.27 -19.25 58.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.357 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.5 t -83.56 -26.09 30.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.462 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -71.29 -25.95 62.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.24 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.5 mm -45.41 -39.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.693 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.9 t -165.99 156.19 11.24 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 4.9 Cg_endo -86.37 -19.89 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.356 2.704 . . . . 0.0 111.749 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -109.21 21.9 16.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.484 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -42.8 -46.51 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.168 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -88.05 3.76 47.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 57.94 12.49 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.851 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 173.21 -50.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -70.11 -144.03 0.22 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.088 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 5.4 mt-30 -137.2 124.93 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 0.0 110.993 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.25 132.12 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.7 t -109.2 163.79 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.42 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.567 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.6 t-20 -111.29 143.08 42.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.354 . . . . 0.0 111.299 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -151.97 154.87 33.19 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 14.5 Cg_endo -57.16 116.61 3.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.746 2.297 . . . . 0.0 111.858 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.45 42.87 57.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.916 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.6 OUTLIER 167.3 -178.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.763 0.316 . . . . 0.0 110.547 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.563 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 11.2 p90 -159.54 176.15 12.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.544 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.517 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -145.51 -172.35 3.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.529 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -147.91 158.73 44.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 0.0 111.38 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.88 74.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.152 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -46.06 -179.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLU . 9.8 t0 -106.62 -141.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.225 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -23.1 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -124.87 23.48 6.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.618 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 23.2 m-85 -75.42 131.04 39.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 111.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.543 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.6 pt-20 -109.86 130.17 55.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -33.96 114.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.038 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' HA3' ' ND2' ' A' ' 44' ' ' ASN . . . -75.59 55.25 2.92 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.491 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 4.0 p90 -56.97 -25.96 59.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.491 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 3.7 mtt -66.59 -19.05 65.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.105 0.479 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.463 ' C ' ' CG ' ' A' ' 42' ' ' MET . 1.8 mmm -119.36 -32.18 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.578 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.463 ' CG ' ' C ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 178.73 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.433 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 178.01 33.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.14 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.474 ' ND2' ' HA3' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -85.21 -157.97 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.669 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.1 m -107.43 116.5 32.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.061 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.475 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -136.15 95.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.633 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -10.91 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.703 0.801 . . . . 0.0 113.028 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.543 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.2 pt -70.37 -173.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.313 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.3 t0 -99.2 74.03 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 9.2 mp0 -48.28 -22.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 65' ' ' ASN . 34.3 m -76.72 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.697 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -117.65 -23.87 7.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.51 -28.46 67.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -128.38 137.97 32.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.117 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.11 -6.44 12.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.964 2.443 . . . . 0.0 112.043 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.516 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -111.78 -17.9 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.147 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -46.94 118.93 2.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.965 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 47.0 m 44.01 26.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.2 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.01 -31.93 19.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.836 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.9 25.47 6.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.095 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.15 -125.59 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.626 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 31.5 t -139.29 135.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 43.5 t -108.92 97.05 6.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.366 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 62.2 m80 -88.87 63.5 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.135 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.458 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.7 t-20 -45.71 122.42 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.514 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -120.01 -165.55 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.994 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 68' ' ' GLY . 9.0 mt-10 -73.65 140.38 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.16 36.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 169.95 -178.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.644 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 3.5 p90 -153.14 148.41 26.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.92 135.85 50.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.36 131.84 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.059 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.42 127.34 37.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.301 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.753 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.49 -31.92 0.89 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.099 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.753 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.6 Cg_exo -71.85 -169.3 6.03 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.641 1.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 75' ' ' PRO . 98.2 Cg_exo -43.22 178.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.904 2.403 . . . . 0.0 112.856 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.55 -18.26 50.53 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 7.5 t-160 -104.23 -127.95 0.24 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.53 59.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.013 0.435 . . . . 0.0 110.056 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -86.26 129.53 34.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.52 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.534 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.36 133.0 88.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.682 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.14 -48.4 19.71 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.675 2.25 . . . . 0.0 112.011 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -146.95 21.21 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.12 -23.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.768 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.584 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 75.57 91.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.928 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 150.61 103.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.97 148.21 48.25 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.226 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.469 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 t0 -90.36 119.81 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.94 169.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.526 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 10.6 t0 -75.08 -49.14 20.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.073 0.463 . . . . 0.0 109.823 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.4 mp0 68.53 -52.91 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.757 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 47.5 t -63.74 -37.11 86.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -66.77 -25.8 66.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HB ' HD12 ' A' ' 14' ' ' LEU . 7.1 mm -39.92 -37.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.148 0.499 . . . . 0.0 110.397 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.85 151.68 8.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.696 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.74 -17.53 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.999 2.466 . . . . 0.0 111.49 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -113.69 21.92 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.988 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -38.25 -61.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.339 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 45' ' ' CYS . 1.6 m -73.26 -3.39 26.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.65 11.13 27.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 178.42 -50.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.87 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.44 -150.97 2.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.638 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -132.93 110.42 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.303 . . . . 0.0 110.963 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.6 p -52.54 131.27 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 28' ' ' GLU . 4.0 p -106.82 167.05 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 6' ' ' ASP . 8.7 t-20 -112.94 140.71 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.367 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.462 HG22 ' CG ' ' A' ' 28' ' ' GLU . 1.9 p -147.29 148.62 32.3 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.109 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HA ' ' OD2' ' A' ' 4' ' ' ASP . 4.0 Cg_endo -46.88 116.38 1.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.021 2.481 . . . . 0.0 111.973 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.73 45.71 39.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.998 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 169.13 -167.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.583 0.23 . . . . 0.0 110.479 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 5.9 p90 -169.66 176.2 5.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 111.465 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -144.74 -145.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.456 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.48 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 1.1 m -163.12 154.43 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.414 . . . . 0.0 111.333 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -105.82 67.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.254 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -45.4 175.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.488 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -141.95 -39.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -122.14 14.44 8.92 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.016 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.541 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 3.1 m-30 -94.99 161.17 14.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.829 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -118.25 131.24 56.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.55 102.69 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.652 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.71 64.66 0.85 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.719 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' A' ' 40' ' ' MET . 4.2 t80 -83.56 -11.59 57.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.7 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.518 ' HG3' ' N ' ' A' ' 41' ' ' MET . 3.3 ptm 176.69 -31.79 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -83.0 -20.17 35.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.08 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 104.62 -21.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.058 0.849 . . . . 0.0 110.626 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 42' ' ' MET . 14.9 mmtm -171.38 100.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.518 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -158.98 33.72 0.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 15' ' ' CYS . 2.8 t 9.52 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.901 0.75 . . . . 0.0 112.406 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -150.59 110.32 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.1 p-10 -2.1 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.947 0.779 . . . . 0.0 112.576 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -50.55 174.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 51.9 t0 -93.7 75.47 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mp0 -51.64 -21.66 2.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.976 0.417 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.46 ' HA ' HD23 ' A' ' 57' ' ' LEU . 78.9 m -76.75 -9.67 58.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.618 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.79 -23.51 6.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -29.82 64.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -125.1 137.2 29.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.86 -8.13 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.014 2.476 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -119.17 -3.51 10.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -53.36 122.17 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.7 m 48.97 24.66 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.515 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -65.22 61.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.474 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 150.06 -16.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.881 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.22 -124.29 4.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.24 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.572 HG13 ' CE1' ' A' ' 64' ' ' HIS . 75.0 t -136.24 132.91 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.315 . . . . 0.0 110.957 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 25.0 t -104.79 94.58 5.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.572 ' CE1' HG13 ' A' ' 62' ' ' VAL . 42.3 m80 -89.96 59.91 4.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.2 t-20 -47.83 109.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.555 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -108.77 178.02 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.019 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER -71.95 121.82 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 68.12 32.91 77.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.2 t 158.06 178.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.637 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -146.92 142.95 28.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.469 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 3.3 mmm180 -109.42 116.64 32.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.683 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -94.87 128.0 41.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.579 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.0 tt0 -128.37 123.29 33.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.693 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.29 -32.24 0.94 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.998 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.693 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 29.5 Cg_exo -64.85 170.93 32.43 Favored 'Cis proline' 0 C--N 1.356 0.926 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.7 1.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 73.8 Cg_exo -35.37 -28.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.992 2.461 . . . . 0.0 113.029 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.37 -31.2 0.04 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.434 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.2 t-80 -91.85 -129.2 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.525 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -140.03 66.34 1.4 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.105 0.479 . . . . 0.0 109.726 179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.95 93.44 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.154 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 33.4 t -43.24 137.79 2.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.477 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 76.1 Cg_endo -79.17 111.94 2.97 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.931 2.421 . . . . 0.0 113.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.4 m120 72.62 -1.24 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.6 mp -81.63 -18.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.77 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.947 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.59 98.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.497 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -59.01 150.75 23.84 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.848 0.356 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -177.9 66.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.77 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 34.0 t0 -86.76 101.14 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -81.11 -24.34 37.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.131 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.2 t -71.09 -41.92 70.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.745 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 1.4 ttt180 -57.44 -32.92 67.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.01 -38.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.473 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -165.22 146.76 6.32 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.687 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 -16.51 8.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.938 2.426 . . . . 0.0 111.799 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.88 16.92 21.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.486 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -44.81 -43.44 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.797 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 55.1 m -74.57 -14.13 60.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 66.61 6.3 34.84 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.137 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 1.9 tpt180 174.11 -29.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -94.65 -151.04 27.87 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.083 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.439 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 1.8 mm100 -127.09 115.34 19.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.289 . . . . 0.0 110.993 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.2 p -57.92 132.71 54.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.027 0.441 . . . . 0.0 111.676 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -116.6 164.25 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.241 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.6 t-20 -107.31 147.21 30.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.479 ' CG2' ' CD ' ' A' ' 28' ' ' GLU . 2.5 p -154.29 154.12 29.17 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.81 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.82 117.74 4.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 111.903 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.13 43.7 41.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER 167.42 -174.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.327 . . . . 0.0 110.482 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.564 ' CE2' HD23 ' A' ' 14' ' ' LEU . 18.9 p90 -157.21 165.94 34.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.025 0.44 . . . . 0.0 111.552 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.522 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -130.39 -171.2 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.006 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.522 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -145.83 168.8 19.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.872 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -128.06 65.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.104 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 30' ' ' LYS . 62.5 m -39.29 166.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.251 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 14.3 t0 -55.73 -96.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.387 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -138.31 0.92 2.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.812 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -173.01 22.94 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.422 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.0 m-30 -100.02 138.96 36.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.422 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.4 120.1 30.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.525 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.35 99.16 11.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.546 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.91 84.89 1.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.894 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 26.1 t80 -131.57 -46.1 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 41' ' ' MET . 1.9 mtp -106.76 5.52 28.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.15 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.7 OUTLIER 84.91 37.04 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' LYS . 4.5 mtp -145.36 15.38 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 37' ' ' SER . 0.8 OUTLIER 34.75 45.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.937 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -88.22 35.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.626 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 69.4 m 22.5 102.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.583 0.552 . . . . 0.0 111.962 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.55 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -126.31 100.41 6.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.044 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.56 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.5 p-10 11.86 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.929 0.768 . . . . 0.0 112.702 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -33.45 155.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.601 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.463 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 54.0 t0 -89.54 74.43 7.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.851 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 19.6 mp0 -49.62 -27.87 5.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.733 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -70.31 -9.26 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.48 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.8 mt-30 -121.78 -31.09 4.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 52' ' ' GLN . 11.8 ttt85 -36.61 -42.53 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.205 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.19 154.32 58.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.437 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' O ' HD21 ' A' ' 56' ' ' LEU . 74.5 Cg_endo -91.41 -2.06 4.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.454 2.769 . . . . 0.0 112.093 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -126.42 10.94 7.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.128 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -58.11 129.24 41.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.2 m 40.21 30.13 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.283 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -60.96 71.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 137.33 -6.1 3.59 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.39 -127.15 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 38.4 t -140.46 117.09 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.406 ' HB2' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.07 101.56 14.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 66.1 m80 -90.47 60.36 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.049 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' A' ' 50' ' ' GLU . 1.7 t-20 -43.68 112.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 64' ' ' HIS . 1.6 p -115.84 -161.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.051 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.35 140.08 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 56.31 19.7 26.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.768 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.4 t 156.32 -175.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.643 0.258 . . . . 0.0 110.724 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.8 p90 -142.19 159.31 42.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.946 0.403 . . . . 0.0 111.317 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.457 ' NE ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -115.54 112.25 21.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.075 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.5 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.86 131.73 35.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.265 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -132.33 121.0 22.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.807 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.697 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.62 -32.61 1.07 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.873 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.697 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 26.2 Cg_exo -65.32 171.4 33.19 Favored 'Cis proline' 0 C--N 1.356 0.96 0 C-N-CA 123.918 -1.284 . . . . 0.0 112.715 1.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 65.8 Cg_exo -33.65 -28.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.151 2.567 . . . . 0.0 113.264 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -35.0 -31.87 0.02 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.695 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -89.4 -125.42 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -144.69 60.56 1.33 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' ' SG ' ' A' ' 87' ' ' CYS . 0.3 OUTLIER -90.47 98.7 11.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.029 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.542 ' HB3' ' HB ' ' A' ' 84' ' ' ILE . 1.4 t -51.75 137.29 34.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.327 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 64.9 Cg_endo -75.07 115.49 4.29 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.917 2.411 . . . . 0.0 113.588 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 21.1 m120 72.89 24.13 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.169 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' A' ' 81' ' ' SER . 1.4 mp -102.06 -27.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.251 0.548 . . . . 0.0 109.858 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.556 ' CA ' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER 74.08 69.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.499 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 85' ' ' SER . . . 166.4 100.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.22 145.84 30.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.11 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.572 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.477 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -176.44 85.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.583 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -91.42 -164.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 12.2 t0 -87.01 -48.18 8.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.851 0.357 . . . . 0.0 111.286 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.6 mp0 72.99 -56.94 0.65 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 8.4 t -63.84 -14.56 54.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.567 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.461 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.2 -33.21 56.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HB ' HD13 ' A' ' 14' ' ' LEU . 12.4 mm -41.86 -37.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.73 163.71 9.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.36 -22.5 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.145 2.564 . . . . 0.0 111.809 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.75 15.94 27.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.621 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -45.79 -49.42 15.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.766 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -59.96 -13.11 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.74 -10.76 37.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.035 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 7.3 tpt180 177.35 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.98 -129.88 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.608 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LYS . 3.3 mt-30 -144.97 118.27 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 111.388 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -69.18 146.35 52.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.879 0.371 . . . . 0.0 110.982 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 43.9 t -128.67 152.79 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 3.2 t-20 -77.75 153.36 33.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.971 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 27' ' ' PHE . 16.3 p -157.46 155.7 27.79 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.605 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.6 Cg_endo -51.46 110.37 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.746 2.297 . . . . 0.0 112.07 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.17 44.17 74.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.118 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.75 -160.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.766 0.317 . . . . 0.0 110.286 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.621 ' CZ ' ' CD2' ' A' ' 14' ' ' LEU . 6.5 p90 -165.08 145.0 6.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -104.77 -146.88 0.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.45 171.43 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.537 0.685 . . . . 0.0 112.793 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLN . 3.1 tmtm? -131.49 65.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.364 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 95.0 m -50.04 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.549 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -136.74 -151.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.263 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 32' ' ' ASP . 26.9 mm-40 -0.71 -86.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.949 0.781 . . . . 0.0 112.871 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.77 9.57 2.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 18.6 m-85 -69.9 106.88 3.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.638 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -89.58 136.02 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -28.54 113.98 0.08 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -38.03 -85.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 88.17 -24.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE ' ' A' ' 46' ' ' MET . 2.8 mtm -72.21 -24.44 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.435 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.5 mmm -124.66 -35.75 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.641 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 164.4 -51.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CE ' ' HB2' ' A' ' 37' ' ' SER . 5.9 mmtp 174.38 104.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -159.66 49.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.131 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 84.7 m 15.65 110.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.669 0.788 . . . . 0.0 112.937 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.516 ' CE ' ' SD ' ' A' ' 40' ' ' MET . 26.2 ptm -124.93 120.06 30.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.9 p30 -25.45 126.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.405 0.621 . . . . 0.0 111.707 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.531 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -54.68 -174.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.455 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 58.3 t0 -101.55 73.05 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.271 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 2.5 mp0 -49.07 -22.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.475 ' HA ' HD22 ' A' ' 57' ' ' LEU . 60.1 m -75.45 -13.22 60.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.676 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 1.8 mt-30 -111.46 -20.3 12.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -60.52 -30.04 69.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.982 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -123.62 138.28 30.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.51 -6.47 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 112.195 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -121.32 -4.27 9.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.535 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.89 119.98 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.839 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 65.0 m 46.71 25.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.519 . . . . 0.0 109.991 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' CB ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.1 -27.01 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.92 30.5 3.71 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.04 -126.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.572 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.62 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 42.7 t -135.68 135.48 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.9 t -109.33 96.94 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.949 0.404 . . . . 0.0 111.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.62 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 57.6 m80 -89.69 62.39 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.454 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.2 t-20 -47.07 118.61 2.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.518 HG23 ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -115.09 -170.15 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 10.1 mp0 -73.11 131.16 41.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 44.11 33.5 2.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.359 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 172.78 168.73 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.681 0.277 . . . . 0.0 110.772 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.643 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.0 p90 -144.72 145.97 31.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.518 ' CD ' HG23 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.0 137.19 48.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.522 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.93 127.73 56.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.061 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.531 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.2 tt0 -126.97 123.97 38.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.787 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.722 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.83 -31.34 0.72 Allowed Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.973 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.722 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 43.3 Cg_endo -67.05 174.22 31.08 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 123.828 -1.321 . . . . 0.0 112.827 1.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 71.5 Cg_exo -35.4 -28.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.006 2.471 . . . . 0.0 113.073 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.25 -30.63 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.469 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 3.3 t-160 -93.72 -130.44 0.13 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.71 65.46 1.43 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.522 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.8 101.43 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.192 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.533 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 32.9 t -50.43 137.48 22.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 85.1 Cg_endo -79.96 112.76 2.9 Favored 'Trans proline' 0 CA--C 1.526 0.121 0 C-N-CA 122.909 2.406 . . . . 0.0 113.59 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 23.4 m120 73.39 -3.21 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.265 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.5 mp -80.68 -25.09 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.156 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.23 87.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 153.78 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.877 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.494 ' HA ' HD11 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -60.7 150.95 30.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.197 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.266 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 3' ' ' THR . 37.9 t70 178.93 84.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -108.18 153.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 32.0 t0 -61.31 84.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.036 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 27.3 mp0 -70.9 -11.92 61.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.1 t -83.22 -43.24 16.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -67.5 -23.62 65.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.738 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.465 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.6 mm -42.97 -39.7 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.36 140.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.16 -18.45 18.38 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 111.388 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -116.6 20.96 13.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.245 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.587 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -37.06 -61.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.307 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -80.27 7.67 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.381 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 78.99 -45.78 2.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.947 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -134.9 -46.74 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -59.25 -177.61 1.08 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.825 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.07 102.63 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.484 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 13.8 p -40.22 150.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.246 0.546 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 16.2 t -130.32 164.39 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.771 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 t-20 -114.31 138.93 49.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.418 . . . . 0.0 111.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 1.5 p -148.8 157.55 40.57 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.63 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 19.0 Cg_endo -59.17 121.0 9.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.598 2.199 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 46.81 44.19 17.43 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.625 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.68 -179.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.358 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CE2' HD22 ' A' ' 14' ' ' LEU . 21.4 p90 -164.04 -177.69 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 111.995 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.0 pt-20 -162.56 -147.52 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.851 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.484 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 13.6 p -170.4 -176.83 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.214 0.53 . . . . 0.0 111.59 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -121.76 73.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.727 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 66.7 m -40.61 167.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 16.4 t0 -60.24 -99.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.258 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -129.9 -32.08 1.89 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' CA ' ' HA2' ' A' ' 68' ' ' GLY . . . -134.84 14.82 4.37 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.507 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.1 m-85 -90.74 125.89 35.83 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.563 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.77 131.72 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.882 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.53 ' OG ' ' CE ' ' A' ' 43' ' ' LYS . 1.6 t -95.34 106.36 18.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.447 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.14 76.19 1.02 Allowed Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.227 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 70.7 t80 -109.1 -51.49 2.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.0 110.009 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -98.98 -3.32 35.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.578 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.8 OUTLIER 86.53 38.11 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.857 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtt -134.84 5.45 3.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.974 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CE ' ' OG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 51.93 96.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.451 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -157.2 44.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.242 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 44' ' ' ASN . 67.1 m 5.2 107.82 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.934 0.771 . . . . 0.0 112.133 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.57 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 24.0 ptm -130.59 111.69 12.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.521 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.4 p-10 -21.81 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.371 0.605 . . . . 0.0 111.987 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -46.91 -178.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.111 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 59.2 t0 -106.82 71.04 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.849 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 29.4 mp0 -48.86 -25.13 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.474 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 40.8 t -73.85 -8.76 57.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.681 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 3.9 mt-30 -118.06 -28.84 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -40.94 -42.2 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.001 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.4 152.14 77.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.473 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.518 ' HG2' ' CD1' ' A' ' 56' ' ' LEU . 96.5 Cg_endo -86.56 -6.6 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.285 2.657 . . . . 0.0 112.086 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.1 mp -104.45 -15.93 15.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.179 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.578 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -51.12 114.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.599 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 76.8 m 53.34 20.96 2.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.176 0.512 . . . . 0.0 109.994 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -36.95 -36.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.691 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.7 -8.55 9.81 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.028 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.14 -150.34 15.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.546 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 38.7 t -116.78 129.6 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.475 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.4 p -94.28 98.9 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.984 0.421 . . . . 0.0 111.081 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 66' ' ' THR . 0.5 OUTLIER -96.18 65.18 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.206 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.7 t-20 -47.12 116.47 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -103.45 -175.59 2.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 4.5 pt-20 -49.84 -102.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.441 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 34' ' ' GLY . . . -85.73 55.24 4.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.363 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 28.9 t 170.44 -161.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.578 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.7 p90 -167.15 146.05 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 3.4 mtp180 -110.38 159.06 17.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -135.65 136.54 41.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.066 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 18.0 tt0 -130.52 118.13 20.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.904 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.69 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -79.53 -33.7 0.84 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.839 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.69 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.03 171.25 37.18 Favored 'Cis proline' 0 C--N 1.354 0.85 0 C-N-CA 123.92 -1.283 . . . . 0.0 112.699 1.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 78' ' ' HIS . 61.7 Cg_exo -37.32 -29.74 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.932 2.421 . . . . 0.0 112.881 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -38.5 -30.38 0.09 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.218 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 6.1 t-160 -87.01 -127.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -142.01 63.55 1.41 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.38 129.01 36.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.288 -178.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.553 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -59.57 131.74 88.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.84 -49.24 18.26 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.846 2.364 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -149.76 33.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.462 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -102.01 -24.87 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.352 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.8 OUTLIER 82.73 84.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.803 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 158.63 102.68 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.531 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.68 152.29 35.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.21 178.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.306 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 3' ' ' THR . 13.7 t0 167.23 91.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -89.9 167.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.5 t0 -69.89 -50.06 46.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 111.056 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.0 mp0 72.07 -55.89 0.66 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.444 ' HA ' HD13 ' A' ' 14' ' ' LEU . 97.9 m -64.62 -18.23 64.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.385 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -72.18 -33.52 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.465 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HB ' HD12 ' A' ' 14' ' ' LEU . 10.9 mm -40.84 -36.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 t -165.48 155.67 11.72 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.679 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -85.75 -19.31 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.3 2.666 . . . . 0.0 111.457 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.52 25.06 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -46.44 -40.06 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.863 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -78.74 4.34 14.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.177 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 34.69 29.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.101 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' NE ' ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER 153.63 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.834 0.35 . . . . 0.0 110.763 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 15' ' ' CYS . . . -86.18 -140.85 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.562 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.496 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.7 mt-30 -142.98 102.73 4.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 0.0 111.019 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.449 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 29.2 t -56.31 146.61 23.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 37.7 t -131.47 162.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.3 t-20 -97.13 150.33 20.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 27' ' ' PHE . 4.6 p -154.76 146.26 16.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.81 112.16 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.897 2.398 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.93 44.38 82.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.92 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.43 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.78 0.324 . . . . 0.0 110.639 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 7.7 p90 -164.83 144.99 7.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 29' ' ' CYS . 2.1 pp20? -117.65 -171.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.605 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.1 166.57 24.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 111.887 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.493 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -123.61 84.05 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.662 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 163.0 12.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.305 0.574 . . . . 0.0 112.386 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.63 -91.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -119.92 16.09 10.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.99 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.615 ' CE2' ' NE ' ' A' ' 17' ' ' ARG . 2.5 m-30 -103.01 166.92 10.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' CB ' HG21 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.62 139.86 53.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.502 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 83.0 p -87.88 94.7 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.034 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 86.48 71.01 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.43 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 33.0 t80 -67.53 -21.01 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.52 -27.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.4 OUTLIER -65.08 -36.16 83.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 179.1 -87.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.748 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.531 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -162.13 37.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.863 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -86.45 173.03 9.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.585 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' ' CB ' ' A' ' 35' ' ' TYR . 49.3 t -111.05 110.07 20.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.598 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 ppp? -145.5 119.99 9.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.54 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 2.2 p-10 -6.5 109.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.97 0.793 . . . . 0.0 112.375 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.524 HG21 ' CB ' ' A' ' 36' ' ' GLU . 1.1 pt -53.85 -177.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.406 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 54.7 t0 -99.58 74.03 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.552 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 3.6 mp0 -48.35 -26.0 1.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.474 ' HA ' HD23 ' A' ' 57' ' ' LEU . 63.4 m -73.51 -12.55 60.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 7.9 mt-30 -115.17 -23.52 8.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.481 ' NH1' ' CG ' ' A' ' 54' ' ' ASP . 1.1 ttt-85 -53.73 -31.51 48.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.024 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' CG ' ' NH1' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -132.19 142.58 45.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.4 -6.26 10.95 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.137 2.558 . . . . 0.0 111.908 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.523 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -112.4 -10.13 13.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.258 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.627 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -51.88 121.87 7.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.8 m 47.83 24.61 0.6 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -55.59 -18.19 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.699 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.74 22.91 5.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.69 -125.34 0.97 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.683 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' CG1' ' NE2' ' A' ' 64' ' ' HIS . 41.8 t -138.62 136.72 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.782 0.325 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.2 t -105.7 96.86 6.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.29 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.557 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 29.4 m80 -89.76 61.21 5.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -46.04 118.87 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.525 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 5.0 p -111.89 -162.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 118.08 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 71.92 24.11 77.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.446 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 166.0 178.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 0.0 110.614 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.9 p90 -142.6 147.18 35.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.525 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.54 112.25 24.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.464 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.76 138.18 31.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.843 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tt0 -143.13 122.11 12.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.704 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -79.86 -29.91 0.59 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.704 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 23.5 Cg_exo -67.3 178.09 20.18 Favored 'Cis proline' 0 C--N 1.358 1.04 0 C-N-CA 124.188 -1.171 . . . . 0.0 112.649 1.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.535 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 78.7 Cg_exo -36.45 -26.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.953 2.436 . . . . 0.0 113.087 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -34.58 -32.33 0.02 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.579 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 10.6 t-160 -90.06 -127.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 24.2 mt-30 -140.73 68.63 1.35 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.4 OUTLIER -90.0 125.55 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.181 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.538 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 1.1 p -59.67 134.08 89.18 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.831 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.89 -46.49 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -158.24 32.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.534 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.37 -12.81 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.572 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.62 85.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.046 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 150.45 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.276 0.36 . . . . 0.0 111.633 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 t -69.33 158.24 35.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.922 0.392 . . . . 0.0 111.007 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.576 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.9 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.4 t0 40.48 69.81 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.96 -176.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.749 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 t0 -92.26 107.81 19.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.972 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 17.9 mp0 -91.28 -22.81 20.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.086 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 41.5 t -78.88 -31.2 45.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.4 ttt85 -64.02 -30.26 71.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.274 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.468 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.6 mm -40.87 -37.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.469 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.1 t -164.79 155.78 12.95 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.968 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.4 Cg_endo -84.33 -21.69 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 0.0 111.477 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -114.41 27.19 9.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.003 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.47 -59.59 0.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.342 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.0 m -88.95 27.43 1.35 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.641 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 43.91 22.23 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.908 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 166.04 -59.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.134 0.467 . . . . 0.0 110.993 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' SG ' ' A' ' 45' ' ' CYS . . . -54.28 -163.69 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.683 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 mm-40 -125.74 109.69 12.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.773 0.321 . . . . 0.0 110.96 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -63.09 125.87 25.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.49 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.4 t -109.05 164.1 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.133 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.559 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.4 t-20 -102.68 148.53 25.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 26' ' ' ASP . 2.5 p -155.42 156.45 30.93 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.862 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 12.4 Cg_endo -56.26 117.93 4.66 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.74 2.293 . . . . 0.0 111.904 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . 49.28 44.41 34.83 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.859 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 166.55 -178.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.741 0.305 . . . . 0.0 110.459 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 7.1 p90 -155.25 155.08 33.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.522 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 pt-20 -123.32 -167.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.03 -177.38 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 112.193 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 1.1 tmtm? -141.74 79.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.567 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 21.8 m -60.15 -179.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.775 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.3 t70 -90.66 -151.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.415 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.3 mt-10 -33.13 -74.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.732 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -135.4 40.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.057 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 3.0 m-30 -88.43 133.72 34.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.58 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.58 121.89 32.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.305 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.521 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.57 98.2 11.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 110.48 76.14 0.85 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.797 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 65.3 t80 -111.94 -76.69 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.564 ' HB3' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -123.16 -12.84 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.193 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 42' ' ' MET . 13.5 mmm -90.89 -22.57 20.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.697 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.7 mmt 123.27 -43.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.402 1.064 . . . . 0.0 110.911 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -158.72 20.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.585 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -67.26 149.86 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.5 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 15.9 m -95.64 102.21 13.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.458 . . . . 0.0 110.34 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 25.5 ptm -127.83 116.59 20.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.087 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -21.36 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.929 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.58 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -46.52 -177.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.441 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.8 t0 -96.8 72.42 2.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.714 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 70' ' ' TYR . 1.6 mp0 -50.86 -22.19 2.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.476 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.4 t -76.01 -8.95 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.705 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.416 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 3.4 mt-30 -119.12 -24.12 6.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -23.74 9.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.52 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 2.1 m-20 -124.99 139.45 33.62 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.041 0.448 . . . . 0.0 111.166 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.79 -9.38 15.74 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.029 2.486 . . . . 0.0 112.279 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -119.13 -6.62 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.53 112.58 0.67 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.582 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 39.6 m 52.69 22.16 2.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.0 109.864 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -38.49 -38.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.51 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.62 24.06 6.2 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.806 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -136.27 -130.88 2.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.531 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 73' ' ' GLU . 70.0 t -137.82 128.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.777 0.322 . . . . 0.0 111.001 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.466 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -98.15 95.02 7.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.57 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 41.0 m80 -88.53 60.45 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 8.3 t-20 -45.93 112.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.514 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.35 -161.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.66 127.03 34.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 56.81 29.86 59.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 168.2 -172.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' CE2' HD21 ' A' ' 57' ' ' LEU . 9.6 p90 -156.97 147.56 21.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.71 116.48 31.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.322 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.5 t -98.42 134.91 40.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.305 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.3 tt0 -150.19 126.2 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.518 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.711 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -49.65 -45.91 79.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.456 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.711 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 3.3 Cg_exo -75.56 -60.21 0.09 OUTLIER 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.669 -1.388 . . . . 0.0 113.193 1.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.672 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.9 Cg_endo -84.39 -155.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.87 2.38 . . . . 0.0 113.155 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.0 37.44 9.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.874 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.516 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 161.0 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.235 0.54 . . . . 0.0 111.255 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -139.22 78.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.105 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -56.98 107.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.463 0.649 . . . . 0.0 111.784 -178.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.52 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 55.4 p -52.03 124.62 29.72 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.526 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -76.42 111.75 3.32 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.796 2.331 . . . . 0.0 113.221 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 23.4 m120 73.66 13.68 4.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.336 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 85' ' ' SER . 3.8 mp -101.24 -44.92 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 5.7 p 91.75 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 154.18 102.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -50.27 130.27 22.73 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.864 0.364 . . . . 0.0 110.901 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.516 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 1.1 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.175 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.768 0.318 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.3 t0 41.58 90.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.87 -165.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 9.4 t0 -87.56 -50.1 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 111.103 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.5 mp0 73.11 -55.49 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 20' ' ' CYS . 91.1 m -63.22 -24.31 67.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.95 -32.58 69.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.463 ' HB ' HD13 ' A' ' 14' ' ' LEU . 11.4 mm -44.04 -39.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 110.281 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.0 t -163.17 153.28 13.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.712 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_endo -85.54 -19.42 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.169 2.58 . . . . 0.0 111.093 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -112.2 26.89 10.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.994 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.585 ' CD2' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.69 -47.73 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -83.2 11.02 7.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.402 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 60.89 9.95 16.73 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.159 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 162.15 -37.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -68.47 -153.49 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.805 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.05 101.59 5.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.1 t -57.15 150.16 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 28' ' ' GLU . 7.1 p -132.06 154.0 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 21' ' ' VAL . 6.4 t-20 -91.55 142.34 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.229 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 27' ' ' PHE . 13.4 p -147.89 151.09 37.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.51 103.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.853 2.368 . . . . 0.0 111.992 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.12 98.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.117 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.2 OUTLIER 178.8 -166.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CE2' ' CD2' ' A' ' 14' ' ' LEU . 4.7 p90 -172.45 139.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.671 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' HG3' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -105.97 -147.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.684 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.2 m -170.08 159.49 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -122.6 71.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.473 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.9 OUTLIER -49.59 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.06 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -125.96 -156.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.109 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER 8.32 -75.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.009 0.818 . . . . 0.0 112.636 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -157.72 29.61 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.136 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 22.9 m-85 -79.24 151.15 31.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 2.1 pt-20 -112.02 128.16 56.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -83.42 92.78 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 114.32 56.86 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 58.4 t80 -77.12 -24.83 51.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.845 0.355 . . . . 0.0 110.787 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.14 -25.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.465 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 42.0 mmm -72.68 -33.36 66.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.421 ' HG2' ' C ' ' A' ' 41' ' ' MET . 1.8 ptm 166.0 -63.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 12.9 tptt -177.01 29.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.451 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -76.91 179.51 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.44 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.572 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.4 m -92.16 106.58 18.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.468 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 mmt -124.0 101.01 7.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.045 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.3 p-10 -21.83 101.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.984 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -48.42 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.094 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 56.3 t0 -94.69 71.7 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.564 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 1.3 mp0 -48.3 -24.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.27 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 18.1 t -76.92 -8.97 58.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.0 mt-30 -116.38 -21.29 9.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 54' ' ' ASP . 7.8 ttt-85 -58.75 -33.25 70.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -115.89 140.58 26.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.091 0.472 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 90.3 Cg_endo -80.83 -5.03 13.02 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.085 2.523 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -128.37 1.22 5.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.56 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.6 HD23 ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.41 115.56 1.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.123 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.516 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER 49.22 21.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.643 -179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.29 87.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.2 -24.4 0.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.098 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -129.15 -98.16 0.87 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.944 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.591 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 19.2 t -150.32 125.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 111.572 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -89.55 99.27 12.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.591 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 71.2 m80 -89.62 59.79 4.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 1.4 t-20 -46.0 117.98 1.71 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.4 p -117.69 -171.05 1.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.089 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.6 pt-20 -73.25 143.2 47.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.9 32.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.612 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER 164.69 174.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.61 0.243 . . . . 0.0 110.43 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.6 ' CD2' HD23 ' A' ' 57' ' ' LEU . 8.7 p90 -146.8 166.44 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.142 0.496 . . . . 0.0 111.783 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HD3' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -122.54 108.15 12.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 19.0 m -89.59 116.33 27.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.152 0.501 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.547 ' CD ' ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -100.75 141.7 33.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.495 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.756 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -78.05 -35.63 1.24 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.026 -178.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.756 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 9.6 Cg_exo -73.74 -168.54 6.18 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.454 0.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 65.0 Cg_exo -40.57 172.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 113.04 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.92 86.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.154 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.592 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -139.74 -136.86 0.12 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.08 84.5 1.39 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.275 0.489 . . . . 0.0 111.254 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.04 123.82 34.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.085 0.469 . . . . 0.0 111.677 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.55 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -49.95 122.22 13.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.264 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 73.2 Cg_exo -37.32 -44.98 1.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.869 2.38 . . . . 0.0 112.713 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 82' ' ' PRO . 32.2 m120 -163.24 24.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -86.91 -27.34 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.427 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.578 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 4.9 p 87.15 87.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.347 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 153.48 84.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 9.6 t -38.34 152.9 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.592 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.898 0.38 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.8 t70 158.66 82.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.782 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 tp -89.75 159.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.525 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 59.5 t0 -75.21 90.04 2.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 0.0 111.041 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.1 mp0 -74.08 -21.86 59.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.054 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -46.74 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.511 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.525 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 1.2 mmt-85 -50.63 -31.95 17.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 15.0 mm -53.31 -55.08 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.504 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 14' ' ' LEU . 1.4 t -143.06 121.95 7.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.84 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.7 -19.56 47.47 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.756 2.304 . . . . 0.0 110.753 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -118.88 25.57 10.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.717 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.652 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.53 -44.43 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.862 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -84.37 15.69 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.459 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.55 5.83 7.39 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.811 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 174.39 -60.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.758 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 31' ' ' CYS . . . -48.71 164.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.749 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.93 84.53 5.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.81 0.338 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -44.46 148.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.161 0.505 . . . . 0.0 111.165 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 39.3 t -135.52 163.45 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.425 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.545 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -91.41 146.25 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.025 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 3.6 p -151.56 156.02 34.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.5 Cg_endo -55.24 107.53 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.239 . . . . 0.0 111.888 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.34 41.79 95.26 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.017 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 173.75 -167.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.652 ' CZ ' ' CD2' ' A' ' 14' ' ' LEU . 2.5 p90 -164.85 145.27 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 5.9 pt-20 -117.21 -167.41 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 2.9 p -167.52 154.4 8.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.192 0.52 . . . . 0.0 111.718 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -101.58 76.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.266 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.52 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . 60.0 m -41.23 169.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.849 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -91.78 -151.23 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.318 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' ASP . 67.1 mm-40 -33.12 -95.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -114.96 36.48 3.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.588 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.8 m-85 -89.8 121.59 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.754 0.311 . . . . 0.0 110.429 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.581 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -94.81 128.1 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 7.7 p -84.07 95.05 8.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.59 34.72 0.68 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 2.3 t80 -55.87 -17.36 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.316 . . . . 0.0 110.913 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.65 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.987 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' MET . 29.2 mmm -75.9 -29.68 58.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.593 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.3 mmt 131.69 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.281 0.988 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 7.8 tptt 177.98 104.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 0.0 111.281 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -166.97 50.52 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.966 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 15' ' ' CYS . 74.6 m 5.93 100.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.154 0.909 . . . . 0.0 112.235 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.484 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.8 mmt -125.95 113.67 17.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.827 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 46' ' ' MET . 9.9 p-10 -20.89 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 O-C-N 123.667 0.604 . . . . 0.0 112.04 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -42.13 176.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.544 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 45.4 t0 -92.97 76.18 4.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.75 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 32.2 mp0 -48.8 -25.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.865 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 45.2 t -74.69 -8.8 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.71 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -117.98 -26.37 6.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.637 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -30.23 61.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB2' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.24 138.05 25.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.98 -4.7 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.99 2.46 . . . . 0.0 112.05 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -119.49 -11.54 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.516 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.49 113.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 75.4 m 51.84 21.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 110.247 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.44 -28.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.649 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.24 -7.83 6.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.101 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.15 -152.43 11.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 64' ' ' HIS . 47.4 t -112.74 129.87 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.325 . . . . 0.0 111.067 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 7.3 p -95.41 101.59 13.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.562 ' CD2' HG11 ' A' ' 62' ' ' VAL . 28.3 m80 -90.19 62.26 5.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 7.9 t-20 -44.53 109.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.465 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -108.51 -178.61 3.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.97 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.3 129.32 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 41.15 29.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -167.72 -169.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.574 ' CE1' HD21 ' A' ' 57' ' ' LEU . 1.6 p90 -171.47 139.76 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.766 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.465 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 1.3 mtp180 -109.83 158.98 17.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.235 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -131.92 143.93 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.258 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 21.6 tt0 -139.79 118.13 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 111.799 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.704 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.93 -32.8 0.93 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.869 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.704 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.35 172.38 34.6 Favored 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.594 1.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.517 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 49.9 Cg_exo -35.36 -27.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.055 2.503 . . . . 0.0 113.162 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.66 -31.08 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.45 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.569 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -89.65 -126.47 0.07 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.19 58.08 1.4 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -81.99 109.04 15.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.624 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.548 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -43.8 133.63 3.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.44 -68.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.54 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -127.35 29.54 5.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.689 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -96.28 -14.76 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.801 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.563 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.7 87.74 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.966 178.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 154.36 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.78 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.511 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.569 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.457 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -177.34 107.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.819 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.0 OUTLIER -118.33 164.69 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 47.8 t0 -81.23 109.19 15.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 14.1 mp0 -92.47 -23.85 19.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.941 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -70.87 -45.64 64.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.566 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.463 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.1 ttt180 -51.9 -35.3 44.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 10.7 mm -41.51 -39.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.338 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.77 150.03 11.11 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.678 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 -16.64 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.135 2.556 . . . . 0.0 111.541 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -108.62 20.21 18.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.328 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.612 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.65 -50.58 4.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.206 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -63.86 -10.07 18.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.7 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 62.74 6.93 13.18 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.883 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.638 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 13.9 tpt180 172.58 -44.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.876 0.369 . . . . 0.0 110.706 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.68 -139.05 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.622 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.1 mt-30 -136.69 111.39 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 110.995 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -68.82 155.36 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 36.8 t -140.76 161.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.736 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.3 t-20 -90.63 155.93 18.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.508 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 27' ' ' PHE . 11.9 p -156.87 155.73 28.8 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.833 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.0 Cg_endo -54.61 110.26 0.5 Allowed 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.71 2.274 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.01 41.92 94.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 168.96 -162.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.536 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.612 ' CZ ' ' CD2' ' A' ' 14' ' ' LEU . 6.3 p90 -163.58 141.44 7.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.029 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -101.61 -150.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -165.86 177.43 7.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.148 0.499 . . . . 0.0 111.78 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' CD ' ' A' ' 30' ' ' LYS . 5.6 tmtm? -145.43 76.24 1.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.192 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 5.8 m -44.83 177.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.694 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.87 -73.44 0.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.313 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.95 -74.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.148 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 48' ' ' ILE . . . -101.09 -0.61 54.65 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.158 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.9 m-85 -71.05 118.15 13.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 tp10 -89.96 141.02 29.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.416 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 37' ' ' SER . 13.0 p -45.49 81.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.154 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' HA3' ' N ' ' A' ' 43' ' ' LYS . . . 82.14 -12.09 45.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.169 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 40' ' ' MET . 0.0 OUTLIER 72.17 4.1 4.9 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.579 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 107.97 -22.41 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.758 0.823 . . . . 0.0 110.97 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 42' ' ' MET . 3.1 ptm -66.63 -32.98 74.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 41' ' ' MET . 21.5 mmt -162.31 -75.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 110.467 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 12.2 tptt 179.97 -24.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.04 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.56 ' ND2' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -46.0 90.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' CYS . 25.2 m -36.15 103.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.393 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.532 ' HA ' ' CD2' ' A' ' 35' ' ' TYR . 3.2 ptp -132.14 135.55 46.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 p-10 -22.39 118.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.34 0.591 . . . . 0.0 111.95 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 36' ' ' GLU . 8.1 pt -58.47 -170.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.475 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 57.4 t0 -97.76 71.98 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.453 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.2 mp0 -50.72 -21.51 1.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.462 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 9.1 t -77.39 -10.03 59.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.441 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.2 mt-30 -117.65 -22.39 8.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HD3' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.45 -24.03 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.095 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.457 ' OD1' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -126.57 138.02 31.59 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.965 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.94 -7.88 13.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.942 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -115.65 -7.94 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.597 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 HD23 ' CE1' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -52.07 114.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.7 m 52.53 22.29 2.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.223 0.535 . . . . 0.0 109.955 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 3.4 ttt180 -40.25 -30.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.56 22.22 4.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.021 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -138.76 -131.11 2.83 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.466 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.572 ' CG1' ' NE2' ' A' ' 64' ' ' HIS . 39.4 t -135.37 129.7 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.763 0.316 . . . . 0.0 110.733 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.457 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.8 p -97.99 95.88 7.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.572 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 38.6 m80 -88.98 60.41 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.679 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.9 t-20 -43.0 117.03 0.98 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.265 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.535 HG22 ' CD ' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -117.58 -179.65 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' N ' ' OG1' ' A' ' 66' ' ' THR . 10.5 pt-20 -64.65 135.4 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.02 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 37.12 31.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.594 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER 172.9 158.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' A' ' 50' ' ' GLU . 4.1 p90 -136.49 147.38 47.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.194 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.535 ' CD ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.18 119.23 38.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.326 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.532 ' CB ' HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -92.07 142.51 27.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.866 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -133.55 122.46 23.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.743 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.99 -34.49 2.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.98 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.743 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.2 Cg_exo -71.96 -174.07 11.15 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.61 1.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 78.5 Cg_exo -39.94 173.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.028 2.485 . . . . 0.0 113.011 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.37 56.54 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -101.12 -126.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.961 179.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 35.2 tt0 -151.3 64.64 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.383 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 72' ' ' CYS . 0.6 OUTLIER -90.9 109.97 21.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.848 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.7 t -58.44 136.79 85.61 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 4.9 Cg_exo -74.15 109.94 2.99 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 113.809 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 22.0 m120 71.1 -1.18 2.8 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.553 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -77.42 -35.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.239 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 3.9 p 85.03 84.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.373 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 151.34 96.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.52 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -55.56 160.89 2.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.282 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.8 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.218 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.783 0.325 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 24' ' ' PRO . 37.4 t70 43.27 73.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 tp -89.85 165.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 14.2 t0 -77.29 92.06 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.063 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 31.8 mp0 -73.93 -17.33 61.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 55.6 m -83.77 -27.58 28.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.14 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -46.11 -44.07 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.295 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -156.2 146.46 15.88 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.586 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.48 -15.92 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.998 2.465 . . . . 0.0 111.626 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.35 19.0 18.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.397 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.19 -49.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 18' ' ' GLY . 8.0 t -89.51 36.84 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.654 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . -14.37 80.38 0.0 OUTLIER Glycine 0 C--N 1.335 0.485 0 O-C-N 123.978 0.799 . . . . 0.0 113.771 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.619 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 116.53 13.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . -148.14 -149.65 5.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.11 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -133.72 106.75 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 37.5 t -56.07 155.59 6.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 20.5 t -136.26 164.91 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.597 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.578 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 9.2 t-20 -115.96 141.78 47.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.211 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 27' ' ' PHE . 9.5 p -146.25 155.46 50.37 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 32.2 Cg_endo -64.06 112.35 1.83 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . 70.52 31.76 68.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER 165.31 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.696 0.284 . . . . 0.0 110.472 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -164.43 -176.01 4.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.215 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' A' ' 27' ' ' PHE . 8.3 pt-20 -167.88 -155.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.284 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 6.2 p -168.15 179.15 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 111.969 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -117.32 80.35 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.607 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -54.67 163.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.081 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 -88.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.088 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -122.61 -80.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.29 -3.92 64.78 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.356 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.53 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 14.5 m-85 -68.63 123.82 21.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.958 0.408 . . . . 0.0 110.218 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -93.59 136.75 33.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.046 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.466 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -92.54 96.83 10.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.944 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 100.67 44.75 2.06 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' MET . 5.8 t80 -40.03 -30.25 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.074 0.464 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.47 -38.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.548 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.517 ' N ' ' HE2' ' A' ' 40' ' ' MET . 4.5 ptm -57.64 -47.99 80.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.818 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 41' ' ' MET . 46.9 mmm -163.09 -94.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -168.47 96.92 0.4 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.474 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -165.21 134.25 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.184 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -42.72 121.91 2.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.355 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -149.77 86.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.53 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 7.9 p-10 -15.77 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.744 0.653 . . . . 0.0 112.142 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -45.04 179.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.451 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 61.0 t0 -95.88 73.63 3.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.538 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.9 mp0 -50.07 -24.35 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.995 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 7.3 t -75.83 -9.43 58.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.721 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.441 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -119.34 -23.33 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -52.86 -34.8 56.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 139.02 28.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.07 0.462 . . . . 0.0 111.019 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.08 -7.91 13.08 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.036 2.49 . . . . 0.0 111.931 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -108.81 -14.24 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.117 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.534 ' CG ' ' HB3' ' A' ' 85' ' ' SER . 0.3 OUTLIER -50.52 120.35 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.666 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.4 m 47.64 24.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.425 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.14 -21.46 3.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.216 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.51 13.02 5.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.049 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.41 -132.46 3.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.628 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 64' ' ' HIS . 34.0 t -133.16 127.53 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 111.089 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.9 p -94.1 106.74 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.033 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.564 ' CE1' HG11 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.45 67.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.519 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.537 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -48.03 110.24 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.517 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -104.93 -170.97 1.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.018 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.62 126.79 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.1 28.54 1.94 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -169.74 -168.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.898 0.38 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.538 ' CD2' ' HB3' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -167.68 140.55 3.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.517 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.6 OUTLIER -110.98 156.07 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.53 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.54 137.32 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 31.5 tt0 -138.59 116.48 11.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.803 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.723 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -80.67 -30.18 0.56 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.723 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 21.9 Cg_exo -67.95 176.79 25.78 Favored 'Cis proline' 0 C--N 1.357 0.978 0 C-N-CA 123.988 -1.255 . . . . 0.0 112.767 1.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 78' ' ' HIS . 76.9 Cg_exo -39.86 -24.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.908 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -35.58 -31.81 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.337 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -83.39 -121.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.503 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 39.5 tt0 -148.73 65.6 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -90.46 111.51 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.9 -178.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.0 t -62.07 137.1 95.55 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.719 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 63.6 Cg_endo -76.57 108.88 2.75 Favored 'Trans proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.052 2.501 . . . . 0.0 114.063 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 20.4 m120 72.51 14.25 5.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.259 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.55 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 2.0 mp -95.75 -19.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 110.201 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.57 86.0 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.11 178.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 147.64 98.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.487 0.492 . . . . 0.0 111.428 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.9 t -63.77 161.7 14.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.591 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.186 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.71 0.291 . . . . 0.0 111.059 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' THR . 63.4 t0 37.37 69.39 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.475 HD11 ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -95.06 153.38 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.367 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 41.1 t0 -69.58 90.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -73.85 -20.52 60.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.68 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.0 t -79.31 -36.26 39.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.491 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.0 ttt85 -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 14' ' ' LEU . 13.3 mm -52.24 -46.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.91 154.14 14.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -87.2 -18.84 2.61 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.29 2.66 . . . . 0.0 111.722 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -108.12 21.35 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.378 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.06 -51.66 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.981 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 45' ' ' CYS . 12.4 m -95.13 17.26 14.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 67.93 3.34 28.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.969 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 175.09 -52.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.988 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 30' ' ' LYS . . . -48.11 176.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.804 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 10.7 mt-30 -105.96 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.809 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 2.9 p -52.27 134.91 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 111.558 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -118.38 164.05 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.21 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.3 t-20 -106.34 142.96 35.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 111.644 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 1.6 p -149.87 157.06 38.36 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 15.9 Cg_endo -57.61 111.84 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.256 . . . . 0.0 111.849 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.55 44.28 67.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.695 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 171.11 -175.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.738 0.304 . . . . 0.0 110.516 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.56 ' CE2' HD23 ' A' ' 14' ' ' LEU . 28.0 p90 -160.23 167.38 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.254 0.549 . . . . 0.0 111.716 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.7 pt-20 -143.51 -165.18 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.583 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.8 p -170.7 168.09 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -114.17 82.19 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.16 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -39.03 165.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 2.7 t70 -77.15 -144.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.17 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.8 mt-10 -28.15 -93.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.859 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -123.51 32.67 4.21 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.22 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 21.2 m-85 -81.6 143.8 31.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.001 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -117.49 132.96 56.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.64 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -42.31 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.353 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -47.25 -76.64 0.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 87.39 -22.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.663 0.268 . . . . 0.0 111.04 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 mtm -59.5 -32.08 69.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.21 0.529 . . . . 0.0 109.884 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.0 mmm -117.42 -23.23 7.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.516 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 179.31 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.224 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' MET . 1.2 tptt 173.31 34.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.994 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -62.44 -177.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.779 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -100.39 105.84 17.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.207 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.544 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 2.2 ptp -123.83 99.87 6.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.302 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -9.14 125.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.846 0.716 . . . . 0.0 112.732 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -64.94 -174.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.256 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -100.44 73.54 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.301 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.561 ' HG2' ' CD1' ' A' ' 70' ' ' TYR . 2.2 mp0 -50.09 -21.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 51.1 m -77.7 -9.83 59.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.45 -22.27 8.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.637 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 33.9 ttt-85 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.105 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -100.97 156.12 35.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.027 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.448 ' O ' HD23 ' A' ' 56' ' ' LEU . 20.8 Cg_endo -90.2 -2.61 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.344 2.696 . . . . 0.0 112.364 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -132.06 14.57 4.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.404 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.546 ' HA ' ' CA ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -62.81 129.16 39.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.7 m 45.93 25.89 0.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.351 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -62.31 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.239 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 129.6 0.46 5.73 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.806 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -122.55 -139.06 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.562 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.578 ' CG1' ' NE2' ' A' ' 64' ' ' HIS . 55.8 t -127.58 117.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 6.3 t -84.1 94.33 8.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 47.8 m80 -89.43 53.73 2.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 17.6 t-20 -49.66 111.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.718 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.52 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -112.7 -161.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.316 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.4 pt-20 -75.53 138.93 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 34.59 46.6 0.58 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.721 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.1 t 157.61 -176.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.561 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 1.8 p90 -154.81 156.13 35.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -122.92 117.19 24.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.01 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.54 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -100.07 135.37 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 62' ' ' VAL . 3.4 tt0 -150.22 120.59 7.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.112 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.691 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -45.68 -47.53 38.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.691 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.4 Cg_exo -76.3 -60.41 0.08 OUTLIER 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.771 -1.345 . . . . 0.0 113.264 0.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.676 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.7 Cg_endo -83.38 -154.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.823 2.349 . . . . 0.0 113.111 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 78' ' ' HIS . . . 45.88 39.36 8.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.917 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.564 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.51 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.0 111.041 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -141.78 73.03 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.54 ' CG ' ' HB3' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -63.83 91.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.211 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.557 ' HB3' ' CG1' ' A' ' 84' ' ' ILE . 0.3 OUTLIER -46.68 130.7 8.38 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 59.2 Cg_endo -74.51 112.58 3.59 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.965 2.444 . . . . 0.0 113.253 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 70' ' ' TYR . 22.9 m120 75.97 34.26 0.55 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.985 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -115.0 -39.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.111 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 4.7 p 88.74 69.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.041 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.03 116.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -62.46 128.49 36.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.564 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.713 0.292 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -64.54 63.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 3' ' ' THR . 1.6 tp -89.86 173.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.516 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 51.5 t0 -84.49 97.81 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.931 0.396 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.8 mp0 -76.75 -25.93 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 11' ' ' SER . 92.3 m -69.51 -45.43 68.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.353 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -50.5 -35.58 29.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.034 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 11.1 mm -42.37 -40.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -161.94 147.88 10.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.578 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.8 Cg_endo -85.24 -17.05 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.038 2.492 . . . . 0.0 111.256 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -112.13 23.76 13.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.059 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.572 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -38.96 -54.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.421 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -77.39 -10.84 59.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.067 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.31 -1.82 48.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.775 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.568 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 6.8 tpt180 -173.57 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.971 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -71.72 -151.61 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.628 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -133.74 99.3 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.7 t -50.77 153.52 1.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.188 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 31.6 t -136.86 161.72 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.724 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 3.7 t-20 -95.69 143.65 26.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -149.18 155.82 39.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.9 Cg_endo -55.59 105.88 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.717 2.278 . . . . 0.0 111.952 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.43 41.51 97.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.906 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 175.57 -168.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.697 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.572 ' CE2' HD23 ' A' ' 14' ' ' LEU . 13.6 p90 -165.82 148.12 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.534 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.0 pt-20 -118.46 -170.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.434 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -147.34 155.78 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 111.531 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -113.36 71.66 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.967 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -50.74 -175.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.856 -178.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.62 -158.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.049 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 32' ' ' ASP . 3.9 mm-40 19.88 -82.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.181 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ASP . . . -152.62 22.45 0.82 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.61 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 28.3 m-85 -79.79 134.38 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.52 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 4.6 pt-20 -99.66 134.83 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.52 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -86.49 88.2 7.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.528 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 125.58 79.87 0.37 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.273 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 22.0 t80 -122.18 -3.07 9.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.72 0.295 . . . . 0.0 111.238 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 159.7 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.091 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -89.88 -24.34 21.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.6 OUTLIER 124.26 -19.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.256 0.972 . . . . 0.0 109.988 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.528 ' HA ' ' N ' ' A' ' 38' ' ' GLY . 1.7 tptt -164.8 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.912 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 21.94 102.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.885 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 1.3 m -39.21 95.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.18 0.514 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -119.74 91.88 3.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.147 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.5 p30 -5.51 123.24 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.087 0.867 . . . . 0.0 112.958 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -63.2 -171.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.606 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 54.3 t0 -94.83 72.82 3.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.814 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.547 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.4 mp0 -51.01 -21.59 1.86 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.458 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.2 t -78.28 -9.01 59.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.748 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.4 mt-30 -116.74 -22.22 8.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.713 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -59.95 -32.71 71.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.138 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -116.15 137.48 23.47 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.037 0.446 . . . . 0.0 110.979 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.77 -4.16 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.193 2.595 . . . . 0.0 112.147 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -118.88 -9.43 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.285 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD1' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -49.96 114.15 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.575 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 35.5 m 50.78 23.54 1.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.271 0.557 . . . . 0.0 109.959 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -39.42 -31.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.689 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.38 21.65 5.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -137.99 -129.76 2.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.573 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' GLU . 28.3 t -136.19 129.67 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 24.6 p -97.4 96.33 8.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.506 ' NE2' HG11 ' A' ' 62' ' ' VAL . 52.0 m80 -88.67 59.85 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.731 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 3.7 t-20 -44.1 119.48 1.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.871 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 64' ' ' HIS . 1.4 p -119.43 -162.07 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 69' ' ' SER . 2.7 mt-10 -77.47 142.61 39.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 69' ' ' SER . . . 33.98 34.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.753 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 65.1 p 172.89 -169.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.628 ' CZ ' ' CD1' ' A' ' 57' ' ' LEU . 1.5 p90 -162.1 147.92 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HG2' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.93 146.39 35.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.963 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.524 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -119.19 138.7 52.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.931 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -131.77 123.45 27.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.744 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.72 -34.1 1.71 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.989 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.744 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 15.1 Cg_exo -70.99 -176.06 13.65 Favored 'Cis proline' 0 C--N 1.356 0.945 0 C-N-CA 124.154 -1.186 . . . . 0.0 112.616 0.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.8 Cg_exo -39.29 172.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.015 2.476 . . . . 0.0 112.928 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.77 48.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.7 t-160 -99.48 -126.12 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.751 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -151.67 64.52 0.86 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.122 0.486 . . . . 0.0 110.011 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.524 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.94 107.52 19.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.247 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 31.3 t -55.3 136.77 68.76 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -77.52 110.49 2.98 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.904 2.403 . . . . 0.0 113.845 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.3 m120 71.83 -0.61 3.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.344 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.541 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -79.33 -35.12 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.251 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 4.4 p 85.98 81.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.181 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 155.02 101.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.491 ' HA ' HD13 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.4 148.95 30.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.319 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.295 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.434 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 28.7 t70 -54.19 113.09 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -120.69 161.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 23.9 t0 -42.39 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.618 ' HB3' ' CG ' ' A' ' 27' ' ' PHE . 1.5 mt-10 95.37 -52.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.121 0.569 . . . . 0.0 110.805 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 5.5 t -66.68 -36.01 81.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -76.89 -26.24 53.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.77 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ARG . 9.2 mm -38.18 -36.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.74 154.02 8.67 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -89.7 -18.58 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 111.471 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -104.97 17.5 24.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.065 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD23 ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.84 -55.39 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -85.73 15.19 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 43.72 24.59 0.47 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.381 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.558 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER 163.29 -59.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.3 -150.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 2.4 mt-30 -137.92 113.08 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 24.6 p -53.49 155.31 3.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.8 t -133.55 163.79 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.565 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -107.06 142.45 36.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.965 0.412 . . . . 0.0 111.64 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 26' ' ' ASP . 2.0 p -152.28 153.59 31.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.55 116.55 2.93 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 111.713 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . 46.42 46.92 17.1 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.576 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 171.41 177.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -157.98 161.27 38.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.431 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.517 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -133.57 -172.25 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.459 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 1.1 m -140.83 159.09 42.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 19' ' ' GLN . 1.6 tmtm? -112.76 75.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.5 m -45.87 155.78 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.334 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.465 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 30.9 t70 -57.3 -81.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 6.2 mt-10 -145.11 -40.19 0.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.48 17.52 6.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.391 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 3.8 m-30 -89.61 158.16 17.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -122.08 124.73 44.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.471 ' HB3' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -88.49 105.41 17.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.72 69.83 0.66 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.389 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 91.5 t80 -104.28 -15.02 15.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.445 ' SD ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 168.32 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.198 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.556 ' O ' ' CB ' ' A' ' 42' ' ' MET . 30.7 mmm -75.53 -16.26 60.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.479 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.556 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.5 mtm 99.17 -15.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.524 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.596 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 1.6 mmtp 172.87 99.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.885 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -168.14 72.53 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.347 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 57.1 m -28.65 108.88 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.722 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 8.6 ptm -138.87 113.17 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.5 p-10 0.08 106.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.982 0.802 . . . . 0.0 112.809 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -56.53 -175.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.66 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.9 t0 -94.6 76.13 3.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.421 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 70' ' ' TYR . 1.8 mp0 -49.68 -21.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.142 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.524 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 44.1 t -77.69 -11.11 59.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -111.59 -23.86 10.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -20.92 40.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.829 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -132.76 142.61 45.41 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 -5.63 11.76 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.94 2.427 . . . . 0.0 112.354 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -122.5 -8.37 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.821 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.575 HD22 ' CE2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -53.12 114.35 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 74.1 m 58.0 16.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.47 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -42.73 -27.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.425 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.23 29.4 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.073 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.59 -132.83 2.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.955 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 73' ' ' GLU . 52.1 t -132.54 136.15 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 88.4 m -93.01 89.94 6.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.572 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 31.7 m80 -89.03 47.78 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 110.041 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 19.5 t-20 -44.61 116.06 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.276 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -115.39 -162.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLY . 1.3 mt-10 -75.66 135.87 40.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.91 37.83 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.58 168.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.727 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.575 ' CE2' HD22 ' A' ' 57' ' ' LEU . 15.1 p90 -140.98 149.57 41.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.505 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.63 106.25 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.512 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.8 t -90.19 132.85 35.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.741 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.7 tt0 -145.81 128.09 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.717 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -50.59 -45.49 85.27 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.558 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.717 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 2.7 Cg_exo -75.08 -60.32 0.08 OUTLIER 'Cis proline' 0 C--N 1.352 0.732 0 C-N-CA 123.664 -1.39 . . . . 0.0 113.183 1.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.8 Cg_endo -85.13 -156.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.884 2.389 . . . . 0.0 113.59 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.05 37.25 9.76 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.0 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 160.52 -165.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 111.342 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.22 86.26 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.637 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -65.73 124.12 21.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.348 0.595 . . . . 0.0 111.932 -178.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -53.34 123.09 34.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.879 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.28 -44.81 43.72 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.578 2.185 . . . . 0.0 112.032 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -145.36 13.81 1.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -89.93 -20.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.622 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.34 103.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.0 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.622 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 127.55 106.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.904 0.752 . . . . 0.0 111.276 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.81 139.14 58.73 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 111.328 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.562 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 25' ' ' GLY . 35.2 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -178.7 51.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.83 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -89.85 165.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 61.7 t0 -71.9 91.93 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 48.9 mp0 -72.56 -24.83 61.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.518 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 20.3 t -70.41 -45.7 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.464 ' HG2' ' OD2' ' A' ' 6' ' ' ASP . 6.8 mmt180 -55.18 -31.25 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 9.5 mm -37.97 -37.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.305 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.86 153.57 8.2 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.642 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.72 -22.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.854 2.37 . . . . 0.0 111.495 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -108.02 18.99 20.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.939 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.58 HD22 ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -29.68 -57.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.516 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -93.29 -18.52 22.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.426 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 84.03 -47.2 3.8 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.033 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 31.5 tpt85 -116.68 -9.69 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 0.0 111.268 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -118.46 -171.96 15.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.615 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -118.29 108.9 15.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -50.58 134.67 23.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.064 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 28' ' ' GLU . 2.1 p -119.43 146.16 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.5 t-20 -84.89 141.25 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.41 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -148.6 155.12 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.754 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.3 Cg_endo -53.0 104.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 57.79 42.77 94.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.752 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER 178.62 -168.68 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CE1' HD22 ' A' ' 14' ' ' LEU . 5.9 p90 -173.61 139.5 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.52 ' HB2' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -106.48 -148.75 0.42 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.284 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 m -163.09 148.35 11.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 0.0 111.493 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' CD ' ' A' ' 30' ' ' LYS . 6.6 tmtm? -100.87 67.3 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.098 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 93.4 m -52.52 171.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.842 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 11.1 t70 -68.58 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.522 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.418 ' HG2' ' C ' ' A' ' 68' ' ' GLY . 1.6 tt0 -128.07 -65.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.506 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.71 5.07 32.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.456 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.576 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 m-85 -69.58 112.64 6.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.023 0.44 . . . . 0.0 110.395 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.46 117.07 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.467 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -81.99 103.13 11.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.585 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . . . 126.86 69.47 0.17 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 77.9 t80 -123.61 11.23 9.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.89 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 0.0 111.431 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.597 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.5 mmt -94.96 -27.96 15.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.597 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.5 OUTLIER 127.45 -20.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.443 1.089 . . . . 0.0 110.101 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 5.6 mptt -148.75 -89.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.772 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 36.27 67.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 15' ' ' CYS . 27.6 m -29.7 96.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.154 0.502 . . . . 0.0 110.889 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -125.85 115.35 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.868 -178.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -20.87 138.92 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.584 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.3 pt -82.94 -174.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.134 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.504 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 41.6 t0 -104.07 72.98 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 6.0 mp0 -47.34 -26.04 1.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.391 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.53 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 48.8 t -75.31 -11.93 60.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.038 0.447 . . . . 0.0 110.833 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.0 mt-30 -111.47 -25.3 9.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.353 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HD3' ' OD2' ' A' ' 54' ' ' ASP . 5.0 ttt180 -51.03 -32.89 22.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.594 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 60.2 m-20 -129.78 150.59 76.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.777 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.48 -3.89 6.62 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.238 2.625 . . . . 0.0 112.491 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -113.89 -10.59 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.576 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -53.17 119.57 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.793 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 61.7 m 46.8 26.1 0.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.499 . . . . 0.0 109.968 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 1.3 ttt85 -41.4 -28.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.535 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.68 21.32 3.4 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.891 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -127.57 -139.98 5.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.716 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 73' ' ' GLU . 79.7 t -121.7 137.13 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 25.9 m -96.08 89.13 5.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.496 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 56.7 m80 -89.99 49.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.447 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 13.2 t-20 -45.73 113.76 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.519 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.5 p -105.06 -173.82 2.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.956 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 1.6 mp0 -50.5 -98.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . -88.8 57.71 4.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.415 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 10.8 t 156.8 -173.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.285 . . . . 0.0 110.67 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.576 ' CE2' HD21 ' A' ' 57' ' ' LEU . 7.5 p90 -148.55 149.9 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.519 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -113.62 118.21 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.051 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.07 142.39 27.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.334 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 62' ' ' VAL . 2.2 tt0 -136.19 122.41 20.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.592 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.75 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.07 -34.55 1.71 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.005 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.75 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 11.8 Cg_exo -72.89 -172.15 9.28 Favored 'Cis proline' 0 C--N 1.356 0.943 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.521 0.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 89.2 Cg_exo -41.0 176.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.943 2.429 . . . . 0.0 113.006 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.28 48.76 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.577 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.3 t-160 -101.68 -126.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.506 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 30.2 tt0 -151.22 64.8 0.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.113 0.482 . . . . 0.0 109.894 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.46 129.22 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.576 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -58.79 134.29 86.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.563 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.83 -50.56 12.08 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.595 2.197 . . . . 0.0 111.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -147.15 28.52 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -96.65 -23.65 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.56 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 74.98 89.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.142 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 151.87 99.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.527 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.25 157.15 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.348 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.577 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -165.8 86.97 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -93.04 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.0 t0 -84.61 -50.81 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.0 mp0 73.6 -56.9 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.616 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 28.3 t -64.68 -18.18 64.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.62 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.508 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -76.89 -34.22 57.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.552 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.458 ' HB ' HD11 ' A' ' 14' ' ' LEU . 24.3 mt -43.3 -37.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.615 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 t -162.25 152.19 13.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.671 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -85.53 -17.8 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.114 2.543 . . . . 0.0 111.466 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.53 22.41 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.216 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.577 HD21 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -43.72 -44.25 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.163 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.8 m -83.91 11.47 7.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 52.73 11.1 1.16 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.942 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 tpm_? 172.81 -55.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.338 0.569 . . . . 0.0 110.877 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -64.98 -145.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.969 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 mt-30 -131.48 124.41 30.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.016 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 2.2 p -75.09 130.43 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 111.252 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 41.5 t -117.34 162.02 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.645 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.63 148.54 22.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.499 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 27' ' ' PHE . 6.4 p -152.72 149.12 21.58 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.59 111.45 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.805 2.337 . . . . 0.0 111.953 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.68 43.7 86.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.888 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.459 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 170.01 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.869 0.366 . . . . 0.0 110.671 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.577 ' CZ ' HD21 ' A' ' 14' ' ' LEU . 16.2 p90 -166.51 144.41 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.6 pt-20 -109.98 -168.12 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.5 m -152.31 165.31 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 111.69 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -124.94 72.26 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.564 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.469 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 98.7 m -41.84 170.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.55 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -80.83 -73.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -131.21 -85.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.646 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 33' ' ' GLU . . . -93.33 -7.6 61.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.639 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.515 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 19.1 m-30 -68.57 127.15 31.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 pt-20 -100.24 128.06 46.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -86.94 105.73 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.21 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 117.13 24.17 3.64 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.798 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 40' ' ' MET . 84.9 t80 -44.6 -26.71 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.557 ' CG ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.14 -34.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.574 ' CG ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -54.14 -44.44 71.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.749 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.75 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 8.8 tptt -167.82 23.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.548 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.574 ' ND2' ' CG ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -76.33 143.26 40.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 86.5 m -85.13 108.84 17.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 22.8 ptm -136.6 113.46 10.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.95 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 2.0 p30 2.57 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 124.028 0.83 . . . . 0.0 112.973 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -53.31 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.163 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 46.0 t0 -97.19 73.47 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.937 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 57' ' ' LEU . 1.7 mp0 -49.47 -23.19 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 110.763 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 24.3 t -76.38 -11.22 59.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.9 mt-30 -114.45 -23.96 9.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -57.79 -31.44 66.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' HB2' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -116.02 137.81 23.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.833 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.01 -2.12 10.1 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.061 2.507 . . . . 0.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.52 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -122.93 -5.62 8.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.596 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -53.05 116.67 2.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.957 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.1 m 52.08 21.49 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.17 -26.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.272 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.57 21.63 6.31 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.95 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -147.48 -129.83 1.97 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.683 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 64' ' ' HIS . 38.7 t -137.16 133.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.825 0.345 . . . . 0.0 110.569 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.0 p -99.95 96.88 7.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.496 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.576 ' CD2' HG11 ' A' ' 62' ' ' VAL . 16.9 m80 -88.4 61.14 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.4 t-20 -41.96 120.45 1.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.902 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.527 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -121.17 172.7 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.3 pt-20 -59.99 139.19 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 67' ' ' GLU . . . 38.08 33.77 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.48 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 179.3 -166.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.131 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -173.63 144.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.446 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.5 OUTLIER -109.36 152.09 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -132.17 135.55 46.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.089 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' VAL . 6.7 tt0 -142.9 124.97 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.977 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.783 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -63.71 -38.57 39.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.783 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.0 Cg_exo -80.16 -172.51 11.19 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.291 -1.129 . . . . 0.0 112.587 1.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 8.9 Cg_exo -28.39 152.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.16 2.573 . . . . 0.0 113.56 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.09 -12.77 16.94 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.574 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.4 t60 -120.53 -131.93 0.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.522 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.32 72.42 1.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 110.16 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -84.16 125.81 32.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.269 0.556 . . . . 0.0 111.861 -179.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.543 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 1.1 p -62.89 132.68 94.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.854 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.29 -48.21 13.65 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.656 2.237 . . . . 0.0 112.395 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -153.69 33.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.61 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -101.96 -12.31 8.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.41 86.88 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.305 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 150.73 104.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.2 t -71.21 145.93 49.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.716 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 2.3 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.24 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.807 0.337 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.9 t0 173.6 99.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -90.5 -165.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 17.8 t0 -91.77 -49.27 6.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.997 0.427 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 16.1 mp0 71.71 -55.32 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 67.4 m -61.37 -27.1 68.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.855 0.359 . . . . 0.0 110.344 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.9 -32.62 73.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.169 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.45 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.4 mm -45.51 -39.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' HD2' ' A' ' 12' ' ' PRO . 17.7 t -168.13 154.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.205 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 76.1 Cg_endo -89.31 -20.12 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.234 2.623 . . . . 0.0 111.289 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.32 22.0 16.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.6 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.541 HD23 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.87 -46.44 5.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.272 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -82.35 2.4 32.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.364 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 65.19 4.24 15.41 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.668 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 175.95 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.109 0.455 . . . . 0.0 111.362 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 30' ' ' LYS . . . -65.05 -131.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.163 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 5.1 mt-30 -148.28 122.0 9.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.39 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -67.95 160.85 27.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.7 t -141.43 164.1 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.746 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 6.3 t-20 -105.25 151.21 24.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.457 HG23 ' OE2' ' A' ' 28' ' ' GLU . 5.7 p -153.77 146.82 17.86 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.876 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.77 111.51 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.904 2.403 . . . . 0.0 112.059 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.8 42.08 96.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.996 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.05 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.481 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 4.1 p90 -165.32 171.75 13.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.971 0.415 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 pt-20 -142.62 175.14 10.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -139.91 153.35 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 111.379 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.21 162.84 12.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.907 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 1.3 m -139.74 153.66 47.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.071 0.463 . . . . 0.0 111.341 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -89.89 -157.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.657 -179.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 32' ' ' ASP . 4.4 mt-10 9.42 -77.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -154.28 31.02 0.71 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.176 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 21.9 m-85 -81.12 155.58 26.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -132.68 133.41 43.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -42.96 100.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' HA2' ' CE ' ' A' ' 46' ' ' MET . . . -51.04 -76.22 0.18 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.695 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 84.48 -12.35 0.77 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.45 ' SD ' ' HE3' ' A' ' 46' ' ' MET . 1.0 OUTLIER -88.85 -16.8 31.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.337 179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -33.15 2.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.22 36.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HD3' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER 51.17 36.62 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -77.21 -152.45 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.2 m -115.73 113.68 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.526 ' CE ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -130.54 103.72 6.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.088 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.0 p-10 -12.57 110.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.062 0.851 . . . . 0.0 112.654 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -48.76 -173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.116 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 60.5 t0 -101.51 72.92 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.378 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' CG ' ' HB3' ' A' ' 70' ' ' TYR . 5.1 mp0 -51.96 -22.01 3.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 110.149 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -11.27 60.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.488 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.443 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -115.27 -29.04 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.643 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -49.35 -38.0 26.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -113.12 130.55 23.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.797 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' C ' HD11 ' A' ' 56' ' ' LEU . 73.0 Cg_endo -77.52 -5.73 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.829 2.353 . . . . 0.0 112.156 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -126.64 -6.73 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 85' ' ' SER . 0.5 OUTLIER -30.39 134.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 1.3 m 38.49 36.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.47 -40.8 0.89 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 21.6 7.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.889 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -136.02 -157.0 7.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.951 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.58 HG12 ' CE1' ' A' ' 64' ' ' HIS . 35.3 t -113.96 123.33 69.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.897 0.38 . . . . 0.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -88.84 98.41 11.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.821 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.58 ' CE1' HG12 ' A' ' 62' ' ' VAL . 47.6 m80 -93.37 61.02 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.252 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 12.9 t-20 -49.04 114.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -116.08 -163.47 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -76.03 144.86 40.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.17 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 33.87 35.03 0.04 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.831 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 166.55 177.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.369 . . . . 0.0 111.263 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.539 ' HB3' ' CG ' ' A' ' 50' ' ' GLU . 1.8 p90 -148.84 147.38 28.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 64' ' ' HIS . 3.5 mmm180 -109.66 148.73 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -130.17 133.35 46.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 4.1 tt0 -125.83 119.12 27.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.697 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -64.29 -40.09 48.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.697 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 17.4 Cg_exo -69.26 174.21 39.75 Favored 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.616 1.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 67.1 Cg_exo -30.85 -32.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.057 2.504 . . . . 0.0 113.096 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.61 -30.62 0.06 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.279 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -103.03 -134.92 0.32 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -137.32 82.61 1.94 Allowed 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.323 0.51 . . . . 0.0 110.992 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -90.28 113.48 25.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 82' ' ' PRO . 18.1 t -67.6 135.77 92.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.903 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 Cg_exo -32.96 -115.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.031 3.154 . . . . 0.0 114.157 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.42 39.74 0.96 Allowed 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.957 -0.464 . . . . 0.0 111.062 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -95.93 -31.01 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER 72.04 89.23 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 179.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 157.37 74.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.463 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.0 t -35.89 146.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.585 0.231 . . . . 0.0 110.431 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.537 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.189 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.792 0.33 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.401 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 22.0 t0 64.06 97.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.61 155.42 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 8' ' ' CYS . 50.7 t0 -76.31 67.66 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.639 ' CB ' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 -45.33 -25.02 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.417 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HA ' HD13 ' A' ' 14' ' ' LEU . 37.3 m -74.48 -39.24 62.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' ASP . 13.6 ttt-85 -55.41 -34.2 64.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.786 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.456 ' HB ' HD12 ' A' ' 14' ' ' LEU . 10.9 mm -42.91 -40.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -160.48 145.88 11.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.484 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -83.08 -17.13 6.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.032 2.488 . . . . 0.0 111.279 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -113.57 24.08 12.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.91 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.62 ' CD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.34 -48.67 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.436 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -81.21 0.28 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.205 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 82.69 -44.33 3.21 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.507 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 1.6 tpt180 -142.34 -40.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -63.83 178.46 7.34 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.669 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.5 mt-30 -100.76 95.91 6.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.624 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.475 ' CA ' ' SG ' ' A' ' 15' ' ' CYS . 50.9 t -47.42 130.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.528 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -116.5 154.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.974 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.495 ' N ' HG13 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -107.1 163.4 13.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 112.069 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 1.1 p -161.4 158.9 23.5 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.478 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 7.1 Cg_endo -49.84 110.39 0.37 Allowed 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.728 2.285 . . . . 0.0 112.192 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.28 43.09 89.48 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.354 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CA ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.53 176.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.639 ' CD1' ' CB ' ' A' ' 7' ' ' GLU . 7.1 p90 -155.87 148.99 24.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.331 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.528 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 pt-20 -114.46 -144.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.973 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.9 m -167.84 159.86 11.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.468 . . . . 0.0 111.702 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -120.16 72.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.319 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 94.7 m -42.09 171.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.7 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 25.6 t0 -85.66 -92.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.554 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 56.4 mt-10 -111.95 -69.86 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.374 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.37 -2.03 35.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 13.7 m-85 -69.32 125.31 26.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.721 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -106.05 127.44 53.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.503 ' CB ' ' HD2' ' A' ' 43' ' ' LYS . 1.3 p -91.05 116.5 28.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.92 37.8 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.79 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 79.4 t80 -77.79 -20.81 52.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 110.808 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.493 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.74 -24.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -72.6 -23.14 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 109.67 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.195 0.934 . . . . 0.0 109.953 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 163.25 104.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.766 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -170.01 47.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.396 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' CYS . 94.4 m -1.6 116.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.365 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.567 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 9.8 ptm -143.02 128.93 19.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.2 p-10 -20.93 113.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -58.48 -173.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.545 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 53.9 t0 -101.67 72.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' CG ' ' HB3' ' A' ' 70' ' ' TYR . 19.9 mp0 -50.22 -22.31 1.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.458 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 70.0 m -75.25 -9.63 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.542 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.06 -20.84 9.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.761 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.57 -31.37 70.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.134 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.56 141.49 41.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.465 ' O ' HD13 ' A' ' 56' ' ' LEU . 91.8 Cg_endo -84.82 -5.76 9.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.134 2.556 . . . . 0.0 112.156 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -119.51 0.38 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -53.65 114.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.508 ' HB3' ' N ' ' A' ' 62' ' ' VAL . 56.7 m 54.4 22.31 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.766 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.19 -35.19 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.458 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.26 18.09 25.95 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.923 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 62' ' ' VAL . . . -148.08 -122.64 1.29 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.76 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 73' ' ' GLU . 19.0 t -150.01 135.36 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.794 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.7 p -102.64 100.98 11.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.141 0.496 . . . . 0.0 110.938 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.511 ' NE2' HG13 ' A' ' 62' ' ' VAL . 37.7 m80 -88.98 64.16 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 16.4 t-20 -46.49 120.15 2.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.181 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.461 HG23 ' HD3' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -117.33 -162.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.991 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 7.3 mt-10 -80.51 133.88 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 46.01 42.85 12.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 3.0 p 159.39 -172.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.793 0.33 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.3 p90 -159.3 150.27 19.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 64' ' ' HIS . 4.2 mmm180 -109.84 146.47 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.7 t -125.79 127.47 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.45 127.94 36.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.472 -178.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.793 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.24 -37.73 14.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.793 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.3 Cg_exo -80.12 -172.61 11.33 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.456 1.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 20.8 Cg_exo -28.08 150.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.148 2.565 . . . . 0.0 113.406 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.12 -16.51 11.9 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -115.76 -131.09 0.31 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.105 -0.548 . . . . 0.0 109.686 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -150.97 71.39 1.02 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.277 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -85.72 105.41 16.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.408 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.553 ' HB3' ' CG1' ' A' ' 84' ' ' ILE . 0.3 OUTLIER -61.15 134.42 93.07 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.911 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 56.1 Cg_endo -72.27 109.34 2.7 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.869 2.379 . . . . 0.0 113.568 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 20.0 m120 73.68 33.29 1.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.533 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -110.82 -32.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.567 ' CA ' ' HA ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER 77.4 72.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.793 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 155.4 99.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.508 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 t -59.76 151.56 25.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 110.7 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.511 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.19 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 3.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 3' ' ' THR . 7.2 t0 161.29 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.92 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.578 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 15.1 t0 -88.02 -49.31 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.6 mp0 72.45 -55.46 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 66.4 m -62.03 -23.89 66.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -66.19 -35.5 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.153 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.452 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -41.6 -37.41 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.327 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' CYS . 1.6 t -164.74 153.54 11.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.605 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.1 Cg_endo -83.28 -20.31 5.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.156 2.571 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -114.26 25.89 10.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.146 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD23 ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.08 -50.16 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.266 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 6.9 t -60.18 -14.06 15.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.71 -3.23 44.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.778 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 10.9 tpt180 176.82 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.052 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -85.85 -139.92 5.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.889 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -132.97 106.73 7.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 111.029 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 40.8 t -59.96 152.17 24.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 111.299 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 39.8 t -138.89 163.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.561 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.2 t-20 -100.27 146.78 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 27' ' ' PHE . 4.9 p -150.54 146.31 19.55 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.77 107.89 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.864 2.376 . . . . 0.0 112.008 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.02 40.6 99.12 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.128 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 171.99 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.573 ' CZ ' HD23 ' A' ' 14' ' ' LEU . 6.3 p90 -169.15 151.81 4.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.4 pt-20 -131.26 -170.97 2.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.152 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -165.49 150.87 9.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 111.681 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -97.23 81.69 3.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.143 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -44.09 174.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.61 -95.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.377 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 9.6 tt0 -114.21 -77.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -103.91 4.13 45.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.83 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 21.8 m-30 -69.94 133.07 46.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.286 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' OE2' ' CD1' ' A' ' 39' ' ' PHE . 1.4 pt-20 -89.29 128.52 35.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 33.5 p -84.1 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 95.64 76.78 1.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.786 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' ' OE2' ' A' ' 36' ' ' GLU . 4.0 t80 -85.64 -18.01 34.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 110.547 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.37 -35.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -60.17 -42.89 95.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.518 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.67 -87.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.013 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -161.2 32.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.25 -174.97 3.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.176 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.585 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 1.5 m -111.02 107.82 17.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' C ' ' A' ' 47' ' ' ASP . 18.1 ptm -141.48 110.57 6.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.09 124.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.985 0.803 . . . . 0.0 112.752 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -78.0 -174.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.209 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.6 t0 -98.52 72.97 2.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 11.8 mp0 -52.74 -21.85 4.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.475 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -74.83 -10.57 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.458 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 7.2 mt-30 -119.63 -25.98 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -28.26 14.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.239 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 5.9 m-20 -133.32 144.4 52.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 111.259 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.11 -5.32 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.157 2.571 . . . . 0.0 112.045 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.04 2.45 10.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -56.9 122.69 12.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' GLY . 76.0 m 49.76 25.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.18 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.72 61.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 151.91 -16.82 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.199 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.51 -120.78 3.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.573 HG13 ' CE1' ' A' ' 64' ' ' HIS . 71.6 t -137.55 135.72 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 0.5 OUTLIER -106.59 92.38 4.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.12 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.573 ' CE1' HG13 ' A' ' 62' ' ' VAL . 37.6 m80 -89.73 60.24 4.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.741 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 22.2 t-20 -51.3 111.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -108.27 -161.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.042 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' HA ' ' CB ' ' A' ' 47' ' ' ASP . 4.1 mt-10 -89.75 128.68 36.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 67.01 26.46 73.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.646 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.0 t 158.14 -176.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.1 p90 -146.82 147.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.451 ' HD3' HG22 ' A' ' 66' ' ' THR . 1.0 OUTLIER -109.79 121.36 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -99.58 131.69 45.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.964 179.372 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -130.33 120.13 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 111.884 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.707 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.0 -31.95 0.85 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.938 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.707 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 40.8 Cg_endo -66.47 173.0 32.82 Favored 'Cis proline' 0 C--N 1.356 0.94 0 C-N-CA 123.802 -1.332 . . . . 0.0 112.76 1.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 72.1 Cg_exo -36.74 -29.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.943 2.428 . . . . 0.0 112.88 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.96 -30.45 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.377 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 5.6 t-160 -89.74 -129.34 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 20.0 mt-30 -138.55 61.16 1.59 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.523 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -87.19 125.55 34.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.408 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.532 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -56.66 134.12 78.08 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.819 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.97 -57.1 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.746 2.297 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -143.98 27.92 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.38 -13.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.669 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.93 91.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.786 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.53 99.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.518 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -63.65 148.84 47.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 4.1 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.821 0.343 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -61.8 79.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.526 ' CG2' ' HG3' ' A' ' 7' ' ' GLU . 1.5 tp -89.54 176.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -74.07 -49.0 25.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.289 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.3 mp0 72.06 -56.38 0.65 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.62 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 90.1 m -62.42 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -69.14 -30.2 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.582 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.478 ' HB ' HD13 ' A' ' 14' ' ' LEU . 13.5 mm -48.73 -41.68 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -161.65 156.51 19.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.125 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.4 -18.17 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 111.597 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -107.09 20.94 18.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.309 179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.578 HD23 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -45.84 -39.44 8.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 45' ' ' CYS . 91.5 m -82.23 -3.88 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.263 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 57.0 13.76 9.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.57 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.561 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 2.7 tpt85 173.61 -54.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.69 -151.38 6.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.69 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.0 mt-30 -123.93 121.43 35.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.968 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.5 t -65.58 154.7 37.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 41.4 t -135.93 160.25 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.918 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.524 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.13 147.84 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.362 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.459 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.2 p -152.68 146.17 17.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.07 111.63 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.889 2.392 . . . . 0.0 111.884 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.47 43.61 90.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.94 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 169.17 -165.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 0.0 110.602 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.578 ' CZ ' HD23 ' A' ' 14' ' ' LEU . 13.3 p90 -164.61 141.72 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 6.9 pt-20 -108.72 -172.38 2.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.06 163.67 27.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.527 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -121.11 55.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.211 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 72.8 m -31.66 152.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.634 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 26.6 t70 -61.03 -72.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 7.7 mt-10 -155.78 -34.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.868 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.18 6.26 8.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.628 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.3 m-85 -92.77 141.78 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.384 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.3 120.19 25.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.379 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.526 ' C ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -8.1 120.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.885 0.741 . . . . 0.0 112.42 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.61 57.74 2.96 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 2.0 p90 -52.42 -24.02 7.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.177 -0.512 . . . . 0.0 111.154 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.522 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 2.1 mtt -66.96 -24.77 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.166 0.508 . . . . 0.0 110.013 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.464 ' HE2' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -107.6 -35.57 6.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.55 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 166.95 -61.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.7 tptt 172.47 65.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.85 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.538 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -131.88 87.95 2.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.268 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 44' ' ' ASN . 66.9 m -10.61 117.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.997 0.811 . . . . 0.0 111.846 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.498 ' O ' ' C ' ' A' ' 47' ' ' ASP . 21.5 mtp -140.11 104.98 4.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.849 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.504 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.9 p-10 7.7 112.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -48.59 -175.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.331 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 57.4 t0 -102.32 72.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.46 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.2 mp0 -49.86 -23.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.468 ' HA ' HD21 ' A' ' 57' ' ' LEU . 59.8 m -76.21 -10.18 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.649 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.465 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.4 mt-30 -116.87 -23.83 7.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.68 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -54.12 -33.53 58.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.044 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 4.9 m-20 -127.52 141.69 41.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.15 -8.35 11.9 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.058 2.506 . . . . 0.0 112.06 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -112.8 -8.71 13.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.507 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.633 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.23 120.57 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 58.9 m 45.98 26.12 0.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.182 0.515 . . . . 0.0 110.086 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.78 -30.24 22.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.745 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.28 18.79 7.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.23 -130.32 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 73' ' ' GLU . 48.7 t -134.21 136.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 50.9 t -106.81 99.08 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.26 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.508 ' NE2' HG12 ' A' ' 62' ' ' VAL . 54.1 m80 -90.81 61.03 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.572 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.473 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 8.3 t-20 -47.42 112.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.914 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.522 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -111.85 -163.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 4.2 mt-10 -72.19 134.39 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.73 36.49 0.12 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 171.52 163.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.744 0.307 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 2.0 p90 -138.03 145.41 41.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.7 115.71 30.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.55 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.68 132.75 35.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.019 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.43 120.81 22.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.825 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.699 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.01 -32.42 0.99 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.926 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.699 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 25.8 Cg_exo -65.33 171.84 31.78 Favored 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 123.883 -1.299 . . . . 0.0 112.67 1.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 71.0 Cg_exo -36.33 -27.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.939 2.426 . . . . 0.0 112.95 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.33 -30.78 0.06 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.272 -0.965 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -91.03 -128.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -140.42 65.16 1.42 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.194 0.521 . . . . 0.0 109.614 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.88 130.33 36.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.408 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.544 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -61.05 134.91 93.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.895 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.9 -53.8 6.49 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.712 2.275 . . . . 0.0 112.47 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -148.06 24.46 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.245 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -91.74 -17.55 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.964 0.411 . . . . 0.0 110.542 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.92 89.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.025 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.8 98.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.516 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.33 151.61 31.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.154 178.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.26 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 24.1 p . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.86 0.362 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 3' ' ' THR . 23.7 t0 175.55 82.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.7 mp -104.09 165.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 62.6 t0 -77.38 97.21 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 29.0 mp0 -81.68 -21.32 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.4 t -70.57 -49.84 43.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.59 -22.58 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 7' ' ' GLU . 27.7 mt -45.5 -40.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -164.56 140.11 4.7 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -76.02 -17.07 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.571 2.181 . . . . 0.0 111.651 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.76 13.93 22.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.559 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.25 -56.36 2.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.3 t -62.56 -11.76 18.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.022 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.46 -2.12 47.92 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.63 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 11.6 tpt180 177.53 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -87.46 -143.88 8.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.948 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -130.45 112.54 13.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.658 0.266 . . . . 0.0 110.961 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 21.2 p -53.95 154.17 4.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 111.195 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 14.2 t -134.79 164.62 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.106 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.0 t-20 -110.29 139.54 45.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 111.595 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 27' ' ' PHE . 2.1 p -147.36 153.9 44.82 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.752 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.22 119.91 7.31 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.794 2.329 . . . . 0.0 111.846 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.11 43.77 25.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.847 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.41 -169.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.363 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' CE2' HD23 ' A' ' 14' ' ' LEU . 20.5 p90 -166.26 176.6 7.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.185 0.517 . . . . 0.0 111.755 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -153.37 -165.47 2.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.892 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 9.3 p -170.32 151.12 3.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 111.576 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -94.36 78.75 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.267 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -42.29 170.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.493 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 13.6 t0 -63.87 -96.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.536 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.94 -74.55 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -99.77 -6.35 54.51 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.086 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 17.6 m-30 -69.14 128.84 38.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.11 149.56 21.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.686 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 69.3 p -59.64 77.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . 102.73 -64.49 0.42 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.882 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 62.6 t80 97.66 -14.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.075 0.55 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.12 -24.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.061 -179.828 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -73.75 -39.32 64.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.309 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 155.02 -59.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.35 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' CD ' ' HB2' ' A' ' 37' ' ' SER . 1.8 tptt 179.35 105.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.732 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -161.21 27.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.899 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' CYS . 2.9 m 42.72 106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.589 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' ASP . 10.2 mmm -148.57 103.4 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.098 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.1 p-10 0.27 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.809 . . . . 0.0 112.763 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.488 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -65.64 -173.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.521 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -91.0 74.24 6.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.939 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.578 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -51.64 -23.83 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.718 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 40.5 t -74.67 -11.87 60.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.52 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.4 mt-30 -116.99 -25.66 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -50.82 -37.99 46.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.506 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -113.11 137.93 22.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 -5.07 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.075 2.517 . . . . 0.0 111.982 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.69 -6.67 9.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.42 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -52.72 124.71 14.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.3 m 45.02 26.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.331 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.89 62.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.431 179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 146.35 -15.43 1.66 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.627 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.52 -116.65 3.6 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.177 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 49.9 t -150.05 130.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.935 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.0 p -100.25 100.91 11.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.043 0.449 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.516 ' O ' ' CG2' ' A' ' 66' ' ' THR . 73.4 m80 -89.93 57.22 3.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -42.28 110.53 0.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.345 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -114.26 -161.63 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.028 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' SER . 6.7 mt-10 -75.47 139.89 42.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.16 32.83 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.795 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER 171.68 177.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.6 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -147.86 148.32 30.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.89 114.63 28.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.569 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.78 136.87 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.007 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 31.3 tt0 -134.48 120.82 20.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.811 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.727 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -81.06 -32.99 0.67 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.856 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.727 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 45.7 Cg_endo -67.74 173.69 35.74 Favored 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.641 0.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 77.1 Cg_exo -36.26 -30.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.994 2.463 . . . . 0.0 112.723 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.51 -30.93 0.06 OUTLIER Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.262 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 5.4 t-160 -88.7 -127.62 0.06 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.98 62.85 1.43 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.76 131.12 35.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.438 -178.901 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.543 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -62.12 134.85 94.65 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.759 179.727 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.14 -55.39 4.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.567 2.178 . . . . 0.0 112.307 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -145.51 25.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.347 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -93.42 -17.62 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.324 179.454 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER 73.79 90.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.979 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.25 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.72 148.73 50.51 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.292 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.2 t0 61.89 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.8 -179.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.711 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -90.31 -48.27 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.587 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.2 mp0 67.43 -53.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.907 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 78.5 m -67.13 -22.47 65.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.865 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.1 ttt85 -72.69 -30.77 64.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.273 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -45.29 -40.77 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.483 179.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -159.02 152.93 19.45 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.616 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -83.48 -23.03 3.57 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.119 2.546 . . . . 0.0 111.14 179.519 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -114.85 31.25 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.709 179.382 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.89 -54.28 0.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.518 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.5 m -88.42 26.61 1.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 32.99 34.68 0.02 OUTLIER Glycine 0 C--O 1.229 -0.18 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.194 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 157.33 -60.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.96 0.409 . . . . 0.0 110.393 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.89 178.27 1.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.097 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.31 102.39 11.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.82 0.343 . . . . 0.0 110.811 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 38.8 t -57.9 142.46 46.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.5 t -129.22 162.52 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.563 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.5 t-20 -96.81 142.13 29.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.373 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -146.42 151.79 44.45 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.872 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.69 117.08 2.98 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.9 2.4 . . . . 0.0 111.923 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.35 44.73 44.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.829 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.81 -164.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.705 0.288 . . . . 0.0 110.462 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 9.6 p90 -164.2 142.83 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.353 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 5.2 pt-20 -111.45 -167.64 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.201 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -153.29 -177.61 6.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.419 0.628 . . . . 0.0 111.76 -179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 4.9 tmtt? -138.42 69.27 1.38 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.797 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 93.8 m -42.41 169.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -64.82 -93.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.257 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.13 -35.47 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.12 27.34 2.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.367 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 4.5 m-30 -94.09 139.01 31.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -90.09 120.44 31.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 15.7 p -79.21 91.28 4.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 103.13 72.56 0.92 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.557 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 18.4 t80 -87.52 -8.03 56.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.93 -32.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.717 -179.871 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.8 mmm -71.8 -36.44 70.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.4 OUTLIER 156.27 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 1.9 mmtm -158.13 22.63 0.25 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -63.62 76.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 111.381 -179.681 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 16.0 m -37.48 100.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -126.39 121.72 33.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 -179.47 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.7 p-10 -21.2 100.23 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.985 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.573 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -47.55 -176.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.282 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.5 t0 -97.62 72.17 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.583 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HB3' ' CD1' ' A' ' 70' ' ' TYR . 2.0 mp0 -51.21 -21.61 2.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.451 ' HA ' HD23 ' A' ' 57' ' ' LEU . 7.1 t -77.72 -8.68 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 6.0 mt-30 -118.92 -22.06 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -53.66 -23.04 10.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.34 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -124.38 140.64 35.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.058 0.456 . . . . 0.0 110.971 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -78.35 -10.3 16.18 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.011 2.474 . . . . 0.0 112.364 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.69 -2.72 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.581 179.702 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -50.9 111.64 0.58 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.691 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HA ' HD22 ' A' ' 80' ' ' LEU . 61.3 m 56.3 18.59 3.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.91 -35.98 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.47 179.507 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.7 22.72 8.11 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.957 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.0 -131.16 2.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.827 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 73' ' ' GLU . 71.6 t -137.14 129.6 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.878 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.467 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.7 p -98.71 94.22 6.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.553 ' NE2' ' CG1' ' A' ' 62' ' ' VAL . 18.8 m80 -88.37 60.6 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.266 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -44.58 115.15 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.524 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.3 p -111.38 -161.61 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -85.72 127.46 34.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 55.52 27.22 47.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.11 174.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.743 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 29.5 p90 -141.64 151.22 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.7 112.29 24.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.189 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.5 t -96.45 135.44 38.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 62' ' ' VAL . 2.9 tt0 -150.06 127.52 11.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.388 -178.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.725 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -49.26 -45.36 76.07 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.443 179.569 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.725 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.1 Cg_exo -76.07 -61.42 0.05 OUTLIER 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.676 -1.385 . . . . 0.0 113.121 0.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.693 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.7 Cg_endo -85.37 -155.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.932 2.421 . . . . 0.0 113.02 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 78' ' ' HIS . . . 51.73 20.48 5.92 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.836 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.59 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 1.1 m-70 168.43 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.218 0.533 . . . . 0.0 111.499 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.36 95.86 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.823 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -73.23 120.53 18.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 -178.931 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.552 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.3 OUTLIER -48.4 123.79 11.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.09 -42.0 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.975 2.45 . . . . 0.0 112.881 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -154.3 19.42 0.49 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -91.28 -11.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.744 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.618 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 63.94 90.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.892 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.618 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 137.38 112.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.714 0.634 . . . . 0.0 111.252 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -68.11 158.67 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 110.697 179.572 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 21.0 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.028 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 4.1 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 3' ' ' THR . 10.8 t0 168.01 88.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 1.4 tp -89.61 177.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.8 t0 -71.88 -48.02 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 71.73 -56.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.743 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 87.5 m -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.455 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -64.49 -34.77 78.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.678 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.465 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.8 mm -42.24 -39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.25 179.368 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.28 151.88 13.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.62 -179.917 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.71 -19.08 3.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.189 2.593 . . . . 0.0 111.041 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -111.97 26.93 10.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.969 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.601 ' CD2' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.86 -48.34 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.352 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -84.64 8.58 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.312 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 39.66 25.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.491 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' CB ' ' HB2' ' A' ' 45' ' ' CYS . 1.1 tpt180 173.24 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -88.4 -156.08 30.42 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.999 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -125.68 110.45 13.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.791 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.3 t -60.74 154.13 22.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.324 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 40.6 t -139.9 161.41 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.721 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.537 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -91.51 142.35 27.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.315 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 27' ' ' PHE . 4.7 p -147.5 150.81 38.22 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.932 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.83 109.25 0.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.788 2.325 . . . . 0.0 111.906 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.06 43.18 93.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.909 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.65 -163.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 0.0 110.727 -179.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.601 ' CE2' ' CD2' ' A' ' 14' ' ' LEU . 11.7 p90 -167.76 139.89 3.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.99 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.7 pt-20 -108.18 -172.65 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.638 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -145.57 157.92 43.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.458 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -109.55 64.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.196 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -50.46 154.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.488 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.422 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 22.9 t70 -37.69 -90.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.304 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 27.0 mt-10 -140.03 -37.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -132.15 20.07 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.342 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.7 m-30 -89.23 155.51 19.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 111.212 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.575 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -112.87 122.41 47.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.656 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -78.47 82.52 4.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 126.63 49.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' MET . 12.1 t80 -66.28 -13.78 60.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.8 -31.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.707 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 42' ' ' MET . 8.9 mmt -66.81 -36.24 81.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.613 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 159.13 -56.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 17.6 tptt -160.68 21.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.992 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -70.51 129.51 39.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.796 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 17' ' ' ARG . 55.8 m -65.69 107.08 1.65 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.643 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 47' ' ' ASP . 6.6 mmt -135.24 103.25 5.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.468 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.1 p-10 -1.21 105.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.967 0.792 . . . . 0.0 112.897 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.575 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.8 pt -63.58 176.11 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 47.6 t0 -91.58 77.36 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 7.1 mp0 -47.97 -30.61 4.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 57' ' ' LEU . 77.9 m -71.11 -10.94 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -118.48 -16.01 9.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -61.22 -36.68 80.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.377 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -129.09 124.43 22.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.402 -179.629 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.7 -8.27 15.02 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.198 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.512 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -111.23 -13.05 14.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.071 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' CD2' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -47.66 114.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.869 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 64.2 m 51.05 21.58 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.358 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.06 -31.42 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.45 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 20.8 5.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.713 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -135.33 -143.43 4.75 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.85 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.614 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 50.8 t -119.39 128.02 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.317 . . . . 0.0 110.913 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 16.1 t -99.36 90.84 4.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 111.483 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.614 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 43.0 m80 -89.63 57.64 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.394 179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -48.64 108.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.483 ' OG1' ' N ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.87 -161.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.953 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' N ' ' OG1' ' A' ' 66' ' ' THR . 2.5 mt-10 -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 75.86 23.24 72.74 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 1.3 p 156.52 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.703 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.635 ' CE2' ' CD2' ' A' ' 57' ' ' LEU . 5.9 p90 -148.62 152.82 37.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 2.5 mmm180 -109.53 106.63 16.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.01 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 1.4 t -92.56 125.17 37.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' VAL . 4.4 tt0 -143.19 116.5 9.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.623 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -38.2 -65.05 0.4 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.008 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.747 ' HD2' ' HD3' ' A' ' 76' ' ' PRO . 84.9 Cg_endo -104.94 14.63 10.76 Favored 'Cis proline' 0 N--CA 1.441 -1.563 0 C-N-CA 123.775 -1.344 . . . . 0.0 113.126 1.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.747 ' HD3' ' HD2' ' A' ' 75' ' ' PRO . 69.9 Cg_exo -41.7 171.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.357 2.038 . . . . 0.0 112.227 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.32 81.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.586 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.83 -159.91 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.0 110.861 -178.946 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.59 80.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -68.88 120.19 14.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.569 . . . . 0.0 111.487 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 84' ' ' ILE . 0.5 OUTLIER -46.87 127.95 8.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.089 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.39 -52.43 7.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.763 2.309 . . . . 0.0 112.422 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -138.45 20.62 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.95 -28.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.781 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.63 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 82.34 100.81 0.05 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.92 179.015 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 129.33 133.99 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.898 0.749 . . . . 0.0 111.308 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 40.5 t -73.28 140.53 46.87 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 5.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.315 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.883 0.373 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 3' ' ' THR . 37.8 t0 179.17 96.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.971 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -94.99 166.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.761 179.783 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.5 t0 -72.95 -51.44 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 109.974 179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 6.5 mp0 69.69 -53.32 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.512 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 86.3 m -63.82 -27.04 68.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.4 mmt180 -68.14 -33.47 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.442 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.5 mt -44.42 -39.9 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.092 0.473 . . . . 0.0 110.445 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.417 ' O ' HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -162.03 150.83 12.8 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.456 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.8 -19.72 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.127 2.552 . . . . 0.0 111.342 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -111.91 25.43 11.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.134 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.563 HD23 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.92 -36.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.331 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -85.66 15.63 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.314 -179.435 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 52.1 16.94 3.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.281 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 153.65 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' N ' ' HB2' ' A' ' 15' ' ' CYS . . . -67.77 -162.6 2.03 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.034 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.4 mt-30 -121.02 112.04 18.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -70.59 149.6 46.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.327 0.584 . . . . 0.0 112.471 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.8 t -135.35 163.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.343 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -99.63 142.41 31.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.219 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.431 ' CG2' ' HG2' ' A' ' 28' ' ' GLU . 4.3 p -146.05 145.67 25.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.22 111.75 0.17 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.965 2.443 . . . . 0.0 112.003 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.56 47.47 44.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.919 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 172.01 -172.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.822 -179.596 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 17.3 p90 -163.05 146.76 10.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 15.5 pt-20 -124.16 -177.4 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.155 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.3 m -141.41 163.98 31.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' GLN . 1.4 tmtt? -110.83 69.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' LYS . 72.7 m -33.0 144.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.58 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 14.7 t70 -51.59 -71.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 4.2 tt0 -153.51 -62.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.575 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.47 28.63 11.26 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.596 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.505 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 4.8 m-30 -98.08 159.91 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.668 0.275 . . . . 0.0 110.783 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.551 ' CB ' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.67 131.23 55.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.547 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -83.0 94.57 7.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 106.58 43.25 1.47 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.432 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 25.0 t80 -46.04 -32.33 2.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 110.347 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.75 -30.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.051 179.67 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.507 ' HG2' ' ND2' ' A' ' 44' ' ' ASN . 4.8 ppp? -55.97 -43.91 77.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.558 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER 171.37 -40.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.0 OUTLIER 156.96 87.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.568 -179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -149.36 93.99 2.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.227 0.537 . . . . 0.0 110.415 179.651 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 40.4 m -36.2 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.073 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 39' ' ' PHE . 3.3 ptm -133.13 131.39 40.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.9 p-10 -18.29 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.544 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' CB ' ' A' ' 36' ' ' GLU . 3.7 pt -49.67 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.328 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 58.3 t0 -101.05 72.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.375 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 70' ' ' TYR . 3.1 mp0 -48.86 -24.94 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.223 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 37.2 t -75.43 -10.16 59.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.422 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 2.4 mt-30 -118.77 -23.3 7.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.879 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -21.04 18.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -128.96 139.2 34.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.998 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.58 -5.32 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.923 2.415 . . . . 0.0 112.072 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.519 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.2 -8.37 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.614 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -51.78 117.12 2.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.871 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 60.7 m 49.28 23.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.041 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 2.4 tmt_? -45.91 -33.68 3.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.741 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.31 11.42 10.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.065 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.89 -138.54 4.09 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 50.4 t -126.48 135.32 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.463 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 14.0 p -103.08 99.48 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 66' ' ' THR . 48.1 m80 -90.01 60.23 4.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -44.5 110.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.352 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -109.69 -178.5 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.667 179.553 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 4.4 pt-20 -79.39 119.35 22.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 73.59 26.54 69.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.7 t 158.4 177.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.727 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.581 ' CE2' HD23 ' A' ' 57' ' ' LEU . 15.0 p90 -144.35 149.51 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.73 114.28 27.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.444 -179.508 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.536 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.03 135.59 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 20.7 tt0 -132.16 117.75 18.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.697 ' N ' ' CA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.73 -33.09 0.98 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.822 179.399 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.697 ' CA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.13 171.86 35.47 Favored 'Cis proline' 0 C--N 1.355 0.907 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.634 1.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 61.5 Cg_exo -36.61 -29.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.022 2.481 . . . . 0.0 112.833 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.8 -30.63 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.328 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.583 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 4.8 t-160 -88.45 -127.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.47 62.88 1.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.151 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.6 130.95 35.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.375 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.538 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -61.38 134.79 93.53 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.45 -53.26 7.41 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.674 2.25 . . . . 0.0 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -148.75 26.25 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.299 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -94.03 -17.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.434 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.6 90.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 179.105 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 156.2 100.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.27 149.26 48.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.101 178.787 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.583 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.353 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.81 0.338 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 3' ' ' THR . 13.0 t0 178.08 71.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -104.87 153.58 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.905 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 44.2 t0 -62.39 74.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 111.068 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.538 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 37.5 mp0 -56.67 -17.04 7.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 13.8 t -81.35 -35.05 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.676 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.47 -27.75 64.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.523 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -45.57 -41.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -164.79 127.36 1.57 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.919 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 11.2 Cg_exo -68.19 -18.27 45.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.659 2.239 . . . . 0.0 111.034 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.28 11.27 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.484 179.633 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.585 HD21 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -43.24 -47.98 6.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.2 t -72.9 -14.35 61.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 76.23 -2.36 57.03 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.1 tpt85 177.35 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.035 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -82.47 -139.16 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.99 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 7.8 mt-30 -140.3 107.5 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.642 0.258 . . . . 0.0 110.916 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 5.2 p -52.37 149.72 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -131.26 163.99 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.555 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -110.27 141.89 42.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.007 0.432 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.449 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.7 p -148.51 157.01 42.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 16.2 Cg_endo -57.86 113.03 1.34 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.658 2.239 . . . . 0.0 111.726 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 52.43 44.88 59.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.541 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 171.58 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.366 -179.502 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.585 ' CE2' HD21 ' A' ' 14' ' ' LEU . 27.3 p90 -166.75 175.91 7.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 111.852 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 10.3 pt-20 -153.59 -164.88 2.0 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 10.4 p -170.09 150.4 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 111.638 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.93 83.54 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.396 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -48.68 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.418 -179.355 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.7 t0 -104.33 -144.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.983 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 32' ' ' ASP . 2.6 mm-40 -29.61 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.83 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -120.0 25.93 7.32 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.663 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 20.9 m-30 -79.91 135.07 36.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 5.0 pt-20 -108.07 131.89 54.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.845 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.442 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.6 99.06 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.914 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.97 44.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.558 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 17.7 t80 -86.46 -6.6 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.775 0.322 . . . . 0.0 111.035 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 158.98 -23.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.643 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.4 OUTLIER -90.72 -20.38 22.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.781 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.3 OUTLIER 100.51 -13.88 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.917 0.76 . . . . 0.0 110.413 -179.528 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 42' ' ' MET . 7.0 tptt 168.35 100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.002 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -166.72 34.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.442 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.7 m 34.66 98.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.429 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.6 mmt -132.83 102.19 5.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.53 179.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.24 123.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.017 0.823 . . . . 0.0 112.796 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -66.84 -173.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.137 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 43.2 t0 -95.13 76.57 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.026 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 70' ' ' TYR . 1.3 mp0 -46.58 -27.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.393 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 34.7 t -75.07 -16.83 60.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.003 0.43 . . . . 0.0 110.605 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.462 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -103.02 -23.31 13.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.216 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -43.98 92.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -100.63 155.92 35.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -93.3 3.77 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.432 2.755 . . . . 0.0 112.733 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.01 11.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.335 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -57.33 118.23 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 34.6 m 50.2 24.14 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.392 0.615 . . . . 0.0 109.653 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.52 -29.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.818 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . -134.18 27.25 3.31 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.961 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.68 -126.36 2.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.83 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 73' ' ' GLU . 43.0 t -137.39 135.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 110.818 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 61.9 m -96.92 92.59 6.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.493 ' CE1' ' CD ' ' A' ' 73' ' ' GLU . 58.2 m80 -88.98 48.84 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.038 0.447 . . . . 0.0 110.27 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 9.1 t-20 -42.42 116.93 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.522 HG23 ' CD ' ' A' ' 71' ' ' ARG . 2.5 p -119.53 -176.44 3.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 5.2 pt-20 -64.0 134.59 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.45 36.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.489 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 171.78 156.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' CE1' HD23 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -133.57 145.61 50.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' CD ' HG23 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.86 114.11 27.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.503 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -89.78 134.13 34.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.863 179.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -131.57 127.06 36.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.749 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.73 -33.68 1.6 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.437 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.749 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 14.6 Cg_exo -71.25 -173.3 9.44 Favored 'Cis proline' 0 C--N 1.356 0.964 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.568 1.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 81.3 Cg_exo -40.92 173.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.938 2.425 . . . . 0.0 112.812 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.51 53.25 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 1.1 t60 -101.08 -125.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 30.4 tt0 -151.05 65.85 0.91 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.001 0.429 . . . . 0.0 110.296 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.91 123.08 34.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.47 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.538 ' CB ' ' HB ' ' A' ' 84' ' ' ILE . 79.8 p -60.41 136.44 91.9 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.756 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.19 -66.0 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.787 2.325 . . . . 0.0 112.541 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -137.48 41.07 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.224 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -106.06 -14.74 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.413 . . . . 0.0 110.47 179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.35 89.12 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.12 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' SER . . . 155.18 93.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.521 ' SG ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -54.58 159.93 1.97 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.766 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.576 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -89.94 179.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 5' ' ' ILE . 29.1 t0 -85.63 93.58 8.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 30.7 mp0 -76.27 -19.25 58.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.357 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.5 t -83.56 -26.09 30.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -71.29 -25.95 62.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.24 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.5 mm -45.41 -39.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.693 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.9 t -165.99 156.19 11.24 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 4.9 Cg_endo -86.37 -19.89 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.356 2.704 . . . . 0.0 111.749 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -109.21 21.9 16.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.484 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.561 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.8 -46.51 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.168 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -88.05 3.76 47.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 57.94 12.49 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.851 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 173.21 -50.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -70.11 -144.03 0.22 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.088 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 5.4 mt-30 -137.2 124.93 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 0.0 110.993 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.25 132.12 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.7 t -109.2 163.79 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.42 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.567 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.9 t30 -111.29 143.08 42.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.354 . . . . 0.0 111.299 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -151.97 154.87 33.19 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 14.5 Cg_endo -57.16 116.61 3.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.746 2.297 . . . . 0.0 111.858 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.45 42.87 57.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.916 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.6 OUTLIER 167.3 -178.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.763 0.316 . . . . 0.0 110.547 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.659 ' HA ' HG23 ' A' ' 23' ' ' THR . 11.2 p90 -159.54 176.15 12.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.544 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -145.51 -172.35 3.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.529 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -147.91 158.73 44.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 0.0 111.38 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.88 74.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.152 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -46.06 -179.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLU . 9.8 t0 -106.62 -141.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.225 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -23.1 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -124.87 23.48 6.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.618 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.555 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 23.2 m-85 -75.42 131.04 39.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 111.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.6 pt-20 -109.86 130.17 55.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -33.96 114.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.038 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.59 55.25 2.92 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 4.0 p90 -56.97 -25.96 59.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.509 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 3.7 mtt -66.59 -19.05 65.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.105 0.479 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.8 mmm -119.36 -32.18 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.578 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 178.73 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.433 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HE2' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 178.01 33.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.14 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 6.4 p-10 -85.21 -157.97 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.669 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.1 m -107.43 116.5 32.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.061 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.475 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -136.15 95.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.633 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -10.91 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.703 0.801 . . . . 0.0 113.028 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.2 pt -70.37 -173.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.313 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.3 t0 -99.2 74.03 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.755 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.2 mp0 -48.28 -22.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.3 m -76.72 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.697 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -117.65 -23.87 7.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.51 -28.46 67.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -128.38 137.97 32.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.117 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.11 -6.44 12.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.964 2.443 . . . . 0.0 112.043 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -111.78 -17.9 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.147 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.906 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -46.94 118.93 2.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.965 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 47.0 m 44.01 26.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.2 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.01 -31.93 19.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.836 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.9 25.47 6.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.095 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.15 -125.59 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.626 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.766 HG11 ' CE1' ' A' ' 64' ' ' HIS . 31.5 t -139.29 135.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 43.5 t -108.92 97.05 6.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.366 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.766 ' CE1' HG11 ' A' ' 62' ' ' VAL . 89.7 m-70 -88.87 63.5 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.135 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.7 t-20 -45.71 122.42 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -120.01 -165.55 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.994 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 68' ' ' GLY . 9.0 mt-10 -73.65 140.38 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.16 36.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 169.95 -178.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.906 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.5 p90 -153.14 148.41 26.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.647 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.92 135.85 50.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.005 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.36 131.84 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.059 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.42 127.34 37.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.301 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.823 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.49 -31.92 0.89 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.099 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.823 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.6 Cg_exo -71.85 -169.3 6.03 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.641 1.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.2 Cg_exo -43.22 178.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.904 2.403 . . . . 0.0 112.856 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.55 -18.26 50.53 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 7.5 t-160 -104.23 -127.95 0.24 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 1.5 mt-30 -150.53 59.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.013 0.435 . . . . 0.0 110.056 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.051 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -86.26 129.53 34.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.52 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.051 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.36 133.0 88.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.682 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.14 -48.4 19.71 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.675 2.25 . . . . 0.0 112.011 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.588 ' C ' HD13 ' A' ' 84' ' ' ILE . 10.2 m120 -146.95 21.21 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.836 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.12 -23.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.768 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 75.57 91.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.928 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.681 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . 150.61 103.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 1.0 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.97 148.21 48.25 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.226 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 t0 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.874 0.369 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.94 169.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.526 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 10.6 t0 -75.08 -49.14 20.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.073 0.463 . . . . 0.0 109.823 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HB3' ' CG ' ' A' ' 27' ' ' PHE . 10.4 mp0 68.53 -52.91 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.757 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 47.5 t -63.74 -37.11 86.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.531 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -66.77 -25.8 66.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 7.1 mm -39.92 -37.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.148 0.499 . . . . 0.0 110.397 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.85 151.68 8.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.696 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.74 -17.53 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.999 2.466 . . . . 0.0 111.49 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -113.69 21.92 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.988 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -38.25 -61.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.339 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 45' ' ' CYS . 1.6 m -73.26 -3.39 26.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.65 11.13 27.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 178.42 -50.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.87 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.44 -150.97 2.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.638 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -132.93 110.42 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.303 . . . . 0.0 110.963 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.6 p -52.54 131.27 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG12 ' CB ' ' A' ' 28' ' ' GLU . 4.0 p -106.82 167.05 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.477 ' H ' HG22 ' A' ' 21' ' ' VAL . 8.7 t-20 -112.94 140.71 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.367 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.644 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -147.29 148.62 32.3 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.109 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' OD2' ' A' ' 4' ' ' ASP . 4.0 Cg_endo -46.88 116.38 1.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.021 2.481 . . . . 0.0 111.973 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.73 45.71 39.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.998 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 169.13 -167.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.583 0.23 . . . . 0.0 110.479 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.644 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -169.66 176.2 5.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 111.465 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.543 ' CB ' HG12 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -144.74 -145.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.456 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 1.1 m -163.12 154.43 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.414 . . . . 0.0 111.333 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -105.82 67.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.254 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -45.4 175.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.488 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' C ' ' HG3' ' A' ' 33' ' ' GLU . 15.1 t70 -72.86 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 32' ' ' ASP . 10.8 mt-10 -141.95 -39.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -122.14 14.44 8.92 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.016 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.1 m-30 -94.99 161.17 14.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.829 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.598 ' HB3' HG22 ' A' ' 48' ' ' ILE . 3.0 pt-20 -118.25 131.24 56.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.55 102.69 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.652 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 42' ' ' MET . . . 98.71 64.66 0.85 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.719 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' MET . 4.2 t80 -83.56 -11.59 57.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.7 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 41' ' ' MET . 3.3 ptm 176.69 -31.79 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -83.0 -20.17 35.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.08 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 104.62 -21.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.058 0.849 . . . . 0.0 110.626 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 29' ' ' CYS . 14.9 mmtm -171.38 100.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.518 ' O ' ' C ' ' A' ' 45' ' ' CYS . 5.0 p-10 -158.98 33.72 0.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 15' ' ' CYS . 2.8 t 9.52 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.901 0.75 . . . . 0.0 112.406 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -150.59 110.32 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -2.1 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.947 0.779 . . . . 0.0 112.576 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -50.55 174.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 51.9 t0 -93.7 75.47 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.903 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 mp0 -51.64 -21.66 2.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.976 0.417 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 78.9 m -76.75 -9.67 58.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.618 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.79 -23.51 6.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -29.82 64.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -125.1 137.2 29.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.86 -8.13 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.014 2.476 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -119.17 -3.51 10.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.982 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -53.36 122.17 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.7 m 48.97 24.66 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.515 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -65.22 61.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.474 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 150.06 -16.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.881 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.22 -124.29 4.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.24 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.748 HG11 ' NE2' ' A' ' 64' ' ' HIS . 75.0 t -136.24 132.91 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.315 . . . . 0.0 110.957 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 25.0 t -104.79 94.58 5.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.748 ' NE2' HG11 ' A' ' 62' ' ' VAL . 42.3 m80 -89.96 59.91 4.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.671 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -47.83 109.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.555 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -108.77 178.02 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.019 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER -71.95 121.82 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 68.12 32.91 77.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.2 t 158.06 178.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.982 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -146.92 142.95 28.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD3' HG21 ' A' ' 66' ' ' THR . 3.3 mmm180 -109.42 116.64 32.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.683 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -94.87 128.0 41.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.579 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.0 tt0 -128.37 123.29 33.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.74 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.29 -32.24 0.94 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.998 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.74 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 29.5 Cg_exo -64.85 170.93 32.43 Favored 'Cis proline' 0 C--N 1.356 0.926 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.7 1.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 73.8 Cg_exo -35.37 -28.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.992 2.461 . . . . 0.0 113.029 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.37 -31.2 0.04 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.434 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.2 t-80 -91.85 -129.2 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 88' ' ' ILE . 4.0 mt-30 -140.03 66.34 1.4 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.105 0.479 . . . . 0.0 109.726 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.008 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.95 93.44 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.154 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 33.4 t -43.24 137.79 2.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.477 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 76.1 Cg_endo -79.17 111.94 2.97 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.931 2.421 . . . . 0.0 113.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.4 m120 72.62 -1.24 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.6 mp -81.63 -18.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.77 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.947 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.59 98.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.974 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -59.01 150.75 23.84 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.5 t0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.77 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' HG23 ' A' ' 5' ' ' ILE . 34.0 t0 -86.76 101.14 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -81.11 -24.34 37.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.131 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.2 t -71.09 -41.92 70.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.745 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 1.4 ttt180 -57.44 -32.92 67.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.01 -38.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.473 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -165.22 146.76 6.32 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.687 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 -16.51 8.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.938 2.426 . . . . 0.0 111.799 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.88 16.92 21.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.486 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -44.81 -43.44 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.797 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 55.1 m -74.57 -14.13 60.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 66.61 6.3 34.84 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.137 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 1.9 tpt180 174.11 -29.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -94.65 -151.04 27.87 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.083 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.439 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 1.8 mm100 -127.09 115.34 19.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.289 . . . . 0.0 110.993 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.2 p -57.92 132.71 54.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.027 0.441 . . . . 0.0 111.676 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -116.6 164.25 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.241 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 11.1 t30 -107.31 147.21 30.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -154.29 154.12 29.17 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.81 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.82 117.74 4.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 111.903 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.13 43.7 41.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER 167.42 -174.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.327 . . . . 0.0 110.482 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.703 ' CE2' HD22 ' A' ' 14' ' ' LEU . 18.9 p90 -157.21 165.94 34.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.025 0.44 . . . . 0.0 111.552 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -130.39 -171.2 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.006 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -145.83 168.8 19.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.872 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -128.06 65.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.104 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 62.5 m -39.29 166.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.251 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 14.3 t0 -55.73 -96.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.387 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -138.31 0.92 2.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.812 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -173.01 22.94 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.422 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HA ' ' CA ' ' A' ' 47' ' ' ASP . 2.0 m-30 -100.02 138.96 36.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.422 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.4 120.1 30.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.542 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.35 99.16 11.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.546 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 115.91 84.89 1.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.894 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 26.1 t80 -131.57 -46.1 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 41' ' ' MET . 1.9 mtp -106.76 5.52 28.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.15 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.7 OUTLIER 84.91 37.04 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' LYS . 4.5 mtp -145.36 15.38 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER 34.75 45.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.937 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -88.22 35.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.626 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 69.4 m 22.5 102.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.583 0.552 . . . . 0.0 111.962 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.55 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -126.31 100.41 6.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.044 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.579 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.5 p-10 11.86 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.929 0.768 . . . . 0.0 112.702 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.915 HD13 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -33.45 155.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.601 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.915 ' N ' HD13 ' A' ' 48' ' ' ILE . 54.0 t0 -89.54 74.43 7.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.851 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.6 mp0 -49.62 -27.87 5.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.733 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.683 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -70.31 -9.26 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.48 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.8 mt-30 -121.78 -31.09 4.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 52' ' ' GLN . 11.8 ttt85 -36.61 -42.53 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.205 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.19 154.32 58.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.437 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.41 -2.06 4.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.454 2.769 . . . . 0.0 112.093 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -126.42 10.94 7.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.128 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.922 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -58.11 129.24 41.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.2 m 40.21 30.13 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.283 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -60.96 71.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 137.33 -6.1 3.59 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.39 -127.15 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 38.4 t -140.46 117.09 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.666 ' HB2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.07 101.56 14.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 66.1 m80 -90.47 60.36 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.049 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.616 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -43.68 112.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 64' ' ' HIS . 1.6 p -115.84 -161.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.051 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.35 140.08 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 56.31 19.7 26.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.768 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.4 t 156.32 -175.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.643 0.258 . . . . 0.0 110.724 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 3.8 p90 -142.19 159.31 42.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.946 0.403 . . . . 0.0 111.317 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.574 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -115.54 112.25 21.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.075 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.66 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.86 131.73 35.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.265 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -132.33 121.0 22.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.807 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.778 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.62 -32.61 1.07 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.873 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 26.2 Cg_exo -65.32 171.4 33.19 Favored 'Cis proline' 0 C--N 1.356 0.96 0 C-N-CA 123.918 -1.284 . . . . 0.0 112.715 1.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.532 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 65.8 Cg_exo -33.65 -28.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.151 2.567 . . . . 0.0 113.264 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -35.0 -31.87 0.02 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.695 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -89.4 -125.42 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -144.69 60.56 1.33 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.3 OUTLIER -90.47 98.7 11.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.029 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.679 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.4 t -51.75 137.29 34.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.327 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 64.9 Cg_endo -75.07 115.49 4.29 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.917 2.411 . . . . 0.0 113.588 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 21.1 m120 72.89 24.13 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.169 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.679 HD13 ' C ' ' A' ' 81' ' ' SER . 1.4 mp -102.06 -27.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.251 0.548 . . . . 0.0 109.858 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.701 ' HB3' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER 74.08 69.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.499 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 166.4 100.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.22 145.84 30.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.11 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.572 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.477 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.328 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -91.42 -164.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 12.2 t0 -87.01 -48.18 8.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.851 0.357 . . . . 0.0 111.286 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.6 mp0 72.99 -56.94 0.65 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 14' ' ' LEU . 8.4 t -63.84 -14.56 54.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.567 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.2 -33.21 56.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.415 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.4 mm -41.86 -37.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.73 163.71 9.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.36 -22.5 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.145 2.564 . . . . 0.0 111.809 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.75 15.94 27.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.78 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -45.79 -49.42 15.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.766 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -59.96 -13.11 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.74 -10.76 37.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.035 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 7.3 tpt180 177.35 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.98 -129.88 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.608 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LYS . 12.1 mt-30 -144.97 118.27 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 111.388 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.18 146.35 52.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.879 0.371 . . . . 0.0 110.982 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 43.9 t -128.67 152.79 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 3.2 t-20 -77.75 153.36 33.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.971 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 27' ' ' PHE . 16.3 p -157.46 155.7 27.79 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.605 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.6 Cg_endo -51.46 110.37 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.746 2.297 . . . . 0.0 112.07 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.17 44.17 74.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.118 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.75 -160.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.766 0.317 . . . . 0.0 110.286 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.78 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.5 p90 -165.08 145.0 6.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -104.77 -146.88 0.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.45 171.43 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.537 0.685 . . . . 0.0 112.793 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLN . 3.1 tmtm? -131.49 65.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.364 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 95.0 m -50.04 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.549 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -136.74 -151.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.263 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 32' ' ' ASP . 26.9 mm-40 -0.71 -86.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.949 0.781 . . . . 0.0 112.871 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.77 9.57 2.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 18.6 m-85 -69.9 106.88 3.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.638 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -89.58 136.02 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -28.54 113.98 0.08 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -38.03 -85.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 88.17 -24.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE ' ' A' ' 46' ' ' MET . 2.8 mtm -72.21 -24.44 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.435 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.5 mmm -124.66 -35.75 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.641 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 164.4 -51.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 5.9 mmtp 174.38 104.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 45' ' ' CYS . 6.2 p-10 -159.66 49.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 84.7 m 15.65 110.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.669 0.788 . . . . 0.0 112.937 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.516 ' CE ' ' SD ' ' A' ' 40' ' ' MET . 26.2 ptm -124.93 120.06 30.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 1.9 p30 -25.45 126.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.405 0.621 . . . . 0.0 111.707 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -54.68 -174.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.455 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 58.3 t0 -101.55 73.05 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.271 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.889 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.5 mp0 -49.07 -22.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.806 ' HA ' HD22 ' A' ' 57' ' ' LEU . 60.1 m -75.45 -13.22 60.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.676 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 1.8 mt-30 -111.46 -20.3 12.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -60.52 -30.04 69.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.982 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.51 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -123.62 138.28 30.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.51 -6.47 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 112.195 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -121.32 -4.27 9.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.535 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.991 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.89 119.98 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.839 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 65.0 m 46.71 25.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.519 . . . . 0.0 109.991 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.1 -27.01 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.92 30.5 3.71 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.04 -126.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.572 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.802 HG11 ' CE1' ' A' ' 64' ' ' HIS . 42.7 t -135.68 135.48 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.9 t -109.33 96.94 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.949 0.404 . . . . 0.0 111.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.802 ' CE1' HG11 ' A' ' 62' ' ' VAL . 90.2 m-70 -89.69 62.39 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.2 t-20 -47.07 118.61 2.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.53 HG21 ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -115.09 -170.15 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 10.1 mp0 -73.11 131.16 41.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 44.11 33.5 2.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.359 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 172.78 168.73 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.681 0.277 . . . . 0.0 110.772 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.991 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -144.72 145.97 31.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.53 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.0 137.19 48.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.016 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.93 127.73 56.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.061 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.2 tt0 -126.97 123.97 38.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.787 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.809 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.83 -31.34 0.72 Allowed Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.973 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.809 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 43.3 Cg_endo -67.05 174.22 31.08 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 123.828 -1.321 . . . . 0.0 112.827 1.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 71.5 Cg_exo -35.4 -28.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.006 2.471 . . . . 0.0 113.073 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.25 -30.63 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.469 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 3.3 t-160 -93.72 -130.44 0.13 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.71 65.46 1.43 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.016 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.8 101.43 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.192 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.533 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 32.9 t -50.43 137.48 22.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 85.1 Cg_endo -79.96 112.76 2.9 Favored 'Trans proline' 0 CA--C 1.526 0.121 0 C-N-CA 122.909 2.406 . . . . 0.0 113.59 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 23.4 m120 73.39 -3.21 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.265 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.5 mp -80.68 -25.09 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.156 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.702 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.23 87.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.78 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.877 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.94 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -60.7 150.95 30.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.197 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.266 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.662 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -108.18 153.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.576 ' C ' HD13 ' A' ' 5' ' ' ILE . 32.0 t0 -61.31 84.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.036 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 27.3 mp0 -70.9 -11.92 61.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.1 t -83.22 -43.24 16.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -67.5 -23.62 65.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.738 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.6 mm -42.97 -39.7 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -164.36 140.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.859 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_exo -75.16 -18.45 18.38 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 111.388 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -116.6 20.96 13.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.245 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -37.06 -61.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.307 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -80.27 7.67 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.381 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 78.99 -45.78 2.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.947 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -134.9 -46.74 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -59.25 -177.61 1.08 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.825 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.07 102.63 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 13.8 p -40.22 150.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.246 0.546 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 16.2 t -130.32 164.39 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.771 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.2 t30 -114.31 138.93 49.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.418 . . . . 0.0 111.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.679 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.5 p -148.8 157.55 40.57 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.63 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 19.0 Cg_endo -59.17 121.0 9.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.598 2.199 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 46.81 44.19 17.43 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.625 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.68 -179.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.358 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' THR . 21.4 p90 -164.04 -177.69 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 111.995 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.0 pt-20 -162.56 -147.52 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.851 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 13.6 p -170.4 -176.83 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.214 0.53 . . . . 0.0 111.59 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -121.76 73.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.727 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 66.7 m -40.61 167.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 16.4 t0 -60.24 -99.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.258 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -129.9 -32.08 1.89 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' N ' ' HA2' ' A' ' 68' ' ' GLY . . . -134.84 14.82 4.37 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.507 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.1 m-85 -90.74 125.89 35.83 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.563 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.77 131.72 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.882 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.53 ' OG ' ' CE ' ' A' ' 43' ' ' LYS . 1.6 t -95.34 106.36 18.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.447 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.14 76.19 1.02 Allowed Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.227 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 70.7 t80 -109.1 -51.49 2.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.0 110.009 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -98.98 -3.32 35.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.578 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.8 OUTLIER 86.53 38.11 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.857 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtt -134.84 5.45 3.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.974 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CE ' ' OG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 51.93 96.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.451 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 45' ' ' CYS . 4.2 p-10 -157.2 44.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 44' ' ' ASN . 67.1 m 5.2 107.82 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.934 0.771 . . . . 0.0 112.133 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.57 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 24.0 ptm -130.59 111.69 12.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.521 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 1.4 p-10 -21.81 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.371 0.605 . . . . 0.0 111.987 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -46.91 -178.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.111 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 59.2 t0 -106.82 71.04 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.849 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.892 ' O ' HD13 ' A' ' 57' ' ' LEU . 29.4 mp0 -48.86 -25.13 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.92 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.8 t -73.85 -8.76 57.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.681 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 3.9 mt-30 -118.06 -28.84 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -40.94 -42.2 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.001 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.4 152.14 77.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.473 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 56' ' ' LEU . 96.5 Cg_endo -86.56 -6.6 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.285 2.657 . . . . 0.0 112.086 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.1 mp -104.45 -15.93 15.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.179 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.92 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.12 114.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.599 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 76.8 m 53.34 20.96 2.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.176 0.512 . . . . 0.0 109.994 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -36.95 -36.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.691 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.7 -8.55 9.81 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.028 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.14 -150.34 15.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.546 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 38.7 t -116.78 129.6 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.4 p -94.28 98.9 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.984 0.421 . . . . 0.0 111.081 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -96.18 65.18 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.206 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.7 t-20 -47.12 116.47 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -103.45 -175.59 2.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 4.5 pt-20 -49.84 -102.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.441 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 34' ' ' GLY . . . -85.73 55.24 4.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.363 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 28.9 t 170.44 -161.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.801 ' CD2' HD21 ' A' ' 57' ' ' LEU . 3.7 p90 -167.15 146.05 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 3.4 mtp180 -110.38 159.06 17.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.035 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -135.65 136.54 41.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.066 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 18.0 tt0 -130.52 118.13 20.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.904 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.765 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -79.53 -33.7 0.84 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.839 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.03 171.25 37.18 Favored 'Cis proline' 0 C--N 1.354 0.85 0 C-N-CA 123.92 -1.283 . . . . 0.0 112.699 1.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 61.7 Cg_exo -37.32 -29.74 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.932 2.421 . . . . 0.0 112.881 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -38.5 -30.38 0.09 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.218 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 6.1 t-160 -87.01 -127.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -142.01 63.55 1.41 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.044 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.38 129.01 36.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.288 -178.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.044 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.57 131.74 88.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.84 -49.24 18.26 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.846 2.364 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.539 ' H ' HD12 ' A' ' 84' ' ' ILE . 5.6 m120 -149.76 33.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.462 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -102.01 -24.87 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.352 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.721 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER 82.73 84.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.803 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 158.63 102.68 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 1.002 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.68 152.29 35.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.21 178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.306 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 t0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -89.9 167.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.5 t0 -69.89 -50.06 46.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 111.056 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.0 mp0 72.07 -55.89 0.66 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 14' ' ' LEU . 97.9 m -64.62 -18.23 64.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.385 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -72.18 -33.52 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.465 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -40.84 -36.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.0 t -165.48 155.67 11.72 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.679 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.1 Cg_endo -85.75 -19.31 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.3 2.666 . . . . 0.0 111.457 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.52 25.06 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -46.44 -40.06 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.863 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -78.74 4.34 14.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.177 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 34.69 29.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.101 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.615 ' NE ' ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER 153.63 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.834 0.35 . . . . 0.0 110.763 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' N ' ' HB3' ' A' ' 15' ' ' CYS . . . -86.18 -140.85 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.562 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.496 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.7 mt-30 -142.98 102.73 4.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 0.0 111.019 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 29.2 t -56.31 146.61 23.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 22' ' ' ASN . 37.7 t -131.47 162.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 21' ' ' VAL . 10.2 t30 -97.13 150.33 20.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.6 p -154.76 146.26 16.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.81 112.16 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.897 2.398 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.93 44.38 82.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.92 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.43 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.78 0.324 . . . . 0.0 110.639 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 7.7 p90 -164.83 144.99 7.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' OE2' HG21 ' A' ' 21' ' ' VAL . 2.1 pp20? -117.65 -171.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.605 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.54 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.1 166.57 24.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 111.887 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -123.61 84.05 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.662 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 163.0 12.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.305 0.574 . . . . 0.0 112.386 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.63 -91.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -119.92 16.09 10.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.99 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.628 ' C ' HG23 ' A' ' 48' ' ' ILE . 2.5 m-30 -103.01 166.92 10.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.714 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.62 139.86 53.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.502 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 83.0 p -87.88 94.7 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.034 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 86.48 71.01 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.43 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 33.0 t80 -67.53 -21.01 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.52 -27.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.472 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.4 OUTLIER -65.08 -36.16 83.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 179.1 -87.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.748 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.54 ' CE ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -162.13 37.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.863 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' SER . 5.9 p-10 -86.45 173.03 9.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.585 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' ' CB ' ' A' ' 35' ' ' TYR . 49.3 t -111.05 110.07 20.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.598 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 ppp? -145.5 119.99 9.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.2 p-10 -6.5 109.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.97 0.793 . . . . 0.0 112.375 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.714 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.1 pt -53.85 -177.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.406 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 54.7 t0 -99.58 74.03 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.552 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.961 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.6 mp0 -48.35 -26.0 1.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 57' ' ' LEU . 63.4 m -73.51 -12.55 60.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 7.9 mt-30 -115.17 -23.52 8.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.481 ' NH1' ' CG ' ' A' ' 54' ' ' ASP . 1.1 ttt-85 -53.73 -31.51 48.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.024 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' CG ' ' NH1' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -132.19 142.58 45.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.4 -6.26 10.95 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.137 2.558 . . . . 0.0 111.908 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -112.4 -10.13 13.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.258 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.88 121.87 7.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.8 m 47.83 24.61 0.6 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -55.59 -18.19 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.699 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.74 22.91 5.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.69 -125.34 0.97 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.683 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.686 HG11 ' NE2' ' A' ' 64' ' ' HIS . 41.8 t -138.62 136.72 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.782 0.325 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.2 t -105.7 96.86 6.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.29 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.686 ' NE2' HG11 ' A' ' 62' ' ' VAL . 29.4 m80 -89.76 61.21 5.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -46.04 118.87 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 5.0 p -111.89 -162.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 118.08 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 71.92 24.11 77.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.446 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.0 178.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 0.0 110.614 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.9 p90 -142.6 147.18 35.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.54 112.25 24.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.464 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.021 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.76 138.18 31.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.843 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tt0 -143.13 122.11 12.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -79.86 -29.91 0.59 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 23.5 Cg_exo -67.3 178.09 20.18 Favored 'Cis proline' 0 C--N 1.358 1.04 0 C-N-CA 124.188 -1.171 . . . . 0.0 112.649 1.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 78.7 Cg_exo -36.45 -26.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.953 2.436 . . . . 0.0 113.087 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -34.58 -32.33 0.02 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.579 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 10.6 t-160 -90.06 -127.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 24.2 mt-30 -140.73 68.63 1.35 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.021 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -90.0 125.55 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.181 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.848 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -59.67 134.08 89.18 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.831 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.89 -46.49 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 84' ' ' ILE . 12.8 m120 -158.24 32.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.534 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.795 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.37 -12.81 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.62 85.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.046 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.45 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.276 0.36 . . . . 0.0 111.633 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 t -69.33 158.24 35.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.922 0.392 . . . . 0.0 111.007 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.576 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.9 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.4 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.819 0.343 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.96 -176.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.749 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.641 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 t0 -92.26 107.81 19.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.972 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.843 ' O ' HD11 ' A' ' 14' ' ' LEU . 17.9 mp0 -91.28 -22.81 20.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.086 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' LEU . 41.5 t -78.88 -31.2 45.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.4 ttt85 -64.02 -30.26 71.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.274 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -40.87 -37.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.469 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -164.79 155.78 12.95 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.968 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.33 -21.69 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 0.0 111.477 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -114.41 27.19 9.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.003 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.843 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.47 -59.59 0.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.342 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.0 m -88.95 27.43 1.35 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.641 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.91 22.23 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.908 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 166.04 -59.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.134 0.467 . . . . 0.0 110.993 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 45' ' ' CYS . . . -54.28 -163.69 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.683 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 mm-40 -125.74 109.69 12.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.773 0.321 . . . . 0.0 110.96 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -63.09 125.87 25.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.49 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.4 t -109.05 164.1 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.133 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.559 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.6 t30 -102.68 148.53 25.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -155.42 156.45 30.93 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.862 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 12.4 Cg_endo -56.26 117.93 4.66 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.74 2.293 . . . . 0.0 111.904 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . 49.28 44.41 34.83 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.859 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 166.55 -178.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.741 0.305 . . . . 0.0 110.459 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.59 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 7.1 p90 -155.25 155.08 33.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 pt-20 -123.32 -167.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.03 -177.38 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 112.193 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 1.1 tmtm? -141.74 79.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.567 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 21.8 m -60.15 -179.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.775 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.3 t70 -90.66 -151.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.415 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.3 mt-10 -33.13 -74.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.732 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -135.4 40.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.057 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -88.43 133.72 34.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.58 121.89 32.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.305 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.57 98.2 11.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 110.48 76.14 0.85 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.797 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 65.3 t80 -111.94 -76.69 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.559 ' HB3' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -123.16 -12.84 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.193 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 42' ' ' MET . 13.5 mmm -90.89 -22.57 20.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.697 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.7 mmt 123.27 -43.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.402 1.064 . . . . 0.0 110.911 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -158.72 20.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.585 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' HG3' ' A' ' 41' ' ' MET . 14.8 p-10 -67.26 149.86 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.5 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 15.9 m -95.64 102.21 13.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.458 . . . . 0.0 110.34 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 25.5 ptm -127.83 116.59 20.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.087 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 5.1 p-10 -21.36 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.929 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.61 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -46.52 -177.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.441 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.8 t0 -96.8 72.42 2.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.714 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.841 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.6 mp0 -50.86 -22.19 2.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.95 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.4 t -76.01 -8.95 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.705 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 3.4 mt-30 -119.12 -24.12 6.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -23.74 9.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 57' ' ' LEU . 2.1 m-20 -124.99 139.45 33.62 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.041 0.448 . . . . 0.0 111.166 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.79 -9.38 15.74 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.029 2.486 . . . . 0.0 112.279 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.632 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -119.13 -6.62 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.95 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.53 112.58 0.67 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.582 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 39.6 m 52.69 22.16 2.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.0 109.864 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.632 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -38.49 -38.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.51 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.62 24.06 6.2 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.806 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -136.27 -130.88 2.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.531 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.712 HG11 ' NE2' ' A' ' 64' ' ' HIS . 70.0 t -137.82 128.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.777 0.322 . . . . 0.0 111.001 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.469 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -98.15 95.02 7.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.712 ' NE2' HG11 ' A' ' 62' ' ' VAL . 41.0 m80 -88.53 60.45 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 8.3 t-20 -45.93 112.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.35 -161.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.66 127.03 34.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 56.81 29.86 59.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 168.2 -172.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.696 ' CD2' HD21 ' A' ' 57' ' ' LEU . 9.6 p90 -156.97 147.56 21.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.71 116.48 31.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.322 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.871 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -98.42 134.91 40.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.305 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.3 tt0 -150.19 126.2 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.518 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -49.65 -45.91 79.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.456 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 3.3 Cg_exo -75.56 -60.21 0.09 OUTLIER 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.669 -1.388 . . . . 0.0 113.193 1.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.9 Cg_endo -84.39 -155.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.87 2.38 . . . . 0.0 113.155 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.0 37.44 9.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.874 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.516 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 161.0 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.235 0.54 . . . . 0.0 111.255 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -139.22 78.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.105 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.871 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -56.98 107.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.463 0.649 . . . . 0.0 111.784 -178.351 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB2' HD13 ' A' ' 84' ' ' ILE . 55.4 p -52.03 124.62 29.72 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.75 ' O ' HD12 ' A' ' 84' ' ' ILE . 73.6 Cg_endo -76.42 111.75 3.32 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.796 2.331 . . . . 0.0 113.221 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 23.4 m120 73.66 13.68 4.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.336 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 82' ' ' PRO . 3.8 mp -101.24 -44.92 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 5.7 p 91.75 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.18 102.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -50.27 130.27 22.73 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.864 0.364 . . . . 0.0 110.901 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.516 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 1.1 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.175 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.3 t0 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.809 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.87 -165.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.809 ' N ' HG23 ' A' ' 5' ' ' ILE . 9.4 t0 -87.56 -50.1 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 111.103 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.643 ' O ' HD11 ' A' ' 14' ' ' LEU . 9.5 mp0 73.11 -55.49 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HA ' HD13 ' A' ' 14' ' ' LEU . 91.1 m -63.22 -24.31 67.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.95 -32.58 69.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.4 mm -44.04 -39.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 110.281 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.0 t -163.17 153.28 13.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.712 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_endo -85.54 -19.42 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.169 2.58 . . . . 0.0 111.093 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -112.2 26.89 10.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.994 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.954 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.69 -47.73 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -83.2 11.02 7.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.402 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 60.89 9.95 16.73 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.159 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 162.15 -37.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -68.47 -153.49 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.805 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.05 101.59 5.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.1 t -57.15 150.16 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 28' ' ' GLU . 7.1 p -132.06 154.0 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' ND2' ' OE1' ' A' ' 7' ' ' GLU . 6.4 t-20 -91.55 142.34 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.229 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 28' ' ' GLU . 13.4 p -147.89 151.09 37.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.51 103.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.853 2.368 . . . . 0.0 111.992 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.12 98.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.117 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.2 OUTLIER 178.8 -166.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.954 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.7 p90 -172.45 139.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.671 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 23' ' ' THR . 0.1 OUTLIER -105.97 -147.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.684 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.2 m -170.08 159.49 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -122.6 71.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.9 OUTLIER -49.59 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.06 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -125.96 -156.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.109 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER 8.32 -75.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.009 0.818 . . . . 0.0 112.636 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -157.72 29.61 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.136 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 22.9 m-85 -79.24 151.15 31.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 2.1 pt-20 -112.02 128.16 56.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -83.42 92.78 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 114.32 56.86 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 58.4 t80 -77.12 -24.83 51.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.845 0.355 . . . . 0.0 110.787 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.14 -25.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.486 ' HG2' ' HE3' ' A' ' 40' ' ' MET . 42.0 mmm -72.68 -33.36 66.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.415 ' CB ' ' O ' ' A' ' 41' ' ' MET . 1.8 ptm 166.0 -63.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 12.9 tptt -177.01 29.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.451 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 41' ' ' MET . 0.2 OUTLIER -76.91 179.51 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.44 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.4 m -92.16 106.58 18.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' PHE . 2.1 mmt -124.0 101.01 7.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.045 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.3 p-10 -21.83 101.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.984 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -48.42 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.094 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 56.3 t0 -94.69 71.7 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.564 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.886 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -48.3 -24.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.27 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 1.028 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.1 t -76.92 -8.97 58.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.0 mt-30 -116.38 -21.29 9.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 54' ' ' ASP . 7.8 ttt-85 -58.75 -33.25 70.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -115.89 140.58 26.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.091 0.472 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 90.3 Cg_endo -80.83 -5.03 13.02 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.085 2.523 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -128.37 1.22 5.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.56 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.028 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.41 115.56 1.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.123 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.97 ' SG ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER 49.22 21.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.643 -179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.29 87.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.2 -24.4 0.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.098 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -129.15 -98.16 0.87 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.944 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.645 HG11 ' CE1' ' A' ' 64' ' ' HIS . 19.2 t -150.32 125.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 111.572 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -89.55 99.27 12.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.645 ' CE1' HG11 ' A' ' 62' ' ' VAL . 88.3 m-70 -89.62 59.79 4.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.694 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.0 OUTLIER -46.0 117.98 1.71 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.678 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -117.69 -171.05 1.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.089 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.6 pt-20 -73.25 143.2 47.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.9 32.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.612 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER 164.69 174.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.61 0.243 . . . . 0.0 110.43 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.865 ' CD2' HD21 ' A' ' 57' ' ' LEU . 8.7 p90 -146.8 166.44 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.142 0.496 . . . . 0.0 111.783 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.678 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -122.54 108.15 12.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.574 ' HB3' HD21 ' A' ' 80' ' ' LEU . 19.0 m -89.59 116.33 27.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.152 0.501 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -100.75 141.7 33.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.495 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.832 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -78.05 -35.63 1.24 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.026 -178.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.832 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 9.6 Cg_exo -73.74 -168.54 6.18 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.454 0.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 65.0 Cg_exo -40.57 172.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 113.04 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.92 86.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.154 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.592 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -139.74 -136.86 0.12 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.08 84.5 1.39 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.275 0.489 . . . . 0.0 111.254 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.04 123.82 34.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.085 0.469 . . . . 0.0 111.677 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -49.95 122.22 13.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.264 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 73.2 Cg_exo -37.32 -44.98 1.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.869 2.38 . . . . 0.0 112.713 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.586 ' H ' HD12 ' A' ' 84' ' ' ILE . 32.2 m120 -163.24 24.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -86.91 -27.34 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.427 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.686 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.9 p 87.15 87.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.347 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.48 84.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.542 ' HA ' HD13 ' A' ' 80' ' ' LEU . 9.6 t -38.34 152.9 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.592 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 24' ' ' PRO . 2.8 t70 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.75 159.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.535 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 59.5 t0 -75.21 90.04 2.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 0.0 111.041 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.1 mp0 -74.08 -21.86 59.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.054 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -46.74 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.511 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.525 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 1.2 mmt-85 -50.63 -31.95 17.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 15.0 mm -53.31 -55.08 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.504 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 14' ' ' LEU . 1.4 t -143.06 121.95 7.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.84 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.7 -19.56 47.47 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.756 2.304 . . . . 0.0 110.753 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -118.88 25.57 10.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.717 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.867 HD22 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.53 -44.43 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.862 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -84.37 15.69 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.459 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.55 5.83 7.39 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.811 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 174.39 -60.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.758 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 31' ' ' CYS . . . -48.71 164.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.749 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.93 84.53 5.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.81 0.338 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -44.46 148.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.161 0.505 . . . . 0.0 111.165 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.3 t -135.52 163.45 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.425 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' HG12 ' A' ' 21' ' ' VAL . 5.5 t-20 -91.41 146.25 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.025 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 27' ' ' PHE . 3.6 p -151.56 156.02 34.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.5 Cg_endo -55.24 107.53 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.239 . . . . 0.0 111.888 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.34 41.79 95.26 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.017 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 173.75 -167.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.867 ' CZ ' HD22 ' A' ' 14' ' ' LEU . 2.5 p90 -164.85 145.27 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 5.9 pt-20 -117.21 -167.41 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 2.9 p -167.52 154.4 8.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.192 0.52 . . . . 0.0 111.718 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -101.58 76.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.266 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.537 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . 60.0 m -41.23 169.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.849 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -91.78 -151.23 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.318 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' ASP . 67.1 mm-40 -33.12 -95.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -114.96 36.48 3.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.588 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.8 m-85 -89.8 121.59 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.754 0.311 . . . . 0.0 110.429 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.581 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -94.81 128.1 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 7.7 p -84.07 95.05 8.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.59 34.72 0.68 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 2.3 t80 -55.87 -17.36 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.316 . . . . 0.0 110.913 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.65 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.987 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' MET . 29.2 mmm -75.9 -29.68 58.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.593 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.3 mmt 131.69 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.281 0.988 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 7.8 tptt 177.98 104.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 0.0 111.281 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -166.97 50.52 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.966 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 74.6 m 5.93 100.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.154 0.909 . . . . 0.0 112.235 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.484 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.8 mmt -125.95 113.67 17.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.827 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 46' ' ' MET . 9.9 p-10 -20.89 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 O-C-N 123.667 0.604 . . . . 0.0 112.04 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -42.13 176.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 45.4 t0 -92.97 76.18 4.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.75 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.952 ' O ' HD13 ' A' ' 57' ' ' LEU . 32.2 mp0 -48.8 -25.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.865 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 1.016 ' HA ' HD22 ' A' ' 57' ' ' LEU . 45.2 t -74.69 -8.8 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.71 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -117.98 -26.37 6.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.637 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -30.23 61.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.24 138.05 25.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.98 -4.7 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.99 2.46 . . . . 0.0 112.05 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -119.49 -11.54 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.516 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.016 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.49 113.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 75.4 m 51.84 21.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 110.247 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.44 -28.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.649 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.24 -7.83 6.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.101 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.15 -152.43 11.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 64' ' ' HIS . 47.4 t -112.74 129.87 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.325 . . . . 0.0 111.067 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.481 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 7.3 p -95.41 101.59 13.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.54 ' O ' HG22 ' A' ' 66' ' ' THR . 28.3 m80 -90.19 62.26 5.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.2 OUTLIER -44.53 109.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.824 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -108.51 -178.61 3.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.97 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.3 129.32 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 41.15 29.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -167.72 -169.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.844 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.6 p90 -171.47 139.76 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.766 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 1.3 mtp180 -109.83 158.98 17.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.235 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.012 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -131.92 143.93 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.258 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 21.6 tt0 -139.79 118.13 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 111.799 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.93 -32.8 0.93 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.869 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.35 172.38 34.6 Favored 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.594 1.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 49.9 Cg_exo -35.36 -27.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.055 2.503 . . . . 0.0 113.162 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.66 -31.08 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.45 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.569 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -89.65 -126.47 0.07 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.19 58.08 1.4 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.012 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -81.99 109.04 15.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.624 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.666 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -43.8 133.63 3.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.44 -68.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.54 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.682 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.4 m120 -127.35 29.54 5.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.689 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.819 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -96.28 -14.76 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.801 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.7 87.74 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.966 178.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.36 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.78 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.987 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.569 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.457 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 57.2 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.0 OUTLIER -118.33 164.69 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 47.8 t0 -81.23 109.19 15.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.734 ' O ' HD11 ' A' ' 14' ' ' LEU . 14.1 mp0 -92.47 -23.85 19.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.941 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.87 -45.64 64.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.566 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.477 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.1 ttt180 -51.9 -35.3 44.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 10.7 mm -41.51 -39.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.338 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.77 150.03 11.11 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.678 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.4 Cg_endo -87.26 -16.64 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.135 2.556 . . . . 0.0 111.541 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.62 20.21 18.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.919 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.65 -50.58 4.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.206 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -63.86 -10.07 18.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.7 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 62.74 6.93 13.18 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.883 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.638 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 13.9 tpt180 172.58 -44.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.876 0.369 . . . . 0.0 110.706 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.68 -139.05 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.622 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.1 mt-30 -136.69 111.39 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 110.995 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -68.82 155.36 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 36.8 t -140.76 161.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.736 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 8.9 t30 -90.63 155.93 18.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.508 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.538 HG23 ' HA ' ' A' ' 27' ' ' PHE . 11.9 p -156.87 155.73 28.8 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.833 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.0 Cg_endo -54.61 110.26 0.5 Allowed 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.71 2.274 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.01 41.92 94.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.96 -162.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.536 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.919 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -163.58 141.44 7.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.029 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -101.61 -150.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -165.86 177.43 7.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.148 0.499 . . . . 0.0 111.78 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 5.6 tmtm? -145.43 76.24 1.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.192 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 5.8 m -44.83 177.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.694 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.87 -73.44 0.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.313 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.95 -74.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.148 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.968 ' O ' HG23 ' A' ' 48' ' ' ILE . . . -101.09 -0.61 54.65 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.158 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.9 m-85 -71.05 118.15 13.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.922 ' HB2' HG22 ' A' ' 48' ' ' ILE . 1.4 tp10 -89.96 141.02 29.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.416 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 13.0 p -45.49 81.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.154 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 43' ' ' LYS . . . 82.14 -12.09 45.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.169 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 40' ' ' MET . 0.0 OUTLIER 72.17 4.1 4.9 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.579 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 107.97 -22.41 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.758 0.823 . . . . 0.0 110.97 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 3.1 ptm -66.63 -32.98 74.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 21.5 mmt -162.31 -75.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 110.467 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 12.2 tptt 179.97 -24.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.04 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -46.0 90.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' CYS . 25.2 m -36.15 103.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.393 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.547 ' HA ' ' CD2' ' A' ' 35' ' ' TYR . 3.2 ptp -132.14 135.55 46.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 p-10 -22.39 118.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.34 0.591 . . . . 0.0 111.95 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.968 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.1 pt -58.47 -170.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.475 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 57.4 t0 -97.76 71.98 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.453 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -50.72 -21.51 1.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 9.1 t -77.39 -10.03 59.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.2 mt-30 -117.65 -22.39 8.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HD3' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.45 -24.03 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.095 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -126.57 138.02 31.59 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.965 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.94 -7.88 13.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.942 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -115.65 -7.94 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.597 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.954 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -52.07 114.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.7 m 52.53 22.29 2.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.223 0.535 . . . . 0.0 109.955 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 3.4 ttt180 -40.25 -30.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.56 22.22 4.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.021 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -138.76 -131.11 2.83 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.466 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.729 HG11 ' NE2' ' A' ' 64' ' ' HIS . 39.4 t -135.37 129.7 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.763 0.316 . . . . 0.0 110.733 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.8 p -97.99 95.88 7.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.729 ' NE2' HG11 ' A' ' 62' ' ' VAL . 38.6 m80 -88.98 60.41 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.679 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.681 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -43.0 117.03 0.98 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.265 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -117.58 -179.65 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' N ' ' OG1' ' A' ' 66' ' ' THR . 10.5 pt-20 -64.65 135.4 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.02 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 37.12 31.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.594 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 66' ' ' THR . 0.2 OUTLIER 172.9 158.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 4.1 p90 -136.49 147.38 47.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.194 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.565 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.18 119.23 38.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.326 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.068 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -92.07 142.51 27.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.866 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -133.55 122.46 23.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.824 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.99 -34.49 2.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.98 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.824 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.2 Cg_exo -71.96 -174.07 11.15 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.61 1.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 78.5 Cg_exo -39.94 173.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.028 2.485 . . . . 0.0 113.011 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.37 56.54 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.663 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 13.5 t-160 -101.12 -126.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.961 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.52 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 35.2 tt0 -151.3 64.64 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.383 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.068 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.6 OUTLIER -90.9 109.97 21.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.848 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.7 t -58.44 136.79 85.61 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 4.9 Cg_exo -74.15 109.94 2.99 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 113.809 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 22.0 m120 71.1 -1.18 2.8 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.553 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -77.42 -35.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.239 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 3.9 p 85.03 84.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.373 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.34 96.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 1.029 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -55.56 160.89 2.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.282 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.663 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.8 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.218 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 24' ' ' PRO . 37.4 t70 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.85 165.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.456 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 14.2 t0 -77.29 92.06 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.063 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.623 ' O ' HD11 ' A' ' 14' ' ' LEU . 31.8 mp0 -73.93 -17.33 61.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.614 ' HA ' HD13 ' A' ' 14' ' ' LEU . 55.6 m -83.77 -27.58 28.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.14 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -46.11 -44.07 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.295 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -156.2 146.46 15.88 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.586 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.9 Cg_endo -84.48 -15.92 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.998 2.465 . . . . 0.0 111.626 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.35 19.0 18.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.397 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.19 -49.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 18' ' ' GLY . 8.0 t -89.51 36.84 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.654 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . -14.37 80.38 0.0 OUTLIER Glycine 0 C--N 1.335 0.485 0 O-C-N 123.978 0.799 . . . . 0.0 113.771 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.619 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 116.53 13.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . -148.14 -149.65 5.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.11 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -133.72 106.75 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 37.5 t -56.07 155.59 6.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 20.5 t -136.26 164.91 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.597 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.578 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 16.3 t30 -115.96 141.78 47.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.211 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASP . 9.5 p -146.25 155.46 50.37 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 32.2 Cg_endo -64.06 112.35 1.83 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . 70.52 31.76 68.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.3 OUTLIER 165.31 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.696 0.284 . . . . 0.0 110.472 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 14' ' ' LEU . 5.5 p90 -164.43 -176.01 4.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.215 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' A' ' 27' ' ' PHE . 8.3 pt-20 -167.88 -155.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.284 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 6.2 p -168.15 179.15 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 111.969 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -117.32 80.35 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.607 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -54.67 163.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.081 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 -88.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.088 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -122.61 -80.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.29 -3.92 64.78 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.356 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 14.5 m-85 -68.63 123.82 21.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.958 0.408 . . . . 0.0 110.218 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -93.59 136.75 33.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.046 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.54 96.83 10.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.944 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 100.67 44.75 2.06 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' MET . 5.8 t80 -40.03 -30.25 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.074 0.464 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.47 -38.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.548 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 4.5 ptm -57.64 -47.99 80.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.818 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 41' ' ' MET . 46.9 mmm -163.09 -94.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HZ1' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -168.47 96.92 0.4 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.474 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -165.21 134.25 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.184 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -42.72 121.91 2.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.355 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -149.77 86.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 7.9 p-10 -15.77 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.744 0.653 . . . . 0.0 112.142 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -45.04 179.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.451 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 61.0 t0 -95.88 73.63 3.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.902 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp0 -50.07 -24.35 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.995 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.961 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.3 t -75.83 -9.43 58.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.721 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -119.34 -23.33 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -52.86 -34.8 56.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 139.02 28.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.07 0.462 . . . . 0.0 111.019 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.08 -7.91 13.08 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.036 2.49 . . . . 0.0 111.931 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.698 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -108.81 -14.24 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.117 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.961 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.52 120.35 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.666 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.4 m 47.64 24.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.425 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.14 -21.46 3.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.216 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.51 13.02 5.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.049 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.41 -132.46 3.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.628 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.581 HG12 ' CE1' ' A' ' 64' ' ' HIS . 34.0 t -133.16 127.53 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 111.089 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.9 p -94.1 106.74 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.033 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.581 ' CE1' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.45 67.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.519 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.541 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.2 OUTLIER -48.03 110.24 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.047 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.558 HG21 HH11 ' A' ' 71' ' ' ARG . 0.3 OUTLIER -104.93 -170.97 1.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.018 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.62 126.79 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.1 28.54 1.94 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -169.74 -168.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.898 0.38 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -167.68 140.55 3.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.558 HH11 HG21 ' A' ' 66' ' ' THR . 0.6 OUTLIER -110.98 156.07 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.08 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.54 137.32 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 31.5 tt0 -138.59 116.48 11.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.803 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.806 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -80.67 -30.18 0.56 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.806 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 21.9 Cg_exo -67.95 176.79 25.78 Favored 'Cis proline' 0 C--N 1.357 0.978 0 C-N-CA 123.988 -1.255 . . . . 0.0 112.767 1.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HG3' ' A' ' 73' ' ' GLU . 76.9 Cg_exo -39.86 -24.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.908 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -35.58 -31.81 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.337 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -83.39 -121.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.517 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 tt0 -148.73 65.6 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.08 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -90.46 111.51 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.9 -178.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.674 ' OG ' HD13 ' A' ' 84' ' ' ILE . 38.0 t -62.07 137.1 95.55 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.719 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 84' ' ' ILE . 63.6 Cg_endo -76.57 108.88 2.75 Favored 'Trans proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.052 2.501 . . . . 0.0 114.063 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 88.9 m-20 72.51 14.25 5.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.259 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.674 HD13 ' OG ' ' A' ' 81' ' ' SER . 2.0 mp -95.75 -19.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 110.201 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.57 86.0 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.11 178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.698 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 147.64 98.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.487 0.492 . . . . 0.0 111.428 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.9 t -63.77 161.7 14.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.591 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.186 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.4 t0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.945 0.402 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.616 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -95.06 153.38 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.367 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' A' ' 9' ' ' ARG . 41.1 t0 -69.58 90.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.597 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.4 mp0 -73.85 -20.52 60.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.68 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.0 t -79.31 -36.26 39.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.491 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.0 ttt85 -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mm -52.24 -46.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -162.91 154.14 14.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.2 -18.84 2.61 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.29 2.66 . . . . 0.0 111.722 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -108.12 21.35 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.378 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.736 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.06 -51.66 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.981 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 45' ' ' CYS . 12.4 m -95.13 17.26 14.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 67.93 3.34 28.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.969 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.513 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 175.09 -52.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.988 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 30' ' ' LYS . . . -48.11 176.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.804 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 10.7 mt-30 -105.96 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.809 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 2.9 p -52.27 134.91 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 111.558 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -118.38 164.05 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.21 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 8.9 t30 -106.34 142.96 35.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 111.644 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -149.87 157.06 38.36 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 15.9 Cg_endo -57.61 111.84 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.256 . . . . 0.0 111.849 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.55 44.28 67.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.695 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 171.11 -175.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.738 0.304 . . . . 0.0 110.516 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.736 ' CE2' HD22 ' A' ' 14' ' ' LEU . 28.0 p90 -160.23 167.38 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.254 0.549 . . . . 0.0 111.716 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.7 pt-20 -143.51 -165.18 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.583 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.8 p -170.7 168.09 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -114.17 82.19 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.16 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -39.03 165.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 2.7 t70 -77.15 -144.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.17 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.8 mt-10 -28.15 -93.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.859 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -123.51 32.67 4.21 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.22 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 21.2 m-85 -81.6 143.8 31.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.001 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -117.49 132.96 56.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.64 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -42.31 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.353 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -47.25 -76.64 0.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 87.39 -22.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.663 0.268 . . . . 0.0 111.04 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 mtm -59.5 -32.08 69.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.21 0.529 . . . . 0.0 109.884 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.0 mmm -117.42 -23.23 7.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.516 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 179.31 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.224 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 42' ' ' MET . 1.2 tptt 173.31 34.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.994 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 3.1 p-10 -62.44 -177.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.779 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.585 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -100.39 105.84 17.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.207 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.555 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 2.2 ptp -123.83 99.87 6.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.302 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -9.14 125.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.846 0.716 . . . . 0.0 112.732 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -64.94 -174.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.256 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -100.44 73.54 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.301 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.885 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.2 mp0 -50.09 -21.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.729 ' HA ' HD22 ' A' ' 57' ' ' LEU . 51.1 m -77.7 -9.83 59.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.663 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.45 -22.27 8.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.637 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 33.9 ttt-85 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.105 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.494 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -100.97 156.12 35.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.027 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 20.8 Cg_endo -90.2 -2.61 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.344 2.696 . . . . 0.0 112.364 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -132.06 14.57 4.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.404 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.885 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -62.81 129.16 39.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.7 m 45.93 25.89 0.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.351 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -62.31 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.239 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 129.6 0.46 5.73 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.806 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -122.55 -139.06 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.562 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.717 HG11 ' NE2' ' A' ' 64' ' ' HIS . 55.8 t -127.58 117.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.45 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 6.3 t -84.1 94.33 8.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.717 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.8 m80 -89.43 53.73 2.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 17.6 t-20 -49.66 111.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.718 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.51 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -112.7 -161.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.316 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.4 pt-20 -75.53 138.93 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 34.59 46.6 0.58 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.721 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.1 t 157.61 -176.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.731 ' CE2' HD21 ' A' ' 57' ' ' LEU . 1.8 p90 -154.81 156.13 35.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -122.92 117.19 24.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.01 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.549 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -100.07 135.37 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' C ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt0 -150.22 120.59 7.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.112 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.754 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -45.68 -47.53 38.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.4 Cg_exo -76.3 -60.41 0.08 OUTLIER 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.771 -1.345 . . . . 0.0 113.264 0.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.707 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.7 Cg_endo -83.38 -154.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.823 2.349 . . . . 0.0 113.111 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 78' ' ' HIS . . . 45.88 39.36 8.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.917 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.564 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.51 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.0 111.041 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -141.78 73.03 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -63.83 91.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.211 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.791 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -46.68 130.7 8.38 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 59.2 Cg_endo -74.51 112.58 3.59 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.965 2.444 . . . . 0.0 113.253 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 75.97 34.26 0.55 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.985 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.791 HD13 ' C ' ' A' ' 81' ' ' SER . 1.1 mp -115.0 -39.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.111 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.7 p 88.74 69.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.041 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.03 116.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.696 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -62.46 128.49 36.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.564 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.0 t0 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.86 173.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 51.5 t0 -84.49 97.81 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.931 0.396 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.746 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.8 mp0 -76.75 -25.93 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.571 ' HA ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -69.51 -45.43 68.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.353 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -50.5 -35.58 29.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.034 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 11.1 mm -42.37 -40.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -161.94 147.88 10.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.578 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.8 Cg_endo -85.24 -17.05 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.038 2.492 . . . . 0.0 111.256 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -112.13 23.76 13.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.059 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -38.96 -54.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.421 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -77.39 -10.84 59.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.067 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.31 -1.82 48.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.775 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 6.8 tpt180 -173.57 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.971 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -71.72 -151.61 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.628 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -133.74 99.3 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.7 t -50.77 153.52 1.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.188 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 31.6 t -136.86 161.72 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.724 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 3.7 t-20 -95.69 143.65 26.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.691 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -149.18 155.82 39.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.9 Cg_endo -55.59 105.88 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.717 2.278 . . . . 0.0 111.952 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.43 41.51 97.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.906 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 175.57 -168.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.697 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.6 p90 -165.82 148.12 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.0 pt-20 -118.46 -170.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.434 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -147.34 155.78 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 111.531 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -113.36 71.66 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.967 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -50.74 -175.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.856 -178.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.62 -158.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.049 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 32' ' ' ASP . 3.9 mm-40 19.88 -82.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.181 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ASP . . . -152.62 22.45 0.82 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.61 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 28.3 m-85 -79.79 134.38 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 4.6 pt-20 -99.66 134.83 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -86.49 88.2 7.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 125.58 79.87 0.37 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.273 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 22.0 t80 -122.18 -3.07 9.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.72 0.295 . . . . 0.0 111.238 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 159.7 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.091 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -89.88 -24.34 21.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.6 OUTLIER 124.26 -19.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.256 0.972 . . . . 0.0 109.988 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HA ' ' N ' ' A' ' 38' ' ' GLY . 1.7 tptt -164.8 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.912 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 21.94 102.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.885 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.3 m -39.21 95.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.18 0.514 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.815 ' HA ' ' HE3' ' A' ' 46' ' ' MET . 0.0 OUTLIER -119.74 91.88 3.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.147 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.5 p30 -5.51 123.24 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.087 0.867 . . . . 0.0 112.958 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -63.2 -171.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.606 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 54.3 t0 -94.83 72.82 3.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.814 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.4 mp0 -51.01 -21.59 1.86 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.2 t -78.28 -9.01 59.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.748 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.4 mt-30 -116.74 -22.22 8.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.713 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -59.95 -32.71 71.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.138 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -116.15 137.48 23.47 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.037 0.446 . . . . 0.0 110.979 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.77 -4.16 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.193 2.595 . . . . 0.0 112.147 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.507 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -118.88 -9.43 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.285 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.957 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -49.96 114.15 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.575 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 35.5 m 50.78 23.54 1.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.271 0.557 . . . . 0.0 109.959 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -39.42 -31.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.689 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.38 21.65 5.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -137.99 -129.76 2.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.573 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' NE2' ' A' ' 64' ' ' HIS . 28.3 t -136.19 129.67 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.455 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 24.6 p -97.4 96.33 8.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' NE2' HG11 ' A' ' 62' ' ' VAL . 52.0 m80 -88.67 59.85 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.731 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 3.7 t-20 -44.1 119.48 1.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.871 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -119.43 -162.07 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 69' ' ' SER . 2.7 mt-10 -77.47 142.61 39.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' SER . . . 33.98 34.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.753 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 65.1 p 172.89 -169.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.874 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 1.5 p90 -162.1 147.92 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.647 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.93 146.39 35.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.963 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.055 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -119.19 138.7 52.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.931 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -131.77 123.45 27.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.72 -34.1 1.71 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.989 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 15.1 Cg_exo -70.99 -176.06 13.65 Favored 'Cis proline' 0 C--N 1.356 0.945 0 C-N-CA 124.154 -1.186 . . . . 0.0 112.616 0.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.8 Cg_exo -39.29 172.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.015 2.476 . . . . 0.0 112.928 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.77 48.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.7 t-160 -99.48 -126.12 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.751 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -151.67 64.52 0.86 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.122 0.486 . . . . 0.0 110.011 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.055 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.94 107.52 19.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.247 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.622 ' N ' HD12 ' A' ' 80' ' ' LEU . 31.3 t -55.3 136.77 68.76 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -77.52 110.49 2.98 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.904 2.403 . . . . 0.0 113.845 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 87.6 m-20 71.83 -0.61 3.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.344 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.541 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -79.33 -35.12 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.251 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.714 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.4 p 85.98 81.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.181 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.02 101.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.948 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.4 148.95 30.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.319 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.295 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.436 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 28.7 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -120.69 161.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 5' ' ' ILE . 23.9 t0 -42.39 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 14' ' ' LEU . 1.5 mt-10 95.37 -52.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.121 0.569 . . . . 0.0 110.805 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 5.5 t -66.68 -36.01 81.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.497 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -76.89 -26.24 53.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.77 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ARG . 9.2 mm -38.18 -36.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.74 154.02 8.67 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -89.7 -18.58 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 111.471 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.97 17.5 24.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.065 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -39.84 -55.39 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -85.73 15.19 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.72 24.59 0.47 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.381 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER 163.29 -59.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.3 -150.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 2.4 mt-30 -137.92 113.08 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 24.6 p -53.49 155.31 3.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.8 t -133.55 163.79 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.565 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.1 t30 -107.06 142.45 36.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.965 0.412 . . . . 0.0 111.64 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.0 p -152.28 153.59 31.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.55 116.55 2.93 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 111.713 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . 46.42 46.92 17.1 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.576 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 171.41 177.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CG ' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -157.98 161.27 38.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.431 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -133.57 -172.25 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 1.1 m -140.83 159.09 42.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 1.6 tmtm? -112.76 75.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 99.5 m -45.87 155.78 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.334 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 30.9 t70 -57.3 -81.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 6.2 mt-10 -145.11 -40.19 0.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.48 17.52 6.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.391 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 3.8 m-30 -89.61 158.16 17.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.665 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -122.08 124.73 44.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.49 105.41 17.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.72 69.83 0.66 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.389 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 91.5 t80 -104.28 -15.02 15.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.445 ' SD ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 168.32 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.198 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.629 ' HG3' ' ND2' ' A' ' 44' ' ' ASN . 30.7 mmm -75.53 -16.26 60.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.479 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.556 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.5 mtm 99.17 -15.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.524 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 1.6 mmtp 172.87 99.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.885 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.629 ' ND2' ' HG3' ' A' ' 41' ' ' MET . 27.8 p-10 -168.14 72.53 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.347 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 57.1 m -28.65 108.88 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.722 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 8.6 ptm -138.87 113.17 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.5 p-10 0.08 106.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.982 0.802 . . . . 0.0 112.809 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -56.53 -175.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.66 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.9 t0 -94.6 76.13 3.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.421 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.867 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.8 mp0 -49.68 -21.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.142 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.959 ' HA ' HD22 ' A' ' 57' ' ' LEU . 44.1 t -77.69 -11.11 59.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.59 -23.86 10.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -20.92 40.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.829 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -132.76 142.61 45.41 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 -5.63 11.76 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.94 2.427 . . . . 0.0 112.354 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -122.5 -8.37 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.821 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.959 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -53.12 114.35 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . 74.1 m 58.0 16.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.47 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -42.73 -27.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.425 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.23 29.4 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.073 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.59 -132.83 2.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.955 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.677 HG11 ' NE2' ' A' ' 64' ' ' HIS . 52.1 t -132.54 136.15 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 88.4 m -93.01 89.94 6.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.677 ' NE2' HG11 ' A' ' 62' ' ' VAL . 31.7 m80 -89.03 47.78 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 110.041 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 19.5 t-20 -44.61 116.06 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.276 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 71' ' ' ARG . 2.4 p -115.39 -162.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLY . 1.3 mt-10 -75.66 135.87 40.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.91 37.83 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.58 168.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.727 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.1 p90 -140.98 149.57 41.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.63 106.25 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.759 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.8 t -90.19 132.85 35.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.741 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.858 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.7 tt0 -145.81 128.09 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.785 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -50.59 -45.49 85.27 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.558 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.785 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 2.7 Cg_exo -75.08 -60.32 0.08 OUTLIER 'Cis proline' 0 C--N 1.352 0.732 0 C-N-CA 123.664 -1.39 . . . . 0.0 113.183 1.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.697 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.8 Cg_endo -85.13 -156.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.884 2.389 . . . . 0.0 113.59 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.05 37.25 9.76 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.0 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 160.52 -165.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 111.342 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.22 86.26 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.637 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -65.73 124.12 21.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.348 0.595 . . . . 0.0 111.932 -178.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.793 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -53.34 123.09 34.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.879 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.28 -44.81 43.72 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.578 2.185 . . . . 0.0 112.032 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.6 m120 -145.36 13.81 1.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -89.93 -20.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.622 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.34 103.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.0 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.835 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 127.55 106.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.904 0.752 . . . . 0.0 111.276 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.81 139.14 58.73 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 111.328 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.562 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.821 0.343 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -89.85 165.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.545 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 61.7 t0 -71.9 91.93 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 14' ' ' LEU . 48.9 mp0 -72.56 -24.83 61.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.518 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.664 ' HA ' HD13 ' A' ' 14' ' ' LEU . 20.3 t -70.41 -45.7 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HG2' ' OD2' ' A' ' 6' ' ' ASP . 6.8 mmt180 -55.18 -31.25 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 9.5 mm -37.97 -37.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.305 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.86 153.57 8.2 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.642 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.72 -22.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.854 2.37 . . . . 0.0 111.495 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -108.02 18.99 20.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.939 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -29.68 -57.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.516 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -93.29 -18.52 22.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.426 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 84.03 -47.2 3.8 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.033 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 31.5 tpt85 -116.68 -9.69 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 0.0 111.268 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -118.46 -171.96 15.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.615 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -118.29 108.9 15.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' CB ' HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -50.58 134.67 23.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.064 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 28' ' ' GLU . 2.1 p -119.43 146.16 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -84.89 141.25 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.41 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -148.6 155.12 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.754 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.3 Cg_endo -53.0 104.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.79 42.77 94.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.752 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.429 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER 178.62 -168.68 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.702 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -173.61 139.5 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.643 ' H ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -106.48 -148.75 0.42 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.284 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 m -163.09 148.35 11.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 0.0 111.493 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' CD ' ' A' ' 30' ' ' LYS . 6.6 tmtm? -100.87 67.3 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.098 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 93.4 m -52.52 171.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.842 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 11.1 t70 -68.58 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.522 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 68' ' ' GLY . 1.6 tt0 -128.07 -65.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.506 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.71 5.07 32.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.456 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 m-85 -69.58 112.64 6.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.023 0.44 . . . . 0.0 110.395 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.46 117.07 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.467 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -81.99 103.13 11.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.585 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . . . 126.86 69.47 0.17 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 77.9 t80 -123.61 11.23 9.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.89 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 0.0 111.431 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.597 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.5 mmt -94.96 -27.96 15.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.597 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.5 OUTLIER 127.45 -20.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.443 1.089 . . . . 0.0 110.101 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 37' ' ' SER . 5.6 mptt -148.75 -89.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.772 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 36.27 67.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 27.6 m -29.7 96.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.154 0.502 . . . . 0.0 110.889 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -125.85 115.35 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.868 -178.556 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.555 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -20.87 138.92 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.584 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.3 pt -82.94 -174.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.134 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.504 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 41.6 t0 -104.07 72.98 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.989 ' O ' HD13 ' A' ' 57' ' ' LEU . 6.0 mp0 -47.34 -26.04 1.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.391 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 1.004 ' HA ' HD22 ' A' ' 57' ' ' LEU . 48.8 t -75.31 -11.93 60.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.038 0.447 . . . . 0.0 110.833 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.0 mt-30 -111.47 -25.3 9.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.353 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HD3' ' OD2' ' A' ' 54' ' ' ASP . 5.0 ttt180 -51.03 -32.89 22.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.594 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 60.2 m-20 -129.78 150.59 76.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.777 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.48 -3.89 6.62 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.238 2.625 . . . . 0.0 112.491 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -113.89 -10.59 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.004 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.4 OUTLIER -53.17 119.57 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.793 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 61.7 m 46.8 26.1 0.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.499 . . . . 0.0 109.968 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 1.3 ttt85 -41.4 -28.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.535 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.68 21.32 3.4 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.891 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -127.57 -139.98 5.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.716 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG11 ' CE1' ' A' ' 64' ' ' HIS . 79.7 t -121.7 137.13 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 25.9 m -96.08 89.13 5.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.607 ' CE1' HG11 ' A' ' 62' ' ' VAL . 98.2 m-70 -89.99 49.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.447 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 13.2 t-20 -45.73 113.76 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.716 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.5 p -105.06 -173.82 2.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.956 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 1.6 mp0 -50.5 -98.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . -88.8 57.71 4.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.415 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 10.8 t 156.8 -173.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.285 . . . . 0.0 110.67 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.772 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 7.5 p90 -148.55 149.9 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.716 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -113.62 118.21 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.051 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.025 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.07 142.39 27.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.334 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 76' ' ' PRO . 2.2 tt0 -136.19 122.41 20.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.592 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.81 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.07 -34.55 1.71 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.005 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.81 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 11.8 Cg_exo -72.89 -172.15 9.28 Favored 'Cis proline' 0 C--N 1.356 0.943 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.521 0.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 89.2 Cg_exo -41.0 176.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.943 2.429 . . . . 0.0 113.006 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.28 48.76 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.577 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.3 t-160 -101.68 -126.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.506 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 30.2 tt0 -151.22 64.8 0.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.113 0.482 . . . . 0.0 109.894 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.46 129.22 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.576 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.053 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -58.79 134.29 86.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.563 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 81' ' ' SER . 45.9 Cg_exo -55.83 -50.56 12.08 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.595 2.197 . . . . 0.0 111.953 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.684 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.3 m120 -147.15 28.52 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.447 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.794 ' N ' HD13 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -96.65 -23.65 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.56 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 74.98 89.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.142 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.87 99.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 1.011 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.25 157.15 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.348 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.577 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -93.04 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 8.0 t0 -84.61 -50.81 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.0 mp0 73.6 -56.9 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.616 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HA ' HD13 ' A' ' 14' ' ' LEU . 28.3 t -64.68 -18.18 64.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.62 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -76.89 -34.22 57.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.552 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.3 mt -43.3 -37.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.615 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.9 t -162.25 152.19 13.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.671 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_endo -85.53 -17.8 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.114 2.543 . . . . 0.0 111.466 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.53 22.41 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.216 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.938 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -43.72 -44.25 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.163 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.8 m -83.91 11.47 7.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 52.73 11.1 1.16 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.942 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 tpm_? 172.81 -55.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.338 0.569 . . . . 0.0 110.877 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -64.98 -145.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.969 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 mt-30 -131.48 124.41 30.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.016 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 2.2 p -75.09 130.43 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 111.252 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' ASN . 41.5 t -117.34 162.02 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.645 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.7 t-20 -93.63 148.54 22.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.499 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 27' ' ' PHE . 6.4 p -152.72 149.12 21.58 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.59 111.45 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.805 2.337 . . . . 0.0 111.953 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.68 43.7 86.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.888 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 170.01 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.869 0.366 . . . . 0.0 110.671 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.938 ' CE2' HD22 ' A' ' 14' ' ' LEU . 16.2 p90 -166.51 144.41 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.6 pt-20 -109.98 -168.12 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.5 m -152.31 165.31 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 111.69 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -124.94 72.26 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.564 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 98.7 m -41.84 170.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.55 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -80.83 -73.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -131.21 -85.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.646 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 33' ' ' GLU . . . -93.33 -7.6 61.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.639 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 19.1 m-30 -68.57 127.15 31.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 pt-20 -100.24 128.06 46.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -86.94 105.73 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.21 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 117.13 24.17 3.64 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.798 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 40' ' ' MET . 84.9 t80 -44.6 -26.71 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.557 ' CG ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.14 -34.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -54.14 -44.44 71.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.749 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.75 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 8.8 tptt -167.82 23.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.548 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' SER . 4.1 p-10 -76.33 143.26 40.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 86.5 m -85.13 108.84 17.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 22.8 ptm -136.6 113.46 10.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.95 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.524 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 2.0 p30 2.57 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 124.028 0.83 . . . . 0.0 112.973 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -53.31 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.163 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 51' ' ' CYS . 46.0 t0 -97.19 73.47 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.937 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.7 mp0 -49.47 -23.19 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 110.763 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.945 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.3 t -76.38 -11.22 59.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.9 mt-30 -114.45 -23.96 9.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -57.79 -31.44 66.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.02 137.81 23.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.833 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.01 -2.12 10.1 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.061 2.507 . . . . 0.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.599 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -122.93 -5.62 8.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.596 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -53.05 116.67 2.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.957 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.1 m 52.08 21.49 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.17 -26.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.272 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.57 21.63 6.31 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.95 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -147.48 -129.83 1.97 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.683 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 64' ' ' HIS . 38.7 t -137.16 133.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.825 0.345 . . . . 0.0 110.569 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.0 p -99.95 96.88 7.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.496 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.57 ' CD2' HG12 ' A' ' 62' ' ' VAL . 16.9 m80 -88.4 61.14 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.654 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -41.96 120.45 1.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.902 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.541 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -121.17 172.7 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.3 pt-20 -59.99 139.19 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 67' ' ' GLU . . . 38.08 33.77 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.48 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 179.3 -166.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.131 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -173.63 144.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.446 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.541 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.5 OUTLIER -109.36 152.09 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.201 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.032 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -132.17 135.55 46.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.089 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG2' ' CD ' ' A' ' 76' ' ' PRO . 6.7 tt0 -142.9 124.97 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.977 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.846 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -63.71 -38.57 39.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.0 Cg_exo -80.16 -172.51 11.19 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.291 -1.129 . . . . 0.0 112.587 1.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 8.9 Cg_exo -28.39 152.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.16 2.573 . . . . 0.0 113.56 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.09 -12.77 16.94 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.676 ' CE1' ' C ' ' A' ' 88' ' ' ILE . 3.7 t-160 -120.53 -131.93 0.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.522 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.539 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -150.32 72.42 1.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 110.16 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.032 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -84.16 125.81 32.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.269 0.556 . . . . 0.0 111.861 -179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.94 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -62.89 132.68 94.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.854 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.29 -48.21 13.65 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.656 2.237 . . . . 0.0 112.395 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 84' ' ' ILE . 13.2 m120 -153.69 33.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.819 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -101.96 -12.31 8.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.41 86.88 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.305 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.73 104.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.2 t -71.21 145.93 49.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.716 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.676 ' C ' ' CE1' ' A' ' 78' ' ' HIS . 2.3 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.24 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.9 t0 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.813 0.34 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -90.5 -165.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.811 ' N ' HG23 ' A' ' 5' ' ' ILE . 17.8 t0 -91.77 -49.27 6.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.997 0.427 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 16.1 mp0 71.71 -55.32 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 67.4 m -61.37 -27.1 68.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.855 0.359 . . . . 0.0 110.344 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.9 -32.62 73.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.169 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.4 mm -45.51 -39.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.477 ' OG ' ' HD2' ' A' ' 12' ' ' PRO . 17.7 t -168.13 154.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.205 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 76.1 Cg_endo -89.31 -20.12 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.234 2.623 . . . . 0.0 111.289 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.32 22.0 16.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.6 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.654 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.87 -46.44 5.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.272 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -82.35 2.4 32.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.364 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 65.19 4.24 15.41 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.668 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 175.95 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.109 0.455 . . . . 0.0 111.362 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 30' ' ' LYS . . . -65.05 -131.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.163 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 1.3 mt-30 -148.28 122.0 9.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.39 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -67.95 160.85 27.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.7 t -141.43 164.1 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.746 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 14.7 t30 -105.25 151.21 24.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.7 p -153.77 146.82 17.86 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.876 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.77 111.51 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.904 2.403 . . . . 0.0 112.059 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.8 42.08 96.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.996 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.05 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.481 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.654 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.1 p90 -165.32 171.75 13.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.971 0.415 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 3.0 pt-20 -142.62 175.14 10.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -139.91 153.35 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 111.379 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.21 162.84 12.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.907 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 1.3 m -139.74 153.66 47.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.071 0.463 . . . . 0.0 111.341 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -89.89 -157.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.657 -179.08 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 32' ' ' ASP . 4.4 mt-10 9.42 -77.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -154.28 31.02 0.71 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.176 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 21.9 m-85 -81.12 155.58 26.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -132.68 133.41 43.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -42.96 100.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.607 ' HA2' ' HE3' ' A' ' 46' ' ' MET . . . -51.04 -76.22 0.18 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.695 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 84.48 -12.35 0.77 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.402 ' SD ' ' HE1' ' A' ' 46' ' ' MET . 1.0 OUTLIER -88.85 -16.8 31.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.337 179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -33.15 2.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.22 36.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HD3' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER 51.17 36.62 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -77.21 -152.45 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.2 m -115.73 113.68 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.607 ' HE3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -130.54 103.72 6.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.088 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.0 p-10 -12.57 110.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.062 0.851 . . . . 0.0 112.654 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -48.76 -173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.116 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.437 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 60.5 t0 -101.51 72.92 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.378 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 57' ' ' LEU . 5.1 mp0 -51.96 -22.01 3.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 110.149 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.439 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.9 -11.27 60.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -115.27 -29.04 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.643 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -49.35 -38.0 26.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -113.12 130.55 23.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.797 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 56' ' ' LEU . 73.0 Cg_endo -77.52 -5.73 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.829 2.353 . . . . 0.0 112.156 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -126.64 -6.73 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -30.39 134.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 1.3 m 38.49 36.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.47 -40.8 0.89 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 21.6 7.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.889 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -136.02 -157.0 7.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.951 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.689 HG11 ' NE2' ' A' ' 64' ' ' HIS . 35.3 t -113.96 123.33 69.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.897 0.38 . . . . 0.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -88.84 98.41 11.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.821 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.689 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.6 m80 -93.37 61.02 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.252 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 12.9 t-20 -49.04 114.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -116.08 -163.47 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -76.03 144.86 40.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.17 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 33.87 35.03 0.04 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.831 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.55 177.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.369 . . . . 0.0 111.263 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 p90 -148.84 147.38 28.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 3.5 mmm180 -109.66 148.73 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -130.17 133.35 46.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.549 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 4.1 tt0 -125.83 119.12 27.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -64.29 -40.09 48.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 17.4 Cg_exo -69.26 174.21 39.75 Favored 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.616 1.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.549 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 67.1 Cg_exo -30.85 -32.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.057 2.504 . . . . 0.0 113.096 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.61 -30.62 0.06 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.279 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 0.4 OUTLIER -103.03 -134.92 0.32 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 1.2 tp-100 -137.32 82.61 1.94 Allowed 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.323 0.51 . . . . 0.0 110.992 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.28 113.48 25.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.699 ' N ' HD12 ' A' ' 80' ' ' LEU . 18.1 t -67.6 135.77 92.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.903 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 Cg_exo -32.96 -115.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.031 3.154 . . . . 0.0 114.157 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.42 39.74 0.96 Allowed 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.957 -0.464 . . . . 0.0 111.062 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -95.93 -31.01 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER 72.04 89.23 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 179.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 157.37 74.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.0 t -35.89 146.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.585 0.231 . . . . 0.0 110.431 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.537 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.189 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 22.0 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.837 0.351 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.61 155.42 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 8' ' ' CYS . 50.7 t0 -76.31 67.66 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.639 ' CB ' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 -45.33 -25.02 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.417 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.615 ' HA ' HD13 ' A' ' 14' ' ' LEU . 37.3 m -74.48 -39.24 62.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' ASP . 13.6 ttt-85 -55.41 -34.2 64.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.786 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.91 -40.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -160.48 145.88 11.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.484 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -83.08 -17.13 6.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.032 2.488 . . . . 0.0 111.279 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -113.57 24.08 12.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.91 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.34 -48.67 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.436 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -81.21 0.28 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.205 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 13' ' ' ASP . . . 82.69 -44.33 3.21 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.507 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 1.6 tpt180 -142.34 -40.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -63.83 178.46 7.34 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.669 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.5 mt-30 -100.76 95.91 6.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.624 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.475 ' CA ' ' SG ' ' A' ' 15' ' ' CYS . 50.9 t -47.42 130.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -116.5 154.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.974 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 23' ' ' THR . 0.9 OUTLIER -107.1 163.4 13.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 112.069 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 22' ' ' ASN . 1.1 p -161.4 158.9 23.5 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.478 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 7.1 Cg_endo -49.84 110.39 0.37 Allowed 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.728 2.285 . . . . 0.0 112.192 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . 56.28 43.09 89.48 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.354 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CA ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.53 176.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.879 ' CE2' HD22 ' A' ' 14' ' ' LEU . 7.1 p90 -155.87 148.99 24.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.331 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 pt-20 -114.46 -144.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.973 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.9 m -167.84 159.86 11.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.468 . . . . 0.0 111.702 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -120.16 72.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.319 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 94.7 m -42.09 171.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.7 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 25.6 t0 -85.66 -92.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.554 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 56.4 mt-10 -111.95 -69.86 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.374 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.37 -2.03 35.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 13.7 m-85 -69.32 125.31 26.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.721 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -106.05 127.44 53.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 43' ' ' LYS . 1.3 p -91.05 116.5 28.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.92 37.8 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.79 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 79.4 t80 -77.79 -20.81 52.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 110.808 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.514 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.74 -24.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -72.6 -23.14 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 109.67 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.195 0.934 . . . . 0.0 109.953 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 163.25 104.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.766 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 45' ' ' CYS . 7.4 p-10 -170.01 47.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.396 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m -1.6 116.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.365 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.567 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 9.8 ptm -143.02 128.93 19.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.2 p-10 -20.93 113.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -58.48 -173.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.545 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 53.9 t0 -101.67 72.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.9 mp0 -50.22 -22.31 1.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.551 ' HA ' HD22 ' A' ' 57' ' ' LEU . 70.0 m -75.25 -9.63 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.542 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -117.06 -20.84 9.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.761 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.57 -31.37 70.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.134 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.56 141.49 41.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.561 ' O ' HD12 ' A' ' 56' ' ' LEU . 91.8 Cg_endo -84.82 -5.76 9.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.134 2.556 . . . . 0.0 112.156 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -119.51 0.38 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.007 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -53.65 114.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 62' ' ' VAL . 56.7 m 54.4 22.31 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.766 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.19 -35.19 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.458 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.26 18.09 25.95 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.923 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.08 -122.64 1.29 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.76 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 73' ' ' GLU . 19.0 t -150.01 135.36 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.794 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.606 ' HB3' HD23 ' A' ' 57' ' ' LEU . 21.7 p -102.64 100.98 11.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.141 0.496 . . . . 0.0 110.938 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 37.7 m80 -88.98 64.16 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 16.4 t-20 -46.49 120.15 2.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.181 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -117.33 -162.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.991 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 7.3 mt-10 -80.51 133.88 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 46.01 42.85 12.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 3.0 p 159.39 -172.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.793 0.33 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.979 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -159.3 150.27 19.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.588 ' HD3' HG21 ' A' ' 66' ' ' THR . 4.2 mmm180 -109.84 146.47 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.009 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.7 t -125.79 127.47 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.45 127.94 36.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.472 -178.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.85 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.24 -37.73 14.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.3 Cg_exo -80.12 -172.61 11.33 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.456 1.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.669 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 20.8 Cg_exo -28.08 150.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.148 2.565 . . . . 0.0 113.406 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.12 -16.51 11.9 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.708 ' CD2' ' O ' ' A' ' 88' ' ' ILE . 7.4 t-160 -115.76 -131.09 0.31 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.105 -0.548 . . . . 0.0 109.686 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -150.97 71.39 1.02 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.277 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.009 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -85.72 105.41 16.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.408 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.722 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -61.15 134.42 93.07 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.911 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 56.1 Cg_endo -72.27 109.34 2.7 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.869 2.379 . . . . 0.0 113.568 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 20.0 m120 73.68 33.29 1.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.533 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -110.82 -32.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER 77.4 72.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.793 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.4 99.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.508 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 t -59.76 151.56 25.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 110.7 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.708 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.19 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.92 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.821 ' N ' HG23 ' A' ' 5' ' ' ILE . 15.1 t0 -88.02 -49.31 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.578 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.6 mp0 72.45 -55.46 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 66.4 m -62.03 -23.89 66.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -66.19 -35.5 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.153 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -41.6 -37.41 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.327 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' CYS . 1.6 t -164.74 153.54 11.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.605 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.1 Cg_endo -83.28 -20.31 5.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.156 2.571 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -114.26 25.89 10.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.146 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.822 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.08 -50.16 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.266 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 6.9 t -60.18 -14.06 15.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 74.71 -3.23 44.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.778 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 10.9 tpt180 176.82 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.052 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -85.85 -139.92 5.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.889 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -132.97 106.73 7.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 111.029 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 40.8 t -59.96 152.17 24.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 111.299 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.8 t -138.89 163.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' HG12 ' A' ' 21' ' ' VAL . 7.2 t-20 -100.27 146.78 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.599 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.9 p -150.54 146.31 19.55 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.77 107.89 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.864 2.376 . . . . 0.0 112.008 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.02 40.6 99.12 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.128 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 171.99 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.822 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -169.15 151.81 4.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.4 pt-20 -131.26 -170.97 2.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.152 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -165.49 150.87 9.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 111.681 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -97.23 81.69 3.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.143 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -44.09 174.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.61 -95.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.377 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 9.6 tt0 -114.21 -77.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -103.91 4.13 45.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.83 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 21.8 m-30 -69.94 133.07 46.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.286 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.614 ' CB ' HG22 ' A' ' 48' ' ' ILE . 1.4 pt-20 -89.29 128.52 35.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 33.5 p -84.1 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 95.64 76.78 1.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.786 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' ' OE2' ' A' ' 36' ' ' GLU . 4.0 t80 -85.64 -18.01 34.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 110.547 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.37 -35.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -60.17 -42.89 95.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.518 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.67 -87.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.013 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -161.2 32.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.6 p-10 -77.25 -174.97 3.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.176 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 1.5 m -111.02 107.82 17.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' C ' ' A' ' 47' ' ' ASP . 18.1 ptm -141.48 110.57 6.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.518 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.09 124.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.985 0.803 . . . . 0.0 112.752 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.614 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -78.0 -174.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.209 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.6 t0 -98.52 72.97 2.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 11.8 mp0 -52.74 -21.85 4.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.475 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.612 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -74.83 -10.57 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.458 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 7.2 mt-30 -119.63 -25.98 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -28.26 14.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.239 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 5.9 m-20 -133.32 144.4 52.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 111.259 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.11 -5.32 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.157 2.571 . . . . 0.0 112.045 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.04 2.45 10.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -56.9 122.69 12.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' GLY . 76.0 m 49.76 25.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.18 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.72 61.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 151.91 -16.82 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.199 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.51 -120.78 3.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.805 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.55 135.72 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 0.5 OUTLIER -106.59 92.38 4.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.12 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.805 ' NE2' HG11 ' A' ' 62' ' ' VAL . 37.6 m80 -89.73 60.24 4.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.741 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 22.2 t-20 -51.3 111.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.497 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -108.27 -161.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.042 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 47' ' ' ASP . 4.1 mt-10 -89.75 128.68 36.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 67.01 26.46 73.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.646 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.0 t 158.14 -176.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.923 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -146.82 147.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.497 ' HD3' HG21 ' A' ' 66' ' ' THR . 1.0 OUTLIER -109.79 121.36 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.019 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -99.58 131.69 45.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.964 179.372 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -130.33 120.13 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 111.884 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.0 -31.95 0.85 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.938 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 40.8 Cg_endo -66.47 173.0 32.82 Favored 'Cis proline' 0 C--N 1.356 0.94 0 C-N-CA 123.802 -1.332 . . . . 0.0 112.76 1.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 72.1 Cg_exo -36.74 -29.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.943 2.428 . . . . 0.0 112.88 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.96 -30.45 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.377 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 5.6 t-160 -89.74 -129.34 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.572 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 54.1 mt-30 -138.55 61.16 1.59 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.019 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -87.19 125.55 34.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.408 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.991 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -56.66 134.12 78.08 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.819 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' HD13 ' A' ' 84' ' ' ILE . 75.1 Cg_exo -49.97 -57.1 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.746 2.297 . . . . 0.0 112.338 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.588 ' H ' HD12 ' A' ' 84' ' ' ILE . 9.2 m120 -143.98 27.92 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.38 -13.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.669 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.691 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.93 91.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.786 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.53 99.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.993 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -63.65 148.84 47.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 4.1 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.892 0.377 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.528 ' CG2' ' HG3' ' A' ' 7' ' ' GLU . 1.5 tp -89.54 176.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -74.07 -49.0 25.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.289 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.3 mp0 72.06 -56.38 0.65 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.62 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HA ' HD13 ' A' ' 14' ' ' LEU . 90.1 m -62.42 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -69.14 -30.2 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.582 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.5 mm -48.73 -41.68 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -161.65 156.51 19.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.125 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.4 -18.17 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 111.597 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.09 20.94 18.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.309 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.921 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -45.84 -39.44 8.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 91.5 m -82.23 -3.88 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.263 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 44' ' ' ASN . . . 57.0 13.76 9.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.57 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.545 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 2.7 tpt85 173.61 -54.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.69 -151.38 6.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.69 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.0 mt-30 -123.93 121.43 35.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.968 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.5 t -65.58 154.7 37.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 41.4 t -135.93 160.25 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.918 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.524 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.13 147.84 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.362 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.2 p -152.68 146.17 17.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.07 111.63 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.889 2.392 . . . . 0.0 111.884 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.47 43.61 90.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.94 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 169.17 -165.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 0.0 110.602 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.921 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.3 p90 -164.61 141.72 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 6.9 pt-20 -108.72 -172.38 2.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.06 163.67 27.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.527 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -121.11 55.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.211 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 72.8 m -31.66 152.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.634 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 26.6 t70 -61.03 -72.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 7.7 mt-10 -155.78 -34.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.868 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.18 6.26 8.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.628 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.3 m-85 -92.77 141.78 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.384 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.3 120.19 25.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.379 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.526 ' C ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -8.1 120.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.885 0.741 . . . . 0.0 112.42 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.61 57.74 2.96 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 2.0 p90 -52.42 -24.02 7.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.177 -0.512 . . . . 0.0 111.154 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.537 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 2.1 mtt -66.96 -24.77 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.166 0.508 . . . . 0.0 110.013 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.524 ' HE3' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -107.6 -35.57 6.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.55 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 166.95 -61.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.7 tptt 172.47 65.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.85 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.538 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -131.88 87.95 2.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.268 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 44' ' ' ASN . 66.9 m -10.61 117.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.997 0.811 . . . . 0.0 111.846 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.498 ' O ' ' C ' ' A' ' 47' ' ' ASP . 21.5 mtp -140.11 104.98 4.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.849 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 4.9 p-10 7.7 112.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.56 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -48.59 -175.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.331 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 57.4 t0 -102.32 72.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.46 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -49.86 -23.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 59.8 m -76.21 -10.18 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.649 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.453 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.4 mt-30 -116.87 -23.83 7.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.68 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -54.12 -33.53 58.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.044 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 4.9 m-20 -127.52 141.69 41.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.15 -8.35 11.9 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.058 2.506 . . . . 0.0 112.06 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -112.8 -8.71 13.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.507 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.23 120.57 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 58.9 m 45.98 26.12 0.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.182 0.515 . . . . 0.0 110.086 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.78 -30.24 22.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.745 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.28 18.79 7.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.23 -130.32 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 73' ' ' GLU . 48.7 t -134.21 136.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 50.9 t -106.81 99.08 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.26 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.492 ' NE2' HG11 ' A' ' 62' ' ' VAL . 54.1 m80 -90.81 61.03 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.572 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 8.3 t-20 -47.42 112.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.914 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -111.85 -163.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 4.2 mt-10 -72.19 134.39 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.73 36.49 0.12 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 171.52 163.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.744 0.307 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.955 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -138.03 145.41 41.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.7 115.71 30.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.55 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.68 132.75 35.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.019 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.43 120.81 22.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.825 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.01 -32.42 0.99 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.926 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 25.8 Cg_exo -65.33 171.84 31.78 Favored 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 123.883 -1.299 . . . . 0.0 112.67 1.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 71.0 Cg_exo -36.33 -27.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.939 2.426 . . . . 0.0 112.95 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.33 -30.78 0.06 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.272 -0.965 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -91.03 -128.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.517 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -140.42 65.16 1.42 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.194 0.521 . . . . 0.0 109.614 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.046 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.88 130.33 36.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.408 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.046 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -61.05 134.91 93.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.895 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' HD13 ' A' ' 84' ' ' ILE . 74.7 Cg_exo -49.9 -53.8 6.49 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.712 2.275 . . . . 0.0 112.47 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 11.0 m120 -148.06 24.46 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.245 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -91.74 -17.55 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.964 0.411 . . . . 0.0 110.542 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.92 89.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.025 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.8 98.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.978 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.33 151.61 31.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.154 178.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.26 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.7 t0 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.7 mp -104.09 165.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 62.6 t0 -77.38 97.21 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 29.0 mp0 -81.68 -21.32 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.4 t -70.57 -49.84 43.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.59 -22.58 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.7 mt -45.5 -40.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -164.56 140.11 4.7 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -76.02 -17.07 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.571 2.181 . . . . 0.0 111.651 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.76 13.93 22.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.559 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.25 -56.36 2.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.3 t -62.56 -11.76 18.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.022 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.46 -2.12 47.92 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.63 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 11.6 tpt180 177.53 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -87.46 -143.88 8.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.948 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -130.45 112.54 13.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.658 0.266 . . . . 0.0 110.961 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 21.2 p -53.95 154.17 4.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 111.195 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 14.2 t -134.79 164.62 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.106 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 13.9 t30 -110.29 139.54 45.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 111.595 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.1 p -147.36 153.9 44.82 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.752 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.22 119.91 7.31 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.794 2.329 . . . . 0.0 111.846 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.11 43.77 25.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.847 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.41 -169.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.363 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' THR . 20.5 p90 -166.26 176.6 7.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.185 0.517 . . . . 0.0 111.755 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -153.37 -165.47 2.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.892 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 9.3 p -170.32 151.12 3.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 111.576 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -94.36 78.75 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.267 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -42.29 170.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.493 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 13.6 t0 -63.87 -96.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.536 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.94 -74.55 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -99.77 -6.35 54.51 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.086 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 17.6 m-30 -69.14 128.84 38.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CG ' ' HA ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.11 149.56 21.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.686 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 69.3 p -59.64 77.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . 102.73 -64.49 0.42 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.882 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 62.6 t80 97.66 -14.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.075 0.55 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.12 -24.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.061 -179.828 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -73.75 -39.32 64.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.309 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 155.02 -59.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.35 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 tptt 179.35 105.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.732 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 45' ' ' CYS . 4.3 p-10 -161.21 27.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' CYS . 2.9 m 42.72 106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.589 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' ASP . 10.2 mmm -148.57 103.4 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.098 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.1 p-10 0.27 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.809 . . . . 0.0 112.763 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.498 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -65.64 -173.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -91.0 74.24 6.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.939 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.92 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -51.64 -23.83 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.718 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.988 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.5 t -74.67 -11.87 60.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.52 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 15.2 mt-30 -116.99 -25.66 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -50.82 -37.99 46.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -113.11 137.93 22.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 -5.07 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.075 2.517 . . . . 0.0 111.982 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.69 -6.67 9.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.42 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.078 HD11 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -52.72 124.71 14.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.3 m 45.02 26.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.331 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.89 62.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.431 179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 146.35 -15.43 1.66 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.627 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.52 -116.65 3.6 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.177 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 49.9 t -150.05 130.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.935 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.0 p -100.25 100.91 11.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.043 0.449 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 66' ' ' THR . 95.6 m-70 -89.93 57.22 3.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -42.28 110.53 0.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.345 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -114.26 -161.63 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.028 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' SER . 6.7 mt-10 -75.47 139.89 42.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.16 32.83 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.795 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER 171.68 177.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 1.078 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -147.86 148.32 30.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.89 114.63 28.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.569 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.78 136.87 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.007 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 31.3 tt0 -134.48 120.82 20.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.811 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.807 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -81.06 -32.99 0.67 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.856 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 45.7 Cg_endo -67.74 173.69 35.74 Favored 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.641 0.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 77.1 Cg_exo -36.26 -30.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.994 2.463 . . . . 0.0 112.723 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.51 -30.93 0.06 OUTLIER Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.262 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 5.4 t-160 -88.7 -127.62 0.06 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.98 62.85 1.43 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.042 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.76 131.12 35.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.438 -178.901 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.042 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.12 134.85 94.65 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.759 179.727 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.47 ' HD2' HD13 ' A' ' 84' ' ' ILE . 58.6 Cg_exo -51.14 -55.39 4.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.567 2.178 . . . . 0.0 112.307 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 8.7 m120 -145.51 25.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.347 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -93.42 -17.62 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.324 179.454 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.79 90.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.979 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.25 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 1.003 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.72 148.73 50.51 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.292 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.2 t0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.8 -179.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.711 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -90.31 -48.27 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.849 ' O ' HD11 ' A' ' 14' ' ' LEU . 7.2 mp0 67.43 -53.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.907 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 78.5 m -67.13 -22.47 65.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.865 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.1 ttt85 -72.69 -30.77 64.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.273 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -45.29 -40.77 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.483 179.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -159.02 152.93 19.45 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.616 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -83.48 -23.03 3.57 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.119 2.546 . . . . 0.0 111.14 179.519 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -114.85 31.25 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.709 179.382 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.89 -54.28 0.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.518 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.5 m -88.42 26.61 1.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 32.99 34.68 0.02 OUTLIER Glycine 0 C--O 1.229 -0.18 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.194 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 157.33 -60.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.96 0.409 . . . . 0.0 110.393 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.89 178.27 1.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.097 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.31 102.39 11.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.82 0.343 . . . . 0.0 110.811 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.47 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 38.8 t -57.9 142.46 46.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.5 t -129.22 162.52 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.563 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.5 t-20 -96.81 142.13 29.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.373 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -146.42 151.79 44.45 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.872 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.69 117.08 2.98 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.9 2.4 . . . . 0.0 111.923 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.35 44.73 44.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.829 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 168.81 -164.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.705 0.288 . . . . 0.0 110.462 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.709 ' HA ' HG23 ' A' ' 23' ' ' THR . 9.6 p90 -164.2 142.83 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.353 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 5.2 pt-20 -111.45 -167.64 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.201 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -153.29 -177.61 6.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.419 0.628 . . . . 0.0 111.76 -179.864 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 4.9 tmtt? -138.42 69.27 1.38 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.797 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 93.8 m -42.41 169.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -64.82 -93.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.257 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.13 -35.47 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.12 27.34 2.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.367 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 4.5 m-30 -94.09 139.01 31.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.631 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -90.09 120.44 31.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 15.7 p -79.21 91.28 4.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 103.13 72.56 0.92 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.557 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 18.4 t80 -87.52 -8.03 56.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.93 -32.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.717 -179.871 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.619 ' HG3' ' ND2' ' A' ' 44' ' ' ASN . 1.8 mmm -71.8 -36.44 70.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.4 OUTLIER 156.27 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 1.9 mmtm -158.13 22.63 0.25 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.619 ' ND2' ' HG3' ' A' ' 41' ' ' MET . 22.7 p-10 -63.62 76.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 111.381 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 16.0 m -37.48 100.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -126.39 121.72 33.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 -179.47 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.7 p-10 -21.2 100.23 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.985 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -47.55 -176.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.282 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -97.62 72.17 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.583 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.804 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.0 mp0 -51.21 -21.61 2.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.941 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.1 t -77.72 -8.68 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 6.0 mt-30 -118.92 -22.06 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -53.66 -23.04 10.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.34 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -124.38 140.64 35.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.058 0.456 . . . . 0.0 110.971 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 76.9 Cg_endo -78.35 -10.3 16.18 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.011 2.474 . . . . 0.0 112.364 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.667 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.69 -2.72 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.581 179.702 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.9 111.64 0.58 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.691 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 80' ' ' LEU . 61.3 m 56.3 18.59 3.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.91 -35.98 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.47 179.507 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.7 22.72 8.11 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.957 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -142.0 -131.16 2.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.827 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.57 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.14 129.6 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.878 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.471 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.7 p -98.71 94.22 6.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.57 ' NE2' HG11 ' A' ' 62' ' ' VAL . 18.8 m80 -88.37 60.6 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.266 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -44.58 115.15 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.532 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.3 p -111.38 -161.61 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -85.72 127.46 34.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 55.52 27.22 47.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.11 174.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.743 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.826 ' CD2' HD21 ' A' ' 57' ' ' LEU . 29.5 p90 -141.64 151.22 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.7 112.29 24.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.189 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.778 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -96.45 135.44 38.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.812 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.9 tt0 -150.06 127.52 11.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.388 -178.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -49.26 -45.36 76.07 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.443 179.569 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.1 Cg_exo -76.07 -61.42 0.05 OUTLIER 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.676 -1.385 . . . . 0.0 113.121 0.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.724 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.7 Cg_endo -85.37 -155.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.932 2.421 . . . . 0.0 113.02 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 78' ' ' HIS . . . 51.73 20.48 5.92 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.836 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.59 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 1.1 m-70 168.43 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.218 0.533 . . . . 0.0 111.499 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -129.36 95.86 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.823 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -73.23 120.53 18.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 -178.931 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.844 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -48.4 123.79 11.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.09 -42.0 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.975 2.45 . . . . 0.0 112.881 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 -154.3 19.42 0.49 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -91.28 -11.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.744 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.618 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 63.94 90.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.892 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.63 ' CB ' HD12 ' A' ' 56' ' ' LEU . . . 137.38 112.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.714 0.634 . . . . 0.0 111.252 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -68.11 158.67 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 110.697 179.572 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.59 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 21.0 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.028 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 10.8 t0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.61 177.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.8 t0 -71.88 -48.02 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 71.73 -56.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.743 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HA ' HD13 ' A' ' 14' ' ' LEU . 87.5 m -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -64.49 -34.77 78.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.678 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 mm -42.24 -39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.25 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.28 151.88 13.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.62 -179.917 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.71 -19.08 3.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.189 2.593 . . . . 0.0 111.041 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -111.97 26.93 10.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.969 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.961 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.86 -48.34 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.352 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -84.64 8.58 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.312 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 39.66 25.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.491 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 45' ' ' CYS . 1.1 tpt180 173.24 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -88.4 -156.08 30.42 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.999 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -125.68 110.45 13.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.791 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.3 t -60.74 154.13 22.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.324 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -139.9 161.41 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.721 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.537 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -91.51 142.35 27.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.315 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.7 p -147.5 150.81 38.22 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.932 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.83 109.25 0.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.788 2.325 . . . . 0.0 111.906 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.06 43.18 93.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.909 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.65 -163.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 0.0 110.727 -179.733 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.961 ' CE2' HD22 ' A' ' 14' ' ' LEU . 11.7 p90 -167.76 139.89 3.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.99 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.7 pt-20 -108.18 -172.65 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.638 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -145.57 157.92 43.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.458 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -109.55 64.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.196 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -50.46 154.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.488 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 22.9 t70 -37.69 -90.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.304 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 27.0 mt-10 -140.03 -37.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -132.15 20.07 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.342 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.7 m-30 -89.23 155.51 19.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 111.212 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.867 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -112.87 122.41 47.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.656 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -78.47 82.52 4.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 126.63 49.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' MET . 12.1 t80 -66.28 -13.78 60.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.8 -31.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.707 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 42' ' ' MET . 8.9 mmt -66.81 -36.24 81.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.613 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 159.13 -56.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 17.6 tptt -160.68 21.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.992 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -70.51 129.51 39.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.796 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 55.8 m -65.69 107.08 1.65 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.643 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 47' ' ' ASP . 6.6 mmt -135.24 103.25 5.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.468 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -1.21 105.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.967 0.792 . . . . 0.0 112.897 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.867 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.8 pt -63.58 176.11 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 47.6 t0 -91.58 77.36 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.91 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.1 mp0 -47.97 -30.61 4.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' HD22 ' A' ' 57' ' ' LEU . 77.9 m -71.11 -10.94 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.436 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -118.48 -16.01 9.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -61.22 -36.68 80.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.377 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -129.09 124.43 22.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.402 -179.629 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 23.4 Cg_exo -63.7 -8.27 15.02 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.198 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.842 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -111.23 -13.05 14.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.071 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -47.66 114.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.869 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 64.2 m 51.05 21.58 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.358 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.06 -31.42 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.45 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 20.8 5.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.713 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -135.33 -143.43 4.75 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.85 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.724 HG11 ' NE2' ' A' ' 64' ' ' HIS . 50.8 t -119.39 128.02 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.317 . . . . 0.0 110.913 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 16.1 t -99.36 90.84 4.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 111.483 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.724 ' NE2' HG11 ' A' ' 62' ' ' VAL . 43.0 m80 -89.63 57.64 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.394 179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -48.64 108.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -105.87 -161.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.953 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' N ' ' OG1' ' A' ' 66' ' ' THR . 2.5 mt-10 -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 75.86 23.24 72.74 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 1.3 p 156.52 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.703 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.837 ' CD2' HD21 ' A' ' 57' ' ' LEU . 5.9 p90 -148.62 152.82 37.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 2.5 mmm180 -109.53 106.63 16.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.01 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.942 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -92.56 125.17 37.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.61 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.4 tt0 -143.19 116.5 9.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.649 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -38.2 -65.05 0.4 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.008 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HD2' ' HD3' ' A' ' 76' ' ' PRO . 84.9 Cg_endo -104.94 14.63 10.76 Favored 'Cis proline' 0 N--CA 1.441 -1.563 0 C-N-CA 123.775 -1.344 . . . . 0.0 113.126 1.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.77 ' HD3' ' HD2' ' A' ' 75' ' ' PRO . 69.9 Cg_exo -41.7 171.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.357 2.038 . . . . 0.0 112.227 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.32 81.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.586 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.83 -159.91 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.0 110.861 -178.946 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.59 80.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -68.88 120.19 14.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.569 . . . . 0.0 111.487 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -46.87 127.95 8.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.089 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.39 -52.43 7.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.763 2.309 . . . . 0.0 112.422 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.6 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.0 m120 -138.45 20.62 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.851 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.95 -28.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.781 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.63 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 82.34 100.81 0.05 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.92 179.015 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.842 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 129.33 133.99 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.898 0.749 . . . . 0.0 111.308 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 40.5 t -73.28 140.53 46.87 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 5.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.315 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.936 0.398 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.792 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -94.99 166.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.761 179.783 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 9' ' ' ARG . 8.5 t0 -72.95 -51.44 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 109.974 179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.592 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 6.5 mp0 69.69 -53.32 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.512 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 86.3 m -63.82 -27.04 68.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 3.4 mmt180 -68.14 -33.47 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 14' ' ' LEU . 28.5 mt -44.42 -39.9 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.092 0.473 . . . . 0.0 110.445 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -162.03 150.83 12.8 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.456 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.1 Cg_endo -84.8 -19.72 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.127 2.552 . . . . 0.0 111.342 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -111.91 25.43 11.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.134 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.887 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.92 -36.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.331 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -85.66 15.63 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.314 -179.435 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 52.1 16.94 3.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.281 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 153.65 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 15' ' ' CYS . . . -67.77 -162.6 2.03 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.034 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.4 mt-30 -121.02 112.04 18.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.1 t -70.59 149.6 46.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.327 0.584 . . . . 0.0 112.471 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.8 t -135.35 163.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.343 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -99.63 142.41 31.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.219 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.433 ' CG2' ' HG2' ' A' ' 28' ' ' GLU . 4.3 p -146.05 145.67 25.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.22 111.75 0.17 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.965 2.443 . . . . 0.0 112.003 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.56 47.47 44.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.919 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 172.01 -172.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.822 -179.596 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.887 ' CE2' HD22 ' A' ' 14' ' ' LEU . 17.3 p90 -163.05 146.76 10.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 15.5 pt-20 -124.16 -177.4 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.155 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.3 m -141.41 163.98 31.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' GLN . 1.4 tmtt? -110.83 69.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' LYS . 72.7 m -33.0 144.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.58 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 14.7 t70 -51.59 -71.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 4.2 tt0 -153.51 -62.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.575 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.47 28.63 11.26 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.596 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.642 ' C ' HG23 ' A' ' 48' ' ' ILE . 4.8 m-30 -98.08 159.91 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.668 0.275 . . . . 0.0 110.783 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.89 ' HB2' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.67 131.23 55.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.564 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -83.0 94.57 7.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 106.58 43.25 1.47 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.432 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 25.0 t80 -46.04 -32.33 2.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 110.347 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.75 -30.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.051 179.67 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.508 ' O ' ' HB3' ' A' ' 42' ' ' MET . 4.8 ppp? -55.97 -43.91 77.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.569 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER 171.37 -40.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.0 OUTLIER 156.96 87.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.568 -179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 6.8 p-10 -149.36 93.99 2.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.227 0.537 . . . . 0.0 110.415 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 40.4 m -36.2 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.073 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 39' ' ' PHE . 3.3 ptm -133.13 131.39 40.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 1.9 p-10 -18.29 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.544 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.7 pt -49.67 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.328 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 58.3 t0 -101.05 72.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.375 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.877 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.1 mp0 -48.86 -24.94 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.223 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.964 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.2 t -75.43 -10.16 59.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 2.4 mt-30 -118.77 -23.3 7.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.879 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -21.04 18.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -128.96 139.2 34.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.998 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 92.4 Cg_endo -80.58 -5.32 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.923 2.415 . . . . 0.0 112.072 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.2 -8.37 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.614 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.78 117.12 2.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.871 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 60.7 m 49.28 23.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.041 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 2.4 tmt_? -45.91 -33.68 3.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.741 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.31 11.42 10.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.065 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.89 -138.54 4.09 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 50.4 t -126.48 135.32 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 14.0 p -103.08 99.48 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 66' ' ' THR . 48.1 m80 -90.01 60.23 4.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.669 ' C ' HD21 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -44.5 110.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.352 -179.52 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -109.69 -178.5 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.667 179.553 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 4.4 pt-20 -79.39 119.35 22.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 73.59 26.54 69.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.7 t 158.4 177.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.727 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.0 p90 -144.35 149.51 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.73 114.28 27.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.444 -179.508 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.034 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.03 135.59 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 20.7 tt0 -132.16 117.75 18.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.771 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.73 -33.09 0.98 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.822 179.399 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.13 171.86 35.47 Favored 'Cis proline' 0 C--N 1.355 0.907 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.634 1.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.521 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 61.5 Cg_exo -36.61 -29.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.022 2.481 . . . . 0.0 112.833 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.8 -30.63 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.328 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.583 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 4.8 t-160 -88.45 -127.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.47 62.88 1.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.151 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.055 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.6 130.95 35.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.375 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.055 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.38 134.79 93.53 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' HD13 ' A' ' 84' ' ' ILE . 69.0 Cg_exo -50.45 -53.26 7.41 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.674 2.25 . . . . 0.0 112.35 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.535 ' H ' HD12 ' A' ' 84' ' ' ILE . 10.8 m120 -148.75 26.25 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.299 -179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.787 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -94.03 -17.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.434 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.706 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.6 90.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 179.105 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.2 100.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.99 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.27 149.26 48.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.101 178.787 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.583 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.353 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 t0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.812 0.339 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.639 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -104.87 153.58 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.905 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.572 ' C ' HD13 ' A' ' 5' ' ' ILE . 44.2 t0 -62.39 74.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 111.068 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 14' ' ' LEU . 37.5 mp0 -56.67 -17.04 7.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 13.8 t -81.35 -35.05 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.676 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.47 -27.75 64.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.523 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -45.57 -41.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -164.79 127.36 1.57 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.919 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 11.2 Cg_exo -68.19 -18.27 45.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.659 2.239 . . . . 0.0 111.034 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.28 11.27 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.484 179.633 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -43.24 -47.98 6.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.2 t -72.9 -14.35 61.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 76.23 -2.36 57.03 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.1 tpt85 177.35 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.035 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -82.47 -139.16 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.99 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 7.8 mt-30 -140.3 107.5 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.642 0.258 . . . . 0.0 110.916 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 5.2 p -52.37 149.72 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -131.26 163.99 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.555 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 11.3 t30 -110.27 141.89 42.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.007 0.432 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.734 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.7 p -148.51 157.01 42.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 16.2 Cg_endo -57.86 113.03 1.34 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.658 2.239 . . . . 0.0 111.726 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.43 44.88 59.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.541 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 171.58 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.366 -179.502 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' THR . 27.3 p90 -166.75 175.91 7.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 111.852 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 10.3 pt-20 -153.59 -164.88 2.0 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 10.4 p -170.09 150.4 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 111.638 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.93 83.54 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.396 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -48.68 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.418 -179.355 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.7 t0 -104.33 -144.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.983 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 32' ' ' ASP . 2.6 mm-40 -29.61 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.83 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -120.0 25.93 7.32 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.663 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 20.9 m-30 -79.91 135.07 36.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 5.0 pt-20 -108.07 131.89 54.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.845 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.6 99.06 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.914 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.97 44.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.558 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 17.7 t80 -86.46 -6.6 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.775 0.322 . . . . 0.0 111.035 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 158.98 -23.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.643 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.4 OUTLIER -90.72 -20.38 22.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.781 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.3 OUTLIER 100.51 -13.88 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.917 0.76 . . . . 0.0 110.413 -179.528 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 7.0 tptt 168.35 100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.002 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' CYS . 7.6 p-10 -166.72 34.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.442 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m 34.66 98.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.429 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.6 mmt -132.83 102.19 5.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.53 179.57 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.24 123.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.017 0.823 . . . . 0.0 112.796 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -66.84 -173.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.137 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 43.2 t0 -95.13 76.57 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.026 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.061 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -46.58 -27.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.393 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 1.0 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.7 t -75.07 -16.83 60.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.003 0.43 . . . . 0.0 110.605 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -103.02 -23.31 13.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.216 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -43.98 92.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -100.63 155.92 35.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -93.3 3.77 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.432 2.755 . . . . 0.0 112.733 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -144.01 11.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.335 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -57.33 118.23 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 34.6 m 50.2 24.14 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.392 0.615 . . . . 0.0 109.653 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.52 -29.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.818 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . -134.18 27.25 3.31 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.961 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.68 -126.36 2.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.83 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 73' ' ' GLU . 43.0 t -137.39 135.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 110.818 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 61.9 m -96.92 92.59 6.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 97.5 m-70 -88.98 48.84 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.038 0.447 . . . . 0.0 110.27 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 9.1 t-20 -42.42 116.93 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.5 p -119.53 -176.44 3.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 5.2 pt-20 -64.0 134.59 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.45 36.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.489 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 171.78 156.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.995 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -133.57 145.61 50.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.86 114.11 27.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.027 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -89.78 134.13 34.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.863 179.341 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.57 127.06 36.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.73 -33.68 1.6 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.437 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 14.6 Cg_exo -71.25 -173.3 9.44 Favored 'Cis proline' 0 C--N 1.356 0.964 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.568 1.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 81.3 Cg_exo -40.92 173.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.938 2.425 . . . . 0.0 112.812 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.51 53.25 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.584 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 13.0 t-160 -101.08 -125.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 4.6 tt0 -151.05 65.85 0.91 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.001 0.429 . . . . 0.0 110.296 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.027 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -90.91 123.08 34.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.47 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.895 ' N ' HD12 ' A' ' 80' ' ' LEU . 79.8 p -60.41 136.44 91.9 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.756 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.19 -66.0 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.787 2.325 . . . . 0.0 112.541 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 84' ' ' ILE . 14.6 m120 -137.48 41.07 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.776 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -106.06 -14.74 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.413 . . . . 0.0 110.47 179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.35 89.12 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.12 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.18 93.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.995 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -54.58 159.93 1.97 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.766 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.584 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 39.2 68.52 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -89.94 179.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 5' ' ' ILE . 29.1 t0 -85.63 93.58 8.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 30.7 mp0 -76.27 -19.25 58.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.357 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.5 t -83.56 -26.09 30.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -71.29 -25.95 62.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.24 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.5 mm -45.41 -39.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.693 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.9 t -165.99 156.19 11.24 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 4.9 Cg_endo -86.37 -19.89 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.356 2.704 . . . . 0.0 111.749 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -109.21 21.9 16.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.484 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.561 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.8 -46.51 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.168 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -88.05 3.76 47.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 57.94 12.49 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.851 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 173.21 -50.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -70.11 -144.03 0.22 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.088 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 5.4 mt-30 -137.2 124.93 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 0.0 110.993 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.25 132.12 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.7 t -109.2 163.79 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.42 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.567 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.6 t-20 -111.29 143.08 42.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.354 . . . . 0.0 111.299 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -151.97 154.87 33.19 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 14.5 Cg_endo -57.16 116.61 3.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.746 2.297 . . . . 0.0 111.858 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.45 42.87 57.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.916 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.6 OUTLIER 167.3 -178.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.763 0.316 . . . . 0.0 110.547 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.659 ' HA ' HG23 ' A' ' 23' ' ' THR . 11.2 p90 -159.54 176.15 12.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.544 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -145.51 -172.35 3.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.529 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -147.91 158.73 44.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 0.0 111.38 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.88 74.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.152 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -46.06 -179.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLU . 9.8 t0 -106.62 -141.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.225 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -23.1 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -124.87 23.48 6.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.618 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.555 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 23.2 m-85 -75.42 131.04 39.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 111.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.6 pt-20 -109.86 130.17 55.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -33.96 114.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.038 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.59 55.25 2.92 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 4.0 p90 -56.97 -25.96 59.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.509 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 3.7 mtt -66.59 -19.05 65.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.105 0.479 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.8 mmm -119.36 -32.18 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.578 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 178.73 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.433 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HE2' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 178.01 33.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.14 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 6.4 p-10 -85.21 -157.97 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.669 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.1 m -107.43 116.5 32.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.061 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.475 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -136.15 95.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.633 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -10.91 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.703 0.801 . . . . 0.0 113.028 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.2 pt -70.37 -173.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.313 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.3 t0 -99.2 74.03 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.755 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.2 mp0 -48.28 -22.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.3 m -76.72 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.697 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -117.65 -23.87 7.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.51 -28.46 67.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -128.38 137.97 32.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.117 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.11 -6.44 12.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.964 2.443 . . . . 0.0 112.043 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -111.78 -17.9 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.147 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.906 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -46.94 118.93 2.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.965 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 47.0 m 44.01 26.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.2 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.01 -31.93 19.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.836 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.9 25.47 6.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.095 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.15 -125.59 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.626 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.766 HG11 ' CE1' ' A' ' 64' ' ' HIS . 31.5 t -139.29 135.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 43.5 t -108.92 97.05 6.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.366 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.766 ' CE1' HG11 ' A' ' 62' ' ' VAL . 89.7 m-70 -88.87 63.5 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.135 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.7 t-20 -45.71 122.42 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -120.01 -165.55 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.994 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 68' ' ' GLY . 9.0 mt-10 -73.65 140.38 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.16 36.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 169.95 -178.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.906 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.5 p90 -153.14 148.41 26.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.647 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.92 135.85 50.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.005 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.36 131.84 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.059 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.42 127.34 37.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.301 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.823 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.49 -31.92 0.89 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.099 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.823 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.6 Cg_exo -71.85 -169.3 6.03 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.641 1.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.2 Cg_exo -43.22 178.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.904 2.403 . . . . 0.0 112.856 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.55 -18.26 50.53 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 7.5 t-160 -104.23 -127.95 0.24 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 1.5 mt-30 -150.53 59.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.013 0.435 . . . . 0.0 110.056 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.051 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -86.26 129.53 34.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.52 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.051 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.36 133.0 88.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.682 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.14 -48.4 19.71 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.675 2.25 . . . . 0.0 112.011 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.588 ' C ' HD13 ' A' ' 84' ' ' ILE . 10.2 m120 -146.95 21.21 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.836 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.12 -23.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.768 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 75.57 91.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.928 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.681 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . 150.61 103.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 1.0 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.97 148.21 48.25 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.226 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 t0 -90.36 119.81 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.94 169.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.526 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 10.6 t0 -75.08 -49.14 20.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.073 0.463 . . . . 0.0 109.823 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HB3' ' CG ' ' A' ' 27' ' ' PHE . 10.4 mp0 68.53 -52.91 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.757 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 47.5 t -63.74 -37.11 86.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -66.77 -25.8 66.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 7.1 mm -39.92 -37.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.148 0.499 . . . . 0.0 110.397 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.85 151.68 8.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.696 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.74 -17.53 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.999 2.466 . . . . 0.0 111.49 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -113.69 21.92 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.988 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -38.25 -61.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.339 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 45' ' ' CYS . 1.6 m -73.26 -3.39 26.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.65 11.13 27.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 178.42 -50.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.87 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.44 -150.97 2.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.638 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -132.93 110.42 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.303 . . . . 0.0 110.963 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.6 p -52.54 131.27 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG12 ' CB ' ' A' ' 28' ' ' GLU . 4.0 p -106.82 167.05 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.477 ' H ' HG22 ' A' ' 21' ' ' VAL . 8.7 t-20 -112.94 140.71 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.367 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.644 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -147.29 148.62 32.3 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.109 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' OD2' ' A' ' 4' ' ' ASP . 4.0 Cg_endo -46.88 116.38 1.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.021 2.481 . . . . 0.0 111.973 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.73 45.71 39.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.998 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 169.13 -167.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.583 0.23 . . . . 0.0 110.479 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.644 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -169.66 176.2 5.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 111.465 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.543 ' CB ' HG12 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -144.74 -145.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.456 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 1.1 m -163.12 154.43 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.414 . . . . 0.0 111.333 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -105.82 67.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.254 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -45.4 175.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.488 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' C ' ' HG3' ' A' ' 33' ' ' GLU . 15.1 t70 -72.86 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 32' ' ' ASP . 10.8 mt-10 -141.95 -39.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -122.14 14.44 8.92 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.016 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.1 m-30 -94.99 161.17 14.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.829 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.598 ' HB3' HG22 ' A' ' 48' ' ' ILE . 3.0 pt-20 -118.25 131.24 56.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.55 102.69 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.652 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 42' ' ' MET . . . 98.71 64.66 0.85 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.719 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' MET . 4.2 t80 -83.56 -11.59 57.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.7 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 41' ' ' MET . 3.3 ptm 176.69 -31.79 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -83.0 -20.17 35.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.08 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 104.62 -21.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.058 0.849 . . . . 0.0 110.626 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 29' ' ' CYS . 14.9 mmtm -171.38 100.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.518 ' O ' ' C ' ' A' ' 45' ' ' CYS . 5.0 p-10 -158.98 33.72 0.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 15' ' ' CYS . 2.8 t 9.52 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.901 0.75 . . . . 0.0 112.406 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -150.59 110.32 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -2.1 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.947 0.779 . . . . 0.0 112.576 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -50.55 174.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 51.9 t0 -93.7 75.47 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.903 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 mp0 -51.64 -21.66 2.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.976 0.417 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 78.9 m -76.75 -9.67 58.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.618 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.79 -23.51 6.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -29.82 64.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -125.1 137.2 29.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.86 -8.13 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.014 2.476 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -119.17 -3.51 10.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.982 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -53.36 122.17 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.7 m 48.97 24.66 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.515 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -65.22 61.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.474 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 150.06 -16.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.881 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.22 -124.29 4.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.24 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.748 HG11 ' NE2' ' A' ' 64' ' ' HIS . 75.0 t -136.24 132.91 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.315 . . . . 0.0 110.957 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 25.0 t -104.79 94.58 5.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.748 ' NE2' HG11 ' A' ' 62' ' ' VAL . 42.3 m80 -89.96 59.91 4.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.2 t-20 -47.83 109.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.555 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -108.77 178.02 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.019 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER -71.95 121.82 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 68.12 32.91 77.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.2 t 158.06 178.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.982 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -146.92 142.95 28.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD3' HG21 ' A' ' 66' ' ' THR . 3.3 mmm180 -109.42 116.64 32.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.683 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -94.87 128.0 41.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.579 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.0 tt0 -128.37 123.29 33.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.74 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.29 -32.24 0.94 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.998 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.74 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 29.5 Cg_exo -64.85 170.93 32.43 Favored 'Cis proline' 0 C--N 1.356 0.926 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.7 1.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 73.8 Cg_exo -35.37 -28.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.992 2.461 . . . . 0.0 113.029 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.37 -31.2 0.04 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.434 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.2 t-80 -91.85 -129.2 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 88' ' ' ILE . 4.0 mt-30 -140.03 66.34 1.4 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.105 0.479 . . . . 0.0 109.726 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.008 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.95 93.44 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.154 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 33.4 t -43.24 137.79 2.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.477 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 76.1 Cg_endo -79.17 111.94 2.97 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.931 2.421 . . . . 0.0 113.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.4 m120 72.62 -1.24 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.6 mp -81.63 -18.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.77 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.947 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.59 98.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.974 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -59.01 150.75 23.84 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.412 ' OG1' ' HA2' ' A' ' 25' ' ' GLY . 1.3 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.848 0.356 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -177.9 66.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.77 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.541 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 34.0 t0 -86.76 101.14 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -81.11 -24.34 37.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.131 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.2 t -71.09 -41.92 70.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.745 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 1.4 ttt180 -57.44 -32.92 67.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.01 -38.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.473 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -165.22 146.76 6.32 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.687 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 -16.51 8.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.938 2.426 . . . . 0.0 111.799 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.88 16.92 21.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.486 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -44.81 -43.44 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.797 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 55.1 m -74.57 -14.13 60.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 66.61 6.3 34.84 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.137 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 1.9 tpt180 174.11 -29.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -94.65 -151.04 27.87 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.083 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.439 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 1.8 mm100 -127.09 115.34 19.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.289 . . . . 0.0 110.993 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.2 p -57.92 132.71 54.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.027 0.441 . . . . 0.0 111.676 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -116.6 164.25 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.241 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.6 t-20 -107.31 147.21 30.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -154.29 154.12 29.17 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.81 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.82 117.74 4.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 111.903 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA2' ' OG1' ' A' ' 3' ' ' THR . . . 50.13 43.7 41.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.877 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER 167.42 -174.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.327 . . . . 0.0 110.482 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.703 ' CE2' HD22 ' A' ' 14' ' ' LEU . 18.9 p90 -157.21 165.94 34.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.025 0.44 . . . . 0.0 111.552 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -130.39 -171.2 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.006 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -145.83 168.8 19.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.872 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -128.06 65.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.104 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 62.5 m -39.29 166.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.251 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 14.3 t0 -55.73 -96.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.387 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -138.31 0.92 2.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.812 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -173.01 22.94 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.422 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HA ' ' CA ' ' A' ' 47' ' ' ASP . 2.0 m-30 -100.02 138.96 36.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.422 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.4 120.1 30.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.542 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.35 99.16 11.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.546 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 115.91 84.89 1.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.894 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 26.1 t80 -131.57 -46.1 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 41' ' ' MET . 1.9 mtp -106.76 5.52 28.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.15 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.7 OUTLIER 84.91 37.04 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' LYS . 4.5 mtp -145.36 15.38 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER 34.75 45.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.937 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -88.22 35.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.626 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 69.4 m 22.5 102.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.583 0.552 . . . . 0.0 111.962 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.55 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -126.31 100.41 6.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.044 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.579 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.5 p-10 11.86 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.929 0.768 . . . . 0.0 112.702 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.915 HD13 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -33.45 155.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.601 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.915 ' N ' HD13 ' A' ' 48' ' ' ILE . 54.0 t0 -89.54 74.43 7.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.851 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.6 mp0 -49.62 -27.87 5.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.733 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.683 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -70.31 -9.26 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.48 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.8 mt-30 -121.78 -31.09 4.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 52' ' ' GLN . 11.8 ttt85 -36.61 -42.53 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.205 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.19 154.32 58.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.437 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.41 -2.06 4.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.454 2.769 . . . . 0.0 112.093 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -126.42 10.94 7.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.128 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.922 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -58.11 129.24 41.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.2 m 40.21 30.13 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.283 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -60.96 71.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 137.33 -6.1 3.59 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.39 -127.15 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 38.4 t -140.46 117.09 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.666 ' HB2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.07 101.56 14.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 66.1 m80 -90.47 60.36 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.049 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 1.7 t-20 -43.68 112.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 64' ' ' HIS . 1.6 p -115.84 -161.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.051 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.35 140.08 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 56.31 19.7 26.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.768 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.4 t 156.32 -175.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.643 0.258 . . . . 0.0 110.724 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 3.8 p90 -142.19 159.31 42.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.946 0.403 . . . . 0.0 111.317 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.574 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -115.54 112.25 21.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.075 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.66 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.86 131.73 35.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.265 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -132.33 121.0 22.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.807 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.778 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.62 -32.61 1.07 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.873 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 26.2 Cg_exo -65.32 171.4 33.19 Favored 'Cis proline' 0 C--N 1.356 0.96 0 C-N-CA 123.918 -1.284 . . . . 0.0 112.715 1.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.532 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 65.8 Cg_exo -33.65 -28.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.151 2.567 . . . . 0.0 113.264 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -35.0 -31.87 0.02 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.695 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -89.4 -125.42 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -144.69 60.56 1.33 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.3 OUTLIER -90.47 98.7 11.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.029 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.679 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.4 t -51.75 137.29 34.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.327 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 64.9 Cg_endo -75.07 115.49 4.29 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.917 2.411 . . . . 0.0 113.588 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 21.1 m120 72.89 24.13 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.169 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.679 HD13 ' C ' ' A' ' 81' ' ' SER . 1.4 mp -102.06 -27.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.251 0.548 . . . . 0.0 109.858 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.701 ' HB3' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER 74.08 69.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.499 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 166.4 100.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.22 145.84 30.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.11 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.572 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.477 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -176.44 85.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -91.42 -164.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 12.2 t0 -87.01 -48.18 8.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.851 0.357 . . . . 0.0 111.286 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.6 mp0 72.99 -56.94 0.65 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 14' ' ' LEU . 8.4 t -63.84 -14.56 54.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.567 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.2 -33.21 56.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.415 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.4 mm -41.86 -37.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.73 163.71 9.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.36 -22.5 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.145 2.564 . . . . 0.0 111.809 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.75 15.94 27.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.78 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -45.79 -49.42 15.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.766 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -59.96 -13.11 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.74 -10.76 37.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.035 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 7.3 tpt180 177.35 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.98 -129.88 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.608 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LYS . 12.1 mt-30 -144.97 118.27 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 111.388 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.18 146.35 52.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.879 0.371 . . . . 0.0 110.982 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 43.9 t -128.67 152.79 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 3.2 t-20 -77.75 153.36 33.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.971 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 27' ' ' PHE . 16.3 p -157.46 155.7 27.79 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.605 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.6 Cg_endo -51.46 110.37 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.746 2.297 . . . . 0.0 112.07 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.17 44.17 74.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.118 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.75 -160.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.766 0.317 . . . . 0.0 110.286 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.78 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.5 p90 -165.08 145.0 6.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -104.77 -146.88 0.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.45 171.43 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.537 0.685 . . . . 0.0 112.793 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLN . 3.1 tmtm? -131.49 65.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.364 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 95.0 m -50.04 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.549 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -136.74 -151.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.263 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 32' ' ' ASP . 26.9 mm-40 -0.71 -86.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.949 0.781 . . . . 0.0 112.871 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.77 9.57 2.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 18.6 m-85 -69.9 106.88 3.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.638 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -89.58 136.02 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -28.54 113.98 0.08 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -38.03 -85.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 88.17 -24.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE ' ' A' ' 46' ' ' MET . 2.8 mtm -72.21 -24.44 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.435 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.5 mmm -124.66 -35.75 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.641 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 164.4 -51.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 5.9 mmtp 174.38 104.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 45' ' ' CYS . 6.2 p-10 -159.66 49.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 84.7 m 15.65 110.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.669 0.788 . . . . 0.0 112.937 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.516 ' CE ' ' SD ' ' A' ' 40' ' ' MET . 26.2 ptm -124.93 120.06 30.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 1.9 p30 -25.45 126.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.405 0.621 . . . . 0.0 111.707 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -54.68 -174.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.455 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 58.3 t0 -101.55 73.05 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.271 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.889 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.5 mp0 -49.07 -22.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.806 ' HA ' HD22 ' A' ' 57' ' ' LEU . 60.1 m -75.45 -13.22 60.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.676 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 1.8 mt-30 -111.46 -20.3 12.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -60.52 -30.04 69.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.982 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.51 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -123.62 138.28 30.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.51 -6.47 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 112.195 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -121.32 -4.27 9.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.535 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.991 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.89 119.98 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.839 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 65.0 m 46.71 25.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.519 . . . . 0.0 109.991 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.1 -27.01 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.92 30.5 3.71 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.04 -126.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.572 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.802 HG11 ' CE1' ' A' ' 64' ' ' HIS . 42.7 t -135.68 135.48 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.9 t -109.33 96.94 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.949 0.404 . . . . 0.0 111.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.802 ' CE1' HG11 ' A' ' 62' ' ' VAL . 90.2 m-70 -89.69 62.39 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.2 t-20 -47.07 118.61 2.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.53 HG21 ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -115.09 -170.15 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 10.1 mp0 -73.11 131.16 41.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 44.11 33.5 2.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.359 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 172.78 168.73 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.681 0.277 . . . . 0.0 110.772 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.991 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -144.72 145.97 31.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.53 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.0 137.19 48.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.016 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.93 127.73 56.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.061 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.2 tt0 -126.97 123.97 38.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.787 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.809 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.83 -31.34 0.72 Allowed Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.973 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.809 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 43.3 Cg_endo -67.05 174.22 31.08 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 123.828 -1.321 . . . . 0.0 112.827 1.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 71.5 Cg_exo -35.4 -28.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.006 2.471 . . . . 0.0 113.073 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.25 -30.63 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.469 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 3.3 t-160 -93.72 -130.44 0.13 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.71 65.46 1.43 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.016 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.8 101.43 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.192 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.533 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 32.9 t -50.43 137.48 22.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 85.1 Cg_endo -79.96 112.76 2.9 Favored 'Trans proline' 0 CA--C 1.526 0.121 0 C-N-CA 122.909 2.406 . . . . 0.0 113.59 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 23.4 m120 73.39 -3.21 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.265 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.5 mp -80.68 -25.09 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.156 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.702 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.23 87.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.78 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.877 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.94 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -60.7 150.95 30.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.197 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.266 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 3' ' ' THR . 37.9 t70 178.93 84.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.662 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -108.18 153.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.576 ' C ' HD13 ' A' ' 5' ' ' ILE . 32.0 t0 -61.31 84.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.036 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 27.3 mp0 -70.9 -11.92 61.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.1 t -83.22 -43.24 16.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -67.5 -23.62 65.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.738 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.6 mm -42.97 -39.7 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -164.36 140.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.859 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_exo -75.16 -18.45 18.38 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 111.388 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -116.6 20.96 13.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.245 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -37.06 -61.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.307 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -80.27 7.67 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.381 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 78.99 -45.78 2.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.947 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -134.9 -46.74 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -59.25 -177.61 1.08 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.825 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.07 102.63 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 13.8 p -40.22 150.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.246 0.546 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 16.2 t -130.32 164.39 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.771 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 t-20 -114.31 138.93 49.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.418 . . . . 0.0 111.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.679 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.5 p -148.8 157.55 40.57 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.63 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 19.0 Cg_endo -59.17 121.0 9.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.598 2.199 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 46.81 44.19 17.43 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.625 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.68 -179.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.358 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' THR . 21.4 p90 -164.04 -177.69 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 111.995 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.0 pt-20 -162.56 -147.52 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.851 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 13.6 p -170.4 -176.83 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.214 0.53 . . . . 0.0 111.59 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -121.76 73.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.727 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 66.7 m -40.61 167.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 16.4 t0 -60.24 -99.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.258 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -129.9 -32.08 1.89 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' N ' ' HA2' ' A' ' 68' ' ' GLY . . . -134.84 14.82 4.37 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.507 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.1 m-85 -90.74 125.89 35.83 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.563 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.77 131.72 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.882 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.53 ' OG ' ' CE ' ' A' ' 43' ' ' LYS . 1.6 t -95.34 106.36 18.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.447 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.14 76.19 1.02 Allowed Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.227 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 70.7 t80 -109.1 -51.49 2.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.0 110.009 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -98.98 -3.32 35.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.578 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.8 OUTLIER 86.53 38.11 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.857 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtt -134.84 5.45 3.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.974 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CE ' ' OG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 51.93 96.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.451 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 45' ' ' CYS . 4.2 p-10 -157.2 44.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 44' ' ' ASN . 67.1 m 5.2 107.82 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.934 0.771 . . . . 0.0 112.133 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.57 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 24.0 ptm -130.59 111.69 12.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.521 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 1.4 p-10 -21.81 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.371 0.605 . . . . 0.0 111.987 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -46.91 -178.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.111 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 59.2 t0 -106.82 71.04 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.849 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.892 ' O ' HD13 ' A' ' 57' ' ' LEU . 29.4 mp0 -48.86 -25.13 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.92 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.8 t -73.85 -8.76 57.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.681 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 3.9 mt-30 -118.06 -28.84 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -40.94 -42.2 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.001 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.4 152.14 77.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.473 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 56' ' ' LEU . 96.5 Cg_endo -86.56 -6.6 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.285 2.657 . . . . 0.0 112.086 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.1 mp -104.45 -15.93 15.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.179 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.92 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.12 114.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.599 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 76.8 m 53.34 20.96 2.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.176 0.512 . . . . 0.0 109.994 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -36.95 -36.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.691 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.7 -8.55 9.81 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.028 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.14 -150.34 15.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.546 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 38.7 t -116.78 129.6 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.4 p -94.28 98.9 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.984 0.421 . . . . 0.0 111.081 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -96.18 65.18 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.206 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.7 t-20 -47.12 116.47 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -103.45 -175.59 2.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 4.5 pt-20 -49.84 -102.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.441 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 34' ' ' GLY . . . -85.73 55.24 4.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.363 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 28.9 t 170.44 -161.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.801 ' CD2' HD21 ' A' ' 57' ' ' LEU . 3.7 p90 -167.15 146.05 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 3.4 mtp180 -110.38 159.06 17.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.035 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -135.65 136.54 41.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.066 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 18.0 tt0 -130.52 118.13 20.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.904 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.765 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -79.53 -33.7 0.84 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.839 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.03 171.25 37.18 Favored 'Cis proline' 0 C--N 1.354 0.85 0 C-N-CA 123.92 -1.283 . . . . 0.0 112.699 1.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 61.7 Cg_exo -37.32 -29.74 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.932 2.421 . . . . 0.0 112.881 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -38.5 -30.38 0.09 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.218 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 6.1 t-160 -87.01 -127.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -142.01 63.55 1.41 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.044 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.38 129.01 36.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.288 -178.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.044 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.57 131.74 88.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.84 -49.24 18.26 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.846 2.364 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.539 ' H ' HD12 ' A' ' 84' ' ' ILE . 5.6 m120 -149.76 33.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.462 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -102.01 -24.87 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.352 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.721 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER 82.73 84.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.803 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 158.63 102.68 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 1.002 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.68 152.29 35.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.21 178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.306 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 3' ' ' THR . 13.7 t0 167.23 91.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -89.9 167.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.5 t0 -69.89 -50.06 46.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 111.056 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.0 mp0 72.07 -55.89 0.66 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 14' ' ' LEU . 97.9 m -64.62 -18.23 64.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.385 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -72.18 -33.52 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.465 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -40.84 -36.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.0 t -165.48 155.67 11.72 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.679 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.1 Cg_endo -85.75 -19.31 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.3 2.666 . . . . 0.0 111.457 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.52 25.06 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -46.44 -40.06 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.863 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -78.74 4.34 14.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.177 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 34.69 29.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.101 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' NE ' ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER 153.63 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.834 0.35 . . . . 0.0 110.763 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' N ' ' HB3' ' A' ' 15' ' ' CYS . . . -86.18 -140.85 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.562 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.496 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.7 mt-30 -142.98 102.73 4.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 0.0 111.019 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 29.2 t -56.31 146.61 23.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 22' ' ' ASN . 37.7 t -131.47 162.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.3 t-20 -97.13 150.33 20.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.6 p -154.76 146.26 16.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.81 112.16 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.897 2.398 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.93 44.38 82.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.92 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.43 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.78 0.324 . . . . 0.0 110.639 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 7.7 p90 -164.83 144.99 7.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' OE2' HG21 ' A' ' 21' ' ' VAL . 2.1 pp20? -117.65 -171.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.605 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.54 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.1 166.57 24.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 111.887 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -123.61 84.05 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.662 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 163.0 12.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.305 0.574 . . . . 0.0 112.386 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.63 -91.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -119.92 16.09 10.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.99 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.628 ' C ' HG23 ' A' ' 48' ' ' ILE . 2.5 m-30 -103.01 166.92 10.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.714 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.62 139.86 53.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.502 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 83.0 p -87.88 94.7 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.034 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 86.48 71.01 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.43 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 33.0 t80 -67.53 -21.01 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.52 -27.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.472 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.4 OUTLIER -65.08 -36.16 83.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 179.1 -87.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.748 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.54 ' CE ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -162.13 37.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.863 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' SER . 5.9 p-10 -86.45 173.03 9.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.585 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' ' CB ' ' A' ' 35' ' ' TYR . 49.3 t -111.05 110.07 20.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.598 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 ppp? -145.5 119.99 9.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.2 p-10 -6.5 109.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.97 0.793 . . . . 0.0 112.375 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.714 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.1 pt -53.85 -177.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.406 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 54.7 t0 -99.58 74.03 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.552 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.961 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.6 mp0 -48.35 -26.0 1.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 57' ' ' LEU . 63.4 m -73.51 -12.55 60.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 7.9 mt-30 -115.17 -23.52 8.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.481 ' NH1' ' CG ' ' A' ' 54' ' ' ASP . 1.1 ttt-85 -53.73 -31.51 48.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.024 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' CG ' ' NH1' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -132.19 142.58 45.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.4 -6.26 10.95 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.137 2.558 . . . . 0.0 111.908 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -112.4 -10.13 13.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.258 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.88 121.87 7.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.8 m 47.83 24.61 0.6 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -55.59 -18.19 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.699 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.74 22.91 5.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.69 -125.34 0.97 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.683 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.686 HG11 ' NE2' ' A' ' 64' ' ' HIS . 41.8 t -138.62 136.72 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.782 0.325 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.2 t -105.7 96.86 6.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.29 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.686 ' NE2' HG11 ' A' ' 62' ' ' VAL . 29.4 m80 -89.76 61.21 5.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -46.04 118.87 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 5.0 p -111.89 -162.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 118.08 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 71.92 24.11 77.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.446 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.0 178.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 0.0 110.614 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.9 p90 -142.6 147.18 35.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.54 112.25 24.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.464 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.021 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.76 138.18 31.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.843 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tt0 -143.13 122.11 12.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -79.86 -29.91 0.59 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 23.5 Cg_exo -67.3 178.09 20.18 Favored 'Cis proline' 0 C--N 1.358 1.04 0 C-N-CA 124.188 -1.171 . . . . 0.0 112.649 1.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 78.7 Cg_exo -36.45 -26.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.953 2.436 . . . . 0.0 113.087 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -34.58 -32.33 0.02 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.579 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 10.6 t-160 -90.06 -127.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 24.2 mt-30 -140.73 68.63 1.35 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.021 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -90.0 125.55 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.181 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.848 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -59.67 134.08 89.18 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.831 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.89 -46.49 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 84' ' ' ILE . 12.8 m120 -158.24 32.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.534 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.795 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.37 -12.81 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.62 85.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.046 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.45 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.276 0.36 . . . . 0.0 111.633 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 t -69.33 158.24 35.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.922 0.392 . . . . 0.0 111.007 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.576 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.9 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.4 t0 40.48 69.81 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.96 -176.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.749 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.641 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 t0 -92.26 107.81 19.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.972 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.843 ' O ' HD11 ' A' ' 14' ' ' LEU . 17.9 mp0 -91.28 -22.81 20.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.086 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' LEU . 41.5 t -78.88 -31.2 45.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.4 ttt85 -64.02 -30.26 71.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.274 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -40.87 -37.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.469 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -164.79 155.78 12.95 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.968 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.33 -21.69 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 0.0 111.477 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -114.41 27.19 9.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.003 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.843 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.47 -59.59 0.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.342 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.0 m -88.95 27.43 1.35 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.641 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.91 22.23 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.908 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 166.04 -59.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.134 0.467 . . . . 0.0 110.993 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 45' ' ' CYS . . . -54.28 -163.69 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.683 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 mm-40 -125.74 109.69 12.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.773 0.321 . . . . 0.0 110.96 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -63.09 125.87 25.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.49 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.4 t -109.05 164.1 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.133 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.559 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.4 t-20 -102.68 148.53 25.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -155.42 156.45 30.93 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.862 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 12.4 Cg_endo -56.26 117.93 4.66 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.74 2.293 . . . . 0.0 111.904 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . 49.28 44.41 34.83 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.859 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 166.55 -178.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.741 0.305 . . . . 0.0 110.459 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.59 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 7.1 p90 -155.25 155.08 33.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 pt-20 -123.32 -167.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.03 -177.38 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 112.193 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 1.1 tmtm? -141.74 79.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.567 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 21.8 m -60.15 -179.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.775 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.3 t70 -90.66 -151.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.415 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.3 mt-10 -33.13 -74.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.732 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -135.4 40.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.057 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -88.43 133.72 34.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.58 121.89 32.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.305 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.57 98.2 11.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 110.48 76.14 0.85 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.797 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 65.3 t80 -111.94 -76.69 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.559 ' HB3' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -123.16 -12.84 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.193 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 42' ' ' MET . 13.5 mmm -90.89 -22.57 20.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.697 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.7 mmt 123.27 -43.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.402 1.064 . . . . 0.0 110.911 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -158.72 20.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.585 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' HG3' ' A' ' 41' ' ' MET . 14.8 p-10 -67.26 149.86 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.5 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 15.9 m -95.64 102.21 13.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.458 . . . . 0.0 110.34 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 25.5 ptm -127.83 116.59 20.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.087 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 5.1 p-10 -21.36 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.929 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.61 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -46.52 -177.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.441 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.8 t0 -96.8 72.42 2.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.714 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.841 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.6 mp0 -50.86 -22.19 2.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.95 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.4 t -76.01 -8.95 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.705 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 3.4 mt-30 -119.12 -24.12 6.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -23.74 9.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 57' ' ' LEU . 2.1 m-20 -124.99 139.45 33.62 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.041 0.448 . . . . 0.0 111.166 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.79 -9.38 15.74 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.029 2.486 . . . . 0.0 112.279 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.632 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -119.13 -6.62 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.95 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.53 112.58 0.67 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.582 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 39.6 m 52.69 22.16 2.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.0 109.864 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.632 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -38.49 -38.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.51 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.62 24.06 6.2 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.806 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -136.27 -130.88 2.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.531 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.712 HG11 ' NE2' ' A' ' 64' ' ' HIS . 70.0 t -137.82 128.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.777 0.322 . . . . 0.0 111.001 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.469 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -98.15 95.02 7.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.712 ' NE2' HG11 ' A' ' 62' ' ' VAL . 41.0 m80 -88.53 60.45 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 8.3 t-20 -45.93 112.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.35 -161.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.66 127.03 34.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 56.81 29.86 59.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 168.2 -172.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.696 ' CD2' HD21 ' A' ' 57' ' ' LEU . 9.6 p90 -156.97 147.56 21.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.71 116.48 31.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.322 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.871 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -98.42 134.91 40.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.305 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.3 tt0 -150.19 126.2 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.518 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -49.65 -45.91 79.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.456 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 3.3 Cg_exo -75.56 -60.21 0.09 OUTLIER 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.669 -1.388 . . . . 0.0 113.193 1.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.9 Cg_endo -84.39 -155.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.87 2.38 . . . . 0.0 113.155 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.0 37.44 9.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.874 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.516 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 161.0 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.235 0.54 . . . . 0.0 111.255 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -139.22 78.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.105 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.871 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -56.98 107.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.463 0.649 . . . . 0.0 111.784 -178.351 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB2' HD13 ' A' ' 84' ' ' ILE . 55.4 p -52.03 124.62 29.72 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.75 ' O ' HD12 ' A' ' 84' ' ' ILE . 73.6 Cg_endo -76.42 111.75 3.32 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.796 2.331 . . . . 0.0 113.221 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 23.4 m120 73.66 13.68 4.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.336 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 82' ' ' PRO . 3.8 mp -101.24 -44.92 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 5.7 p 91.75 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.18 102.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -50.27 130.27 22.73 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.864 0.364 . . . . 0.0 110.901 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.516 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 1.1 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.175 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.768 0.318 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.3 t0 41.58 90.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.809 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.87 -165.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.809 ' N ' HG23 ' A' ' 5' ' ' ILE . 9.4 t0 -87.56 -50.1 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 111.103 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.643 ' O ' HD11 ' A' ' 14' ' ' LEU . 9.5 mp0 73.11 -55.49 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HA ' HD13 ' A' ' 14' ' ' LEU . 91.1 m -63.22 -24.31 67.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.95 -32.58 69.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.4 mm -44.04 -39.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 110.281 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.0 t -163.17 153.28 13.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.712 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_endo -85.54 -19.42 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.169 2.58 . . . . 0.0 111.093 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -112.2 26.89 10.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.994 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.954 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.69 -47.73 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -83.2 11.02 7.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.402 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 60.89 9.95 16.73 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.159 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 162.15 -37.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -68.47 -153.49 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.805 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.05 101.59 5.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.1 t -57.15 150.16 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 28' ' ' GLU . 7.1 p -132.06 154.0 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' ND2' ' OE1' ' A' ' 7' ' ' GLU . 6.4 t-20 -91.55 142.34 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.229 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 28' ' ' GLU . 13.4 p -147.89 151.09 37.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.51 103.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.853 2.368 . . . . 0.0 111.992 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.12 98.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.117 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.2 OUTLIER 178.8 -166.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.954 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.7 p90 -172.45 139.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.671 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 23' ' ' THR . 0.1 OUTLIER -105.97 -147.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.684 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.2 m -170.08 159.49 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -122.6 71.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.9 OUTLIER -49.59 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.06 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -125.96 -156.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.109 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER 8.32 -75.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.009 0.818 . . . . 0.0 112.636 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -157.72 29.61 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.136 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 22.9 m-85 -79.24 151.15 31.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 2.1 pt-20 -112.02 128.16 56.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -83.42 92.78 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 114.32 56.86 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 58.4 t80 -77.12 -24.83 51.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.845 0.355 . . . . 0.0 110.787 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.14 -25.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.486 ' HG2' ' HE3' ' A' ' 40' ' ' MET . 42.0 mmm -72.68 -33.36 66.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.415 ' CB ' ' O ' ' A' ' 41' ' ' MET . 1.8 ptm 166.0 -63.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 12.9 tptt -177.01 29.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.451 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 41' ' ' MET . 0.2 OUTLIER -76.91 179.51 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.44 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.4 m -92.16 106.58 18.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' PHE . 2.1 mmt -124.0 101.01 7.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.045 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.3 p-10 -21.83 101.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.984 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -48.42 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.094 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 56.3 t0 -94.69 71.7 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.564 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.886 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -48.3 -24.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.27 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 1.028 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.1 t -76.92 -8.97 58.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.0 mt-30 -116.38 -21.29 9.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 54' ' ' ASP . 7.8 ttt-85 -58.75 -33.25 70.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -115.89 140.58 26.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.091 0.472 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 90.3 Cg_endo -80.83 -5.03 13.02 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.085 2.523 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -128.37 1.22 5.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.56 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.028 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.41 115.56 1.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.123 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.97 ' SG ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER 49.22 21.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.643 -179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.29 87.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.2 -24.4 0.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.098 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -129.15 -98.16 0.87 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.944 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.645 HG11 ' CE1' ' A' ' 64' ' ' HIS . 19.2 t -150.32 125.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 111.572 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -89.55 99.27 12.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.645 ' CE1' HG11 ' A' ' 62' ' ' VAL . 88.3 m-70 -89.62 59.79 4.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 1.4 t-20 -46.0 117.98 1.71 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.678 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -117.69 -171.05 1.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.089 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.6 pt-20 -73.25 143.2 47.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.9 32.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.612 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER 164.69 174.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.61 0.243 . . . . 0.0 110.43 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.865 ' CD2' HD21 ' A' ' 57' ' ' LEU . 8.7 p90 -146.8 166.44 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.142 0.496 . . . . 0.0 111.783 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.678 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -122.54 108.15 12.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.574 ' HB3' HD21 ' A' ' 80' ' ' LEU . 19.0 m -89.59 116.33 27.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.152 0.501 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -100.75 141.7 33.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.495 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.832 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -78.05 -35.63 1.24 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.026 -178.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.832 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 9.6 Cg_exo -73.74 -168.54 6.18 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.454 0.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 65.0 Cg_exo -40.57 172.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 113.04 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.92 86.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.154 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.592 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -139.74 -136.86 0.12 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.08 84.5 1.39 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.275 0.489 . . . . 0.0 111.254 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.04 123.82 34.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.085 0.469 . . . . 0.0 111.677 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -49.95 122.22 13.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.264 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 73.2 Cg_exo -37.32 -44.98 1.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.869 2.38 . . . . 0.0 112.713 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.586 ' H ' HD12 ' A' ' 84' ' ' ILE . 32.2 m120 -163.24 24.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -86.91 -27.34 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.427 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.686 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.9 p 87.15 87.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.347 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.48 84.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.542 ' HA ' HD13 ' A' ' 80' ' ' LEU . 9.6 t -38.34 152.9 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.592 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.898 0.38 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.8 t70 158.66 82.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.782 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.75 159.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.535 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 59.5 t0 -75.21 90.04 2.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 0.0 111.041 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.1 mp0 -74.08 -21.86 59.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.054 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -46.74 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.511 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.525 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 1.2 mmt-85 -50.63 -31.95 17.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 15.0 mm -53.31 -55.08 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.504 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 14' ' ' LEU . 1.4 t -143.06 121.95 7.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.84 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.7 -19.56 47.47 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.756 2.304 . . . . 0.0 110.753 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -118.88 25.57 10.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.717 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.867 HD22 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.53 -44.43 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.862 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -84.37 15.69 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.459 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.55 5.83 7.39 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.811 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 174.39 -60.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.758 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 31' ' ' CYS . . . -48.71 164.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.749 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.93 84.53 5.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.81 0.338 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -44.46 148.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.161 0.505 . . . . 0.0 111.165 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.3 t -135.52 163.45 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.425 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' HG12 ' A' ' 21' ' ' VAL . 5.5 t-20 -91.41 146.25 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.025 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 27' ' ' PHE . 3.6 p -151.56 156.02 34.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.5 Cg_endo -55.24 107.53 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.239 . . . . 0.0 111.888 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.34 41.79 95.26 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.017 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 173.75 -167.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.867 ' CZ ' HD22 ' A' ' 14' ' ' LEU . 2.5 p90 -164.85 145.27 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 5.9 pt-20 -117.21 -167.41 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 2.9 p -167.52 154.4 8.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.192 0.52 . . . . 0.0 111.718 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -101.58 76.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.266 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.537 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . 60.0 m -41.23 169.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.849 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -91.78 -151.23 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.318 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' ASP . 67.1 mm-40 -33.12 -95.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -114.96 36.48 3.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.588 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.8 m-85 -89.8 121.59 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.754 0.311 . . . . 0.0 110.429 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.581 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -94.81 128.1 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 7.7 p -84.07 95.05 8.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.59 34.72 0.68 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 2.3 t80 -55.87 -17.36 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.316 . . . . 0.0 110.913 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.65 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.987 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' MET . 29.2 mmm -75.9 -29.68 58.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.593 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.3 mmt 131.69 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.281 0.988 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 7.8 tptt 177.98 104.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 0.0 111.281 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -166.97 50.52 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.966 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 74.6 m 5.93 100.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.154 0.909 . . . . 0.0 112.235 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.484 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.8 mmt -125.95 113.67 17.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.827 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 46' ' ' MET . 9.9 p-10 -20.89 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 O-C-N 123.667 0.604 . . . . 0.0 112.04 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -42.13 176.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 45.4 t0 -92.97 76.18 4.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.75 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.952 ' O ' HD13 ' A' ' 57' ' ' LEU . 32.2 mp0 -48.8 -25.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.865 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 1.016 ' HA ' HD22 ' A' ' 57' ' ' LEU . 45.2 t -74.69 -8.8 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.71 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -117.98 -26.37 6.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.637 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -30.23 61.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.24 138.05 25.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.98 -4.7 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.99 2.46 . . . . 0.0 112.05 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -119.49 -11.54 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.516 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.016 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.49 113.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 75.4 m 51.84 21.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 110.247 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.44 -28.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.649 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.24 -7.83 6.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.101 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.15 -152.43 11.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 64' ' ' HIS . 47.4 t -112.74 129.87 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.325 . . . . 0.0 111.067 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.481 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 7.3 p -95.41 101.59 13.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.54 ' O ' HG22 ' A' ' 66' ' ' THR . 28.3 m80 -90.19 62.26 5.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.557 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 7.9 t-20 -44.53 109.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -108.51 -178.61 3.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.97 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.3 129.32 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 41.15 29.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -167.72 -169.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.844 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.6 p90 -171.47 139.76 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.766 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 1.3 mtp180 -109.83 158.98 17.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.235 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.012 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -131.92 143.93 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.258 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 21.6 tt0 -139.79 118.13 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 111.799 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.93 -32.8 0.93 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.869 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.35 172.38 34.6 Favored 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.594 1.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 49.9 Cg_exo -35.36 -27.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.055 2.503 . . . . 0.0 113.162 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.66 -31.08 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.45 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.569 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -89.65 -126.47 0.07 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.19 58.08 1.4 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.012 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -81.99 109.04 15.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.624 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.666 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -43.8 133.63 3.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.44 -68.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.54 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.682 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.4 m120 -127.35 29.54 5.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.689 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.819 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -96.28 -14.76 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.801 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.7 87.74 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.966 178.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.36 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.78 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.987 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.569 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.457 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -177.34 107.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.819 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.0 OUTLIER -118.33 164.69 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 47.8 t0 -81.23 109.19 15.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.734 ' O ' HD11 ' A' ' 14' ' ' LEU . 14.1 mp0 -92.47 -23.85 19.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.941 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.87 -45.64 64.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.566 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.477 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.1 ttt180 -51.9 -35.3 44.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 10.7 mm -41.51 -39.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.338 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.77 150.03 11.11 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.678 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.4 Cg_endo -87.26 -16.64 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.135 2.556 . . . . 0.0 111.541 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.62 20.21 18.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.919 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.65 -50.58 4.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.206 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -63.86 -10.07 18.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.7 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 62.74 6.93 13.18 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.883 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.638 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 13.9 tpt180 172.58 -44.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.876 0.369 . . . . 0.0 110.706 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.68 -139.05 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.622 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.1 mt-30 -136.69 111.39 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 110.995 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -68.82 155.36 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 36.8 t -140.76 161.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.736 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.3 t-20 -90.63 155.93 18.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.508 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.538 HG23 ' HA ' ' A' ' 27' ' ' PHE . 11.9 p -156.87 155.73 28.8 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.833 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.0 Cg_endo -54.61 110.26 0.5 Allowed 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.71 2.274 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.01 41.92 94.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 168.96 -162.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.536 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.919 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -163.58 141.44 7.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.029 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -101.61 -150.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -165.86 177.43 7.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.148 0.499 . . . . 0.0 111.78 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 5.6 tmtm? -145.43 76.24 1.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.192 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 5.8 m -44.83 177.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.694 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.87 -73.44 0.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.313 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.95 -74.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.148 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.968 ' O ' HG23 ' A' ' 48' ' ' ILE . . . -101.09 -0.61 54.65 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.158 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.9 m-85 -71.05 118.15 13.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.922 ' HB2' HG22 ' A' ' 48' ' ' ILE . 1.4 tp10 -89.96 141.02 29.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.416 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 13.0 p -45.49 81.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.154 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 43' ' ' LYS . . . 82.14 -12.09 45.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.169 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 40' ' ' MET . 0.0 OUTLIER 72.17 4.1 4.9 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.579 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 107.97 -22.41 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.758 0.823 . . . . 0.0 110.97 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 3.1 ptm -66.63 -32.98 74.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 21.5 mmt -162.31 -75.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 110.467 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 12.2 tptt 179.97 -24.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.04 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -46.0 90.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' CYS . 25.2 m -36.15 103.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.393 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.547 ' HA ' ' CD2' ' A' ' 35' ' ' TYR . 3.2 ptp -132.14 135.55 46.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 p-10 -22.39 118.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.34 0.591 . . . . 0.0 111.95 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.968 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.1 pt -58.47 -170.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.475 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 57.4 t0 -97.76 71.98 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.453 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -50.72 -21.51 1.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 9.1 t -77.39 -10.03 59.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.2 mt-30 -117.65 -22.39 8.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HD3' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.45 -24.03 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.095 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -126.57 138.02 31.59 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.965 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.94 -7.88 13.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.942 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -115.65 -7.94 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.597 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.954 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -52.07 114.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.7 m 52.53 22.29 2.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.223 0.535 . . . . 0.0 109.955 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 3.4 ttt180 -40.25 -30.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.56 22.22 4.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.021 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -138.76 -131.11 2.83 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.466 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.729 HG11 ' NE2' ' A' ' 64' ' ' HIS . 39.4 t -135.37 129.7 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.763 0.316 . . . . 0.0 110.733 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.8 p -97.99 95.88 7.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.729 ' NE2' HG11 ' A' ' 62' ' ' VAL . 38.6 m80 -88.98 60.41 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.679 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.9 t-20 -43.0 117.03 0.98 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.265 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -117.58 -179.65 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' N ' ' OG1' ' A' ' 66' ' ' THR . 10.5 pt-20 -64.65 135.4 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.02 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 37.12 31.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.594 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 66' ' ' THR . 0.2 OUTLIER 172.9 158.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 4.1 p90 -136.49 147.38 47.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.194 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.565 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.18 119.23 38.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.326 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.068 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -92.07 142.51 27.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.866 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -133.55 122.46 23.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.824 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.99 -34.49 2.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.98 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.824 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.2 Cg_exo -71.96 -174.07 11.15 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.61 1.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 78.5 Cg_exo -39.94 173.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.028 2.485 . . . . 0.0 113.011 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.37 56.54 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.663 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 13.5 t-160 -101.12 -126.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.961 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.52 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 35.2 tt0 -151.3 64.64 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.383 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.068 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.6 OUTLIER -90.9 109.97 21.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.848 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.7 t -58.44 136.79 85.61 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 4.9 Cg_exo -74.15 109.94 2.99 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 113.809 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 22.0 m120 71.1 -1.18 2.8 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.553 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -77.42 -35.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.239 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 3.9 p 85.03 84.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.373 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.34 96.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 1.029 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -55.56 160.89 2.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.282 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.663 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.8 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.218 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.783 0.325 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 24' ' ' PRO . 37.4 t70 43.27 73.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.85 165.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 14.2 t0 -77.29 92.06 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.063 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.623 ' O ' HD11 ' A' ' 14' ' ' LEU . 31.8 mp0 -73.93 -17.33 61.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.614 ' HA ' HD13 ' A' ' 14' ' ' LEU . 55.6 m -83.77 -27.58 28.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.14 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -46.11 -44.07 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.295 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -156.2 146.46 15.88 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.586 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.9 Cg_endo -84.48 -15.92 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.998 2.465 . . . . 0.0 111.626 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.35 19.0 18.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.397 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.19 -49.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 18' ' ' GLY . 8.0 t -89.51 36.84 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.654 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . -14.37 80.38 0.0 OUTLIER Glycine 0 C--N 1.335 0.485 0 O-C-N 123.978 0.799 . . . . 0.0 113.771 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.619 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 116.53 13.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . -148.14 -149.65 5.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.11 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -133.72 106.75 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 37.5 t -56.07 155.59 6.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 20.5 t -136.26 164.91 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.597 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.578 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 9.2 t-20 -115.96 141.78 47.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.211 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASP . 9.5 p -146.25 155.46 50.37 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 32.2 Cg_endo -64.06 112.35 1.83 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . 70.52 31.76 68.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.3 OUTLIER 165.31 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.696 0.284 . . . . 0.0 110.472 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 14' ' ' LEU . 5.5 p90 -164.43 -176.01 4.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.215 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' A' ' 27' ' ' PHE . 8.3 pt-20 -167.88 -155.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.284 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 6.2 p -168.15 179.15 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 111.969 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -117.32 80.35 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.607 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -54.67 163.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.081 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 -88.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.088 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -122.61 -80.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.29 -3.92 64.78 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.356 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 14.5 m-85 -68.63 123.82 21.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.958 0.408 . . . . 0.0 110.218 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -93.59 136.75 33.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.046 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.54 96.83 10.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.944 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 100.67 44.75 2.06 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' MET . 5.8 t80 -40.03 -30.25 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.074 0.464 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.47 -38.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.548 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 4.5 ptm -57.64 -47.99 80.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.818 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 41' ' ' MET . 46.9 mmm -163.09 -94.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HZ1' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -168.47 96.92 0.4 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.474 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -165.21 134.25 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.184 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -42.72 121.91 2.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.355 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -149.77 86.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 7.9 p-10 -15.77 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.744 0.653 . . . . 0.0 112.142 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -45.04 179.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.451 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 61.0 t0 -95.88 73.63 3.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.902 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp0 -50.07 -24.35 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.995 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.961 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.3 t -75.83 -9.43 58.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.721 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -119.34 -23.33 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -52.86 -34.8 56.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 139.02 28.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.07 0.462 . . . . 0.0 111.019 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.08 -7.91 13.08 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.036 2.49 . . . . 0.0 111.931 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.698 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -108.81 -14.24 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.117 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.961 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.52 120.35 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.666 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.4 m 47.64 24.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.425 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.14 -21.46 3.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.216 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.51 13.02 5.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.049 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.41 -132.46 3.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.628 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.581 HG12 ' CE1' ' A' ' 64' ' ' HIS . 34.0 t -133.16 127.53 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 111.089 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.9 p -94.1 106.74 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.033 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.581 ' CE1' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.45 67.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.519 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -48.03 110.24 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.558 HG21 HH11 ' A' ' 71' ' ' ARG . 0.3 OUTLIER -104.93 -170.97 1.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.018 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.62 126.79 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.1 28.54 1.94 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -169.74 -168.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.898 0.38 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -167.68 140.55 3.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.558 HH11 HG21 ' A' ' 66' ' ' THR . 0.6 OUTLIER -110.98 156.07 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.08 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.54 137.32 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 31.5 tt0 -138.59 116.48 11.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.803 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.806 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -80.67 -30.18 0.56 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.806 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 21.9 Cg_exo -67.95 176.79 25.78 Favored 'Cis proline' 0 C--N 1.357 0.978 0 C-N-CA 123.988 -1.255 . . . . 0.0 112.767 1.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HG3' ' A' ' 73' ' ' GLU . 76.9 Cg_exo -39.86 -24.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.908 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -35.58 -31.81 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.337 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -83.39 -121.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 tt0 -148.73 65.6 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.08 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -90.46 111.51 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.9 -178.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.674 ' OG ' HD13 ' A' ' 84' ' ' ILE . 38.0 t -62.07 137.1 95.55 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.719 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 84' ' ' ILE . 63.6 Cg_endo -76.57 108.88 2.75 Favored 'Trans proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.052 2.501 . . . . 0.0 114.063 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 88.9 m-20 72.51 14.25 5.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.259 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.674 HD13 ' OG ' ' A' ' 81' ' ' SER . 2.0 mp -95.75 -19.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 110.201 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.57 86.0 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.11 178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.698 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 147.64 98.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.487 0.492 . . . . 0.0 111.428 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.9 t -63.77 161.7 14.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.591 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.186 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.71 0.291 . . . . 0.0 111.059 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' THR . 63.4 t0 37.37 69.39 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.616 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -95.06 153.38 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.367 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.533 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 41.1 t0 -69.58 90.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.597 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.4 mp0 -73.85 -20.52 60.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.68 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.0 t -79.31 -36.26 39.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.491 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.0 ttt85 -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mm -52.24 -46.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -162.91 154.14 14.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.2 -18.84 2.61 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.29 2.66 . . . . 0.0 111.722 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -108.12 21.35 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.378 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.736 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.06 -51.66 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.981 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 45' ' ' CYS . 12.4 m -95.13 17.26 14.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 67.93 3.34 28.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.969 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.513 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 175.09 -52.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.988 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 30' ' ' LYS . . . -48.11 176.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.804 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 10.7 mt-30 -105.96 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.809 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 2.9 p -52.27 134.91 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 111.558 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -118.38 164.05 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.21 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.3 t-20 -106.34 142.96 35.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 111.644 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -149.87 157.06 38.36 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 15.9 Cg_endo -57.61 111.84 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.256 . . . . 0.0 111.849 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.55 44.28 67.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.695 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 171.11 -175.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.738 0.304 . . . . 0.0 110.516 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.736 ' CE2' HD22 ' A' ' 14' ' ' LEU . 28.0 p90 -160.23 167.38 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.254 0.549 . . . . 0.0 111.716 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.7 pt-20 -143.51 -165.18 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.583 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.8 p -170.7 168.09 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -114.17 82.19 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.16 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -39.03 165.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 2.7 t70 -77.15 -144.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.17 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.8 mt-10 -28.15 -93.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.859 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -123.51 32.67 4.21 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.22 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 21.2 m-85 -81.6 143.8 31.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.001 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -117.49 132.96 56.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.64 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -42.31 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.353 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -47.25 -76.64 0.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 87.39 -22.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.663 0.268 . . . . 0.0 111.04 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 mtm -59.5 -32.08 69.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.21 0.529 . . . . 0.0 109.884 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.0 mmm -117.42 -23.23 7.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.516 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 179.31 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.224 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 42' ' ' MET . 1.2 tptt 173.31 34.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.994 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 3.1 p-10 -62.44 -177.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.779 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.585 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -100.39 105.84 17.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.207 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.555 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 2.2 ptp -123.83 99.87 6.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.302 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -9.14 125.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.846 0.716 . . . . 0.0 112.732 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -64.94 -174.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.256 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -100.44 73.54 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.301 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.885 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.2 mp0 -50.09 -21.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.729 ' HA ' HD22 ' A' ' 57' ' ' LEU . 51.1 m -77.7 -9.83 59.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.663 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.45 -22.27 8.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.637 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 33.9 ttt-85 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.105 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -100.97 156.12 35.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.027 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 20.8 Cg_endo -90.2 -2.61 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.344 2.696 . . . . 0.0 112.364 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -132.06 14.57 4.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.404 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.885 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -62.81 129.16 39.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.7 m 45.93 25.89 0.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.351 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -62.31 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.239 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 129.6 0.46 5.73 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.806 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -122.55 -139.06 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.562 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.717 HG11 ' NE2' ' A' ' 64' ' ' HIS . 55.8 t -127.58 117.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.45 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 6.3 t -84.1 94.33 8.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.717 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.8 m80 -89.43 53.73 2.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 17.6 t-20 -49.66 111.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.718 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.51 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -112.7 -161.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.316 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.4 pt-20 -75.53 138.93 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 34.59 46.6 0.58 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.721 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.1 t 157.61 -176.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.731 ' CE2' HD21 ' A' ' 57' ' ' LEU . 1.8 p90 -154.81 156.13 35.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -122.92 117.19 24.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.01 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.549 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -100.07 135.37 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' C ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt0 -150.22 120.59 7.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.112 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.754 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -45.68 -47.53 38.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.4 Cg_exo -76.3 -60.41 0.08 OUTLIER 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.771 -1.345 . . . . 0.0 113.264 0.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.707 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.7 Cg_endo -83.38 -154.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.823 2.349 . . . . 0.0 113.111 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 78' ' ' HIS . . . 45.88 39.36 8.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.917 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.564 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.51 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.0 111.041 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -141.78 73.03 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -63.83 91.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.211 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.791 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -46.68 130.7 8.38 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 59.2 Cg_endo -74.51 112.58 3.59 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.965 2.444 . . . . 0.0 113.253 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 75.97 34.26 0.55 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.985 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.791 HD13 ' C ' ' A' ' 81' ' ' SER . 1.1 mp -115.0 -39.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.111 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.7 p 88.74 69.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.041 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.03 116.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.696 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -62.46 128.49 36.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.564 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.713 0.292 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -64.54 63.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.86 173.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 51.5 t0 -84.49 97.81 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.931 0.396 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.746 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.8 mp0 -76.75 -25.93 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.571 ' HA ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -69.51 -45.43 68.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.353 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -50.5 -35.58 29.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.034 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 11.1 mm -42.37 -40.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -161.94 147.88 10.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.578 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.8 Cg_endo -85.24 -17.05 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.038 2.492 . . . . 0.0 111.256 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -112.13 23.76 13.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.059 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -38.96 -54.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.421 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -77.39 -10.84 59.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.067 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.31 -1.82 48.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.775 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 6.8 tpt180 -173.57 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.971 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -71.72 -151.61 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.628 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -133.74 99.3 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.7 t -50.77 153.52 1.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.188 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 31.6 t -136.86 161.72 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.724 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 3.7 t-20 -95.69 143.65 26.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.691 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -149.18 155.82 39.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.9 Cg_endo -55.59 105.88 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.717 2.278 . . . . 0.0 111.952 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.43 41.51 97.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.906 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 175.57 -168.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.697 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.6 p90 -165.82 148.12 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.0 pt-20 -118.46 -170.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.434 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -147.34 155.78 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 111.531 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -113.36 71.66 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.967 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -50.74 -175.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.856 -178.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.62 -158.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.049 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 32' ' ' ASP . 3.9 mm-40 19.88 -82.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.181 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ASP . . . -152.62 22.45 0.82 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.61 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 28.3 m-85 -79.79 134.38 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 4.6 pt-20 -99.66 134.83 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -86.49 88.2 7.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 125.58 79.87 0.37 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.273 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 22.0 t80 -122.18 -3.07 9.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.72 0.295 . . . . 0.0 111.238 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 159.7 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.091 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -89.88 -24.34 21.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.6 OUTLIER 124.26 -19.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.256 0.972 . . . . 0.0 109.988 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HA ' ' N ' ' A' ' 38' ' ' GLY . 1.7 tptt -164.8 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.912 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 21.94 102.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.885 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.3 m -39.21 95.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.18 0.514 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.815 ' HA ' ' HE3' ' A' ' 46' ' ' MET . 0.0 OUTLIER -119.74 91.88 3.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.147 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.5 p30 -5.51 123.24 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.087 0.867 . . . . 0.0 112.958 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -63.2 -171.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.606 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 54.3 t0 -94.83 72.82 3.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.814 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.4 mp0 -51.01 -21.59 1.86 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.2 t -78.28 -9.01 59.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.748 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.4 mt-30 -116.74 -22.22 8.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.713 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -59.95 -32.71 71.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.138 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -116.15 137.48 23.47 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.037 0.446 . . . . 0.0 110.979 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.77 -4.16 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.193 2.595 . . . . 0.0 112.147 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.507 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -118.88 -9.43 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.285 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.957 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -49.96 114.15 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.575 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 35.5 m 50.78 23.54 1.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.271 0.557 . . . . 0.0 109.959 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -39.42 -31.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.689 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.38 21.65 5.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -137.99 -129.76 2.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.573 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' NE2' ' A' ' 64' ' ' HIS . 28.3 t -136.19 129.67 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.455 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 24.6 p -97.4 96.33 8.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' NE2' HG11 ' A' ' 62' ' ' VAL . 52.0 m80 -88.67 59.85 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.731 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 3.7 t-20 -44.1 119.48 1.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.871 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -119.43 -162.07 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 69' ' ' SER . 2.7 mt-10 -77.47 142.61 39.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' SER . . . 33.98 34.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.753 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 65.1 p 172.89 -169.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.874 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 1.5 p90 -162.1 147.92 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.647 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.93 146.39 35.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.963 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.055 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -119.19 138.7 52.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.931 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -131.77 123.45 27.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.72 -34.1 1.71 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.989 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 15.1 Cg_exo -70.99 -176.06 13.65 Favored 'Cis proline' 0 C--N 1.356 0.945 0 C-N-CA 124.154 -1.186 . . . . 0.0 112.616 0.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.8 Cg_exo -39.29 172.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.015 2.476 . . . . 0.0 112.928 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.77 48.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.7 t-160 -99.48 -126.12 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.751 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -151.67 64.52 0.86 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.122 0.486 . . . . 0.0 110.011 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.055 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.94 107.52 19.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.247 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.622 ' N ' HD12 ' A' ' 80' ' ' LEU . 31.3 t -55.3 136.77 68.76 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -77.52 110.49 2.98 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.904 2.403 . . . . 0.0 113.845 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 87.6 m-20 71.83 -0.61 3.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.344 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.541 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -79.33 -35.12 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.251 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.714 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.4 p 85.98 81.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.181 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.02 101.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.948 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.4 148.95 30.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.319 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.295 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 28.7 t70 -54.19 113.09 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -120.69 161.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 5' ' ' ILE . 23.9 t0 -42.39 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 14' ' ' LEU . 1.5 mt-10 95.37 -52.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.121 0.569 . . . . 0.0 110.805 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 5.5 t -66.68 -36.01 81.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -76.89 -26.24 53.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.77 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ARG . 9.2 mm -38.18 -36.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.74 154.02 8.67 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -89.7 -18.58 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 111.471 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.97 17.5 24.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.065 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -39.84 -55.39 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -85.73 15.19 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.72 24.59 0.47 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.381 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER 163.29 -59.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.3 -150.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 2.4 mt-30 -137.92 113.08 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 24.6 p -53.49 155.31 3.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.8 t -133.55 163.79 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.565 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -107.06 142.45 36.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.965 0.412 . . . . 0.0 111.64 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.0 p -152.28 153.59 31.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.55 116.55 2.93 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 111.713 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . 46.42 46.92 17.1 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.576 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 171.41 177.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CG ' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -157.98 161.27 38.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.431 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -133.57 -172.25 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 1.1 m -140.83 159.09 42.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 1.6 tmtm? -112.76 75.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 99.5 m -45.87 155.78 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.334 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 30.9 t70 -57.3 -81.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 6.2 mt-10 -145.11 -40.19 0.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.48 17.52 6.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.391 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 3.8 m-30 -89.61 158.16 17.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.665 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -122.08 124.73 44.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.49 105.41 17.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.72 69.83 0.66 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.389 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 91.5 t80 -104.28 -15.02 15.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.445 ' SD ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 168.32 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.198 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.629 ' HG3' ' ND2' ' A' ' 44' ' ' ASN . 30.7 mmm -75.53 -16.26 60.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.479 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.556 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.5 mtm 99.17 -15.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.524 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 1.6 mmtp 172.87 99.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.885 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.629 ' ND2' ' HG3' ' A' ' 41' ' ' MET . 27.8 p-10 -168.14 72.53 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.347 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 57.1 m -28.65 108.88 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.722 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 8.6 ptm -138.87 113.17 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.5 p-10 0.08 106.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.982 0.802 . . . . 0.0 112.809 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -56.53 -175.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.66 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.9 t0 -94.6 76.13 3.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.421 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.867 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.8 mp0 -49.68 -21.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.142 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.959 ' HA ' HD22 ' A' ' 57' ' ' LEU . 44.1 t -77.69 -11.11 59.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -111.59 -23.86 10.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -20.92 40.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.829 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -132.76 142.61 45.41 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 -5.63 11.76 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.94 2.427 . . . . 0.0 112.354 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -122.5 -8.37 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.821 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.959 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -53.12 114.35 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . 74.1 m 58.0 16.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.47 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -42.73 -27.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.425 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.23 29.4 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.073 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.59 -132.83 2.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.955 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.677 HG11 ' NE2' ' A' ' 64' ' ' HIS . 52.1 t -132.54 136.15 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 88.4 m -93.01 89.94 6.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.677 ' NE2' HG11 ' A' ' 62' ' ' VAL . 31.7 m80 -89.03 47.78 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 110.041 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 19.5 t-20 -44.61 116.06 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.276 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 71' ' ' ARG . 2.4 p -115.39 -162.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLY . 1.3 mt-10 -75.66 135.87 40.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.91 37.83 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.58 168.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.727 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.1 p90 -140.98 149.57 41.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.63 106.25 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.759 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.8 t -90.19 132.85 35.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.741 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.858 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.7 tt0 -145.81 128.09 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.785 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -50.59 -45.49 85.27 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.558 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.785 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 2.7 Cg_exo -75.08 -60.32 0.08 OUTLIER 'Cis proline' 0 C--N 1.352 0.732 0 C-N-CA 123.664 -1.39 . . . . 0.0 113.183 1.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.697 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.8 Cg_endo -85.13 -156.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.884 2.389 . . . . 0.0 113.59 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.05 37.25 9.76 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.0 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 160.52 -165.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 111.342 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.22 86.26 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.637 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -65.73 124.12 21.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.348 0.595 . . . . 0.0 111.932 -178.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.793 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -53.34 123.09 34.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.879 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.28 -44.81 43.72 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.578 2.185 . . . . 0.0 112.032 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.6 m120 -145.36 13.81 1.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -89.93 -20.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.622 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.34 103.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.0 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.835 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 127.55 106.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.904 0.752 . . . . 0.0 111.276 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.81 139.14 58.73 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 111.328 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.562 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.562 HG22 ' N ' ' A' ' 4' ' ' ASP . 35.2 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.562 ' N ' HG22 ' A' ' 3' ' ' THR . 23.4 t0 -178.7 51.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.83 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -89.85 165.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.546 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 61.7 t0 -71.9 91.93 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 14' ' ' LEU . 48.9 mp0 -72.56 -24.83 61.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.518 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.664 ' HA ' HD13 ' A' ' 14' ' ' LEU . 20.3 t -70.41 -45.7 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HG2' ' OD2' ' A' ' 6' ' ' ASP . 6.8 mmt180 -55.18 -31.25 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 9.5 mm -37.97 -37.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.305 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.86 153.57 8.2 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.642 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.72 -22.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.854 2.37 . . . . 0.0 111.495 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -108.02 18.99 20.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.939 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -29.68 -57.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.516 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -93.29 -18.52 22.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.426 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 84.03 -47.2 3.8 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.033 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 31.5 tpt85 -116.68 -9.69 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 0.0 111.268 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -118.46 -171.96 15.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.615 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -118.29 108.9 15.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' CB ' HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -50.58 134.67 23.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.064 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 28' ' ' GLU . 2.1 p -119.43 146.16 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.5 t-20 -84.89 141.25 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.41 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -148.6 155.12 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.754 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.3 Cg_endo -53.0 104.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 57.79 42.77 94.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.752 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER 178.62 -168.68 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.702 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -173.61 139.5 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.643 ' H ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -106.48 -148.75 0.42 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.284 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 m -163.09 148.35 11.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 0.0 111.493 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 6.6 tmtm? -100.87 67.3 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.098 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 93.4 m -52.52 171.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.842 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 11.1 t70 -68.58 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.522 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' ' C ' ' A' ' 68' ' ' GLY . 1.6 tt0 -128.07 -65.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.506 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.71 5.07 32.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.456 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 m-85 -69.58 112.64 6.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.023 0.44 . . . . 0.0 110.395 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.46 117.07 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.467 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -81.99 103.13 11.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.585 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . . . 126.86 69.47 0.17 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 77.9 t80 -123.61 11.23 9.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.89 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 0.0 111.431 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.597 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.5 mmt -94.96 -27.96 15.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.597 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.5 OUTLIER 127.45 -20.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.443 1.089 . . . . 0.0 110.101 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 37' ' ' SER . 5.6 mptt -148.75 -89.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.772 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 36.27 67.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 27.6 m -29.7 96.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.154 0.502 . . . . 0.0 110.889 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -125.85 115.35 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.868 -178.556 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.555 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -20.87 138.92 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.584 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.3 pt -82.94 -174.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.134 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.504 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 41.6 t0 -104.07 72.98 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.989 ' O ' HD13 ' A' ' 57' ' ' LEU . 6.0 mp0 -47.34 -26.04 1.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.391 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 1.004 ' HA ' HD22 ' A' ' 57' ' ' LEU . 48.8 t -75.31 -11.93 60.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.038 0.447 . . . . 0.0 110.833 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.0 mt-30 -111.47 -25.3 9.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.353 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HD3' ' OD2' ' A' ' 54' ' ' ASP . 5.0 ttt180 -51.03 -32.89 22.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.594 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 60.2 m-20 -129.78 150.59 76.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.777 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.48 -3.89 6.62 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.238 2.625 . . . . 0.0 112.491 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -113.89 -10.59 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.004 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.4 OUTLIER -53.17 119.57 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.793 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 61.7 m 46.8 26.1 0.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.499 . . . . 0.0 109.968 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 1.3 ttt85 -41.4 -28.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.535 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.68 21.32 3.4 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.891 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -127.57 -139.98 5.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.716 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG11 ' CE1' ' A' ' 64' ' ' HIS . 79.7 t -121.7 137.13 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 25.9 m -96.08 89.13 5.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.607 ' CE1' HG11 ' A' ' 62' ' ' VAL . 98.2 m-70 -89.99 49.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.447 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 13.2 t-20 -45.73 113.76 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.716 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.5 p -105.06 -173.82 2.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.956 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 1.6 mp0 -50.5 -98.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . -88.8 57.71 4.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.415 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 10.8 t 156.8 -173.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.285 . . . . 0.0 110.67 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.772 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 7.5 p90 -148.55 149.9 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.716 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -113.62 118.21 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.051 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.025 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.07 142.39 27.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.334 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 76' ' ' PRO . 2.2 tt0 -136.19 122.41 20.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.592 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.81 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.07 -34.55 1.71 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.005 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.81 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 11.8 Cg_exo -72.89 -172.15 9.28 Favored 'Cis proline' 0 C--N 1.356 0.943 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.521 0.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 89.2 Cg_exo -41.0 176.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.943 2.429 . . . . 0.0 113.006 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.28 48.76 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.577 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.3 t-160 -101.68 -126.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.506 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 30.2 tt0 -151.22 64.8 0.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.113 0.482 . . . . 0.0 109.894 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.46 129.22 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.576 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.053 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -58.79 134.29 86.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.563 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 81' ' ' SER . 45.9 Cg_exo -55.83 -50.56 12.08 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.595 2.197 . . . . 0.0 111.953 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.684 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.3 m120 -147.15 28.52 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.447 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.794 ' N ' HD13 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -96.65 -23.65 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.56 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 74.98 89.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.142 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.87 99.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 1.011 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.25 157.15 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.348 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.577 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -165.8 86.97 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -93.04 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 8.0 t0 -84.61 -50.81 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.0 mp0 73.6 -56.9 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.616 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HA ' HD13 ' A' ' 14' ' ' LEU . 28.3 t -64.68 -18.18 64.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.62 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -76.89 -34.22 57.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.552 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.3 mt -43.3 -37.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.615 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.9 t -162.25 152.19 13.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.671 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_endo -85.53 -17.8 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.114 2.543 . . . . 0.0 111.466 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.53 22.41 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.216 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.938 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -43.72 -44.25 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.163 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.8 m -83.91 11.47 7.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 52.73 11.1 1.16 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.942 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 tpm_? 172.81 -55.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.338 0.569 . . . . 0.0 110.877 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -64.98 -145.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.969 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 mt-30 -131.48 124.41 30.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.016 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 2.2 p -75.09 130.43 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 111.252 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' ASN . 41.5 t -117.34 162.02 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.645 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.7 t-20 -93.63 148.54 22.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.499 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 27' ' ' PHE . 6.4 p -152.72 149.12 21.58 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.59 111.45 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.805 2.337 . . . . 0.0 111.953 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.68 43.7 86.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.888 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.459 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 170.01 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.869 0.366 . . . . 0.0 110.671 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.938 ' CE2' HD22 ' A' ' 14' ' ' LEU . 16.2 p90 -166.51 144.41 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.6 pt-20 -109.98 -168.12 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.5 m -152.31 165.31 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 111.69 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -124.94 72.26 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.564 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 98.7 m -41.84 170.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.55 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -80.83 -73.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -131.21 -85.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.646 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 33' ' ' GLU . . . -93.33 -7.6 61.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.639 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 19.1 m-30 -68.57 127.15 31.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 pt-20 -100.24 128.06 46.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -86.94 105.73 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.21 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 117.13 24.17 3.64 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.798 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 40' ' ' MET . 84.9 t80 -44.6 -26.71 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.557 ' CG ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.14 -34.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -54.14 -44.44 71.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.749 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.75 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 8.8 tptt -167.82 23.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.548 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' SER . 4.1 p-10 -76.33 143.26 40.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 86.5 m -85.13 108.84 17.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 22.8 ptm -136.6 113.46 10.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.95 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.524 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 2.0 p30 2.57 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 124.028 0.83 . . . . 0.0 112.973 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -53.31 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.163 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.542 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 46.0 t0 -97.19 73.47 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.937 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.7 mp0 -49.47 -23.19 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 110.763 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.945 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.3 t -76.38 -11.22 59.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.9 mt-30 -114.45 -23.96 9.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -57.79 -31.44 66.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.02 137.81 23.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.833 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.01 -2.12 10.1 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.061 2.507 . . . . 0.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.599 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -122.93 -5.62 8.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.596 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -53.05 116.67 2.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.957 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.1 m 52.08 21.49 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.17 -26.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.272 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.57 21.63 6.31 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.95 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -147.48 -129.83 1.97 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.683 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 64' ' ' HIS . 38.7 t -137.16 133.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.825 0.345 . . . . 0.0 110.569 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.0 p -99.95 96.88 7.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.496 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.57 ' CD2' HG12 ' A' ' 62' ' ' VAL . 16.9 m80 -88.4 61.14 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.4 t-20 -41.96 120.45 1.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.902 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.541 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -121.17 172.7 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.3 pt-20 -59.99 139.19 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 67' ' ' GLU . . . 38.08 33.77 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.48 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 179.3 -166.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.131 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -173.63 144.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.446 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.541 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.5 OUTLIER -109.36 152.09 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.201 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.032 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -132.17 135.55 46.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.089 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG2' ' CD ' ' A' ' 76' ' ' PRO . 6.7 tt0 -142.9 124.97 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.977 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.846 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -63.71 -38.57 39.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.0 Cg_exo -80.16 -172.51 11.19 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.291 -1.129 . . . . 0.0 112.587 1.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 8.9 Cg_exo -28.39 152.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.16 2.573 . . . . 0.0 113.56 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.09 -12.77 16.94 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.676 ' CE1' ' C ' ' A' ' 88' ' ' ILE . 3.7 t-160 -120.53 -131.93 0.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.522 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.539 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -150.32 72.42 1.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 110.16 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.032 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -84.16 125.81 32.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.269 0.556 . . . . 0.0 111.861 -179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.94 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -62.89 132.68 94.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.854 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.29 -48.21 13.65 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.656 2.237 . . . . 0.0 112.395 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 84' ' ' ILE . 13.2 m120 -153.69 33.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.819 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -101.96 -12.31 8.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.41 86.88 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.305 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.73 104.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.2 t -71.21 145.93 49.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.716 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.676 ' C ' ' CE1' ' A' ' 78' ' ' HIS . 2.3 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.24 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.807 0.337 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.9 t0 173.6 99.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -90.5 -165.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.811 ' N ' HG23 ' A' ' 5' ' ' ILE . 17.8 t0 -91.77 -49.27 6.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.997 0.427 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 16.1 mp0 71.71 -55.32 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 67.4 m -61.37 -27.1 68.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.855 0.359 . . . . 0.0 110.344 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.9 -32.62 73.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.169 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.4 mm -45.51 -39.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.477 ' OG ' ' HD2' ' A' ' 12' ' ' PRO . 17.7 t -168.13 154.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.205 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 76.1 Cg_endo -89.31 -20.12 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.234 2.623 . . . . 0.0 111.289 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.32 22.0 16.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.6 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.654 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.87 -46.44 5.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.272 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -82.35 2.4 32.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.364 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 65.19 4.24 15.41 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.668 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 175.95 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.109 0.455 . . . . 0.0 111.362 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 30' ' ' LYS . . . -65.05 -131.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.163 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 1.3 mt-30 -148.28 122.0 9.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.39 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -67.95 160.85 27.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.7 t -141.43 164.1 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.746 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 6.3 t-20 -105.25 151.21 24.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.7 p -153.77 146.82 17.86 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.876 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.77 111.51 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.904 2.403 . . . . 0.0 112.059 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.8 42.08 96.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.996 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.05 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.481 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.654 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.1 p90 -165.32 171.75 13.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.971 0.415 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 3.0 pt-20 -142.62 175.14 10.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -139.91 153.35 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 111.379 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.21 162.84 12.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.907 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 1.3 m -139.74 153.66 47.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.071 0.463 . . . . 0.0 111.341 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -89.89 -157.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.657 -179.08 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 32' ' ' ASP . 4.4 mt-10 9.42 -77.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -154.28 31.02 0.71 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.176 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 21.9 m-85 -81.12 155.58 26.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -132.68 133.41 43.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -42.96 100.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.607 ' HA2' ' HE3' ' A' ' 46' ' ' MET . . . -51.04 -76.22 0.18 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.695 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 84.48 -12.35 0.77 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.402 ' SD ' ' HE1' ' A' ' 46' ' ' MET . 1.0 OUTLIER -88.85 -16.8 31.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.337 179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -33.15 2.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.22 36.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HD3' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER 51.17 36.62 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -77.21 -152.45 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.2 m -115.73 113.68 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.607 ' HE3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -130.54 103.72 6.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.088 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.0 p-10 -12.57 110.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.062 0.851 . . . . 0.0 112.654 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -48.76 -173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.116 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 60.5 t0 -101.51 72.92 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.378 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 57' ' ' LEU . 5.1 mp0 -51.96 -22.01 3.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 110.149 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.439 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.9 -11.27 60.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -115.27 -29.04 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.643 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -49.35 -38.0 26.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -113.12 130.55 23.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.797 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 56' ' ' LEU . 73.0 Cg_endo -77.52 -5.73 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.829 2.353 . . . . 0.0 112.156 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -126.64 -6.73 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -30.39 134.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 1.3 m 38.49 36.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.47 -40.8 0.89 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 21.6 7.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.889 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -136.02 -157.0 7.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.951 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG11 ' NE2' ' A' ' 64' ' ' HIS . 35.3 t -113.96 123.33 69.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.897 0.38 . . . . 0.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -88.84 98.41 11.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.821 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.689 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.6 m80 -93.37 61.02 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.252 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 12.9 t-20 -49.04 114.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -116.08 -163.47 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -76.03 144.86 40.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.17 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 33.87 35.03 0.04 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.831 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.55 177.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.369 . . . . 0.0 111.263 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 p90 -148.84 147.38 28.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 3.5 mmm180 -109.66 148.73 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -130.17 133.35 46.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.549 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 4.1 tt0 -125.83 119.12 27.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -64.29 -40.09 48.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 17.4 Cg_exo -69.26 174.21 39.75 Favored 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.616 1.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.549 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 67.1 Cg_exo -30.85 -32.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.057 2.504 . . . . 0.0 113.096 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.61 -30.62 0.06 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.279 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 0.4 OUTLIER -103.03 -134.92 0.32 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 1.2 tp-100 -137.32 82.61 1.94 Allowed 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.323 0.51 . . . . 0.0 110.992 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.699 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.28 113.48 25.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.699 ' N ' HD12 ' A' ' 80' ' ' LEU . 18.1 t -67.6 135.77 92.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.903 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 Cg_exo -32.96 -115.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.031 3.154 . . . . 0.0 114.157 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.42 39.74 0.96 Allowed 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.957 -0.464 . . . . 0.0 111.062 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -95.93 -31.01 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER 72.04 89.23 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 179.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 157.37 74.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.0 t -35.89 146.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.585 0.231 . . . . 0.0 110.431 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.537 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.189 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.792 0.33 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 22.0 t0 64.06 97.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.61 155.42 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 8' ' ' CYS . 50.7 t0 -76.31 67.66 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.639 ' CB ' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 -45.33 -25.02 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.417 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.615 ' HA ' HD13 ' A' ' 14' ' ' LEU . 37.3 m -74.48 -39.24 62.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' ASP . 13.6 ttt-85 -55.41 -34.2 64.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.786 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.91 -40.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -160.48 145.88 11.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.484 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -83.08 -17.13 6.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.032 2.488 . . . . 0.0 111.279 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -113.57 24.08 12.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.91 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.34 -48.67 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.436 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -81.21 0.28 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.205 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 13' ' ' ASP . . . 82.69 -44.33 3.21 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.507 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 1.6 tpt180 -142.34 -40.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -63.83 178.46 7.34 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.669 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.5 mt-30 -100.76 95.91 6.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.624 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.475 ' CA ' ' SG ' ' A' ' 15' ' ' CYS . 50.9 t -47.42 130.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -116.5 154.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.974 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 23' ' ' THR . 0.6 OUTLIER -107.1 163.4 13.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 112.069 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 22' ' ' ASN . 1.1 p -161.4 158.9 23.5 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.478 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 7.1 Cg_endo -49.84 110.39 0.37 Allowed 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.728 2.285 . . . . 0.0 112.192 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . 56.28 43.09 89.48 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.354 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CA ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.53 176.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.879 ' CE2' HD22 ' A' ' 14' ' ' LEU . 7.1 p90 -155.87 148.99 24.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.331 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 pt-20 -114.46 -144.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.973 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.9 m -167.84 159.86 11.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.468 . . . . 0.0 111.702 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -120.16 72.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.319 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 94.7 m -42.09 171.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.7 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 25.6 t0 -85.66 -92.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.554 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 56.4 mt-10 -111.95 -69.86 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.374 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.37 -2.03 35.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 13.7 m-85 -69.32 125.31 26.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.721 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -106.05 127.44 53.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 43' ' ' LYS . 1.3 p -91.05 116.5 28.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.92 37.8 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.79 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 79.4 t80 -77.79 -20.81 52.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 110.808 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.514 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.74 -24.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -72.6 -23.14 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 109.67 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.195 0.934 . . . . 0.0 109.953 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 163.25 104.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.766 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 45' ' ' CYS . 7.4 p-10 -170.01 47.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.396 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m -1.6 116.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.365 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.567 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 9.8 ptm -143.02 128.93 19.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.2 p-10 -20.93 113.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -58.48 -173.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.545 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 53.9 t0 -101.67 72.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.9 mp0 -50.22 -22.31 1.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.551 ' HA ' HD22 ' A' ' 57' ' ' LEU . 70.0 m -75.25 -9.63 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.542 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -117.06 -20.84 9.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.761 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.57 -31.37 70.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.134 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.56 141.49 41.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.561 ' O ' HD12 ' A' ' 56' ' ' LEU . 91.8 Cg_endo -84.82 -5.76 9.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.134 2.556 . . . . 0.0 112.156 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -119.51 0.38 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.007 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -53.65 114.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 62' ' ' VAL . 56.7 m 54.4 22.31 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.766 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.19 -35.19 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.458 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.26 18.09 25.95 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.923 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.08 -122.64 1.29 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.76 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 73' ' ' GLU . 19.0 t -150.01 135.36 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.794 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.606 ' HB3' HD23 ' A' ' 57' ' ' LEU . 21.7 p -102.64 100.98 11.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.141 0.496 . . . . 0.0 110.938 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 37.7 m80 -88.98 64.16 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 16.4 t-20 -46.49 120.15 2.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.181 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -117.33 -162.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.991 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 7.3 mt-10 -80.51 133.88 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 46.01 42.85 12.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 3.0 p 159.39 -172.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.793 0.33 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.979 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -159.3 150.27 19.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.588 ' HD3' HG21 ' A' ' 66' ' ' THR . 4.2 mmm180 -109.84 146.47 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.009 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.7 t -125.79 127.47 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.45 127.94 36.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.472 -178.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.85 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.24 -37.73 14.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.3 Cg_exo -80.12 -172.61 11.33 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.456 1.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.669 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 20.8 Cg_exo -28.08 150.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.148 2.565 . . . . 0.0 113.406 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.12 -16.51 11.9 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.708 ' CD2' ' O ' ' A' ' 88' ' ' ILE . 7.4 t-160 -115.76 -131.09 0.31 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.105 -0.548 . . . . 0.0 109.686 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -150.97 71.39 1.02 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.277 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.009 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -85.72 105.41 16.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.408 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.722 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -61.15 134.42 93.07 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.911 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 56.1 Cg_endo -72.27 109.34 2.7 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.869 2.379 . . . . 0.0 113.568 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 20.0 m120 73.68 33.29 1.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.533 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -110.82 -32.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER 77.4 72.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.793 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.4 99.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.508 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 t -59.76 151.56 25.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 110.7 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.708 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 2.0 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.19 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 3.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 3' ' ' THR . 7.2 t0 161.29 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.92 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.821 ' N ' HG23 ' A' ' 5' ' ' ILE . 15.1 t0 -88.02 -49.31 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.578 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.6 mp0 72.45 -55.46 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 66.4 m -62.03 -23.89 66.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -66.19 -35.5 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.153 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -41.6 -37.41 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.327 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' CYS . 1.6 t -164.74 153.54 11.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.605 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.1 Cg_endo -83.28 -20.31 5.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.156 2.571 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -114.26 25.89 10.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.146 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.822 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.08 -50.16 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.266 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 6.9 t -60.18 -14.06 15.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 74.71 -3.23 44.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.778 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 10.9 tpt180 176.82 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.052 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -85.85 -139.92 5.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.889 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -132.97 106.73 7.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 111.029 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 40.8 t -59.96 152.17 24.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 111.299 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.8 t -138.89 163.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' HG12 ' A' ' 21' ' ' VAL . 7.2 t-20 -100.27 146.78 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.599 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.9 p -150.54 146.31 19.55 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.77 107.89 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.864 2.376 . . . . 0.0 112.008 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.02 40.6 99.12 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.128 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 171.99 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.822 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -169.15 151.81 4.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.4 pt-20 -131.26 -170.97 2.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.152 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -165.49 150.87 9.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 111.681 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -97.23 81.69 3.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.143 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -44.09 174.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.61 -95.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.377 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 9.6 tt0 -114.21 -77.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -103.91 4.13 45.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.83 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 21.8 m-30 -69.94 133.07 46.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.286 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.614 ' CB ' HG22 ' A' ' 48' ' ' ILE . 1.4 pt-20 -89.29 128.52 35.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 33.5 p -84.1 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 95.64 76.78 1.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.786 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' ' OE2' ' A' ' 36' ' ' GLU . 4.0 t80 -85.64 -18.01 34.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 110.547 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.37 -35.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -60.17 -42.89 95.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.518 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.67 -87.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.013 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -161.2 32.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.6 p-10 -77.25 -174.97 3.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.176 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 1.5 m -111.02 107.82 17.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' C ' ' A' ' 47' ' ' ASP . 18.1 ptm -141.48 110.57 6.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.09 124.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.985 0.803 . . . . 0.0 112.752 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.614 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -78.0 -174.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.209 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.6 t0 -98.52 72.97 2.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 11.8 mp0 -52.74 -21.85 4.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.475 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.612 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -74.83 -10.57 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.458 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 7.2 mt-30 -119.63 -25.98 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -28.26 14.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.239 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 5.9 m-20 -133.32 144.4 52.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 111.259 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.11 -5.32 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.157 2.571 . . . . 0.0 112.045 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.04 2.45 10.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -56.9 122.69 12.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' GLY . 76.0 m 49.76 25.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.18 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.72 61.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 151.91 -16.82 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.199 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.51 -120.78 3.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.805 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.55 135.72 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 0.5 OUTLIER -106.59 92.38 4.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.12 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.805 ' NE2' HG11 ' A' ' 62' ' ' VAL . 37.6 m80 -89.73 60.24 4.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.741 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 22.2 t-20 -51.3 111.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.497 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -108.27 -161.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.042 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 47' ' ' ASP . 4.1 mt-10 -89.75 128.68 36.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 67.01 26.46 73.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.646 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.0 t 158.14 -176.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.923 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -146.82 147.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.497 ' HD3' HG21 ' A' ' 66' ' ' THR . 1.0 OUTLIER -109.79 121.36 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.019 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -99.58 131.69 45.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.964 179.372 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -130.33 120.13 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 111.884 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.0 -31.95 0.85 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.938 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 40.8 Cg_endo -66.47 173.0 32.82 Favored 'Cis proline' 0 C--N 1.356 0.94 0 C-N-CA 123.802 -1.332 . . . . 0.0 112.76 1.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 72.1 Cg_exo -36.74 -29.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.943 2.428 . . . . 0.0 112.88 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.96 -30.45 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.377 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 5.6 t-160 -89.74 -129.34 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.572 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 54.1 mt-30 -138.55 61.16 1.59 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.019 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -87.19 125.55 34.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.408 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.991 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -56.66 134.12 78.08 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.819 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' HD13 ' A' ' 84' ' ' ILE . 75.1 Cg_exo -49.97 -57.1 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.746 2.297 . . . . 0.0 112.338 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.588 ' H ' HD12 ' A' ' 84' ' ' ILE . 9.2 m120 -143.98 27.92 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.38 -13.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.669 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.691 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.93 91.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.786 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.53 99.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.993 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -63.65 148.84 47.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 4.1 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.821 0.343 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -61.8 79.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.528 ' CG2' ' HG3' ' A' ' 7' ' ' GLU . 1.5 tp -89.54 176.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -74.07 -49.0 25.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.289 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.3 mp0 72.06 -56.38 0.65 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.62 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HA ' HD13 ' A' ' 14' ' ' LEU . 90.1 m -62.42 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -69.14 -30.2 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.582 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.5 mm -48.73 -41.68 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -161.65 156.51 19.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.125 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.4 -18.17 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 111.597 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.09 20.94 18.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.309 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.921 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -45.84 -39.44 8.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 91.5 m -82.23 -3.88 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.263 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 44' ' ' ASN . . . 57.0 13.76 9.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.57 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.545 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 2.7 tpt85 173.61 -54.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.69 -151.38 6.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.69 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.0 mt-30 -123.93 121.43 35.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.968 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.5 t -65.58 154.7 37.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 41.4 t -135.93 160.25 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.918 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.524 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.13 147.84 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.362 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.2 p -152.68 146.17 17.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.07 111.63 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.889 2.392 . . . . 0.0 111.884 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.47 43.61 90.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.94 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 169.17 -165.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 0.0 110.602 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.921 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.3 p90 -164.61 141.72 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 6.9 pt-20 -108.72 -172.38 2.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.06 163.67 27.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.527 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -121.11 55.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.211 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 72.8 m -31.66 152.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.634 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 26.6 t70 -61.03 -72.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 7.7 mt-10 -155.78 -34.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.868 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.18 6.26 8.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.628 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.3 m-85 -92.77 141.78 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.384 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.3 120.19 25.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.379 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.526 ' C ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -8.1 120.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.885 0.741 . . . . 0.0 112.42 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.61 57.74 2.96 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 2.0 p90 -52.42 -24.02 7.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.177 -0.512 . . . . 0.0 111.154 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.537 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 2.1 mtt -66.96 -24.77 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.166 0.508 . . . . 0.0 110.013 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.524 ' HE3' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -107.6 -35.57 6.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.55 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 166.95 -61.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.7 tptt 172.47 65.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.85 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.538 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -131.88 87.95 2.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.268 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 44' ' ' ASN . 66.9 m -10.61 117.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.997 0.811 . . . . 0.0 111.846 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.498 ' O ' ' C ' ' A' ' 47' ' ' ASP . 21.5 mtp -140.11 104.98 4.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.849 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 4.9 p-10 7.7 112.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.56 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -48.59 -175.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.331 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 57.4 t0 -102.32 72.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.46 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -49.86 -23.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 59.8 m -76.21 -10.18 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.649 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.453 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.4 mt-30 -116.87 -23.83 7.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.68 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -54.12 -33.53 58.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.044 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 4.9 m-20 -127.52 141.69 41.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.15 -8.35 11.9 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.058 2.506 . . . . 0.0 112.06 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -112.8 -8.71 13.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.507 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.23 120.57 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 58.9 m 45.98 26.12 0.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.182 0.515 . . . . 0.0 110.086 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.78 -30.24 22.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.745 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.28 18.79 7.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.23 -130.32 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 73' ' ' GLU . 48.7 t -134.21 136.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 50.9 t -106.81 99.08 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.26 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.492 ' NE2' HG11 ' A' ' 62' ' ' VAL . 54.1 m80 -90.81 61.03 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.572 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 8.3 t-20 -47.42 112.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.914 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -111.85 -163.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 4.2 mt-10 -72.19 134.39 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.73 36.49 0.12 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 171.52 163.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.744 0.307 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.955 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -138.03 145.41 41.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.7 115.71 30.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.55 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.68 132.75 35.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.019 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.43 120.81 22.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.825 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.01 -32.42 0.99 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.926 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 25.8 Cg_exo -65.33 171.84 31.78 Favored 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 123.883 -1.299 . . . . 0.0 112.67 1.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 71.0 Cg_exo -36.33 -27.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.939 2.426 . . . . 0.0 112.95 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.33 -30.78 0.06 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.272 -0.965 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -91.03 -128.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -140.42 65.16 1.42 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.194 0.521 . . . . 0.0 109.614 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.046 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.88 130.33 36.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.408 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.046 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -61.05 134.91 93.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.895 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' HD13 ' A' ' 84' ' ' ILE . 74.7 Cg_exo -49.9 -53.8 6.49 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.712 2.275 . . . . 0.0 112.47 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 11.0 m120 -148.06 24.46 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.245 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -91.74 -17.55 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.964 0.411 . . . . 0.0 110.542 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.92 89.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.025 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.8 98.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.978 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.33 151.61 31.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.154 178.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.26 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 24.1 p . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.86 0.362 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 3' ' ' THR . 23.7 t0 175.55 82.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.7 mp -104.09 165.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 62.6 t0 -77.38 97.21 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 29.0 mp0 -81.68 -21.32 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.4 t -70.57 -49.84 43.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.59 -22.58 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.7 mt -45.5 -40.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -164.56 140.11 4.7 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -76.02 -17.07 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.571 2.181 . . . . 0.0 111.651 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.76 13.93 22.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.559 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.25 -56.36 2.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.3 t -62.56 -11.76 18.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.022 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.46 -2.12 47.92 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.63 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 11.6 tpt180 177.53 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -87.46 -143.88 8.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.948 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -130.45 112.54 13.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.658 0.266 . . . . 0.0 110.961 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 21.2 p -53.95 154.17 4.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 111.195 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 14.2 t -134.79 164.62 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.106 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.0 t-20 -110.29 139.54 45.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 111.595 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.1 p -147.36 153.9 44.82 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.752 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.22 119.91 7.31 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.794 2.329 . . . . 0.0 111.846 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.11 43.77 25.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.847 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.41 -169.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.363 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' THR . 20.5 p90 -166.26 176.6 7.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.185 0.517 . . . . 0.0 111.755 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -153.37 -165.47 2.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.892 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 9.3 p -170.32 151.12 3.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 111.576 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -94.36 78.75 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.267 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -42.29 170.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.493 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 13.6 t0 -63.87 -96.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.536 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.94 -74.55 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -99.77 -6.35 54.51 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.086 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 17.6 m-30 -69.14 128.84 38.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CG ' ' HA ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.11 149.56 21.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.686 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 69.3 p -59.64 77.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . 102.73 -64.49 0.42 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.882 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 62.6 t80 97.66 -14.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.075 0.55 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.12 -24.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.061 -179.828 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -73.75 -39.32 64.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.309 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 155.02 -59.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.35 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 tptt 179.35 105.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.732 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 45' ' ' CYS . 4.3 p-10 -161.21 27.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' CYS . 2.9 m 42.72 106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.589 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' ASP . 10.2 mmm -148.57 103.4 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.098 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.1 p-10 0.27 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.809 . . . . 0.0 112.763 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.498 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -65.64 -173.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -91.0 74.24 6.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.939 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.92 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -51.64 -23.83 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.718 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.988 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.5 t -74.67 -11.87 60.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.52 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 15.2 mt-30 -116.99 -25.66 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -50.82 -37.99 46.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -113.11 137.93 22.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 -5.07 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.075 2.517 . . . . 0.0 111.982 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.69 -6.67 9.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.42 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.078 HD11 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -52.72 124.71 14.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.3 m 45.02 26.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.331 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.89 62.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.431 179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 146.35 -15.43 1.66 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.627 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.52 -116.65 3.6 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.177 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 49.9 t -150.05 130.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.935 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.0 p -100.25 100.91 11.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.043 0.449 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 66' ' ' THR . 95.6 m-70 -89.93 57.22 3.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -42.28 110.53 0.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.345 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -114.26 -161.63 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.028 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' SER . 6.7 mt-10 -75.47 139.89 42.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.16 32.83 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.795 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER 171.68 177.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 1.078 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -147.86 148.32 30.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.89 114.63 28.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.569 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.78 136.87 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.007 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 31.3 tt0 -134.48 120.82 20.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.811 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.807 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -81.06 -32.99 0.67 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.856 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 45.7 Cg_endo -67.74 173.69 35.74 Favored 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.641 0.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 77.1 Cg_exo -36.26 -30.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.994 2.463 . . . . 0.0 112.723 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.51 -30.93 0.06 OUTLIER Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.262 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 5.4 t-160 -88.7 -127.62 0.06 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.98 62.85 1.43 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.042 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.76 131.12 35.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.438 -178.901 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.042 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.12 134.85 94.65 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.759 179.727 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.47 ' HD2' HD13 ' A' ' 84' ' ' ILE . 58.6 Cg_exo -51.14 -55.39 4.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.567 2.178 . . . . 0.0 112.307 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 8.7 m120 -145.51 25.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.347 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -93.42 -17.62 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.324 179.454 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.79 90.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.979 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.25 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 1.003 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.72 148.73 50.51 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.292 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.2 t0 61.89 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.8 -179.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.711 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -90.31 -48.27 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.849 ' O ' HD11 ' A' ' 14' ' ' LEU . 7.2 mp0 67.43 -53.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.907 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 78.5 m -67.13 -22.47 65.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.865 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.1 ttt85 -72.69 -30.77 64.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.273 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -45.29 -40.77 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.483 179.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -159.02 152.93 19.45 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.616 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -83.48 -23.03 3.57 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.119 2.546 . . . . 0.0 111.14 179.519 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -114.85 31.25 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.709 179.382 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.89 -54.28 0.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.518 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.5 m -88.42 26.61 1.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 32.99 34.68 0.02 OUTLIER Glycine 0 C--O 1.229 -0.18 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.194 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 157.33 -60.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.96 0.409 . . . . 0.0 110.393 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.89 178.27 1.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.097 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.31 102.39 11.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.82 0.343 . . . . 0.0 110.811 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.47 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 38.8 t -57.9 142.46 46.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.5 t -129.22 162.52 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.563 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.5 t-20 -96.81 142.13 29.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.373 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -146.42 151.79 44.45 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.872 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.69 117.08 2.98 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.9 2.4 . . . . 0.0 111.923 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.35 44.73 44.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.829 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.81 -164.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.705 0.288 . . . . 0.0 110.462 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.709 ' HA ' HG23 ' A' ' 23' ' ' THR . 9.6 p90 -164.2 142.83 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.353 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 5.2 pt-20 -111.45 -167.64 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.201 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -153.29 -177.61 6.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.419 0.628 . . . . 0.0 111.76 -179.864 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 4.9 tmtt? -138.42 69.27 1.38 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.797 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 93.8 m -42.41 169.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -64.82 -93.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.257 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.13 -35.47 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.12 27.34 2.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.367 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 4.5 m-30 -94.09 139.01 31.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.631 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -90.09 120.44 31.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 15.7 p -79.21 91.28 4.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 103.13 72.56 0.92 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.557 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 18.4 t80 -87.52 -8.03 56.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.93 -32.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.717 -179.871 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.619 ' HG3' ' ND2' ' A' ' 44' ' ' ASN . 1.8 mmm -71.8 -36.44 70.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.4 OUTLIER 156.27 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 1.9 mmtm -158.13 22.63 0.25 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.619 ' ND2' ' HG3' ' A' ' 41' ' ' MET . 22.7 p-10 -63.62 76.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 111.381 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 16.0 m -37.48 100.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -126.39 121.72 33.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 -179.47 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.7 p-10 -21.2 100.23 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.985 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -47.55 -176.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.282 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -97.62 72.17 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.583 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.804 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.0 mp0 -51.21 -21.61 2.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.941 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.1 t -77.72 -8.68 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 6.0 mt-30 -118.92 -22.06 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -53.66 -23.04 10.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.34 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -124.38 140.64 35.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.058 0.456 . . . . 0.0 110.971 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 76.9 Cg_endo -78.35 -10.3 16.18 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.011 2.474 . . . . 0.0 112.364 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.667 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.69 -2.72 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.581 179.702 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.9 111.64 0.58 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.691 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 80' ' ' LEU . 61.3 m 56.3 18.59 3.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.91 -35.98 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.47 179.507 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.7 22.72 8.11 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.957 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -142.0 -131.16 2.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.827 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.57 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.14 129.6 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.878 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.471 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.7 p -98.71 94.22 6.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.57 ' NE2' HG11 ' A' ' 62' ' ' VAL . 18.8 m80 -88.37 60.6 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.266 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -44.58 115.15 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.532 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.3 p -111.38 -161.61 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -85.72 127.46 34.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 55.52 27.22 47.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.11 174.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.743 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.826 ' CD2' HD21 ' A' ' 57' ' ' LEU . 29.5 p90 -141.64 151.22 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.7 112.29 24.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.189 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.778 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -96.45 135.44 38.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.812 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.9 tt0 -150.06 127.52 11.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.388 -178.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -49.26 -45.36 76.07 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.443 179.569 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.1 Cg_exo -76.07 -61.42 0.05 OUTLIER 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.676 -1.385 . . . . 0.0 113.121 0.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.724 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.7 Cg_endo -85.37 -155.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.932 2.421 . . . . 0.0 113.02 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 78' ' ' HIS . . . 51.73 20.48 5.92 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.836 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.59 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 1.1 m-70 168.43 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.218 0.533 . . . . 0.0 111.499 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -129.36 95.86 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.823 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -73.23 120.53 18.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 -178.931 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.844 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -48.4 123.79 11.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.09 -42.0 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.975 2.45 . . . . 0.0 112.881 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 -154.3 19.42 0.49 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -91.28 -11.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.744 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.618 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 63.94 90.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.892 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.63 ' CB ' HD12 ' A' ' 56' ' ' LEU . . . 137.38 112.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.714 0.634 . . . . 0.0 111.252 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -68.11 158.67 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 110.697 179.572 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 21.0 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.028 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 4.1 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 3' ' ' THR . 10.8 t0 168.01 88.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.61 177.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.8 t0 -71.88 -48.02 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 71.73 -56.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.743 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HA ' HD13 ' A' ' 14' ' ' LEU . 87.5 m -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -64.49 -34.77 78.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.678 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 mm -42.24 -39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.25 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.28 151.88 13.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.62 -179.917 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.71 -19.08 3.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.189 2.593 . . . . 0.0 111.041 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -111.97 26.93 10.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.969 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.961 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.86 -48.34 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.352 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -84.64 8.58 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.312 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 39.66 25.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.491 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 45' ' ' CYS . 1.1 tpt180 173.24 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -88.4 -156.08 30.42 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.999 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -125.68 110.45 13.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.791 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.3 t -60.74 154.13 22.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.324 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -139.9 161.41 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.721 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.537 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -91.51 142.35 27.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.315 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.7 p -147.5 150.81 38.22 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.932 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.83 109.25 0.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.788 2.325 . . . . 0.0 111.906 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.06 43.18 93.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.909 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.65 -163.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 0.0 110.727 -179.733 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.961 ' CE2' HD22 ' A' ' 14' ' ' LEU . 11.7 p90 -167.76 139.89 3.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.99 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.7 pt-20 -108.18 -172.65 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.638 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -145.57 157.92 43.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.458 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -109.55 64.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.196 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -50.46 154.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.488 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 22.9 t70 -37.69 -90.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.304 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 27.0 mt-10 -140.03 -37.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -132.15 20.07 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.342 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.7 m-30 -89.23 155.51 19.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 111.212 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.867 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -112.87 122.41 47.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.656 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -78.47 82.52 4.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 126.63 49.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' MET . 12.1 t80 -66.28 -13.78 60.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.8 -31.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.707 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 42' ' ' MET . 8.9 mmt -66.81 -36.24 81.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.613 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 159.13 -56.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 17.6 tptt -160.68 21.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.992 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -70.51 129.51 39.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.796 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 55.8 m -65.69 107.08 1.65 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.643 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 47' ' ' ASP . 6.6 mmt -135.24 103.25 5.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.468 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -1.21 105.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.967 0.792 . . . . 0.0 112.897 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.867 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.8 pt -63.58 176.11 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 47.6 t0 -91.58 77.36 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.91 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.1 mp0 -47.97 -30.61 4.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' HD22 ' A' ' 57' ' ' LEU . 77.9 m -71.11 -10.94 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.436 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -118.48 -16.01 9.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -61.22 -36.68 80.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.377 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -129.09 124.43 22.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.402 -179.629 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 23.4 Cg_exo -63.7 -8.27 15.02 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.198 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.842 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -111.23 -13.05 14.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.071 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -47.66 114.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.869 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 64.2 m 51.05 21.58 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.358 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.06 -31.42 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.45 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 20.8 5.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.713 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -135.33 -143.43 4.75 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.85 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.724 HG11 ' NE2' ' A' ' 64' ' ' HIS . 50.8 t -119.39 128.02 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.317 . . . . 0.0 110.913 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 16.1 t -99.36 90.84 4.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 111.483 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.724 ' NE2' HG11 ' A' ' 62' ' ' VAL . 43.0 m80 -89.63 57.64 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.394 179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -48.64 108.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -105.87 -161.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.953 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' N ' ' OG1' ' A' ' 66' ' ' THR . 2.5 mt-10 -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 75.86 23.24 72.74 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 1.3 p 156.52 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.703 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.837 ' CD2' HD21 ' A' ' 57' ' ' LEU . 5.9 p90 -148.62 152.82 37.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 2.5 mmm180 -109.53 106.63 16.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.01 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.942 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -92.56 125.17 37.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.61 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.4 tt0 -143.19 116.5 9.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.649 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -38.2 -65.05 0.4 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.008 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HD2' ' HD3' ' A' ' 76' ' ' PRO . 84.9 Cg_endo -104.94 14.63 10.76 Favored 'Cis proline' 0 N--CA 1.441 -1.563 0 C-N-CA 123.775 -1.344 . . . . 0.0 113.126 1.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.77 ' HD3' ' HD2' ' A' ' 75' ' ' PRO . 69.9 Cg_exo -41.7 171.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.357 2.038 . . . . 0.0 112.227 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.32 81.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.586 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.83 -159.91 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.0 110.861 -178.946 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.59 80.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -68.88 120.19 14.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.569 . . . . 0.0 111.487 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -46.87 127.95 8.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.089 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.39 -52.43 7.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.763 2.309 . . . . 0.0 112.422 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.6 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.0 m120 -138.45 20.62 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.851 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.95 -28.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.781 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.63 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 82.34 100.81 0.05 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.92 179.015 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.842 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 129.33 133.99 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.898 0.749 . . . . 0.0 111.308 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 40.5 t -73.28 140.53 46.87 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 5.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.315 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.883 0.373 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 3' ' ' THR . 37.8 t0 179.17 96.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.971 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.792 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -94.99 166.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.761 179.783 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 9' ' ' ARG . 8.5 t0 -72.95 -51.44 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 109.974 179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.592 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 6.5 mp0 69.69 -53.32 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.512 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 86.3 m -63.82 -27.04 68.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 3.4 mmt180 -68.14 -33.47 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 14' ' ' LEU . 28.5 mt -44.42 -39.9 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.092 0.473 . . . . 0.0 110.445 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -162.03 150.83 12.8 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.456 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.1 Cg_endo -84.8 -19.72 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.127 2.552 . . . . 0.0 111.342 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -111.91 25.43 11.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.134 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.887 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.92 -36.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.331 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -85.66 15.63 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.314 -179.435 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 52.1 16.94 3.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.281 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 153.65 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 15' ' ' CYS . . . -67.77 -162.6 2.03 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.034 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.4 mt-30 -121.02 112.04 18.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.1 t -70.59 149.6 46.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.327 0.584 . . . . 0.0 112.471 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.8 t -135.35 163.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.343 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -99.63 142.41 31.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.219 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.433 ' CG2' ' HG2' ' A' ' 28' ' ' GLU . 4.3 p -146.05 145.67 25.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.22 111.75 0.17 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.965 2.443 . . . . 0.0 112.003 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.56 47.47 44.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.919 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 172.01 -172.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.822 -179.596 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.887 ' CE2' HD22 ' A' ' 14' ' ' LEU . 17.3 p90 -163.05 146.76 10.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 15.5 pt-20 -124.16 -177.4 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.155 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.3 m -141.41 163.98 31.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' GLN . 1.4 tmtt? -110.83 69.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' LYS . 72.7 m -33.0 144.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.58 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 14.7 t70 -51.59 -71.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 4.2 tt0 -153.51 -62.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.575 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.47 28.63 11.26 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.596 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.642 ' C ' HG23 ' A' ' 48' ' ' ILE . 4.8 m-30 -98.08 159.91 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.668 0.275 . . . . 0.0 110.783 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.89 ' HB2' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.67 131.23 55.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.564 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -83.0 94.57 7.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 106.58 43.25 1.47 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.432 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 25.0 t80 -46.04 -32.33 2.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 110.347 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.75 -30.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.051 179.67 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.508 ' O ' ' HB3' ' A' ' 42' ' ' MET . 4.8 ppp? -55.97 -43.91 77.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.569 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER 171.37 -40.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.0 OUTLIER 156.96 87.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.568 -179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 6.8 p-10 -149.36 93.99 2.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.227 0.537 . . . . 0.0 110.415 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 40.4 m -36.2 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.073 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 39' ' ' PHE . 3.3 ptm -133.13 131.39 40.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 1.9 p-10 -18.29 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.544 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.7 pt -49.67 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.328 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 58.3 t0 -101.05 72.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.375 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.877 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.1 mp0 -48.86 -24.94 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.223 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.964 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.2 t -75.43 -10.16 59.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 2.4 mt-30 -118.77 -23.3 7.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.879 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -21.04 18.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -128.96 139.2 34.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.998 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 92.4 Cg_endo -80.58 -5.32 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.923 2.415 . . . . 0.0 112.072 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.2 -8.37 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.614 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.78 117.12 2.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.871 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 60.7 m 49.28 23.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.041 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 2.4 tmt_? -45.91 -33.68 3.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.741 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.31 11.42 10.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.065 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.89 -138.54 4.09 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 50.4 t -126.48 135.32 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 14.0 p -103.08 99.48 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 66' ' ' THR . 48.1 m80 -90.01 60.23 4.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -44.5 110.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.352 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -109.69 -178.5 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.667 179.553 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 4.4 pt-20 -79.39 119.35 22.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 73.59 26.54 69.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.7 t 158.4 177.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.727 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.0 p90 -144.35 149.51 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.73 114.28 27.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.444 -179.508 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.034 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.03 135.59 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 20.7 tt0 -132.16 117.75 18.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.771 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.73 -33.09 0.98 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.822 179.399 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.13 171.86 35.47 Favored 'Cis proline' 0 C--N 1.355 0.907 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.634 1.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.521 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 61.5 Cg_exo -36.61 -29.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.022 2.481 . . . . 0.0 112.833 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.8 -30.63 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.328 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.583 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 4.8 t-160 -88.45 -127.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.47 62.88 1.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.151 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.055 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.6 130.95 35.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.375 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.055 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.38 134.79 93.53 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' HD13 ' A' ' 84' ' ' ILE . 69.0 Cg_exo -50.45 -53.26 7.41 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.674 2.25 . . . . 0.0 112.35 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.535 ' H ' HD12 ' A' ' 84' ' ' ILE . 10.8 m120 -148.75 26.25 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.299 -179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.787 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -94.03 -17.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.434 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.706 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.6 90.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 179.105 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.2 100.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.99 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.27 149.26 48.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.101 178.787 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.583 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.353 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.81 0.338 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 3' ' ' THR . 13.0 t0 178.08 71.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.639 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -104.87 153.58 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.905 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.572 ' C ' HD13 ' A' ' 5' ' ' ILE . 44.2 t0 -62.39 74.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 111.068 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 14' ' ' LEU . 37.5 mp0 -56.67 -17.04 7.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 13.8 t -81.35 -35.05 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.676 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.47 -27.75 64.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.523 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -45.57 -41.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -164.79 127.36 1.57 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.919 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 11.2 Cg_exo -68.19 -18.27 45.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.659 2.239 . . . . 0.0 111.034 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.28 11.27 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.484 179.633 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -43.24 -47.98 6.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.2 t -72.9 -14.35 61.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 76.23 -2.36 57.03 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.1 tpt85 177.35 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.035 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -82.47 -139.16 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.99 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 7.8 mt-30 -140.3 107.5 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.642 0.258 . . . . 0.0 110.916 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 5.2 p -52.37 149.72 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -131.26 163.99 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.7 t-20 -110.27 141.89 42.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.007 0.432 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.734 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.7 p -148.51 157.01 42.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 16.2 Cg_endo -57.86 113.03 1.34 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.658 2.239 . . . . 0.0 111.726 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 52.43 44.88 59.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.541 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 171.58 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.366 -179.502 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' THR . 27.3 p90 -166.75 175.91 7.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 111.852 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 10.3 pt-20 -153.59 -164.88 2.0 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 10.4 p -170.09 150.4 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 111.638 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.93 83.54 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.396 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -48.68 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.418 -179.355 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.7 t0 -104.33 -144.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.983 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 32' ' ' ASP . 2.6 mm-40 -29.61 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.83 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -120.0 25.93 7.32 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.663 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 20.9 m-30 -79.91 135.07 36.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 5.0 pt-20 -108.07 131.89 54.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.845 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.6 99.06 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.914 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.97 44.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.558 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 17.7 t80 -86.46 -6.6 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.775 0.322 . . . . 0.0 111.035 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 158.98 -23.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.643 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.4 OUTLIER -90.72 -20.38 22.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.781 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.3 OUTLIER 100.51 -13.88 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.917 0.76 . . . . 0.0 110.413 -179.528 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 7.0 tptt 168.35 100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.002 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' CYS . 7.6 p-10 -166.72 34.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.442 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m 34.66 98.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.429 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.6 mmt -132.83 102.19 5.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.53 179.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.24 123.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.017 0.823 . . . . 0.0 112.796 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -66.84 -173.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.137 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 43.2 t0 -95.13 76.57 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.026 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.061 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -46.58 -27.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.393 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 1.0 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.7 t -75.07 -16.83 60.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.003 0.43 . . . . 0.0 110.605 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -103.02 -23.31 13.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.216 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -43.98 92.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -100.63 155.92 35.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -93.3 3.77 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.432 2.755 . . . . 0.0 112.733 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -144.01 11.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.335 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -57.33 118.23 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 34.6 m 50.2 24.14 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.392 0.615 . . . . 0.0 109.653 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.52 -29.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.818 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . -134.18 27.25 3.31 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.961 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.68 -126.36 2.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.83 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 73' ' ' GLU . 43.0 t -137.39 135.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 110.818 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 61.9 m -96.92 92.59 6.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 97.5 m-70 -88.98 48.84 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.038 0.447 . . . . 0.0 110.27 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 9.1 t-20 -42.42 116.93 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.5 p -119.53 -176.44 3.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 5.2 pt-20 -64.0 134.59 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.45 36.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.489 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 171.78 156.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.995 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -133.57 145.61 50.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.86 114.11 27.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.027 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -89.78 134.13 34.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.863 179.341 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.57 127.06 36.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.73 -33.68 1.6 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.437 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 14.6 Cg_exo -71.25 -173.3 9.44 Favored 'Cis proline' 0 C--N 1.356 0.964 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.568 1.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 81.3 Cg_exo -40.92 173.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.938 2.425 . . . . 0.0 112.812 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.51 53.25 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.584 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 13.0 t-160 -101.08 -125.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 4.6 tt0 -151.05 65.85 0.91 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.001 0.429 . . . . 0.0 110.296 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.027 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -90.91 123.08 34.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.47 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.895 ' N ' HD12 ' A' ' 80' ' ' LEU . 79.8 p -60.41 136.44 91.9 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.756 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.19 -66.0 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.787 2.325 . . . . 0.0 112.541 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 84' ' ' ILE . 14.6 m120 -137.48 41.07 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.776 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -106.06 -14.74 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.413 . . . . 0.0 110.47 179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.35 89.12 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.12 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.18 93.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.995 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -54.58 159.93 1.97 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.766 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.584 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -89.94 179.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 5' ' ' ILE . 29.1 t0 -85.63 93.58 8.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 30.7 mp0 -76.27 -19.25 58.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.357 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.5 t -83.56 -26.09 30.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -71.29 -25.95 62.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.24 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.5 mm -45.41 -39.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.693 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.9 t -165.99 156.19 11.24 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 4.9 Cg_endo -86.37 -19.89 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.356 2.704 . . . . 0.0 111.749 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -109.21 21.9 16.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.484 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.561 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.8 -46.51 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.168 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -88.05 3.76 47.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 57.94 12.49 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.851 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 173.21 -50.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -70.11 -144.03 0.22 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.088 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 5.4 mt-30 -137.2 124.93 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 0.0 110.993 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.25 132.12 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.7 t -109.2 163.79 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.42 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.567 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.6 t-20 -111.29 143.08 42.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.354 . . . . 0.0 111.299 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -151.97 154.87 33.19 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 14.5 Cg_endo -57.16 116.61 3.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.746 2.297 . . . . 0.0 111.858 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.45 42.87 57.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.916 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.6 OUTLIER 167.3 -178.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.763 0.316 . . . . 0.0 110.547 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.659 ' HA ' HG23 ' A' ' 23' ' ' THR . 11.2 p90 -159.54 176.15 12.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.544 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -145.51 -172.35 3.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.529 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -147.91 158.73 44.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 0.0 111.38 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.88 74.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.152 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -46.06 -179.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLU . 9.8 t0 -106.62 -141.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.225 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -23.1 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -124.87 23.48 6.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.618 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.555 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 23.2 m-85 -75.42 131.04 39.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 111.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.6 pt-20 -109.86 130.17 55.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -33.96 114.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.038 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' HA3' ' ND2' ' A' ' 44' ' ' ASN . . . -75.59 55.25 2.92 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 4.0 p90 -56.97 -25.96 59.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.509 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 3.7 mtt -66.59 -19.05 65.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.105 0.479 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.8 mmm -119.36 -32.18 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.578 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 178.73 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.433 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HE2' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 178.01 33.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.14 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -85.21 -157.97 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.669 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.1 m -107.43 116.5 32.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.061 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.475 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -136.15 95.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.633 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -10.91 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.703 0.801 . . . . 0.0 113.028 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.2 pt -70.37 -173.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.313 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.3 t0 -99.2 74.03 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.755 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.2 mp0 -48.28 -22.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.3 m -76.72 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.697 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -117.65 -23.87 7.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.51 -28.46 67.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -128.38 137.97 32.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.117 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.11 -6.44 12.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.964 2.443 . . . . 0.0 112.043 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -111.78 -17.9 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.147 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.906 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -46.94 118.93 2.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.965 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 47.0 m 44.01 26.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.2 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.01 -31.93 19.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.836 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.9 25.47 6.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.095 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.15 -125.59 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.626 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 31.5 t -139.29 135.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 43.5 t -108.92 97.05 6.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.366 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 62.2 m80 -88.87 63.5 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.135 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.7 t-20 -45.71 122.42 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -120.01 -165.55 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.994 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 68' ' ' GLY . 9.0 mt-10 -73.65 140.38 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.16 36.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 169.95 -178.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.906 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.5 p90 -153.14 148.41 26.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.647 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.92 135.85 50.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.005 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.36 131.84 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.059 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.42 127.34 37.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.301 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.823 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.49 -31.92 0.89 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.099 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.823 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.6 Cg_exo -71.85 -169.3 6.03 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.641 1.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.2 Cg_exo -43.22 178.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.904 2.403 . . . . 0.0 112.856 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.55 -18.26 50.53 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 7.5 t-160 -104.23 -127.95 0.24 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.53 59.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.013 0.435 . . . . 0.0 110.056 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.051 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -86.26 129.53 34.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.52 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.051 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.36 133.0 88.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.682 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.14 -48.4 19.71 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.675 2.25 . . . . 0.0 112.011 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.588 ' C ' HD13 ' A' ' 84' ' ' ILE . 10.2 m120 -146.95 21.21 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.836 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.12 -23.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.768 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 75.57 91.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.928 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.681 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . 150.61 103.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 1.0 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.97 148.21 48.25 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.226 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 t0 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.874 0.369 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.94 169.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.526 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 10.6 t0 -75.08 -49.14 20.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.073 0.463 . . . . 0.0 109.823 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HB3' ' CG ' ' A' ' 27' ' ' PHE . 10.4 mp0 68.53 -52.91 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.757 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 47.5 t -63.74 -37.11 86.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.531 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -66.77 -25.8 66.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 7.1 mm -39.92 -37.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.148 0.499 . . . . 0.0 110.397 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.85 151.68 8.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.696 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.74 -17.53 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.999 2.466 . . . . 0.0 111.49 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -113.69 21.92 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.988 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -38.25 -61.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.339 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 45' ' ' CYS . 1.6 m -73.26 -3.39 26.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.65 11.13 27.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 178.42 -50.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.87 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.44 -150.97 2.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.638 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -132.93 110.42 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.303 . . . . 0.0 110.963 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.6 p -52.54 131.27 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG12 ' CB ' ' A' ' 28' ' ' GLU . 4.0 p -106.82 167.05 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.477 ' H ' HG22 ' A' ' 21' ' ' VAL . 8.7 t-20 -112.94 140.71 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.367 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.644 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -147.29 148.62 32.3 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.109 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' OD2' ' A' ' 4' ' ' ASP . 4.0 Cg_endo -46.88 116.38 1.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.021 2.481 . . . . 0.0 111.973 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.73 45.71 39.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.998 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 169.13 -167.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.583 0.23 . . . . 0.0 110.479 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.644 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -169.66 176.2 5.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 111.465 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.543 ' CB ' HG12 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -144.74 -145.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.456 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 1.1 m -163.12 154.43 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.414 . . . . 0.0 111.333 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -105.82 67.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.254 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -45.4 175.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.488 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' C ' ' HG3' ' A' ' 33' ' ' GLU . 15.1 t70 -72.86 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 32' ' ' ASP . 10.8 mt-10 -141.95 -39.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -122.14 14.44 8.92 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.016 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.1 m-30 -94.99 161.17 14.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.829 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.598 ' HB3' HG22 ' A' ' 48' ' ' ILE . 3.0 pt-20 -118.25 131.24 56.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.55 102.69 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.652 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 42' ' ' MET . . . 98.71 64.66 0.85 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.719 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' MET . 4.2 t80 -83.56 -11.59 57.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.7 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 41' ' ' MET . 3.3 ptm 176.69 -31.79 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -83.0 -20.17 35.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.08 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 104.62 -21.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.058 0.849 . . . . 0.0 110.626 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 29' ' ' CYS . 14.9 mmtm -171.38 100.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.518 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -158.98 33.72 0.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 15' ' ' CYS . 2.8 t 9.52 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.901 0.75 . . . . 0.0 112.406 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -150.59 110.32 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -2.1 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.947 0.779 . . . . 0.0 112.576 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -50.55 174.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 51.9 t0 -93.7 75.47 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.903 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 mp0 -51.64 -21.66 2.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.976 0.417 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 78.9 m -76.75 -9.67 58.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.618 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.79 -23.51 6.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -29.82 64.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -125.1 137.2 29.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.86 -8.13 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.014 2.476 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -119.17 -3.51 10.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.982 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -53.36 122.17 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.7 m 48.97 24.66 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.515 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -65.22 61.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.474 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 150.06 -16.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.881 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.22 -124.29 4.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.24 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.748 HG11 ' NE2' ' A' ' 64' ' ' HIS . 75.0 t -136.24 132.91 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.315 . . . . 0.0 110.957 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 25.0 t -104.79 94.58 5.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.748 ' NE2' HG11 ' A' ' 62' ' ' VAL . 42.3 m80 -89.96 59.91 4.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.2 t-20 -47.83 109.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.555 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -108.77 178.02 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.019 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER -71.95 121.82 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 68.12 32.91 77.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.2 t 158.06 178.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.982 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -146.92 142.95 28.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD3' HG21 ' A' ' 66' ' ' THR . 3.3 mmm180 -109.42 116.64 32.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.683 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -94.87 128.0 41.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.579 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.0 tt0 -128.37 123.29 33.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.74 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.29 -32.24 0.94 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.998 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.74 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 29.5 Cg_exo -64.85 170.93 32.43 Favored 'Cis proline' 0 C--N 1.356 0.926 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.7 1.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 73.8 Cg_exo -35.37 -28.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.992 2.461 . . . . 0.0 113.029 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.37 -31.2 0.04 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.434 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.2 t-80 -91.85 -129.2 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -140.03 66.34 1.4 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.105 0.479 . . . . 0.0 109.726 179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.008 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.95 93.44 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.154 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 33.4 t -43.24 137.79 2.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.477 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 76.1 Cg_endo -79.17 111.94 2.97 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.931 2.421 . . . . 0.0 113.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.4 m120 72.62 -1.24 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.6 mp -81.63 -18.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.77 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.947 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.59 98.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.974 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -59.01 150.75 23.84 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.5 t0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.77 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.541 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 34.0 t0 -86.76 101.14 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -81.11 -24.34 37.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.131 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.2 t -71.09 -41.92 70.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.745 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 1.4 ttt180 -57.44 -32.92 67.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.01 -38.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.473 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -165.22 146.76 6.32 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.687 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 -16.51 8.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.938 2.426 . . . . 0.0 111.799 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.88 16.92 21.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.486 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -44.81 -43.44 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.797 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 55.1 m -74.57 -14.13 60.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 66.61 6.3 34.84 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.137 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 1.9 tpt180 174.11 -29.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -94.65 -151.04 27.87 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.083 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.439 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 1.8 mm100 -127.09 115.34 19.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.289 . . . . 0.0 110.993 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.2 p -57.92 132.71 54.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.027 0.441 . . . . 0.0 111.676 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -116.6 164.25 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.241 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.6 t-20 -107.31 147.21 30.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -154.29 154.12 29.17 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.81 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.82 117.74 4.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 111.903 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.13 43.7 41.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER 167.42 -174.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.327 . . . . 0.0 110.482 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.703 ' CE2' HD22 ' A' ' 14' ' ' LEU . 18.9 p90 -157.21 165.94 34.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.025 0.44 . . . . 0.0 111.552 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -130.39 -171.2 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.006 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -145.83 168.8 19.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.872 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -128.06 65.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.104 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 62.5 m -39.29 166.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.251 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 14.3 t0 -55.73 -96.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.387 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -138.31 0.92 2.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.812 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -173.01 22.94 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.422 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HA ' ' CA ' ' A' ' 47' ' ' ASP . 2.0 m-30 -100.02 138.96 36.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.422 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.4 120.1 30.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.542 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.35 99.16 11.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.546 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 115.91 84.89 1.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.894 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 26.1 t80 -131.57 -46.1 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 41' ' ' MET . 1.9 mtp -106.76 5.52 28.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.15 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.7 OUTLIER 84.91 37.04 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' LYS . 4.5 mtp -145.36 15.38 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER 34.75 45.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.937 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -88.22 35.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.626 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 69.4 m 22.5 102.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.583 0.552 . . . . 0.0 111.962 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.55 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -126.31 100.41 6.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.044 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.579 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.5 p-10 11.86 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.929 0.768 . . . . 0.0 112.702 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.915 HD13 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -33.45 155.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.601 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.915 ' N ' HD13 ' A' ' 48' ' ' ILE . 54.0 t0 -89.54 74.43 7.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.851 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.6 mp0 -49.62 -27.87 5.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.733 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.683 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -70.31 -9.26 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.48 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.8 mt-30 -121.78 -31.09 4.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 52' ' ' GLN . 11.8 ttt85 -36.61 -42.53 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.205 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.19 154.32 58.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.437 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.41 -2.06 4.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.454 2.769 . . . . 0.0 112.093 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -126.42 10.94 7.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.128 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.922 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -58.11 129.24 41.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.2 m 40.21 30.13 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.283 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -60.96 71.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 137.33 -6.1 3.59 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.39 -127.15 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 38.4 t -140.46 117.09 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.666 ' HB2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.07 101.56 14.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 66.1 m80 -90.47 60.36 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.049 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 1.7 t-20 -43.68 112.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 64' ' ' HIS . 1.6 p -115.84 -161.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.051 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.35 140.08 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 56.31 19.7 26.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.768 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.4 t 156.32 -175.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.643 0.258 . . . . 0.0 110.724 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 3.8 p90 -142.19 159.31 42.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.946 0.403 . . . . 0.0 111.317 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.574 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -115.54 112.25 21.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.075 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.66 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.86 131.73 35.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.265 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -132.33 121.0 22.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.807 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.778 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.62 -32.61 1.07 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.873 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 26.2 Cg_exo -65.32 171.4 33.19 Favored 'Cis proline' 0 C--N 1.356 0.96 0 C-N-CA 123.918 -1.284 . . . . 0.0 112.715 1.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.532 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 65.8 Cg_exo -33.65 -28.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.151 2.567 . . . . 0.0 113.264 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -35.0 -31.87 0.02 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.695 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -89.4 -125.42 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -144.69 60.56 1.33 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.3 OUTLIER -90.47 98.7 11.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.029 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.679 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.4 t -51.75 137.29 34.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.327 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 64.9 Cg_endo -75.07 115.49 4.29 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.917 2.411 . . . . 0.0 113.588 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 21.1 m120 72.89 24.13 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.169 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.679 HD13 ' C ' ' A' ' 81' ' ' SER . 1.4 mp -102.06 -27.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.251 0.548 . . . . 0.0 109.858 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.701 ' HB3' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER 74.08 69.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.499 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 166.4 100.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.22 145.84 30.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.11 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.572 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.477 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.328 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -91.42 -164.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 12.2 t0 -87.01 -48.18 8.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.851 0.357 . . . . 0.0 111.286 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.6 mp0 72.99 -56.94 0.65 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 14' ' ' LEU . 8.4 t -63.84 -14.56 54.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.567 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.2 -33.21 56.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.415 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.4 mm -41.86 -37.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.73 163.71 9.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.36 -22.5 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.145 2.564 . . . . 0.0 111.809 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.75 15.94 27.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.78 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -45.79 -49.42 15.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.766 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -59.96 -13.11 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.74 -10.76 37.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.035 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 7.3 tpt180 177.35 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.98 -129.88 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.608 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LYS . 3.3 mt-30 -144.97 118.27 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 111.388 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.18 146.35 52.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.879 0.371 . . . . 0.0 110.982 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 43.9 t -128.67 152.79 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 3.2 t-20 -77.75 153.36 33.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.971 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 27' ' ' PHE . 16.3 p -157.46 155.7 27.79 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.605 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.6 Cg_endo -51.46 110.37 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.746 2.297 . . . . 0.0 112.07 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.17 44.17 74.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.118 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.75 -160.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.766 0.317 . . . . 0.0 110.286 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.78 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.5 p90 -165.08 145.0 6.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -104.77 -146.88 0.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.45 171.43 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.537 0.685 . . . . 0.0 112.793 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLN . 3.1 tmtm? -131.49 65.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.364 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 95.0 m -50.04 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.549 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -136.74 -151.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.263 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 32' ' ' ASP . 26.9 mm-40 -0.71 -86.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.949 0.781 . . . . 0.0 112.871 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.77 9.57 2.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 18.6 m-85 -69.9 106.88 3.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.638 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -89.58 136.02 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -28.54 113.98 0.08 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -38.03 -85.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 88.17 -24.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE ' ' A' ' 46' ' ' MET . 2.8 mtm -72.21 -24.44 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.435 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.5 mmm -124.66 -35.75 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.641 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 164.4 -51.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 5.9 mmtp 174.38 104.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -159.66 49.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.131 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 84.7 m 15.65 110.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.669 0.788 . . . . 0.0 112.937 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.516 ' CE ' ' SD ' ' A' ' 40' ' ' MET . 26.2 ptm -124.93 120.06 30.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 1.9 p30 -25.45 126.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.405 0.621 . . . . 0.0 111.707 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -54.68 -174.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.455 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 58.3 t0 -101.55 73.05 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.271 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.889 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.5 mp0 -49.07 -22.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.806 ' HA ' HD22 ' A' ' 57' ' ' LEU . 60.1 m -75.45 -13.22 60.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.676 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 1.8 mt-30 -111.46 -20.3 12.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -60.52 -30.04 69.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.982 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.51 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -123.62 138.28 30.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.51 -6.47 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 112.195 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -121.32 -4.27 9.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.535 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.991 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.89 119.98 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.839 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 65.0 m 46.71 25.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.519 . . . . 0.0 109.991 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.1 -27.01 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.92 30.5 3.71 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.04 -126.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.572 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.62 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 42.7 t -135.68 135.48 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.9 t -109.33 96.94 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.949 0.404 . . . . 0.0 111.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.62 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 57.6 m80 -89.69 62.39 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.2 t-20 -47.07 118.61 2.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.53 HG21 ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -115.09 -170.15 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 10.1 mp0 -73.11 131.16 41.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 44.11 33.5 2.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.359 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 172.78 168.73 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.681 0.277 . . . . 0.0 110.772 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.991 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -144.72 145.97 31.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.53 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.0 137.19 48.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.016 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.93 127.73 56.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.061 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.2 tt0 -126.97 123.97 38.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.787 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.809 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.83 -31.34 0.72 Allowed Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.973 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.809 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 43.3 Cg_endo -67.05 174.22 31.08 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 123.828 -1.321 . . . . 0.0 112.827 1.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 71.5 Cg_exo -35.4 -28.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.006 2.471 . . . . 0.0 113.073 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.25 -30.63 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.469 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 3.3 t-160 -93.72 -130.44 0.13 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.71 65.46 1.43 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.016 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.8 101.43 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.192 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.533 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 32.9 t -50.43 137.48 22.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 85.1 Cg_endo -79.96 112.76 2.9 Favored 'Trans proline' 0 CA--C 1.526 0.121 0 C-N-CA 122.909 2.406 . . . . 0.0 113.59 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 23.4 m120 73.39 -3.21 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.265 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.5 mp -80.68 -25.09 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.156 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.702 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.23 87.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.78 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.877 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.94 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -60.7 150.95 30.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.197 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.266 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.662 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -108.18 153.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.576 ' C ' HD13 ' A' ' 5' ' ' ILE . 32.0 t0 -61.31 84.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.036 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 27.3 mp0 -70.9 -11.92 61.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.1 t -83.22 -43.24 16.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -67.5 -23.62 65.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.738 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.6 mm -42.97 -39.7 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -164.36 140.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.859 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_exo -75.16 -18.45 18.38 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 111.388 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -116.6 20.96 13.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.245 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -37.06 -61.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.307 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -80.27 7.67 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.381 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 78.99 -45.78 2.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.947 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -134.9 -46.74 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -59.25 -177.61 1.08 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.825 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.07 102.63 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 13.8 p -40.22 150.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.246 0.546 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 16.2 t -130.32 164.39 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.771 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 t-20 -114.31 138.93 49.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.418 . . . . 0.0 111.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.679 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.5 p -148.8 157.55 40.57 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.63 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 19.0 Cg_endo -59.17 121.0 9.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.598 2.199 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 46.81 44.19 17.43 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.625 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.68 -179.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.358 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' THR . 21.4 p90 -164.04 -177.69 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 111.995 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.0 pt-20 -162.56 -147.52 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.851 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 13.6 p -170.4 -176.83 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.214 0.53 . . . . 0.0 111.59 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -121.76 73.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.727 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 66.7 m -40.61 167.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 16.4 t0 -60.24 -99.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.258 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -129.9 -32.08 1.89 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' N ' ' HA2' ' A' ' 68' ' ' GLY . . . -134.84 14.82 4.37 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.507 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.1 m-85 -90.74 125.89 35.83 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.563 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.77 131.72 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.882 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.53 ' OG ' ' CE ' ' A' ' 43' ' ' LYS . 1.6 t -95.34 106.36 18.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.447 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.14 76.19 1.02 Allowed Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.227 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 70.7 t80 -109.1 -51.49 2.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.0 110.009 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -98.98 -3.32 35.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.578 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.8 OUTLIER 86.53 38.11 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.857 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtt -134.84 5.45 3.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.974 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CE ' ' OG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 51.93 96.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.451 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -157.2 44.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.242 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 44' ' ' ASN . 67.1 m 5.2 107.82 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.934 0.771 . . . . 0.0 112.133 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.57 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 24.0 ptm -130.59 111.69 12.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.521 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 1.4 p-10 -21.81 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.371 0.605 . . . . 0.0 111.987 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -46.91 -178.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.111 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 59.2 t0 -106.82 71.04 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.849 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.892 ' O ' HD13 ' A' ' 57' ' ' LEU . 29.4 mp0 -48.86 -25.13 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.92 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.8 t -73.85 -8.76 57.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.681 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 3.9 mt-30 -118.06 -28.84 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -40.94 -42.2 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.001 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.4 152.14 77.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.473 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 56' ' ' LEU . 96.5 Cg_endo -86.56 -6.6 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.285 2.657 . . . . 0.0 112.086 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.1 mp -104.45 -15.93 15.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.179 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.92 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.12 114.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.599 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 76.8 m 53.34 20.96 2.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.176 0.512 . . . . 0.0 109.994 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -36.95 -36.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.691 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.7 -8.55 9.81 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.028 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.14 -150.34 15.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.546 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 38.7 t -116.78 129.6 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.4 p -94.28 98.9 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.984 0.421 . . . . 0.0 111.081 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -96.18 65.18 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.206 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.7 t-20 -47.12 116.47 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -103.45 -175.59 2.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 4.5 pt-20 -49.84 -102.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.441 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 34' ' ' GLY . . . -85.73 55.24 4.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.363 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 28.9 t 170.44 -161.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.801 ' CD2' HD21 ' A' ' 57' ' ' LEU . 3.7 p90 -167.15 146.05 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 3.4 mtp180 -110.38 159.06 17.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.035 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -135.65 136.54 41.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.066 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 18.0 tt0 -130.52 118.13 20.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.904 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.765 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -79.53 -33.7 0.84 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.839 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.03 171.25 37.18 Favored 'Cis proline' 0 C--N 1.354 0.85 0 C-N-CA 123.92 -1.283 . . . . 0.0 112.699 1.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 61.7 Cg_exo -37.32 -29.74 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.932 2.421 . . . . 0.0 112.881 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -38.5 -30.38 0.09 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.218 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 6.1 t-160 -87.01 -127.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -142.01 63.55 1.41 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.044 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.38 129.01 36.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.288 -178.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.044 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.57 131.74 88.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.84 -49.24 18.26 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.846 2.364 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.539 ' H ' HD12 ' A' ' 84' ' ' ILE . 5.6 m120 -149.76 33.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.462 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -102.01 -24.87 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.352 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.721 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER 82.73 84.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.803 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 158.63 102.68 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 1.002 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.68 152.29 35.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.21 178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.306 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 t0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -89.9 167.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.5 t0 -69.89 -50.06 46.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 111.056 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.0 mp0 72.07 -55.89 0.66 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 14' ' ' LEU . 97.9 m -64.62 -18.23 64.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.385 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -72.18 -33.52 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.465 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -40.84 -36.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.0 t -165.48 155.67 11.72 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.679 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.1 Cg_endo -85.75 -19.31 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.3 2.666 . . . . 0.0 111.457 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.52 25.06 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -46.44 -40.06 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.863 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -78.74 4.34 14.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.177 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 34.69 29.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.101 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.615 ' NE ' ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER 153.63 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.834 0.35 . . . . 0.0 110.763 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' N ' ' HB3' ' A' ' 15' ' ' CYS . . . -86.18 -140.85 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.562 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.496 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.7 mt-30 -142.98 102.73 4.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 0.0 111.019 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 29.2 t -56.31 146.61 23.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 22' ' ' ASN . 37.7 t -131.47 162.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.3 t-20 -97.13 150.33 20.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.6 p -154.76 146.26 16.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.81 112.16 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.897 2.398 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.93 44.38 82.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.92 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.43 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.78 0.324 . . . . 0.0 110.639 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 7.7 p90 -164.83 144.99 7.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' OE2' HG21 ' A' ' 21' ' ' VAL . 2.1 pp20? -117.65 -171.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.605 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.54 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.1 166.57 24.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 111.887 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -123.61 84.05 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.662 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 163.0 12.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.305 0.574 . . . . 0.0 112.386 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.63 -91.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -119.92 16.09 10.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.99 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.628 ' C ' HG23 ' A' ' 48' ' ' ILE . 2.5 m-30 -103.01 166.92 10.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.714 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.62 139.86 53.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.502 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 83.0 p -87.88 94.7 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.034 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 86.48 71.01 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.43 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 33.0 t80 -67.53 -21.01 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.52 -27.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.472 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.4 OUTLIER -65.08 -36.16 83.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 179.1 -87.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.748 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.54 ' CE ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -162.13 37.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.863 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -86.45 173.03 9.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.585 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' ' CB ' ' A' ' 35' ' ' TYR . 49.3 t -111.05 110.07 20.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.598 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 ppp? -145.5 119.99 9.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.2 p-10 -6.5 109.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.97 0.793 . . . . 0.0 112.375 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.714 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.1 pt -53.85 -177.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.406 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 54.7 t0 -99.58 74.03 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.552 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.961 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.6 mp0 -48.35 -26.0 1.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 57' ' ' LEU . 63.4 m -73.51 -12.55 60.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 7.9 mt-30 -115.17 -23.52 8.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.481 ' NH1' ' CG ' ' A' ' 54' ' ' ASP . 1.1 ttt-85 -53.73 -31.51 48.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.024 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' CG ' ' NH1' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -132.19 142.58 45.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.4 -6.26 10.95 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.137 2.558 . . . . 0.0 111.908 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -112.4 -10.13 13.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.258 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.88 121.87 7.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.8 m 47.83 24.61 0.6 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -55.59 -18.19 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.699 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.74 22.91 5.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.69 -125.34 0.97 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.683 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.686 HG11 ' NE2' ' A' ' 64' ' ' HIS . 41.8 t -138.62 136.72 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.782 0.325 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.2 t -105.7 96.86 6.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.29 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.686 ' NE2' HG11 ' A' ' 62' ' ' VAL . 29.4 m80 -89.76 61.21 5.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -46.04 118.87 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 5.0 p -111.89 -162.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 118.08 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 71.92 24.11 77.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.446 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.0 178.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 0.0 110.614 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.9 p90 -142.6 147.18 35.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.54 112.25 24.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.464 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.021 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.76 138.18 31.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.843 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tt0 -143.13 122.11 12.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -79.86 -29.91 0.59 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 23.5 Cg_exo -67.3 178.09 20.18 Favored 'Cis proline' 0 C--N 1.358 1.04 0 C-N-CA 124.188 -1.171 . . . . 0.0 112.649 1.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 78.7 Cg_exo -36.45 -26.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.953 2.436 . . . . 0.0 113.087 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -34.58 -32.33 0.02 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.579 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 10.6 t-160 -90.06 -127.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 24.2 mt-30 -140.73 68.63 1.35 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.021 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -90.0 125.55 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.181 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.848 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -59.67 134.08 89.18 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.831 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.89 -46.49 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 84' ' ' ILE . 12.8 m120 -158.24 32.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.534 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.795 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.37 -12.81 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.62 85.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.046 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.45 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.276 0.36 . . . . 0.0 111.633 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 t -69.33 158.24 35.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.922 0.392 . . . . 0.0 111.007 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.576 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.9 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.4 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.819 0.343 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.96 -176.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.749 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.641 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 t0 -92.26 107.81 19.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.972 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.843 ' O ' HD11 ' A' ' 14' ' ' LEU . 17.9 mp0 -91.28 -22.81 20.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.086 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' LEU . 41.5 t -78.88 -31.2 45.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.4 ttt85 -64.02 -30.26 71.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.274 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -40.87 -37.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.469 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -164.79 155.78 12.95 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.968 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.33 -21.69 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 0.0 111.477 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -114.41 27.19 9.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.003 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.843 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.47 -59.59 0.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.342 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.0 m -88.95 27.43 1.35 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.641 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.91 22.23 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.908 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 166.04 -59.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.134 0.467 . . . . 0.0 110.993 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 45' ' ' CYS . . . -54.28 -163.69 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.683 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 mm-40 -125.74 109.69 12.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.773 0.321 . . . . 0.0 110.96 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -63.09 125.87 25.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.49 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.4 t -109.05 164.1 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.133 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.559 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.4 t-20 -102.68 148.53 25.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -155.42 156.45 30.93 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.862 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 12.4 Cg_endo -56.26 117.93 4.66 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.74 2.293 . . . . 0.0 111.904 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . 49.28 44.41 34.83 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.859 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 166.55 -178.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.741 0.305 . . . . 0.0 110.459 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.59 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 7.1 p90 -155.25 155.08 33.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 pt-20 -123.32 -167.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.03 -177.38 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 112.193 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 1.1 tmtm? -141.74 79.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.567 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 21.8 m -60.15 -179.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.775 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.3 t70 -90.66 -151.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.415 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.3 mt-10 -33.13 -74.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.732 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -135.4 40.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.057 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -88.43 133.72 34.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.61 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.58 121.89 32.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.305 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.57 98.2 11.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 110.48 76.14 0.85 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.797 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 65.3 t80 -111.94 -76.69 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.559 ' HB3' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -123.16 -12.84 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.193 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 42' ' ' MET . 13.5 mmm -90.89 -22.57 20.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.697 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.7 mmt 123.27 -43.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.402 1.064 . . . . 0.0 110.911 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -158.72 20.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.585 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -67.26 149.86 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.5 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 15.9 m -95.64 102.21 13.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.458 . . . . 0.0 110.34 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 25.5 ptm -127.83 116.59 20.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.087 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 5.1 p-10 -21.36 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.929 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.61 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -46.52 -177.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.441 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.8 t0 -96.8 72.42 2.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.714 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.841 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.6 mp0 -50.86 -22.19 2.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.95 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.4 t -76.01 -8.95 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.705 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 3.4 mt-30 -119.12 -24.12 6.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -23.74 9.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 57' ' ' LEU . 2.1 m-20 -124.99 139.45 33.62 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.041 0.448 . . . . 0.0 111.166 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.79 -9.38 15.74 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.029 2.486 . . . . 0.0 112.279 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.632 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -119.13 -6.62 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.95 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.53 112.58 0.67 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.582 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 39.6 m 52.69 22.16 2.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.0 109.864 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.632 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -38.49 -38.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.51 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.62 24.06 6.2 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.806 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -136.27 -130.88 2.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.531 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.712 HG11 ' NE2' ' A' ' 64' ' ' HIS . 70.0 t -137.82 128.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.777 0.322 . . . . 0.0 111.001 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.469 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -98.15 95.02 7.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.712 ' NE2' HG11 ' A' ' 62' ' ' VAL . 41.0 m80 -88.53 60.45 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 8.3 t-20 -45.93 112.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.35 -161.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.66 127.03 34.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 56.81 29.86 59.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 168.2 -172.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.696 ' CE2' HD21 ' A' ' 57' ' ' LEU . 9.6 p90 -156.97 147.56 21.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.71 116.48 31.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.322 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.871 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -98.42 134.91 40.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.305 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.3 tt0 -150.19 126.2 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.518 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -49.65 -45.91 79.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.456 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 3.3 Cg_exo -75.56 -60.21 0.09 OUTLIER 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.669 -1.388 . . . . 0.0 113.193 1.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.9 Cg_endo -84.39 -155.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.87 2.38 . . . . 0.0 113.155 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.0 37.44 9.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.874 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.516 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 161.0 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.235 0.54 . . . . 0.0 111.255 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -139.22 78.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.105 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.871 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -56.98 107.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.463 0.649 . . . . 0.0 111.784 -178.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB2' HD13 ' A' ' 84' ' ' ILE . 55.4 p -52.03 124.62 29.72 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.75 ' O ' HD12 ' A' ' 84' ' ' ILE . 73.6 Cg_endo -76.42 111.75 3.32 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.796 2.331 . . . . 0.0 113.221 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 23.4 m120 73.66 13.68 4.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.336 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 82' ' ' PRO . 3.8 mp -101.24 -44.92 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 5.7 p 91.75 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.18 102.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -50.27 130.27 22.73 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.864 0.364 . . . . 0.0 110.901 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.516 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 1.1 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.175 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.3 t0 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.809 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.87 -165.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.809 ' N ' HG23 ' A' ' 5' ' ' ILE . 9.4 t0 -87.56 -50.1 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 111.103 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.643 ' O ' HD11 ' A' ' 14' ' ' LEU . 9.5 mp0 73.11 -55.49 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HA ' HD13 ' A' ' 14' ' ' LEU . 91.1 m -63.22 -24.31 67.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.95 -32.58 69.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.4 mm -44.04 -39.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 110.281 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.0 t -163.17 153.28 13.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.712 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_endo -85.54 -19.42 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.169 2.58 . . . . 0.0 111.093 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -112.2 26.89 10.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.994 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.954 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.69 -47.73 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -83.2 11.02 7.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.402 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 60.89 9.95 16.73 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.159 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 162.15 -37.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -68.47 -153.49 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.805 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.05 101.59 5.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.1 t -57.15 150.16 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 28' ' ' GLU . 7.1 p -132.06 154.0 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' ND2' ' OE1' ' A' ' 7' ' ' GLU . 6.4 t-20 -91.55 142.34 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.229 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 28' ' ' GLU . 13.4 p -147.89 151.09 37.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.51 103.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.853 2.368 . . . . 0.0 111.992 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.12 98.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.117 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.2 OUTLIER 178.8 -166.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.954 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.7 p90 -172.45 139.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.671 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 23' ' ' THR . 0.1 OUTLIER -105.97 -147.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.684 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.2 m -170.08 159.49 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -122.6 71.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.9 OUTLIER -49.59 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.06 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -125.96 -156.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.109 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER 8.32 -75.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.009 0.818 . . . . 0.0 112.636 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -157.72 29.61 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.136 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 22.9 m-85 -79.24 151.15 31.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 2.1 pt-20 -112.02 128.16 56.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -83.42 92.78 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 114.32 56.86 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 58.4 t80 -77.12 -24.83 51.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.845 0.355 . . . . 0.0 110.787 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.14 -25.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.486 ' HG2' ' HE3' ' A' ' 40' ' ' MET . 42.0 mmm -72.68 -33.36 66.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.415 ' CB ' ' O ' ' A' ' 41' ' ' MET . 1.8 ptm 166.0 -63.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 12.9 tptt -177.01 29.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.451 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 41' ' ' MET . 0.2 OUTLIER -76.91 179.51 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.44 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.4 m -92.16 106.58 18.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' PHE . 2.1 mmt -124.0 101.01 7.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.045 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.3 p-10 -21.83 101.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.984 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -48.42 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.094 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 56.3 t0 -94.69 71.7 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.564 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.886 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -48.3 -24.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.27 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 1.028 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.1 t -76.92 -8.97 58.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.0 mt-30 -116.38 -21.29 9.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 54' ' ' ASP . 7.8 ttt-85 -58.75 -33.25 70.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -115.89 140.58 26.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.091 0.472 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 90.3 Cg_endo -80.83 -5.03 13.02 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.085 2.523 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -128.37 1.22 5.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.56 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.028 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.41 115.56 1.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.123 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.97 ' SG ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER 49.22 21.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.643 -179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.29 87.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.2 -24.4 0.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.098 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -129.15 -98.16 0.87 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.944 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.591 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 19.2 t -150.32 125.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 111.572 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -89.55 99.27 12.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.591 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 71.2 m80 -89.62 59.79 4.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 1.4 t-20 -46.0 117.98 1.71 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.678 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -117.69 -171.05 1.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.089 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.6 pt-20 -73.25 143.2 47.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.9 32.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.612 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER 164.69 174.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.61 0.243 . . . . 0.0 110.43 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.865 ' CD2' HD21 ' A' ' 57' ' ' LEU . 8.7 p90 -146.8 166.44 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.142 0.496 . . . . 0.0 111.783 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.678 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -122.54 108.15 12.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.574 ' HB3' HD21 ' A' ' 80' ' ' LEU . 19.0 m -89.59 116.33 27.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.152 0.501 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -100.75 141.7 33.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.495 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.832 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -78.05 -35.63 1.24 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.026 -178.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.832 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 9.6 Cg_exo -73.74 -168.54 6.18 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.454 0.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 65.0 Cg_exo -40.57 172.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 113.04 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.92 86.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.154 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.592 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -139.74 -136.86 0.12 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.08 84.5 1.39 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.275 0.489 . . . . 0.0 111.254 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.04 123.82 34.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.085 0.469 . . . . 0.0 111.677 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -49.95 122.22 13.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.264 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 73.2 Cg_exo -37.32 -44.98 1.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.869 2.38 . . . . 0.0 112.713 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.586 ' H ' HD12 ' A' ' 84' ' ' ILE . 32.2 m120 -163.24 24.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -86.91 -27.34 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.427 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.686 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.9 p 87.15 87.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.347 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.48 84.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.542 ' HA ' HD13 ' A' ' 80' ' ' LEU . 9.6 t -38.34 152.9 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.592 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 24' ' ' PRO . 2.8 t70 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.75 159.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.535 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 59.5 t0 -75.21 90.04 2.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 0.0 111.041 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.1 mp0 -74.08 -21.86 59.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.054 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -46.74 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.511 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.525 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 1.2 mmt-85 -50.63 -31.95 17.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 15.0 mm -53.31 -55.08 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.504 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 14' ' ' LEU . 1.4 t -143.06 121.95 7.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.84 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.7 -19.56 47.47 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.756 2.304 . . . . 0.0 110.753 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -118.88 25.57 10.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.717 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.867 HD22 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.53 -44.43 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.862 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -84.37 15.69 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.459 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.55 5.83 7.39 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.811 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 174.39 -60.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.758 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 31' ' ' CYS . . . -48.71 164.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.749 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.93 84.53 5.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.81 0.338 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -44.46 148.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.161 0.505 . . . . 0.0 111.165 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.3 t -135.52 163.45 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.425 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' HG12 ' A' ' 21' ' ' VAL . 5.5 t-20 -91.41 146.25 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.025 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 27' ' ' PHE . 3.6 p -151.56 156.02 34.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.5 Cg_endo -55.24 107.53 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.239 . . . . 0.0 111.888 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.34 41.79 95.26 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.017 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 173.75 -167.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.867 ' CZ ' HD22 ' A' ' 14' ' ' LEU . 2.5 p90 -164.85 145.27 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 5.9 pt-20 -117.21 -167.41 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 2.9 p -167.52 154.4 8.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.192 0.52 . . . . 0.0 111.718 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -101.58 76.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.266 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.537 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . 60.0 m -41.23 169.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.849 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -91.78 -151.23 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.318 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' ASP . 67.1 mm-40 -33.12 -95.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -114.96 36.48 3.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.588 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.8 m-85 -89.8 121.59 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.754 0.311 . . . . 0.0 110.429 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.581 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -94.81 128.1 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 7.7 p -84.07 95.05 8.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.59 34.72 0.68 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 2.3 t80 -55.87 -17.36 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.316 . . . . 0.0 110.913 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.65 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.987 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' MET . 29.2 mmm -75.9 -29.68 58.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.593 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.3 mmt 131.69 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.281 0.988 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 7.8 tptt 177.98 104.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 0.0 111.281 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -166.97 50.52 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.966 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 74.6 m 5.93 100.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.154 0.909 . . . . 0.0 112.235 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.484 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.8 mmt -125.95 113.67 17.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.827 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 46' ' ' MET . 9.9 p-10 -20.89 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 O-C-N 123.667 0.604 . . . . 0.0 112.04 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -42.13 176.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 45.4 t0 -92.97 76.18 4.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.75 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.952 ' O ' HD13 ' A' ' 57' ' ' LEU . 32.2 mp0 -48.8 -25.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.865 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 1.016 ' HA ' HD22 ' A' ' 57' ' ' LEU . 45.2 t -74.69 -8.8 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.71 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -117.98 -26.37 6.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.637 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -30.23 61.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.24 138.05 25.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.98 -4.7 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.99 2.46 . . . . 0.0 112.05 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -119.49 -11.54 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.516 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.016 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.49 113.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 75.4 m 51.84 21.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 110.247 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.44 -28.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.649 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.24 -7.83 6.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.101 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.15 -152.43 11.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 64' ' ' HIS . 47.4 t -112.74 129.87 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.325 . . . . 0.0 111.067 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.481 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 7.3 p -95.41 101.59 13.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.54 ' O ' HG22 ' A' ' 66' ' ' THR . 28.3 m80 -90.19 62.26 5.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.557 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 7.9 t-20 -44.53 109.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -108.51 -178.61 3.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.97 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.3 129.32 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 41.15 29.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -167.72 -169.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.844 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.6 p90 -171.47 139.76 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.766 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 1.3 mtp180 -109.83 158.98 17.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.235 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.012 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -131.92 143.93 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.258 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 21.6 tt0 -139.79 118.13 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 111.799 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.93 -32.8 0.93 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.869 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.35 172.38 34.6 Favored 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.594 1.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 49.9 Cg_exo -35.36 -27.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.055 2.503 . . . . 0.0 113.162 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.66 -31.08 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.45 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.569 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -89.65 -126.47 0.07 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.19 58.08 1.4 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.012 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -81.99 109.04 15.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.624 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.666 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -43.8 133.63 3.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.44 -68.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.54 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.682 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.4 m120 -127.35 29.54 5.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.689 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.819 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -96.28 -14.76 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.801 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.7 87.74 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.966 178.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.36 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.78 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.987 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.569 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.457 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 57.2 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.0 OUTLIER -118.33 164.69 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 47.8 t0 -81.23 109.19 15.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.734 ' O ' HD11 ' A' ' 14' ' ' LEU . 14.1 mp0 -92.47 -23.85 19.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.941 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.87 -45.64 64.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.566 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.477 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.1 ttt180 -51.9 -35.3 44.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 10.7 mm -41.51 -39.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.338 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.77 150.03 11.11 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.678 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.4 Cg_endo -87.26 -16.64 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.135 2.556 . . . . 0.0 111.541 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.62 20.21 18.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.919 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.65 -50.58 4.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.206 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -63.86 -10.07 18.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.7 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 62.74 6.93 13.18 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.883 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.638 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 13.9 tpt180 172.58 -44.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.876 0.369 . . . . 0.0 110.706 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.68 -139.05 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.622 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.1 mt-30 -136.69 111.39 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 110.995 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -68.82 155.36 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 36.8 t -140.76 161.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.736 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.3 t-20 -90.63 155.93 18.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.508 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.538 HG23 ' HA ' ' A' ' 27' ' ' PHE . 11.9 p -156.87 155.73 28.8 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.833 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.0 Cg_endo -54.61 110.26 0.5 Allowed 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.71 2.274 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.01 41.92 94.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.96 -162.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.536 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.919 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -163.58 141.44 7.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.029 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -101.61 -150.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -165.86 177.43 7.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.148 0.499 . . . . 0.0 111.78 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 5.6 tmtm? -145.43 76.24 1.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.192 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 5.8 m -44.83 177.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.694 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.87 -73.44 0.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.313 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.95 -74.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.148 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.968 ' O ' HG23 ' A' ' 48' ' ' ILE . . . -101.09 -0.61 54.65 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.158 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.9 m-85 -71.05 118.15 13.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.922 ' HB2' HG22 ' A' ' 48' ' ' ILE . 1.4 tp10 -89.96 141.02 29.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.416 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 13.0 p -45.49 81.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.154 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 43' ' ' LYS . . . 82.14 -12.09 45.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.169 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 40' ' ' MET . 0.0 OUTLIER 72.17 4.1 4.9 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.579 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 107.97 -22.41 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.758 0.823 . . . . 0.0 110.97 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 3.1 ptm -66.63 -32.98 74.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 21.5 mmt -162.31 -75.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 110.467 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 12.2 tptt 179.97 -24.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.04 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -46.0 90.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' CYS . 25.2 m -36.15 103.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.393 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.547 ' HA ' ' CD2' ' A' ' 35' ' ' TYR . 3.2 ptp -132.14 135.55 46.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 p-10 -22.39 118.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.34 0.591 . . . . 0.0 111.95 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.968 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.1 pt -58.47 -170.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.475 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 57.4 t0 -97.76 71.98 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.453 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -50.72 -21.51 1.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 9.1 t -77.39 -10.03 59.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.2 mt-30 -117.65 -22.39 8.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HD3' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.45 -24.03 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.095 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -126.57 138.02 31.59 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.965 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.94 -7.88 13.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.942 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -115.65 -7.94 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.597 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.954 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -52.07 114.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.7 m 52.53 22.29 2.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.223 0.535 . . . . 0.0 109.955 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 3.4 ttt180 -40.25 -30.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.56 22.22 4.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.021 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -138.76 -131.11 2.83 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.466 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.729 HG11 ' NE2' ' A' ' 64' ' ' HIS . 39.4 t -135.37 129.7 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.763 0.316 . . . . 0.0 110.733 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.8 p -97.99 95.88 7.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.729 ' NE2' HG11 ' A' ' 62' ' ' VAL . 38.6 m80 -88.98 60.41 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.679 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.9 t-20 -43.0 117.03 0.98 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.265 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -117.58 -179.65 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' N ' ' OG1' ' A' ' 66' ' ' THR . 10.5 pt-20 -64.65 135.4 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.02 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 37.12 31.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.594 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 66' ' ' THR . 0.2 OUTLIER 172.9 158.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 4.1 p90 -136.49 147.38 47.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.194 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.565 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.18 119.23 38.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.326 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.068 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -92.07 142.51 27.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.866 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -133.55 122.46 23.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.824 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.99 -34.49 2.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.98 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.824 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.2 Cg_exo -71.96 -174.07 11.15 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.61 1.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 78.5 Cg_exo -39.94 173.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.028 2.485 . . . . 0.0 113.011 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.37 56.54 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -101.12 -126.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.961 179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.52 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 35.2 tt0 -151.3 64.64 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.383 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.068 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.6 OUTLIER -90.9 109.97 21.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.848 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.7 t -58.44 136.79 85.61 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 4.9 Cg_exo -74.15 109.94 2.99 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 113.809 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 22.0 m120 71.1 -1.18 2.8 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.553 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -77.42 -35.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.239 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 3.9 p 85.03 84.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.373 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.34 96.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 1.029 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -55.56 160.89 2.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.282 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.8 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.218 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 24' ' ' PRO . 37.4 t70 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.85 165.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 14.2 t0 -77.29 92.06 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.063 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.623 ' O ' HD11 ' A' ' 14' ' ' LEU . 31.8 mp0 -73.93 -17.33 61.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.614 ' HA ' HD13 ' A' ' 14' ' ' LEU . 55.6 m -83.77 -27.58 28.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.14 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -46.11 -44.07 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.295 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -156.2 146.46 15.88 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.586 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.9 Cg_endo -84.48 -15.92 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.998 2.465 . . . . 0.0 111.626 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.35 19.0 18.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.397 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.19 -49.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 18' ' ' GLY . 8.0 t -89.51 36.84 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.654 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . -14.37 80.38 0.0 OUTLIER Glycine 0 C--N 1.335 0.485 0 O-C-N 123.978 0.799 . . . . 0.0 113.771 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.619 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 116.53 13.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . -148.14 -149.65 5.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.11 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -133.72 106.75 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 37.5 t -56.07 155.59 6.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 20.5 t -136.26 164.91 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.597 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.578 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 9.2 t-20 -115.96 141.78 47.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.211 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASP . 9.5 p -146.25 155.46 50.37 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 32.2 Cg_endo -64.06 112.35 1.83 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . 70.52 31.76 68.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.3 OUTLIER 165.31 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.696 0.284 . . . . 0.0 110.472 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 14' ' ' LEU . 5.5 p90 -164.43 -176.01 4.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.215 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' A' ' 27' ' ' PHE . 8.3 pt-20 -167.88 -155.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.284 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 6.2 p -168.15 179.15 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 111.969 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -117.32 80.35 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.607 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -54.67 163.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.081 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 -88.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.088 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -122.61 -80.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.29 -3.92 64.78 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.356 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 14.5 m-85 -68.63 123.82 21.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.958 0.408 . . . . 0.0 110.218 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -93.59 136.75 33.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.046 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.54 96.83 10.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.944 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 100.67 44.75 2.06 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' MET . 5.8 t80 -40.03 -30.25 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.074 0.464 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.47 -38.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.548 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 4.5 ptm -57.64 -47.99 80.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.818 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 41' ' ' MET . 46.9 mmm -163.09 -94.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HZ1' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -168.47 96.92 0.4 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.474 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -165.21 134.25 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.184 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -42.72 121.91 2.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.355 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -149.77 86.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 7.9 p-10 -15.77 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.744 0.653 . . . . 0.0 112.142 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -45.04 179.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.451 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 61.0 t0 -95.88 73.63 3.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.902 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp0 -50.07 -24.35 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.995 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.961 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.3 t -75.83 -9.43 58.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.721 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -119.34 -23.33 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -52.86 -34.8 56.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 139.02 28.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.07 0.462 . . . . 0.0 111.019 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.08 -7.91 13.08 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.036 2.49 . . . . 0.0 111.931 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.698 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -108.81 -14.24 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.117 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.961 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.52 120.35 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.666 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.4 m 47.64 24.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.425 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.14 -21.46 3.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.216 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.51 13.02 5.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.049 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.41 -132.46 3.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.628 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.581 HG12 ' CE1' ' A' ' 64' ' ' HIS . 34.0 t -133.16 127.53 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 111.089 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.9 p -94.1 106.74 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.033 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.581 ' CE1' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.45 67.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.519 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -48.03 110.24 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.558 HG21 HH11 ' A' ' 71' ' ' ARG . 0.3 OUTLIER -104.93 -170.97 1.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.018 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.62 126.79 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.1 28.54 1.94 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -169.74 -168.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.898 0.38 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -167.68 140.55 3.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.558 HH11 HG21 ' A' ' 66' ' ' THR . 0.6 OUTLIER -110.98 156.07 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.08 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.54 137.32 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 31.5 tt0 -138.59 116.48 11.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.803 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.806 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -80.67 -30.18 0.56 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.806 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 21.9 Cg_exo -67.95 176.79 25.78 Favored 'Cis proline' 0 C--N 1.357 0.978 0 C-N-CA 123.988 -1.255 . . . . 0.0 112.767 1.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HG3' ' A' ' 73' ' ' GLU . 76.9 Cg_exo -39.86 -24.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.908 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -35.58 -31.81 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.337 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -83.39 -121.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.61 ' NE2' HG21 ' A' ' 88' ' ' ILE . 39.5 tt0 -148.73 65.6 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.08 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -90.46 111.51 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.9 -178.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.674 ' OG ' HD13 ' A' ' 84' ' ' ILE . 38.0 t -62.07 137.1 95.55 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.719 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 84' ' ' ILE . 63.6 Cg_endo -76.57 108.88 2.75 Favored 'Trans proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.052 2.501 . . . . 0.0 114.063 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 20.4 m120 72.51 14.25 5.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.259 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.674 HD13 ' OG ' ' A' ' 81' ' ' SER . 2.0 mp -95.75 -19.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 110.201 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.57 86.0 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.11 178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.698 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 147.64 98.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.487 0.492 . . . . 0.0 111.428 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.9 t -63.77 161.7 14.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.591 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.61 HG21 ' NE2' ' A' ' 79' ' ' GLN . 2.0 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.186 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.4 t0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.945 0.402 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.616 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -95.06 153.38 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.367 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.533 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 41.1 t0 -69.58 90.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.597 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.4 mp0 -73.85 -20.52 60.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.68 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.0 t -79.31 -36.26 39.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.491 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.0 ttt85 -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mm -52.24 -46.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -162.91 154.14 14.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.2 -18.84 2.61 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.29 2.66 . . . . 0.0 111.722 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -108.12 21.35 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.378 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.736 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.06 -51.66 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.981 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 45' ' ' CYS . 12.4 m -95.13 17.26 14.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 67.93 3.34 28.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.969 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.513 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 175.09 -52.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.988 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 30' ' ' LYS . . . -48.11 176.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.804 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 10.7 mt-30 -105.96 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.809 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 2.9 p -52.27 134.91 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 111.558 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -118.38 164.05 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.21 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.3 t-20 -106.34 142.96 35.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 111.644 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -149.87 157.06 38.36 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 15.9 Cg_endo -57.61 111.84 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.256 . . . . 0.0 111.849 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.55 44.28 67.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.695 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 171.11 -175.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.738 0.304 . . . . 0.0 110.516 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.736 ' CE2' HD22 ' A' ' 14' ' ' LEU . 28.0 p90 -160.23 167.38 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.254 0.549 . . . . 0.0 111.716 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.7 pt-20 -143.51 -165.18 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.583 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.8 p -170.7 168.09 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -114.17 82.19 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.16 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -39.03 165.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 2.7 t70 -77.15 -144.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.17 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.8 mt-10 -28.15 -93.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.859 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -123.51 32.67 4.21 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.22 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 21.2 m-85 -81.6 143.8 31.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.001 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -117.49 132.96 56.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.64 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -42.31 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.353 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -47.25 -76.64 0.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 87.39 -22.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.663 0.268 . . . . 0.0 111.04 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 mtm -59.5 -32.08 69.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.21 0.529 . . . . 0.0 109.884 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.0 mmm -117.42 -23.23 7.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.516 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 179.31 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.224 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 42' ' ' MET . 1.2 tptt 173.31 34.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.994 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -62.44 -177.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.779 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.585 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -100.39 105.84 17.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.207 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.555 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 2.2 ptp -123.83 99.87 6.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.302 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -9.14 125.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.846 0.716 . . . . 0.0 112.732 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -64.94 -174.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.256 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -100.44 73.54 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.301 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.885 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.2 mp0 -50.09 -21.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.729 ' HA ' HD22 ' A' ' 57' ' ' LEU . 51.1 m -77.7 -9.83 59.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.663 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.45 -22.27 8.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.637 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 33.9 ttt-85 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.105 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.494 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -100.97 156.12 35.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.027 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 20.8 Cg_endo -90.2 -2.61 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.344 2.696 . . . . 0.0 112.364 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -132.06 14.57 4.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.404 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.885 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -62.81 129.16 39.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.7 m 45.93 25.89 0.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.351 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -62.31 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.239 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 129.6 0.46 5.73 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.806 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -122.55 -139.06 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.562 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.717 HG11 ' NE2' ' A' ' 64' ' ' HIS . 55.8 t -127.58 117.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.45 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 6.3 t -84.1 94.33 8.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.717 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.8 m80 -89.43 53.73 2.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 17.6 t-20 -49.66 111.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.718 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.51 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -112.7 -161.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.316 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.4 pt-20 -75.53 138.93 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 34.59 46.6 0.58 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.721 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.1 t 157.61 -176.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.731 ' CE2' HD21 ' A' ' 57' ' ' LEU . 1.8 p90 -154.81 156.13 35.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -122.92 117.19 24.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.01 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.549 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -100.07 135.37 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' C ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt0 -150.22 120.59 7.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.112 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.754 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -45.68 -47.53 38.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.4 Cg_exo -76.3 -60.41 0.08 OUTLIER 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.771 -1.345 . . . . 0.0 113.264 0.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.707 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.7 Cg_endo -83.38 -154.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.823 2.349 . . . . 0.0 113.111 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 78' ' ' HIS . . . 45.88 39.36 8.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.917 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.564 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.51 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.0 111.041 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -141.78 73.03 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -63.83 91.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.211 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.791 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -46.68 130.7 8.38 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 59.2 Cg_endo -74.51 112.58 3.59 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.965 2.444 . . . . 0.0 113.253 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 75.97 34.26 0.55 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.985 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.791 HD13 ' C ' ' A' ' 81' ' ' SER . 1.1 mp -115.0 -39.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.111 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.7 p 88.74 69.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.041 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.03 116.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.696 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -62.46 128.49 36.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.564 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.0 t0 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.86 173.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 51.5 t0 -84.49 97.81 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.931 0.396 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.746 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.8 mp0 -76.75 -25.93 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.571 ' HA ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -69.51 -45.43 68.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.353 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -50.5 -35.58 29.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.034 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 11.1 mm -42.37 -40.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -161.94 147.88 10.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.578 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.8 Cg_endo -85.24 -17.05 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.038 2.492 . . . . 0.0 111.256 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -112.13 23.76 13.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.059 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -38.96 -54.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.421 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -77.39 -10.84 59.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.067 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.31 -1.82 48.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.775 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 6.8 tpt180 -173.57 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.971 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -71.72 -151.61 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.628 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -133.74 99.3 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.7 t -50.77 153.52 1.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.188 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 31.6 t -136.86 161.72 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.724 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 3.7 t-20 -95.69 143.65 26.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.691 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -149.18 155.82 39.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.9 Cg_endo -55.59 105.88 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.717 2.278 . . . . 0.0 111.952 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.43 41.51 97.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.906 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 175.57 -168.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.697 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.6 p90 -165.82 148.12 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.0 pt-20 -118.46 -170.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.434 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -147.34 155.78 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 111.531 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -113.36 71.66 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.967 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -50.74 -175.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.856 -178.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.62 -158.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.049 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 32' ' ' ASP . 3.9 mm-40 19.88 -82.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.181 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ASP . . . -152.62 22.45 0.82 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.61 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 28.3 m-85 -79.79 134.38 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 4.6 pt-20 -99.66 134.83 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -86.49 88.2 7.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 125.58 79.87 0.37 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.273 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 22.0 t80 -122.18 -3.07 9.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.72 0.295 . . . . 0.0 111.238 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 159.7 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.091 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -89.88 -24.34 21.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.6 OUTLIER 124.26 -19.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.256 0.972 . . . . 0.0 109.988 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HA ' ' N ' ' A' ' 38' ' ' GLY . 1.7 tptt -164.8 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.912 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 21.94 102.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.885 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.3 m -39.21 95.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.18 0.514 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.815 ' HA ' ' HE3' ' A' ' 46' ' ' MET . 0.0 OUTLIER -119.74 91.88 3.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.147 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.5 p30 -5.51 123.24 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.087 0.867 . . . . 0.0 112.958 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -63.2 -171.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.606 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 54.3 t0 -94.83 72.82 3.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.814 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.4 mp0 -51.01 -21.59 1.86 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.2 t -78.28 -9.01 59.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.748 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.4 mt-30 -116.74 -22.22 8.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.713 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -59.95 -32.71 71.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.138 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -116.15 137.48 23.47 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.037 0.446 . . . . 0.0 110.979 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.77 -4.16 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.193 2.595 . . . . 0.0 112.147 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.507 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -118.88 -9.43 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.285 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.957 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -49.96 114.15 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.575 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 35.5 m 50.78 23.54 1.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.271 0.557 . . . . 0.0 109.959 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -39.42 -31.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.689 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.38 21.65 5.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -137.99 -129.76 2.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.573 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' NE2' ' A' ' 64' ' ' HIS . 28.3 t -136.19 129.67 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.455 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 24.6 p -97.4 96.33 8.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' NE2' HG11 ' A' ' 62' ' ' VAL . 52.0 m80 -88.67 59.85 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.731 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 3.7 t-20 -44.1 119.48 1.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.871 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -119.43 -162.07 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 69' ' ' SER . 2.7 mt-10 -77.47 142.61 39.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' SER . . . 33.98 34.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.753 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 65.1 p 172.89 -169.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.874 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 1.5 p90 -162.1 147.92 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.647 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.93 146.39 35.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.963 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.055 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -119.19 138.7 52.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.931 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -131.77 123.45 27.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.72 -34.1 1.71 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.989 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 15.1 Cg_exo -70.99 -176.06 13.65 Favored 'Cis proline' 0 C--N 1.356 0.945 0 C-N-CA 124.154 -1.186 . . . . 0.0 112.616 0.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.8 Cg_exo -39.29 172.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.015 2.476 . . . . 0.0 112.928 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.77 48.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.7 t-160 -99.48 -126.12 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.751 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -151.67 64.52 0.86 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.122 0.486 . . . . 0.0 110.011 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.055 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.94 107.52 19.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.247 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.622 ' N ' HD12 ' A' ' 80' ' ' LEU . 31.3 t -55.3 136.77 68.76 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -77.52 110.49 2.98 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.904 2.403 . . . . 0.0 113.845 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.3 m120 71.83 -0.61 3.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.344 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.541 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -79.33 -35.12 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.251 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.714 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.4 p 85.98 81.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.181 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.02 101.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.948 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.4 148.95 30.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.319 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.295 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.436 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 28.7 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -120.69 161.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 5' ' ' ILE . 23.9 t0 -42.39 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 14' ' ' LEU . 1.5 mt-10 95.37 -52.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.121 0.569 . . . . 0.0 110.805 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 5.5 t -66.68 -36.01 81.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.497 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -76.89 -26.24 53.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.77 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ARG . 9.2 mm -38.18 -36.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.74 154.02 8.67 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -89.7 -18.58 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 111.471 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.97 17.5 24.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.065 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -39.84 -55.39 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -85.73 15.19 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.72 24.59 0.47 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.381 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER 163.29 -59.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.3 -150.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 2.4 mt-30 -137.92 113.08 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 24.6 p -53.49 155.31 3.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.8 t -133.55 163.79 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.565 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -107.06 142.45 36.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.965 0.412 . . . . 0.0 111.64 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.0 p -152.28 153.59 31.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.55 116.55 2.93 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 111.713 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . 46.42 46.92 17.1 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.576 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 171.41 177.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CG ' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -157.98 161.27 38.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.431 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -133.57 -172.25 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 1.1 m -140.83 159.09 42.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 1.6 tmtm? -112.76 75.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 99.5 m -45.87 155.78 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.334 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 30.9 t70 -57.3 -81.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 6.2 mt-10 -145.11 -40.19 0.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.48 17.52 6.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.391 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 3.8 m-30 -89.61 158.16 17.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.665 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -122.08 124.73 44.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.49 105.41 17.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.72 69.83 0.66 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.389 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 91.5 t80 -104.28 -15.02 15.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.445 ' SD ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 168.32 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.198 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.556 ' O ' ' CB ' ' A' ' 42' ' ' MET . 30.7 mmm -75.53 -16.26 60.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.479 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.556 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.5 mtm 99.17 -15.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.524 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 1.6 mmtp 172.87 99.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.885 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -168.14 72.53 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.347 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 57.1 m -28.65 108.88 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.722 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 8.6 ptm -138.87 113.17 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.5 p-10 0.08 106.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.982 0.802 . . . . 0.0 112.809 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -56.53 -175.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.66 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.9 t0 -94.6 76.13 3.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.421 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.867 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.8 mp0 -49.68 -21.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.142 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.959 ' HA ' HD22 ' A' ' 57' ' ' LEU . 44.1 t -77.69 -11.11 59.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -111.59 -23.86 10.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -20.92 40.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.829 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -132.76 142.61 45.41 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 -5.63 11.76 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.94 2.427 . . . . 0.0 112.354 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -122.5 -8.37 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.821 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.959 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -53.12 114.35 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . 74.1 m 58.0 16.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.47 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -42.73 -27.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.425 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.23 29.4 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.073 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.59 -132.83 2.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.955 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.677 HG11 ' NE2' ' A' ' 64' ' ' HIS . 52.1 t -132.54 136.15 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 88.4 m -93.01 89.94 6.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.677 ' NE2' HG11 ' A' ' 62' ' ' VAL . 31.7 m80 -89.03 47.78 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 110.041 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 19.5 t-20 -44.61 116.06 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.276 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 71' ' ' ARG . 2.4 p -115.39 -162.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLY . 1.3 mt-10 -75.66 135.87 40.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.91 37.83 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.58 168.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.727 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.1 p90 -140.98 149.57 41.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.63 106.25 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.759 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.8 t -90.19 132.85 35.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.741 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.858 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.7 tt0 -145.81 128.09 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.785 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -50.59 -45.49 85.27 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.558 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.785 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 2.7 Cg_exo -75.08 -60.32 0.08 OUTLIER 'Cis proline' 0 C--N 1.352 0.732 0 C-N-CA 123.664 -1.39 . . . . 0.0 113.183 1.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.697 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.8 Cg_endo -85.13 -156.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.884 2.389 . . . . 0.0 113.59 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.05 37.25 9.76 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.0 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 160.52 -165.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 111.342 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.22 86.26 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.637 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -65.73 124.12 21.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.348 0.595 . . . . 0.0 111.932 -178.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.793 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -53.34 123.09 34.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.879 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.28 -44.81 43.72 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.578 2.185 . . . . 0.0 112.032 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.6 m120 -145.36 13.81 1.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -89.93 -20.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.622 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.34 103.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.0 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.835 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 127.55 106.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.904 0.752 . . . . 0.0 111.276 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.81 139.14 58.73 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 111.328 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.562 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.821 0.343 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -89.85 165.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.546 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 61.7 t0 -71.9 91.93 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 14' ' ' LEU . 48.9 mp0 -72.56 -24.83 61.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.518 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.664 ' HA ' HD13 ' A' ' 14' ' ' LEU . 20.3 t -70.41 -45.7 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HG2' ' OD2' ' A' ' 6' ' ' ASP . 6.8 mmt180 -55.18 -31.25 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 9.5 mm -37.97 -37.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.305 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.86 153.57 8.2 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.642 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.72 -22.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.854 2.37 . . . . 0.0 111.495 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -108.02 18.99 20.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.939 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -29.68 -57.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.516 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -93.29 -18.52 22.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.426 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 84.03 -47.2 3.8 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.033 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 31.5 tpt85 -116.68 -9.69 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 0.0 111.268 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -118.46 -171.96 15.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.615 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -118.29 108.9 15.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' CB ' HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -50.58 134.67 23.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.064 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 28' ' ' GLU . 2.1 p -119.43 146.16 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.5 t-20 -84.89 141.25 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.41 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -148.6 155.12 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.754 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.3 Cg_endo -53.0 104.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.79 42.77 94.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.752 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.429 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER 178.62 -168.68 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.702 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -173.61 139.5 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.643 ' H ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -106.48 -148.75 0.42 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.284 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 m -163.09 148.35 11.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 0.0 111.493 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 6.6 tmtm? -100.87 67.3 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.098 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 93.4 m -52.52 171.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.842 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 11.1 t70 -68.58 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.522 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' ' C ' ' A' ' 68' ' ' GLY . 1.6 tt0 -128.07 -65.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.506 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.71 5.07 32.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.456 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 m-85 -69.58 112.64 6.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.023 0.44 . . . . 0.0 110.395 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.46 117.07 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.467 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -81.99 103.13 11.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.585 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . . . 126.86 69.47 0.17 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 77.9 t80 -123.61 11.23 9.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.89 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 0.0 111.431 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.597 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.5 mmt -94.96 -27.96 15.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.597 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.5 OUTLIER 127.45 -20.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.443 1.089 . . . . 0.0 110.101 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 37' ' ' SER . 5.6 mptt -148.75 -89.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.772 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 36.27 67.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 27.6 m -29.7 96.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.154 0.502 . . . . 0.0 110.889 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -125.85 115.35 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.868 -178.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.555 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -20.87 138.92 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.584 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.3 pt -82.94 -174.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.134 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.504 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 41.6 t0 -104.07 72.98 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.989 ' O ' HD13 ' A' ' 57' ' ' LEU . 6.0 mp0 -47.34 -26.04 1.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.391 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 1.004 ' HA ' HD22 ' A' ' 57' ' ' LEU . 48.8 t -75.31 -11.93 60.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.038 0.447 . . . . 0.0 110.833 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.0 mt-30 -111.47 -25.3 9.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.353 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HD3' ' OD2' ' A' ' 54' ' ' ASP . 5.0 ttt180 -51.03 -32.89 22.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.594 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 60.2 m-20 -129.78 150.59 76.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.777 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.48 -3.89 6.62 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.238 2.625 . . . . 0.0 112.491 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -113.89 -10.59 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.004 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.4 OUTLIER -53.17 119.57 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.793 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 61.7 m 46.8 26.1 0.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.499 . . . . 0.0 109.968 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 1.3 ttt85 -41.4 -28.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.535 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.68 21.32 3.4 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.891 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -127.57 -139.98 5.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.716 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 73' ' ' GLU . 79.7 t -121.7 137.13 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 25.9 m -96.08 89.13 5.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.496 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 56.7 m80 -89.99 49.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.447 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 13.2 t-20 -45.73 113.76 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.716 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.5 p -105.06 -173.82 2.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.956 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 1.6 mp0 -50.5 -98.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . -88.8 57.71 4.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.415 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 10.8 t 156.8 -173.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.285 . . . . 0.0 110.67 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.772 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 7.5 p90 -148.55 149.9 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.716 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -113.62 118.21 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.051 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.025 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.07 142.39 27.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.334 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 76' ' ' PRO . 2.2 tt0 -136.19 122.41 20.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.592 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.81 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.07 -34.55 1.71 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.005 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.81 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 11.8 Cg_exo -72.89 -172.15 9.28 Favored 'Cis proline' 0 C--N 1.356 0.943 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.521 0.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 89.2 Cg_exo -41.0 176.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.943 2.429 . . . . 0.0 113.006 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.28 48.76 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.577 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.3 t-160 -101.68 -126.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.506 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 30.2 tt0 -151.22 64.8 0.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.113 0.482 . . . . 0.0 109.894 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.46 129.22 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.576 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.053 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -58.79 134.29 86.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.563 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 81' ' ' SER . 45.9 Cg_exo -55.83 -50.56 12.08 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.595 2.197 . . . . 0.0 111.953 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.684 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.3 m120 -147.15 28.52 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.447 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.794 ' N ' HD13 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -96.65 -23.65 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.56 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 74.98 89.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.142 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.87 99.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 1.011 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.25 157.15 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.348 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.577 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -93.04 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 8.0 t0 -84.61 -50.81 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.0 mp0 73.6 -56.9 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.616 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HA ' HD13 ' A' ' 14' ' ' LEU . 28.3 t -64.68 -18.18 64.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.62 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -76.89 -34.22 57.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.552 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.3 mt -43.3 -37.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.615 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.9 t -162.25 152.19 13.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.671 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_endo -85.53 -17.8 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.114 2.543 . . . . 0.0 111.466 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.53 22.41 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.216 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.938 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -43.72 -44.25 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.163 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.8 m -83.91 11.47 7.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 52.73 11.1 1.16 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.942 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 tpm_? 172.81 -55.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.338 0.569 . . . . 0.0 110.877 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -64.98 -145.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.969 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 mt-30 -131.48 124.41 30.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.016 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 2.2 p -75.09 130.43 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 111.252 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' ASN . 41.5 t -117.34 162.02 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.645 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.7 t-20 -93.63 148.54 22.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.499 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 27' ' ' PHE . 6.4 p -152.72 149.12 21.58 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.59 111.45 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.805 2.337 . . . . 0.0 111.953 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.68 43.7 86.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.888 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 170.01 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.869 0.366 . . . . 0.0 110.671 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.938 ' CE2' HD22 ' A' ' 14' ' ' LEU . 16.2 p90 -166.51 144.41 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.6 pt-20 -109.98 -168.12 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.5 m -152.31 165.31 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 111.69 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -124.94 72.26 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.564 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 98.7 m -41.84 170.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.55 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -80.83 -73.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.477 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -131.21 -85.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.646 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 33' ' ' GLU . . . -93.33 -7.6 61.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.639 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 19.1 m-30 -68.57 127.15 31.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 pt-20 -100.24 128.06 46.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -86.94 105.73 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.21 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 117.13 24.17 3.64 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.798 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 40' ' ' MET . 84.9 t80 -44.6 -26.71 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.557 ' CG ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.14 -34.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.574 ' CG ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -54.14 -44.44 71.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.749 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.75 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 8.8 tptt -167.82 23.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.548 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.574 ' ND2' ' CG ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -76.33 143.26 40.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 86.5 m -85.13 108.84 17.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 22.8 ptm -136.6 113.46 10.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.95 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.524 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 2.0 p30 2.57 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 124.028 0.83 . . . . 0.0 112.973 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -53.31 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.163 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.542 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 46.0 t0 -97.19 73.47 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.937 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.7 mp0 -49.47 -23.19 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 110.763 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.945 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.3 t -76.38 -11.22 59.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.9 mt-30 -114.45 -23.96 9.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -57.79 -31.44 66.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.02 137.81 23.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.833 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.01 -2.12 10.1 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.061 2.507 . . . . 0.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.599 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -122.93 -5.62 8.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.596 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -53.05 116.67 2.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.957 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.1 m 52.08 21.49 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.17 -26.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.272 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.57 21.63 6.31 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.95 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -147.48 -129.83 1.97 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.683 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 64' ' ' HIS . 38.7 t -137.16 133.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.825 0.345 . . . . 0.0 110.569 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.0 p -99.95 96.88 7.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.496 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.57 ' CD2' HG12 ' A' ' 62' ' ' VAL . 16.9 m80 -88.4 61.14 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.4 t-20 -41.96 120.45 1.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.902 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.541 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -121.17 172.7 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.3 pt-20 -59.99 139.19 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 67' ' ' GLU . . . 38.08 33.77 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.48 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 179.3 -166.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.131 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -173.63 144.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.446 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.541 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.5 OUTLIER -109.36 152.09 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.032 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -132.17 135.55 46.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.089 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG2' ' CD ' ' A' ' 76' ' ' PRO . 6.7 tt0 -142.9 124.97 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.977 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.846 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -63.71 -38.57 39.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.0 Cg_exo -80.16 -172.51 11.19 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.291 -1.129 . . . . 0.0 112.587 1.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 8.9 Cg_exo -28.39 152.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.16 2.573 . . . . 0.0 113.56 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.09 -12.77 16.94 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.574 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.4 t60 -120.53 -131.93 0.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.522 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.539 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.32 72.42 1.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 110.16 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.032 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -84.16 125.81 32.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.269 0.556 . . . . 0.0 111.861 -179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.94 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -62.89 132.68 94.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.854 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.29 -48.21 13.65 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.656 2.237 . . . . 0.0 112.395 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 84' ' ' ILE . 13.2 m120 -153.69 33.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.819 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -101.96 -12.31 8.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.41 86.88 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.305 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.73 104.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.2 t -71.21 145.93 49.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.716 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 2.3 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.24 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.9 t0 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.813 0.34 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -90.5 -165.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.811 ' N ' HG23 ' A' ' 5' ' ' ILE . 17.8 t0 -91.77 -49.27 6.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.997 0.427 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 16.1 mp0 71.71 -55.32 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 67.4 m -61.37 -27.1 68.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.855 0.359 . . . . 0.0 110.344 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.9 -32.62 73.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.169 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.4 mm -45.51 -39.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.477 ' OG ' ' HD2' ' A' ' 12' ' ' PRO . 17.7 t -168.13 154.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.205 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 76.1 Cg_endo -89.31 -20.12 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.234 2.623 . . . . 0.0 111.289 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.32 22.0 16.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.6 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.654 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.87 -46.44 5.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.272 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -82.35 2.4 32.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.364 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 65.19 4.24 15.41 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.668 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 175.95 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.109 0.455 . . . . 0.0 111.362 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 30' ' ' LYS . . . -65.05 -131.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.163 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 5.1 mt-30 -148.28 122.0 9.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.39 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -67.95 160.85 27.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.7 t -141.43 164.1 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.746 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 6.3 t-20 -105.25 151.21 24.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.7 p -153.77 146.82 17.86 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.876 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.77 111.51 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.904 2.403 . . . . 0.0 112.059 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.8 42.08 96.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.996 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.05 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.481 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.654 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.1 p90 -165.32 171.75 13.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.971 0.415 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 3.0 pt-20 -142.62 175.14 10.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -139.91 153.35 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 111.379 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.21 162.84 12.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.907 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 1.3 m -139.74 153.66 47.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.071 0.463 . . . . 0.0 111.341 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -89.89 -157.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.657 -179.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 32' ' ' ASP . 4.4 mt-10 9.42 -77.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -154.28 31.02 0.71 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.176 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 21.9 m-85 -81.12 155.58 26.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -132.68 133.41 43.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -42.96 100.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.607 ' HA2' ' HE3' ' A' ' 46' ' ' MET . . . -51.04 -76.22 0.18 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.695 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 84.48 -12.35 0.77 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.402 ' SD ' ' HE1' ' A' ' 46' ' ' MET . 1.0 OUTLIER -88.85 -16.8 31.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.337 179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -33.15 2.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.22 36.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HD3' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER 51.17 36.62 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -77.21 -152.45 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.2 m -115.73 113.68 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.607 ' HE3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -130.54 103.72 6.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.088 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.0 p-10 -12.57 110.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.062 0.851 . . . . 0.0 112.654 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -48.76 -173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.116 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.437 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 60.5 t0 -101.51 72.92 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.378 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 57' ' ' LEU . 5.1 mp0 -51.96 -22.01 3.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 110.149 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.439 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.9 -11.27 60.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -115.27 -29.04 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.643 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -49.35 -38.0 26.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -113.12 130.55 23.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.797 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 56' ' ' LEU . 73.0 Cg_endo -77.52 -5.73 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.829 2.353 . . . . 0.0 112.156 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -126.64 -6.73 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -30.39 134.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 1.3 m 38.49 36.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.47 -40.8 0.89 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 21.6 7.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.889 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -136.02 -157.0 7.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.951 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.689 HG11 ' NE2' ' A' ' 64' ' ' HIS . 35.3 t -113.96 123.33 69.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.897 0.38 . . . . 0.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -88.84 98.41 11.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.821 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.689 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.6 m80 -93.37 61.02 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.252 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 12.9 t-20 -49.04 114.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -116.08 -163.47 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -76.03 144.86 40.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.17 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 33.87 35.03 0.04 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.831 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.55 177.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.369 . . . . 0.0 111.263 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 p90 -148.84 147.38 28.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 3.5 mmm180 -109.66 148.73 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -130.17 133.35 46.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.549 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 4.1 tt0 -125.83 119.12 27.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -64.29 -40.09 48.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 17.4 Cg_exo -69.26 174.21 39.75 Favored 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.616 1.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.549 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 67.1 Cg_exo -30.85 -32.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.057 2.504 . . . . 0.0 113.096 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.61 -30.62 0.06 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.279 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 0.4 OUTLIER -103.03 -134.92 0.32 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -137.32 82.61 1.94 Allowed 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.323 0.51 . . . . 0.0 110.992 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.28 113.48 25.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.699 ' N ' HD12 ' A' ' 80' ' ' LEU . 18.1 t -67.6 135.77 92.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.903 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 Cg_exo -32.96 -115.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.031 3.154 . . . . 0.0 114.157 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.42 39.74 0.96 Allowed 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.957 -0.464 . . . . 0.0 111.062 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -95.93 -31.01 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER 72.04 89.23 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 179.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 157.37 74.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.0 t -35.89 146.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.585 0.231 . . . . 0.0 110.431 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.537 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.189 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 22.0 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.837 0.351 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.61 155.42 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 8' ' ' CYS . 50.7 t0 -76.31 67.66 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.639 ' CB ' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 -45.33 -25.02 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.417 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.615 ' HA ' HD13 ' A' ' 14' ' ' LEU . 37.3 m -74.48 -39.24 62.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' ASP . 13.6 ttt-85 -55.41 -34.2 64.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.786 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.91 -40.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -160.48 145.88 11.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.484 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -83.08 -17.13 6.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.032 2.488 . . . . 0.0 111.279 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -113.57 24.08 12.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.91 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.34 -48.67 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.436 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -81.21 0.28 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.205 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 13' ' ' ASP . . . 82.69 -44.33 3.21 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.507 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 1.6 tpt180 -142.34 -40.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -63.83 178.46 7.34 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.669 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.5 mt-30 -100.76 95.91 6.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.624 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.475 ' CA ' ' SG ' ' A' ' 15' ' ' CYS . 50.9 t -47.42 130.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -116.5 154.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.974 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 23' ' ' THR . 0.6 OUTLIER -107.1 163.4 13.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 112.069 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 22' ' ' ASN . 1.1 p -161.4 158.9 23.5 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.478 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 7.1 Cg_endo -49.84 110.39 0.37 Allowed 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.728 2.285 . . . . 0.0 112.192 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . 56.28 43.09 89.48 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.354 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CA ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.53 176.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.879 ' CE2' HD22 ' A' ' 14' ' ' LEU . 7.1 p90 -155.87 148.99 24.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.331 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 pt-20 -114.46 -144.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.973 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.9 m -167.84 159.86 11.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.468 . . . . 0.0 111.702 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -120.16 72.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.319 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 94.7 m -42.09 171.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.7 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 25.6 t0 -85.66 -92.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.554 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 56.4 mt-10 -111.95 -69.86 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.374 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.37 -2.03 35.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 13.7 m-85 -69.32 125.31 26.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.721 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -106.05 127.44 53.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 43' ' ' LYS . 1.3 p -91.05 116.5 28.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.92 37.8 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.79 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 79.4 t80 -77.79 -20.81 52.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 110.808 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.514 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.74 -24.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -72.6 -23.14 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 109.67 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.195 0.934 . . . . 0.0 109.953 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 163.25 104.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.766 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -170.01 47.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.396 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m -1.6 116.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.365 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.567 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 9.8 ptm -143.02 128.93 19.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.2 p-10 -20.93 113.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -58.48 -173.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.545 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 53.9 t0 -101.67 72.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.9 mp0 -50.22 -22.31 1.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.551 ' HA ' HD22 ' A' ' 57' ' ' LEU . 70.0 m -75.25 -9.63 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.542 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.06 -20.84 9.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.761 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.57 -31.37 70.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.134 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.56 141.49 41.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.561 ' O ' HD12 ' A' ' 56' ' ' LEU . 91.8 Cg_endo -84.82 -5.76 9.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.134 2.556 . . . . 0.0 112.156 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -119.51 0.38 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.007 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -53.65 114.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 62' ' ' VAL . 56.7 m 54.4 22.31 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.766 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.19 -35.19 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.458 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.26 18.09 25.95 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.923 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.08 -122.64 1.29 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.76 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 73' ' ' GLU . 19.0 t -150.01 135.36 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.794 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.606 ' HB3' HD23 ' A' ' 57' ' ' LEU . 21.7 p -102.64 100.98 11.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.141 0.496 . . . . 0.0 110.938 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 37.7 m80 -88.98 64.16 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 16.4 t-20 -46.49 120.15 2.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.181 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -117.33 -162.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.991 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 7.3 mt-10 -80.51 133.88 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 46.01 42.85 12.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 3.0 p 159.39 -172.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.793 0.33 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.979 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -159.3 150.27 19.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.588 ' HD3' HG21 ' A' ' 66' ' ' THR . 4.2 mmm180 -109.84 146.47 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.009 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.7 t -125.79 127.47 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.45 127.94 36.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.472 -178.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.85 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.24 -37.73 14.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.3 Cg_exo -80.12 -172.61 11.33 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.456 1.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.669 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 20.8 Cg_exo -28.08 150.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.148 2.565 . . . . 0.0 113.406 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.12 -16.51 11.9 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -115.76 -131.09 0.31 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.105 -0.548 . . . . 0.0 109.686 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.652 HE22 HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -150.97 71.39 1.02 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.277 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.009 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -85.72 105.41 16.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.408 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.722 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -61.15 134.42 93.07 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.911 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 56.1 Cg_endo -72.27 109.34 2.7 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.869 2.379 . . . . 0.0 113.568 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 20.0 m120 73.68 33.29 1.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.533 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -110.82 -32.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER 77.4 72.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.793 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.4 99.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.508 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 t -59.76 151.56 25.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 110.7 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.652 HD12 HE22 ' A' ' 79' ' ' GLN . 2.0 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.19 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.92 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.821 ' N ' HG23 ' A' ' 5' ' ' ILE . 15.1 t0 -88.02 -49.31 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.578 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.6 mp0 72.45 -55.46 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 66.4 m -62.03 -23.89 66.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -66.19 -35.5 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.153 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -41.6 -37.41 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.327 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' CYS . 1.6 t -164.74 153.54 11.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.605 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.1 Cg_endo -83.28 -20.31 5.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.156 2.571 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -114.26 25.89 10.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.146 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.822 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.08 -50.16 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.266 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 6.9 t -60.18 -14.06 15.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 74.71 -3.23 44.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.778 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 10.9 tpt180 176.82 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.052 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -85.85 -139.92 5.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.889 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -132.97 106.73 7.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 111.029 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 40.8 t -59.96 152.17 24.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 111.299 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.8 t -138.89 163.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' HG12 ' A' ' 21' ' ' VAL . 7.2 t-20 -100.27 146.78 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.599 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.9 p -150.54 146.31 19.55 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.77 107.89 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.864 2.376 . . . . 0.0 112.008 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.02 40.6 99.12 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.128 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 171.99 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.822 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -169.15 151.81 4.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.4 pt-20 -131.26 -170.97 2.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.152 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -165.49 150.87 9.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 111.681 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -97.23 81.69 3.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.143 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -44.09 174.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.61 -95.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.377 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 9.6 tt0 -114.21 -77.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -103.91 4.13 45.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.83 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 21.8 m-30 -69.94 133.07 46.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.286 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.614 ' CB ' HG22 ' A' ' 48' ' ' ILE . 1.4 pt-20 -89.29 128.52 35.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 33.5 p -84.1 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 95.64 76.78 1.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.786 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' ' OE2' ' A' ' 36' ' ' GLU . 4.0 t80 -85.64 -18.01 34.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 110.547 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.37 -35.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -60.17 -42.89 95.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.518 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.67 -87.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.013 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -161.2 32.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.25 -174.97 3.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.176 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 1.5 m -111.02 107.82 17.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' C ' ' A' ' 47' ' ' ASP . 18.1 ptm -141.48 110.57 6.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.518 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.09 124.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.985 0.803 . . . . 0.0 112.752 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.614 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -78.0 -174.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.209 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.6 t0 -98.52 72.97 2.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 11.8 mp0 -52.74 -21.85 4.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.475 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.612 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -74.83 -10.57 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.458 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 7.2 mt-30 -119.63 -25.98 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -28.26 14.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.239 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 5.9 m-20 -133.32 144.4 52.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 111.259 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.11 -5.32 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.157 2.571 . . . . 0.0 112.045 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.04 2.45 10.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -56.9 122.69 12.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' GLY . 76.0 m 49.76 25.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.18 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.72 61.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 151.91 -16.82 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.199 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.51 -120.78 3.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.805 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.55 135.72 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 0.5 OUTLIER -106.59 92.38 4.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.12 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.805 ' NE2' HG11 ' A' ' 62' ' ' VAL . 37.6 m80 -89.73 60.24 4.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.741 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 22.2 t-20 -51.3 111.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.497 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -108.27 -161.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.042 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 47' ' ' ASP . 4.1 mt-10 -89.75 128.68 36.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 67.01 26.46 73.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.646 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.0 t 158.14 -176.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.923 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -146.82 147.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.497 ' HD3' HG21 ' A' ' 66' ' ' THR . 1.0 OUTLIER -109.79 121.36 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.019 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -99.58 131.69 45.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.964 179.372 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -130.33 120.13 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 111.884 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.0 -31.95 0.85 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.938 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 40.8 Cg_endo -66.47 173.0 32.82 Favored 'Cis proline' 0 C--N 1.356 0.94 0 C-N-CA 123.802 -1.332 . . . . 0.0 112.76 1.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 72.1 Cg_exo -36.74 -29.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.943 2.428 . . . . 0.0 112.88 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.96 -30.45 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.377 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 5.6 t-160 -89.74 -129.34 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.572 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 20.0 mt-30 -138.55 61.16 1.59 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.019 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -87.19 125.55 34.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.408 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.991 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -56.66 134.12 78.08 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.819 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' HD13 ' A' ' 84' ' ' ILE . 75.1 Cg_exo -49.97 -57.1 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.746 2.297 . . . . 0.0 112.338 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.588 ' H ' HD12 ' A' ' 84' ' ' ILE . 9.2 m120 -143.98 27.92 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.38 -13.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.669 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.691 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.93 91.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.786 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.53 99.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.993 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -63.65 148.84 47.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 4.1 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.892 0.377 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.528 ' CG2' ' HG3' ' A' ' 7' ' ' GLU . 1.5 tp -89.54 176.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -74.07 -49.0 25.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.289 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.3 mp0 72.06 -56.38 0.65 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.62 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HA ' HD13 ' A' ' 14' ' ' LEU . 90.1 m -62.42 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -69.14 -30.2 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.582 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.5 mm -48.73 -41.68 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -161.65 156.51 19.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.125 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.4 -18.17 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 111.597 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.09 20.94 18.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.309 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.921 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -45.84 -39.44 8.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 91.5 m -82.23 -3.88 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.263 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 44' ' ' ASN . . . 57.0 13.76 9.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.57 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.545 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 2.7 tpt85 173.61 -54.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.69 -151.38 6.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.69 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.0 mt-30 -123.93 121.43 35.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.968 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.5 t -65.58 154.7 37.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 41.4 t -135.93 160.25 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.918 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.524 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.13 147.84 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.362 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.2 p -152.68 146.17 17.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.07 111.63 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.889 2.392 . . . . 0.0 111.884 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.47 43.61 90.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.94 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 169.17 -165.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 0.0 110.602 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.921 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.3 p90 -164.61 141.72 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 6.9 pt-20 -108.72 -172.38 2.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.06 163.67 27.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.527 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -121.11 55.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.211 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 72.8 m -31.66 152.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.634 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 26.6 t70 -61.03 -72.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 7.7 mt-10 -155.78 -34.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.868 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.18 6.26 8.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.628 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.3 m-85 -92.77 141.78 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.384 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.3 120.19 25.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.379 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.526 ' C ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -8.1 120.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.885 0.741 . . . . 0.0 112.42 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.61 57.74 2.96 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 2.0 p90 -52.42 -24.02 7.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.177 -0.512 . . . . 0.0 111.154 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.537 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 2.1 mtt -66.96 -24.77 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.166 0.508 . . . . 0.0 110.013 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.524 ' HE3' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -107.6 -35.57 6.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.55 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 166.95 -61.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.7 tptt 172.47 65.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.85 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.538 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -131.88 87.95 2.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.268 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 44' ' ' ASN . 66.9 m -10.61 117.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.997 0.811 . . . . 0.0 111.846 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.498 ' O ' ' C ' ' A' ' 47' ' ' ASP . 21.5 mtp -140.11 104.98 4.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.849 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 4.9 p-10 7.7 112.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.56 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -48.59 -175.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.331 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 57.4 t0 -102.32 72.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.46 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -49.86 -23.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 59.8 m -76.21 -10.18 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.649 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.453 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.4 mt-30 -116.87 -23.83 7.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.68 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -54.12 -33.53 58.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.044 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 4.9 m-20 -127.52 141.69 41.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.15 -8.35 11.9 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.058 2.506 . . . . 0.0 112.06 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -112.8 -8.71 13.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.507 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.23 120.57 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 58.9 m 45.98 26.12 0.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.182 0.515 . . . . 0.0 110.086 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.78 -30.24 22.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.745 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.28 18.79 7.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.23 -130.32 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 73' ' ' GLU . 48.7 t -134.21 136.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 50.9 t -106.81 99.08 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.26 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.492 ' NE2' HG11 ' A' ' 62' ' ' VAL . 54.1 m80 -90.81 61.03 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.572 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 8.3 t-20 -47.42 112.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.914 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -111.85 -163.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 4.2 mt-10 -72.19 134.39 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.73 36.49 0.12 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 171.52 163.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.744 0.307 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.955 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -138.03 145.41 41.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.7 115.71 30.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.55 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.68 132.75 35.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.019 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.43 120.81 22.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.825 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.01 -32.42 0.99 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.926 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 25.8 Cg_exo -65.33 171.84 31.78 Favored 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 123.883 -1.299 . . . . 0.0 112.67 1.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 71.0 Cg_exo -36.33 -27.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.939 2.426 . . . . 0.0 112.95 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.33 -30.78 0.06 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.272 -0.965 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -91.03 -128.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.517 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -140.42 65.16 1.42 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.194 0.521 . . . . 0.0 109.614 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.046 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.88 130.33 36.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.408 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.046 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -61.05 134.91 93.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.895 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' HD13 ' A' ' 84' ' ' ILE . 74.7 Cg_exo -49.9 -53.8 6.49 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.712 2.275 . . . . 0.0 112.47 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 11.0 m120 -148.06 24.46 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.245 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -91.74 -17.55 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.964 0.411 . . . . 0.0 110.542 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.92 89.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.025 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.8 98.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.978 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.33 151.61 31.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.154 178.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.26 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.7 t0 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.837 0.351 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.7 mp -104.09 165.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 62.6 t0 -77.38 97.21 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 29.0 mp0 -81.68 -21.32 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.4 t -70.57 -49.84 43.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.59 -22.58 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.7 mt -45.5 -40.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -164.56 140.11 4.7 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -76.02 -17.07 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.571 2.181 . . . . 0.0 111.651 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.76 13.93 22.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.559 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.25 -56.36 2.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.3 t -62.56 -11.76 18.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.022 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.46 -2.12 47.92 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.63 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 11.6 tpt180 177.53 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -87.46 -143.88 8.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.948 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -130.45 112.54 13.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.658 0.266 . . . . 0.0 110.961 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 21.2 p -53.95 154.17 4.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 111.195 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 14.2 t -134.79 164.62 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.106 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.0 t-20 -110.29 139.54 45.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 111.595 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.1 p -147.36 153.9 44.82 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.752 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.22 119.91 7.31 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.794 2.329 . . . . 0.0 111.846 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.11 43.77 25.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.847 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.41 -169.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.363 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' THR . 20.5 p90 -166.26 176.6 7.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.185 0.517 . . . . 0.0 111.755 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -153.37 -165.47 2.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.892 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 9.3 p -170.32 151.12 3.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 111.576 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -94.36 78.75 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.267 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -42.29 170.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.493 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 13.6 t0 -63.87 -96.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.536 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.94 -74.55 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -99.77 -6.35 54.51 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.086 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 17.6 m-30 -69.14 128.84 38.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CG ' ' HA ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.11 149.56 21.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.686 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 69.3 p -59.64 77.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . 102.73 -64.49 0.42 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.882 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 62.6 t80 97.66 -14.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.075 0.55 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.12 -24.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.061 -179.828 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -73.75 -39.32 64.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.309 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 155.02 -59.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.35 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 tptt 179.35 105.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.732 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -161.21 27.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.899 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' CYS . 2.9 m 42.72 106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.589 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' ASP . 10.2 mmm -148.57 103.4 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.098 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.1 p-10 0.27 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.809 . . . . 0.0 112.763 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.498 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -65.64 -173.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -91.0 74.24 6.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.939 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.92 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -51.64 -23.83 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.718 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.988 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.5 t -74.67 -11.87 60.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.52 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.4 mt-30 -116.99 -25.66 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -50.82 -37.99 46.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -113.11 137.93 22.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 -5.07 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.075 2.517 . . . . 0.0 111.982 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.69 -6.67 9.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.42 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.078 HD11 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -52.72 124.71 14.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.3 m 45.02 26.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.331 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.89 62.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.431 179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 146.35 -15.43 1.66 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.627 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.52 -116.65 3.6 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.177 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 49.9 t -150.05 130.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.935 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.0 p -100.25 100.91 11.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.043 0.449 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 66' ' ' THR . 73.4 m80 -89.93 57.22 3.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -42.28 110.53 0.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.345 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -114.26 -161.63 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.028 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' SER . 6.7 mt-10 -75.47 139.89 42.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.16 32.83 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.795 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER 171.68 177.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 1.078 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -147.86 148.32 30.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.89 114.63 28.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.569 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.78 136.87 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.007 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 31.3 tt0 -134.48 120.82 20.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.811 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.807 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -81.06 -32.99 0.67 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.856 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 45.7 Cg_endo -67.74 173.69 35.74 Favored 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.641 0.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 77.1 Cg_exo -36.26 -30.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.994 2.463 . . . . 0.0 112.723 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.51 -30.93 0.06 OUTLIER Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.262 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 5.4 t-160 -88.7 -127.62 0.06 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.98 62.85 1.43 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.042 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.76 131.12 35.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.438 -178.901 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.042 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.12 134.85 94.65 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.759 179.727 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.47 ' HD2' HD13 ' A' ' 84' ' ' ILE . 58.6 Cg_exo -51.14 -55.39 4.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.567 2.178 . . . . 0.0 112.307 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 8.7 m120 -145.51 25.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.347 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -93.42 -17.62 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.324 179.454 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.79 90.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.979 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.25 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 1.003 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.72 148.73 50.51 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.292 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.2 t0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.8 -179.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.711 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -90.31 -48.27 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.849 ' O ' HD11 ' A' ' 14' ' ' LEU . 7.2 mp0 67.43 -53.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.907 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 78.5 m -67.13 -22.47 65.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.865 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.1 ttt85 -72.69 -30.77 64.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.273 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -45.29 -40.77 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.483 179.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -159.02 152.93 19.45 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.616 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -83.48 -23.03 3.57 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.119 2.546 . . . . 0.0 111.14 179.519 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -114.85 31.25 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.709 179.382 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.89 -54.28 0.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.518 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.5 m -88.42 26.61 1.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 32.99 34.68 0.02 OUTLIER Glycine 0 C--O 1.229 -0.18 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.194 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 157.33 -60.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.96 0.409 . . . . 0.0 110.393 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.89 178.27 1.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.097 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.31 102.39 11.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.82 0.343 . . . . 0.0 110.811 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.47 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 38.8 t -57.9 142.46 46.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.5 t -129.22 162.52 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.563 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.5 t-20 -96.81 142.13 29.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.373 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -146.42 151.79 44.45 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.872 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.69 117.08 2.98 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.9 2.4 . . . . 0.0 111.923 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.35 44.73 44.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.829 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 168.81 -164.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.705 0.288 . . . . 0.0 110.462 -179.499 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.709 ' HA ' HG23 ' A' ' 23' ' ' THR . 9.6 p90 -164.2 142.83 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.353 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 5.2 pt-20 -111.45 -167.64 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.201 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -153.29 -177.61 6.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.419 0.628 . . . . 0.0 111.76 -179.864 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 4.9 tmtt? -138.42 69.27 1.38 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.797 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 93.8 m -42.41 169.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -64.82 -93.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.257 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.13 -35.47 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.12 27.34 2.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.367 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 4.5 m-30 -94.09 139.01 31.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.631 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -90.09 120.44 31.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 15.7 p -79.21 91.28 4.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 103.13 72.56 0.92 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.557 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 18.4 t80 -87.52 -8.03 56.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.93 -32.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.717 -179.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.8 mmm -71.8 -36.44 70.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.4 OUTLIER 156.27 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 1.9 mmtm -158.13 22.63 0.25 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -63.62 76.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 111.381 -179.681 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 16.0 m -37.48 100.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -126.39 121.72 33.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 -179.47 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.7 p-10 -21.2 100.23 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.985 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -47.55 -176.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.282 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -97.62 72.17 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.583 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.804 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.0 mp0 -51.21 -21.61 2.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.941 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.1 t -77.72 -8.68 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 6.0 mt-30 -118.92 -22.06 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -53.66 -23.04 10.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.34 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -124.38 140.64 35.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.058 0.456 . . . . 0.0 110.971 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 76.9 Cg_endo -78.35 -10.3 16.18 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.011 2.474 . . . . 0.0 112.364 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.667 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.69 -2.72 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.581 179.702 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.9 111.64 0.58 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.691 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 80' ' ' LEU . 61.3 m 56.3 18.59 3.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.91 -35.98 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.47 179.507 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.7 22.72 8.11 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.957 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -142.0 -131.16 2.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.827 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.57 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.14 129.6 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.878 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.471 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.7 p -98.71 94.22 6.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.57 ' NE2' HG11 ' A' ' 62' ' ' VAL . 18.8 m80 -88.37 60.6 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.266 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -44.58 115.15 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.532 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.3 p -111.38 -161.61 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -85.72 127.46 34.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 55.52 27.22 47.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.11 174.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.743 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.826 ' CD2' HD21 ' A' ' 57' ' ' LEU . 29.5 p90 -141.64 151.22 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.7 112.29 24.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.189 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.778 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -96.45 135.44 38.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.812 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.9 tt0 -150.06 127.52 11.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.388 -178.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -49.26 -45.36 76.07 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.443 179.569 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.1 Cg_exo -76.07 -61.42 0.05 OUTLIER 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.676 -1.385 . . . . 0.0 113.121 0.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.724 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.7 Cg_endo -85.37 -155.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.932 2.421 . . . . 0.0 113.02 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 78' ' ' HIS . . . 51.73 20.48 5.92 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.836 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.59 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 1.1 m-70 168.43 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.218 0.533 . . . . 0.0 111.499 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.36 95.86 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.823 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -73.23 120.53 18.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 -178.931 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.844 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -48.4 123.79 11.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.09 -42.0 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.975 2.45 . . . . 0.0 112.881 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 -154.3 19.42 0.49 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -91.28 -11.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.744 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.618 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 63.94 90.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.892 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.63 ' CB ' HD12 ' A' ' 56' ' ' LEU . . . 137.38 112.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.714 0.634 . . . . 0.0 111.252 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -68.11 158.67 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 110.697 179.572 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.59 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 21.0 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.028 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 10.8 t0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.61 177.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.8 t0 -71.88 -48.02 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 71.73 -56.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.743 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HA ' HD13 ' A' ' 14' ' ' LEU . 87.5 m -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -64.49 -34.77 78.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.678 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 mm -42.24 -39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.25 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.28 151.88 13.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.62 -179.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.71 -19.08 3.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.189 2.593 . . . . 0.0 111.041 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -111.97 26.93 10.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.969 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.961 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.86 -48.34 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.352 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -84.64 8.58 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.312 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 39.66 25.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.491 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 45' ' ' CYS . 1.1 tpt180 173.24 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -88.4 -156.08 30.42 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.999 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -125.68 110.45 13.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.791 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.3 t -60.74 154.13 22.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.324 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -139.9 161.41 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.721 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.537 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -91.51 142.35 27.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.315 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.7 p -147.5 150.81 38.22 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.932 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.83 109.25 0.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.788 2.325 . . . . 0.0 111.906 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.06 43.18 93.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.909 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.65 -163.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 0.0 110.727 -179.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.961 ' CE2' HD22 ' A' ' 14' ' ' LEU . 11.7 p90 -167.76 139.89 3.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.99 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.7 pt-20 -108.18 -172.65 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.638 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -145.57 157.92 43.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.458 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -109.55 64.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.196 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -50.46 154.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.488 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 22.9 t70 -37.69 -90.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.304 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 27.0 mt-10 -140.03 -37.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -132.15 20.07 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.342 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.7 m-30 -89.23 155.51 19.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 111.212 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.867 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -112.87 122.41 47.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.656 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -78.47 82.52 4.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 126.63 49.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' MET . 12.1 t80 -66.28 -13.78 60.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.8 -31.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.707 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 42' ' ' MET . 8.9 mmt -66.81 -36.24 81.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.613 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 159.13 -56.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 17.6 tptt -160.68 21.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.992 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -70.51 129.51 39.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.796 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 55.8 m -65.69 107.08 1.65 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.643 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 47' ' ' ASP . 6.6 mmt -135.24 103.25 5.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.468 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -1.21 105.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.967 0.792 . . . . 0.0 112.897 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.867 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.8 pt -63.58 176.11 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 47.6 t0 -91.58 77.36 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.91 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.1 mp0 -47.97 -30.61 4.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' HD22 ' A' ' 57' ' ' LEU . 77.9 m -71.11 -10.94 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.436 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -118.48 -16.01 9.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -61.22 -36.68 80.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.377 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -129.09 124.43 22.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.402 -179.629 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 23.4 Cg_exo -63.7 -8.27 15.02 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.198 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.842 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -111.23 -13.05 14.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.071 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -47.66 114.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.869 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 64.2 m 51.05 21.58 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.358 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.06 -31.42 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.45 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 20.8 5.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.713 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -135.33 -143.43 4.75 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.85 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.724 HG11 ' NE2' ' A' ' 64' ' ' HIS . 50.8 t -119.39 128.02 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.317 . . . . 0.0 110.913 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 16.1 t -99.36 90.84 4.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 111.483 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.724 ' NE2' HG11 ' A' ' 62' ' ' VAL . 43.0 m80 -89.63 57.64 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.394 179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -48.64 108.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -105.87 -161.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.953 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' N ' ' OG1' ' A' ' 66' ' ' THR . 2.5 mt-10 -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 75.86 23.24 72.74 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 1.3 p 156.52 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.703 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.837 ' CD2' HD21 ' A' ' 57' ' ' LEU . 5.9 p90 -148.62 152.82 37.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 2.5 mmm180 -109.53 106.63 16.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.01 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.942 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -92.56 125.17 37.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.61 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.4 tt0 -143.19 116.5 9.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.649 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -38.2 -65.05 0.4 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.008 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HD2' ' HD3' ' A' ' 76' ' ' PRO . 84.9 Cg_endo -104.94 14.63 10.76 Favored 'Cis proline' 0 N--CA 1.441 -1.563 0 C-N-CA 123.775 -1.344 . . . . 0.0 113.126 1.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.77 ' HD3' ' HD2' ' A' ' 75' ' ' PRO . 69.9 Cg_exo -41.7 171.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.357 2.038 . . . . 0.0 112.227 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.32 81.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.586 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.83 -159.91 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.0 110.861 -178.946 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.59 80.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -68.88 120.19 14.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.569 . . . . 0.0 111.487 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -46.87 127.95 8.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.089 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.39 -52.43 7.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.763 2.309 . . . . 0.0 112.422 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.6 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.0 m120 -138.45 20.62 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.851 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.95 -28.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.781 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.63 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 82.34 100.81 0.05 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.92 179.015 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.842 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 129.33 133.99 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.898 0.749 . . . . 0.0 111.308 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 40.5 t -73.28 140.53 46.87 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.578 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 5.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.315 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.936 0.398 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.792 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -94.99 166.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.761 179.783 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 9' ' ' ARG . 8.5 t0 -72.95 -51.44 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 109.974 179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.592 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 6.5 mp0 69.69 -53.32 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.512 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 86.3 m -63.82 -27.04 68.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 3.4 mmt180 -68.14 -33.47 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 14' ' ' LEU . 28.5 mt -44.42 -39.9 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.092 0.473 . . . . 0.0 110.445 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -162.03 150.83 12.8 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.456 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.1 Cg_endo -84.8 -19.72 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.127 2.552 . . . . 0.0 111.342 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -111.91 25.43 11.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.134 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.887 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.92 -36.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.331 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -85.66 15.63 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.314 -179.435 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 52.1 16.94 3.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.281 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 153.65 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 15' ' ' CYS . . . -67.77 -162.6 2.03 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.034 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.4 mt-30 -121.02 112.04 18.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.1 t -70.59 149.6 46.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.327 0.584 . . . . 0.0 112.471 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.8 t -135.35 163.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.343 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -99.63 142.41 31.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.219 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.433 ' CG2' ' HG2' ' A' ' 28' ' ' GLU . 4.3 p -146.05 145.67 25.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.22 111.75 0.17 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.965 2.443 . . . . 0.0 112.003 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.56 47.47 44.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.919 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 172.01 -172.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.822 -179.596 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.887 ' CE2' HD22 ' A' ' 14' ' ' LEU . 17.3 p90 -163.05 146.76 10.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 15.5 pt-20 -124.16 -177.4 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.155 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.3 m -141.41 163.98 31.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' GLN . 1.4 tmtt? -110.83 69.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' LYS . 72.7 m -33.0 144.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.58 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 14.7 t70 -51.59 -71.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 4.2 tt0 -153.51 -62.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.575 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.47 28.63 11.26 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.596 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.642 ' C ' HG23 ' A' ' 48' ' ' ILE . 4.8 m-30 -98.08 159.91 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.668 0.275 . . . . 0.0 110.783 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.89 ' HB2' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.67 131.23 55.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.564 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -83.0 94.57 7.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 106.58 43.25 1.47 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.432 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 25.0 t80 -46.04 -32.33 2.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 110.347 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.75 -30.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.051 179.67 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.533 ' HG2' ' ND2' ' A' ' 44' ' ' ASN . 4.8 ppp? -55.97 -43.91 77.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.569 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER 171.37 -40.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.0 OUTLIER 156.96 87.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.568 -179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' ' HG2' ' A' ' 41' ' ' MET . 0.0 OUTLIER -149.36 93.99 2.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.227 0.537 . . . . 0.0 110.415 179.651 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 40.4 m -36.2 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.073 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 39' ' ' PHE . 3.3 ptm -133.13 131.39 40.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 1.9 p-10 -18.29 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.544 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.7 pt -49.67 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.328 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 58.3 t0 -101.05 72.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.375 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.877 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.1 mp0 -48.86 -24.94 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.223 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.964 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.2 t -75.43 -10.16 59.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 2.4 mt-30 -118.77 -23.3 7.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.879 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -21.04 18.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -128.96 139.2 34.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.998 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 92.4 Cg_endo -80.58 -5.32 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.923 2.415 . . . . 0.0 112.072 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.2 -8.37 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.614 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.78 117.12 2.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.871 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 60.7 m 49.28 23.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.041 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 2.4 tmt_? -45.91 -33.68 3.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.741 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.31 11.42 10.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.065 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.89 -138.54 4.09 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 50.4 t -126.48 135.32 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 14.0 p -103.08 99.48 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 66' ' ' THR . 48.1 m80 -90.01 60.23 4.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -44.5 110.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.352 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -109.69 -178.5 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.667 179.553 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 4.4 pt-20 -79.39 119.35 22.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 73.59 26.54 69.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.7 t 158.4 177.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.727 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.0 p90 -144.35 149.51 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.73 114.28 27.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.444 -179.508 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.034 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.03 135.59 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 20.7 tt0 -132.16 117.75 18.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.771 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.73 -33.09 0.98 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.822 179.399 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.13 171.86 35.47 Favored 'Cis proline' 0 C--N 1.355 0.907 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.634 1.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.521 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 61.5 Cg_exo -36.61 -29.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.022 2.481 . . . . 0.0 112.833 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.8 -30.63 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.328 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.583 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 4.8 t-160 -88.45 -127.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.47 62.88 1.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.151 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.055 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.6 130.95 35.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.375 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.055 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.38 134.79 93.53 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' HD13 ' A' ' 84' ' ' ILE . 69.0 Cg_exo -50.45 -53.26 7.41 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.674 2.25 . . . . 0.0 112.35 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.535 ' H ' HD12 ' A' ' 84' ' ' ILE . 10.8 m120 -148.75 26.25 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.299 -179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.787 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -94.03 -17.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.434 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.706 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.6 90.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 179.105 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.2 100.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.99 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.27 149.26 48.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.101 178.787 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.583 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.353 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 t0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.812 0.339 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.639 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -104.87 153.58 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.905 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.572 ' C ' HD13 ' A' ' 5' ' ' ILE . 44.2 t0 -62.39 74.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 111.068 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 14' ' ' LEU . 37.5 mp0 -56.67 -17.04 7.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 13.8 t -81.35 -35.05 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.676 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.47 -27.75 64.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.523 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -45.57 -41.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -164.79 127.36 1.57 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.919 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 11.2 Cg_exo -68.19 -18.27 45.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.659 2.239 . . . . 0.0 111.034 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.28 11.27 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.484 179.633 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -43.24 -47.98 6.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.2 t -72.9 -14.35 61.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 76.23 -2.36 57.03 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.1 tpt85 177.35 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.035 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -82.47 -139.16 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.99 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 7.8 mt-30 -140.3 107.5 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.642 0.258 . . . . 0.0 110.916 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 5.2 p -52.37 149.72 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -131.26 163.99 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.7 t-20 -110.27 141.89 42.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.007 0.432 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.734 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.7 p -148.51 157.01 42.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 16.2 Cg_endo -57.86 113.03 1.34 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.658 2.239 . . . . 0.0 111.726 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.43 44.88 59.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.541 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 171.58 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.366 -179.502 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' THR . 27.3 p90 -166.75 175.91 7.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 111.852 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 10.3 pt-20 -153.59 -164.88 2.0 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 10.4 p -170.09 150.4 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 111.638 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.93 83.54 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.396 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -48.68 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.418 -179.355 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.7 t0 -104.33 -144.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.983 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 32' ' ' ASP . 2.6 mm-40 -29.61 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.83 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -120.0 25.93 7.32 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.663 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 20.9 m-30 -79.91 135.07 36.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 5.0 pt-20 -108.07 131.89 54.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.845 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.6 99.06 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.914 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.97 44.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.558 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 17.7 t80 -86.46 -6.6 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.775 0.322 . . . . 0.0 111.035 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 158.98 -23.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.643 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.4 OUTLIER -90.72 -20.38 22.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.781 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.3 OUTLIER 100.51 -13.88 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.917 0.76 . . . . 0.0 110.413 -179.528 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 7.0 tptt 168.35 100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.002 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -166.72 34.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.442 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m 34.66 98.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.429 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.6 mmt -132.83 102.19 5.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.53 179.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.24 123.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.017 0.823 . . . . 0.0 112.796 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -66.84 -173.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.137 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 43.2 t0 -95.13 76.57 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.026 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.061 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -46.58 -27.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.393 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 1.0 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.7 t -75.07 -16.83 60.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.003 0.43 . . . . 0.0 110.605 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -103.02 -23.31 13.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.216 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -43.98 92.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -100.63 155.92 35.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -93.3 3.77 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.432 2.755 . . . . 0.0 112.733 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -144.01 11.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.335 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -57.33 118.23 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 34.6 m 50.2 24.14 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.392 0.615 . . . . 0.0 109.653 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.52 -29.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.818 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . -134.18 27.25 3.31 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.961 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.68 -126.36 2.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.83 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 73' ' ' GLU . 43.0 t -137.39 135.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 110.818 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 61.9 m -96.92 92.59 6.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 58.2 m80 -88.98 48.84 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.038 0.447 . . . . 0.0 110.27 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 9.1 t-20 -42.42 116.93 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.5 p -119.53 -176.44 3.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 5.2 pt-20 -64.0 134.59 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.45 36.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.489 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 171.78 156.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.995 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -133.57 145.61 50.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.86 114.11 27.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.027 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -89.78 134.13 34.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.863 179.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.57 127.06 36.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.73 -33.68 1.6 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.437 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 14.6 Cg_exo -71.25 -173.3 9.44 Favored 'Cis proline' 0 C--N 1.356 0.964 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.568 1.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 81.3 Cg_exo -40.92 173.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.938 2.425 . . . . 0.0 112.812 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.51 53.25 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 1.1 t60 -101.08 -125.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 30.4 tt0 -151.05 65.85 0.91 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.001 0.429 . . . . 0.0 110.296 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.027 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -90.91 123.08 34.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.47 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.895 ' N ' HD12 ' A' ' 80' ' ' LEU . 79.8 p -60.41 136.44 91.9 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.756 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.19 -66.0 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.787 2.325 . . . . 0.0 112.541 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 84' ' ' ILE . 14.6 m120 -137.48 41.07 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.776 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -106.06 -14.74 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.413 . . . . 0.0 110.47 179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.35 89.12 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.12 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.18 93.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.995 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -54.58 159.93 1.97 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.766 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.576 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 39.2 68.52 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -89.94 179.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 5' ' ' ILE . 29.1 t0 -85.63 93.58 8.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 30.7 mp0 -76.27 -19.25 58.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.357 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.5 t -83.56 -26.09 30.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -71.29 -25.95 62.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.24 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.5 mm -45.41 -39.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.693 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.9 t -165.99 156.19 11.24 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.953 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 4.9 Cg_endo -86.37 -19.89 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.356 2.704 . . . . 0.0 111.749 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -109.21 21.9 16.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.484 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.561 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.8 -46.51 5.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.168 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -88.05 3.76 47.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 57.94 12.49 11.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.851 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 173.21 -50.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -70.11 -144.03 0.22 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.088 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 5.4 mt-30 -137.2 124.93 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 0.0 110.993 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.25 132.12 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.7 t -109.2 163.79 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.42 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.567 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.6 t-20 -111.29 143.08 42.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.354 . . . . 0.0 111.299 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.659 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -151.97 154.87 33.19 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 14.5 Cg_endo -57.16 116.61 3.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.746 2.297 . . . . 0.0 111.858 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.45 42.87 57.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.916 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.6 OUTLIER 167.3 -178.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.763 0.316 . . . . 0.0 110.547 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.659 ' HA ' HG23 ' A' ' 23' ' ' THR . 11.2 p90 -159.54 176.15 12.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 111.544 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.527 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -145.51 -172.35 3.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.529 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -147.91 158.73 44.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 0.0 111.38 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.88 74.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.152 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -46.06 -179.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 33' ' ' GLU . 9.8 t0 -106.62 -141.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.225 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -23.1 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -124.87 23.48 6.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.618 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.555 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 23.2 m-85 -75.42 131.04 39.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 111.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.6 pt-20 -109.86 130.17 55.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -33.96 114.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.038 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' HA3' ' ND2' ' A' ' 44' ' ' ASN . . . -75.59 55.25 2.92 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 4.0 p90 -56.97 -25.96 59.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.509 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 3.7 mtt -66.59 -19.05 65.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.105 0.479 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 1.8 mmm -119.36 -32.18 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.578 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 178.73 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.433 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HE2' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 178.01 33.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.14 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -85.21 -157.97 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.669 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.1 m -107.43 116.5 32.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.061 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.475 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -136.15 95.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.633 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 46' ' ' MET . 5.1 p-10 -10.91 131.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.703 0.801 . . . . 0.0 113.028 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.2 pt -70.37 -173.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.313 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.3 t0 -99.2 74.03 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.755 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.2 mp0 -48.28 -22.6 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.3 m -76.72 -8.58 57.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.697 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -117.65 -23.87 7.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.51 -28.46 67.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -128.38 137.97 32.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.117 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.11 -6.44 12.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.964 2.443 . . . . 0.0 112.043 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -111.78 -17.9 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.147 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.906 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -46.94 118.93 2.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.965 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 47.0 m 44.01 26.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.2 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.01 -31.93 19.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.836 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.9 25.47 6.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.095 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.15 -125.59 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.626 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 31.5 t -139.29 135.07 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 43.5 t -108.92 97.05 6.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.366 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 62.2 m80 -88.87 63.5 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.135 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.7 t-20 -45.71 122.42 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -120.01 -165.55 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.994 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 68' ' ' GLY . 9.0 mt-10 -73.65 140.38 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.066 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.16 36.56 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 169.95 -178.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.906 ' CE2' HD21 ' A' ' 57' ' ' LEU . 3.5 p90 -153.14 148.41 26.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.647 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.92 135.85 50.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.007 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.005 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -111.36 131.84 54.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.059 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.42 127.34 37.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.301 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.823 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.49 -31.92 0.89 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.099 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.823 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.6 Cg_exo -71.85 -169.3 6.03 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.641 1.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.2 Cg_exo -43.22 178.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.904 2.403 . . . . 0.0 112.856 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.55 -18.26 50.53 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 7.5 t-160 -104.23 -127.95 0.24 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.53 59.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.013 0.435 . . . . 0.0 110.056 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.051 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -86.26 129.53 34.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.52 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.051 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.36 133.0 88.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.682 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.14 -48.4 19.71 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.675 2.25 . . . . 0.0 112.011 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.588 ' C ' HD13 ' A' ' 84' ' ' ILE . 10.2 m120 -146.95 21.21 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.836 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.12 -23.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.768 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 75.57 91.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.928 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.681 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . 150.61 103.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.914 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 1.0 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.97 148.21 48.25 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.589 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.226 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 t0 -90.36 119.81 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.94 169.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.526 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' ARG . 10.6 t0 -75.08 -49.14 20.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.073 0.463 . . . . 0.0 109.823 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HB3' ' CG ' ' A' ' 27' ' ' PHE . 10.4 mp0 68.53 -52.91 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.757 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 47.5 t -63.74 -37.11 86.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -66.77 -25.8 66.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.541 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 7.1 mm -39.92 -37.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.148 0.499 . . . . 0.0 110.397 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.85 151.68 8.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.696 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.74 -17.53 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.999 2.466 . . . . 0.0 111.49 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -113.69 21.92 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.988 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -38.25 -61.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.339 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 45' ' ' CYS . 1.6 m -73.26 -3.39 26.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.65 11.13 27.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 178.42 -50.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.87 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.44 -150.97 2.22 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.638 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -132.93 110.42 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.303 . . . . 0.0 110.963 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.6 p -52.54 131.27 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 111.221 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG12 ' CB ' ' A' ' 28' ' ' GLU . 4.0 p -106.82 167.05 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.477 ' H ' HG22 ' A' ' 21' ' ' VAL . 8.7 t-20 -112.94 140.71 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.367 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.644 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -147.29 148.62 32.3 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.109 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' OD2' ' A' ' 4' ' ' ASP . 4.0 Cg_endo -46.88 116.38 1.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.021 2.481 . . . . 0.0 111.973 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.73 45.71 39.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.998 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 169.13 -167.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.583 0.23 . . . . 0.0 110.479 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.644 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -169.66 176.2 5.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 111.465 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.543 ' CB ' HG12 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -144.74 -145.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.456 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 1.1 m -163.12 154.43 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.414 . . . . 0.0 111.333 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -105.82 67.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.254 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -45.4 175.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.488 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' C ' ' HG3' ' A' ' 33' ' ' GLU . 15.1 t70 -72.86 -93.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 32' ' ' ASP . 10.8 mt-10 -141.95 -39.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -122.14 14.44 8.92 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.016 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.1 m-30 -94.99 161.17 14.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.829 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.598 ' HB3' HG22 ' A' ' 48' ' ' ILE . 3.0 pt-20 -118.25 131.24 56.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.55 102.69 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.652 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 42' ' ' MET . . . 98.71 64.66 0.85 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.719 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' MET . 4.2 t80 -83.56 -11.59 57.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.7 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 41' ' ' MET . 3.3 ptm 176.69 -31.79 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.045 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -83.0 -20.17 35.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.08 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 104.62 -21.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.058 0.849 . . . . 0.0 110.626 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 29' ' ' CYS . 14.9 mmtm -171.38 100.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.518 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -158.98 33.72 0.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 15' ' ' CYS . 2.8 t 9.52 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.901 0.75 . . . . 0.0 112.406 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -150.59 110.32 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -2.1 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.947 0.779 . . . . 0.0 112.576 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -50.55 174.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 51.9 t0 -93.7 75.47 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.903 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 mp0 -51.64 -21.66 2.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.976 0.417 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 78.9 m -76.75 -9.67 58.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.618 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.79 -23.51 6.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -29.82 64.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -125.1 137.2 29.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.86 -8.13 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.014 2.476 . . . . 0.0 112.01 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -119.17 -3.51 10.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.982 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -53.36 122.17 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.7 m 48.97 24.66 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.515 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -65.22 61.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.474 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 150.06 -16.9 1.05 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.881 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.22 -124.29 4.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.24 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.748 HG11 ' NE2' ' A' ' 64' ' ' HIS . 75.0 t -136.24 132.91 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.315 . . . . 0.0 110.957 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 25.0 t -104.79 94.58 5.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.748 ' NE2' HG11 ' A' ' 62' ' ' VAL . 42.3 m80 -89.96 59.91 4.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.807 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.2 t-20 -47.83 109.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.555 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.543 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -108.77 178.02 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.019 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER -71.95 121.82 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 68.12 32.91 77.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.2 t 158.06 178.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.982 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -146.92 142.95 28.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD3' HG21 ' A' ' 66' ' ' THR . 3.3 mmm180 -109.42 116.64 32.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.683 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -94.87 128.0 41.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.579 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.0 tt0 -128.37 123.29 33.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.74 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.29 -32.24 0.94 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.998 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.74 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 29.5 Cg_exo -64.85 170.93 32.43 Favored 'Cis proline' 0 C--N 1.356 0.926 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.7 1.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 73.8 Cg_exo -35.37 -28.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.992 2.461 . . . . 0.0 113.029 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.37 -31.2 0.04 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.434 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.2 t-80 -91.85 -129.2 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -140.03 66.34 1.4 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.105 0.479 . . . . 0.0 109.726 179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.008 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.95 93.44 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.154 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 33.4 t -43.24 137.79 2.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.477 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 76.1 Cg_endo -79.17 111.94 2.97 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.931 2.421 . . . . 0.0 113.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.4 m120 72.62 -1.24 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 1.6 mp -81.63 -18.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.0 110.092 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.77 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.947 178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.59 98.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.974 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -59.01 150.75 23.84 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.412 ' OG1' ' HA2' ' A' ' 25' ' ' GLY . 1.3 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.848 0.356 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -177.9 66.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.77 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.541 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 34.0 t0 -86.76 101.14 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.086 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 28.4 mp0 -81.11 -24.34 37.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.131 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.2 t -71.09 -41.92 70.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.745 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 1.4 ttt180 -57.44 -32.92 67.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.01 -38.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.473 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -165.22 146.76 6.32 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.687 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.17 -16.51 8.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.938 2.426 . . . . 0.0 111.799 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.88 16.92 21.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.486 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -44.81 -43.44 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.797 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 55.1 m -74.57 -14.13 60.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.136 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 66.61 6.3 34.84 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.137 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 1.9 tpt180 174.11 -29.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -94.65 -151.04 27.87 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.083 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.439 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 1.8 mm100 -127.09 115.34 19.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.289 . . . . 0.0 110.993 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.2 p -57.92 132.71 54.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.027 0.441 . . . . 0.0 111.676 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -116.6 164.25 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.241 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.6 t-20 -107.31 147.21 30.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -154.29 154.12 29.17 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.81 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.82 117.74 4.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 111.903 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA2' ' OG1' ' A' ' 3' ' ' THR . . . 50.13 43.7 41.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.877 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER 167.42 -174.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.786 0.327 . . . . 0.0 110.482 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.703 ' CE2' HD22 ' A' ' 14' ' ' LEU . 18.9 p90 -157.21 165.94 34.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.025 0.44 . . . . 0.0 111.552 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -130.39 -171.2 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.006 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -145.83 168.8 19.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.872 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -128.06 65.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.104 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 62.5 m -39.29 166.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.251 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 14.3 t0 -55.73 -96.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.387 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -138.31 0.92 2.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.812 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -173.01 22.94 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.422 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HA ' ' CA ' ' A' ' 47' ' ' ASP . 2.0 m-30 -100.02 138.96 36.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.422 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.4 120.1 30.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 111.228 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.542 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.35 99.16 11.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.546 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 115.91 84.89 1.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.894 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 26.1 t80 -131.57 -46.1 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.525 ' O ' ' CB ' ' A' ' 41' ' ' MET . 1.9 mtp -106.76 5.52 28.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.15 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.7 OUTLIER 84.91 37.04 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' LYS . 4.5 mtp -145.36 15.38 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER 34.75 45.56 0.16 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.937 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -88.22 35.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.626 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 69.4 m 22.5 102.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.583 0.552 . . . . 0.0 111.962 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.55 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -126.31 100.41 6.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.044 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.579 ' CA ' ' HA ' ' A' ' 35' ' ' TYR . 4.5 p-10 11.86 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.929 0.768 . . . . 0.0 112.702 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.915 HD13 ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -33.45 155.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.601 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.915 ' N ' HD13 ' A' ' 48' ' ' ILE . 54.0 t0 -89.54 74.43 7.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.851 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.6 mp0 -49.62 -27.87 5.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.733 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.683 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -70.31 -9.26 55.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.48 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.8 mt-30 -121.78 -31.09 4.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 52' ' ' GLN . 11.8 ttt85 -36.61 -42.53 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.205 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.19 154.32 58.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.437 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.41 -2.06 4.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.454 2.769 . . . . 0.0 112.093 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -126.42 10.94 7.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.128 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.922 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -58.11 129.24 41.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.2 m 40.21 30.13 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.283 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -60.96 71.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.264 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 137.33 -6.1 3.59 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.39 -127.15 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 38.4 t -140.46 117.09 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.666 ' HB2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.07 101.56 14.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.768 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 66.1 m80 -90.47 60.36 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.049 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 1.7 t-20 -43.68 112.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 64' ' ' HIS . 1.6 p -115.84 -161.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.051 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.35 140.08 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 56.31 19.7 26.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.768 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.4 t 156.32 -175.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.643 0.258 . . . . 0.0 110.724 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 3.8 p90 -142.19 159.31 42.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.946 0.403 . . . . 0.0 111.317 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.574 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -115.54 112.25 21.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.075 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.66 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -89.86 131.73 35.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.265 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -132.33 121.0 22.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.807 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.778 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.62 -32.61 1.07 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.873 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.778 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 26.2 Cg_exo -65.32 171.4 33.19 Favored 'Cis proline' 0 C--N 1.356 0.96 0 C-N-CA 123.918 -1.284 . . . . 0.0 112.715 1.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.532 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 65.8 Cg_exo -33.65 -28.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.151 2.567 . . . . 0.0 113.264 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -35.0 -31.87 0.02 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.695 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -89.4 -125.42 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -144.69 60.56 1.33 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.3 OUTLIER -90.47 98.7 11.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.029 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.679 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.4 t -51.75 137.29 34.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.327 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 64.9 Cg_endo -75.07 115.49 4.29 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.917 2.411 . . . . 0.0 113.588 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 21.1 m120 72.89 24.13 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.169 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.679 HD13 ' C ' ' A' ' 81' ' ' SER . 1.4 mp -102.06 -27.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.251 0.548 . . . . 0.0 109.858 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.701 ' HB3' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER 74.08 69.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.499 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 166.4 100.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.22 145.84 30.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.11 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.572 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.477 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -176.44 85.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -91.42 -164.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 12.2 t0 -87.01 -48.18 8.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.851 0.357 . . . . 0.0 111.286 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 10.6 mp0 72.99 -56.94 0.65 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.411 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 14' ' ' LEU . 8.4 t -63.84 -14.56 54.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.567 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.2 -33.21 56.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.415 ' HB ' HD11 ' A' ' 14' ' ' LEU . 12.4 mm -41.86 -37.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.73 163.71 9.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.36 -22.5 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.145 2.564 . . . . 0.0 111.809 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.75 15.94 27.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.78 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -45.79 -49.42 15.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.766 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -59.96 -13.11 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.65 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.74 -10.76 37.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.035 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 7.3 tpt180 177.35 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.98 -129.88 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.608 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LYS . 3.3 mt-30 -144.97 118.27 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 111.388 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 p -69.18 146.35 52.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.879 0.371 . . . . 0.0 110.982 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 43.9 t -128.67 152.79 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 3.2 t-20 -77.75 153.36 33.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.971 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 27' ' ' PHE . 16.3 p -157.46 155.7 27.79 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.605 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.6 Cg_endo -51.46 110.37 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.746 2.297 . . . . 0.0 112.07 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.17 44.17 74.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.118 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.75 -160.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.766 0.317 . . . . 0.0 110.286 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.78 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.5 p90 -165.08 145.0 6.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.078 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -104.77 -146.88 0.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.45 171.43 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.537 0.685 . . . . 0.0 112.793 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' GLN . 3.1 tmtm? -131.49 65.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.364 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 35' ' ' TYR . 95.0 m -50.04 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.549 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -136.74 -151.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.263 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.507 ' C ' ' O ' ' A' ' 32' ' ' ASP . 26.9 mm-40 -0.71 -86.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.949 0.781 . . . . 0.0 112.871 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.77 9.57 2.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . 18.6 m-85 -69.9 106.88 3.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.638 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -89.58 136.02 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -28.54 113.98 0.08 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.42 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -38.03 -85.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 88.17 -24.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE ' ' A' ' 46' ' ' MET . 2.8 mtm -72.21 -24.44 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.435 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 42' ' ' MET . 7.5 mmm -124.66 -35.75 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.641 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 164.4 -51.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.457 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 5.9 mmtp 174.38 104.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -159.66 49.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.131 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 84.7 m 15.65 110.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.669 0.788 . . . . 0.0 112.937 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.516 ' CE ' ' SD ' ' A' ' 40' ' ' MET . 26.2 ptm -124.93 120.06 30.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 1.9 p30 -25.45 126.53 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.405 0.621 . . . . 0.0 111.707 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -54.68 -174.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.455 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 58.3 t0 -101.55 73.05 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.271 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.889 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.5 mp0 -49.07 -22.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.806 ' HA ' HD22 ' A' ' 57' ' ' LEU . 60.1 m -75.45 -13.22 60.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.676 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 1.8 mt-30 -111.46 -20.3 12.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -60.52 -30.04 69.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.982 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.51 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -123.62 138.28 30.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.51 -6.47 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.018 2.479 . . . . 0.0 112.195 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -121.32 -4.27 9.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.535 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.991 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.89 119.98 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.839 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 65.0 m 46.71 25.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.519 . . . . 0.0 109.991 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.1 -27.01 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.02 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.92 30.5 3.71 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.04 -126.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.572 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.62 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 42.7 t -135.68 135.48 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.9 t -109.33 96.94 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.949 0.404 . . . . 0.0 111.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.62 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 57.6 m80 -89.69 62.39 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.491 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 9.2 t-20 -47.07 118.61 2.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.53 HG21 ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -115.09 -170.15 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 10.1 mp0 -73.11 131.16 41.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 44.11 33.5 2.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.359 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 172.78 168.73 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.681 0.277 . . . . 0.0 110.772 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.991 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -144.72 145.97 31.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.53 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.0 137.19 48.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.016 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -113.93 127.73 56.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.061 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 3.2 tt0 -126.97 123.97 38.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.787 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.809 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.83 -31.34 0.72 Allowed Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.973 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.809 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 43.3 Cg_endo -67.05 174.22 31.08 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 123.828 -1.321 . . . . 0.0 112.827 1.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 71.5 Cg_exo -35.4 -28.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.006 2.471 . . . . 0.0 113.073 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.25 -30.63 0.05 OUTLIER Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.469 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 3.3 t-160 -93.72 -130.44 0.13 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.71 65.46 1.43 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.016 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -89.8 101.43 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.192 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.533 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 32.9 t -50.43 137.48 22.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 85.1 Cg_endo -79.96 112.76 2.9 Favored 'Trans proline' 0 CA--C 1.526 0.121 0 C-N-CA 122.909 2.406 . . . . 0.0 113.59 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 23.4 m120 73.39 -3.21 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.265 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.5 mp -80.68 -25.09 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.156 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.702 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.23 87.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.78 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.877 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.94 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -60.7 150.95 30.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.197 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.266 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 3' ' ' THR . 37.9 t70 178.93 84.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.662 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -108.18 153.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.576 ' C ' HD13 ' A' ' 5' ' ' ILE . 32.0 t0 -61.31 84.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.036 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 27.3 mp0 -70.9 -11.92 61.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.1 t -83.22 -43.24 16.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -67.5 -23.62 65.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.738 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.64 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.6 mm -42.97 -39.7 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -164.36 140.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.859 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_exo -75.16 -18.45 18.38 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 111.388 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -116.6 20.96 13.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.245 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -37.06 -61.88 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.307 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -80.27 7.67 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.381 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 78.99 -45.78 2.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.947 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -134.9 -46.74 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 0.0 111.05 -179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -59.25 -177.61 1.08 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.825 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.07 102.63 11.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 13.8 p -40.22 150.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.246 0.546 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 16.2 t -130.32 164.39 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.771 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 t-20 -114.31 138.93 49.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.418 . . . . 0.0 111.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.679 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.5 p -148.8 157.55 40.57 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.63 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 19.0 Cg_endo -59.17 121.0 9.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.598 2.199 . . . . 0.0 111.759 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 46.81 44.19 17.43 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.625 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.68 -179.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.358 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' THR . 21.4 p90 -164.04 -177.69 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 111.995 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.0 pt-20 -162.56 -147.52 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.851 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 13.6 p -170.4 -176.83 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.214 0.53 . . . . 0.0 111.59 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -121.76 73.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.727 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 66.7 m -40.61 167.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 16.4 t0 -60.24 -99.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.258 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -129.9 -32.08 1.89 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' N ' ' HA2' ' A' ' 68' ' ' GLY . . . -134.84 14.82 4.37 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.507 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.1 m-85 -90.74 125.89 35.83 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.563 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.77 131.72 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 0.0 110.882 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.53 ' OG ' ' CE ' ' A' ' 43' ' ' LYS . 1.6 t -95.34 106.36 18.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.447 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.14 76.19 1.02 Allowed Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.227 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 70.7 t80 -109.1 -51.49 2.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.0 110.009 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -98.98 -3.32 35.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.578 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' MET . 0.8 OUTLIER 86.53 38.11 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.857 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtt -134.84 5.45 3.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.974 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CE ' ' OG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 51.93 96.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.451 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -157.2 44.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.242 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 44' ' ' ASN . 67.1 m 5.2 107.82 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.934 0.771 . . . . 0.0 112.133 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.57 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 24.0 ptm -130.59 111.69 12.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.521 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 1.4 p-10 -21.81 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.371 0.605 . . . . 0.0 111.987 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -46.91 -178.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.111 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 59.2 t0 -106.82 71.04 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.849 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.892 ' O ' HD13 ' A' ' 57' ' ' LEU . 29.4 mp0 -48.86 -25.13 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.92 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.8 t -73.85 -8.76 57.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.681 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 3.9 mt-30 -118.06 -28.84 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -40.94 -42.2 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.001 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.4 152.14 77.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.473 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 56' ' ' LEU . 96.5 Cg_endo -86.56 -6.6 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.285 2.657 . . . . 0.0 112.086 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.1 mp -104.45 -15.93 15.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.179 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.92 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.12 114.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.599 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 76.8 m 53.34 20.96 2.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.176 0.512 . . . . 0.0 109.994 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -36.95 -36.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.691 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.7 -8.55 9.81 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.028 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.14 -150.34 15.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.546 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 38.7 t -116.78 129.6 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.4 p -94.28 98.9 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.984 0.421 . . . . 0.0 111.081 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -96.18 65.18 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.206 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.7 t-20 -47.12 116.47 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.112 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -103.45 -175.59 2.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 4.5 pt-20 -49.84 -102.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.441 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.544 ' HA2' ' N ' ' A' ' 34' ' ' GLY . . . -85.73 55.24 4.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.363 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 28.9 t 170.44 -161.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.801 ' CD2' HD21 ' A' ' 57' ' ' LEU . 3.7 p90 -167.15 146.05 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.652 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.52 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 3.4 mtp180 -110.38 159.06 17.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.035 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -135.65 136.54 41.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.066 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 75' ' ' PRO . 18.0 tt0 -130.52 118.13 20.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.904 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.765 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -79.53 -33.7 0.84 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.839 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.765 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.03 171.25 37.18 Favored 'Cis proline' 0 C--N 1.354 0.85 0 C-N-CA 123.92 -1.283 . . . . 0.0 112.699 1.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 61.7 Cg_exo -37.32 -29.74 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.932 2.421 . . . . 0.0 112.881 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -38.5 -30.38 0.09 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.218 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 6.1 t-160 -87.01 -127.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -142.01 63.55 1.41 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.044 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.38 129.01 36.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.288 -178.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.044 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -59.57 131.74 88.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.84 -49.24 18.26 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.846 2.364 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.539 ' H ' HD12 ' A' ' 84' ' ' ILE . 5.6 m120 -149.76 33.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.462 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -102.01 -24.87 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.352 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.721 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER 82.73 84.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.803 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 158.63 102.68 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 1.002 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.68 152.29 35.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.21 178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.306 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 3' ' ' THR . 13.7 t0 167.23 91.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -89.9 167.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.394 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.573 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 8.5 t0 -69.89 -50.06 46.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 111.056 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.0 mp0 72.07 -55.89 0.66 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.498 ' HA ' HD13 ' A' ' 14' ' ' LEU . 97.9 m -64.62 -18.23 64.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.385 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -72.18 -33.52 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.465 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -40.84 -36.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.0 t -165.48 155.67 11.72 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.679 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.1 Cg_endo -85.75 -19.31 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.3 2.666 . . . . 0.0 111.457 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.52 25.06 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -46.44 -40.06 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.863 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -78.74 4.34 14.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.177 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 34.69 29.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.101 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' NE ' ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER 153.63 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.834 0.35 . . . . 0.0 110.763 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' N ' ' HB3' ' A' ' 15' ' ' CYS . . . -86.18 -140.85 5.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.562 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.496 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 1.7 mt-30 -142.98 102.73 4.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 0.0 111.019 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 29.2 t -56.31 146.61 23.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 22' ' ' ASN . 37.7 t -131.47 162.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.3 t-20 -97.13 150.33 20.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.6 p -154.76 146.26 16.82 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.81 112.16 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.897 2.398 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.93 44.38 82.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.92 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.43 -168.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.78 0.324 . . . . 0.0 110.639 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 7.7 p90 -164.83 144.99 7.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' OE2' HG21 ' A' ' 21' ' ' VAL . 2.1 pp20? -117.65 -171.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.605 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.54 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.1 166.57 24.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 111.887 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -123.61 84.05 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.662 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 163.0 12.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.305 0.574 . . . . 0.0 112.386 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.63 -91.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -119.92 16.09 10.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.99 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.628 ' C ' HG23 ' A' ' 48' ' ' ILE . 2.5 m-30 -103.01 166.92 10.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.714 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -122.62 139.86 53.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.502 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 83.0 p -87.88 94.7 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.034 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 86.48 71.01 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.43 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 33.0 t80 -67.53 -21.01 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.52 -27.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.472 ' O ' ' HG2' ' A' ' 42' ' ' MET . 0.4 OUTLIER -65.08 -36.16 83.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.902 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 179.1 -87.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.748 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.54 ' CE ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -162.13 37.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.863 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -86.45 173.03 9.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.585 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' ' CB ' ' A' ' 35' ' ' TYR . 49.3 t -111.05 110.07 20.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.598 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 2.1 ppp? -145.5 119.99 9.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.2 p-10 -6.5 109.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.97 0.793 . . . . 0.0 112.375 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.714 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.1 pt -53.85 -177.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.406 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 54.7 t0 -99.58 74.03 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.552 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.961 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.6 mp0 -48.35 -26.0 1.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 57' ' ' LEU . 63.4 m -73.51 -12.55 60.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 7.9 mt-30 -115.17 -23.52 8.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.481 ' NH1' ' CG ' ' A' ' 54' ' ' ASP . 1.1 ttt-85 -53.73 -31.51 48.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.024 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' CG ' ' NH1' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -132.19 142.58 45.57 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.4 -6.26 10.95 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.137 2.558 . . . . 0.0 111.908 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -112.4 -10.13 13.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.258 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.88 121.87 7.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.8 m 47.83 24.61 0.6 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.353 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -55.59 -18.19 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.699 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.74 22.91 5.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.69 -125.34 0.97 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.683 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.686 HG11 ' NE2' ' A' ' 64' ' ' HIS . 41.8 t -138.62 136.72 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.782 0.325 . . . . 0.0 110.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 48.2 t -105.7 96.86 6.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.29 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.686 ' NE2' HG11 ' A' ' 62' ' ' VAL . 29.4 m80 -89.76 61.21 5.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -46.04 118.87 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 5.0 p -111.89 -162.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 118.08 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 71.92 24.11 77.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.446 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.0 178.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 0.0 110.614 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.9 p90 -142.6 147.18 35.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.54 112.25 24.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.464 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.021 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.76 138.18 31.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.843 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 2.4 tt0 -143.13 122.11 12.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -79.86 -29.91 0.59 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 23.5 Cg_exo -67.3 178.09 20.18 Favored 'Cis proline' 0 C--N 1.358 1.04 0 C-N-CA 124.188 -1.171 . . . . 0.0 112.649 1.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.572 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 78.7 Cg_exo -36.45 -26.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.953 2.436 . . . . 0.0 113.087 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -34.58 -32.33 0.02 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.579 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 10.6 t-160 -90.06 -127.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 24.2 mt-30 -140.73 68.63 1.35 Allowed 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.021 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -90.0 125.55 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.181 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.848 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -59.67 134.08 89.18 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.831 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.89 -46.49 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.553 ' H ' HD12 ' A' ' 84' ' ' ILE . 12.8 m120 -158.24 32.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.534 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.795 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.37 -12.81 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.562 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.62 85.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.046 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.45 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.276 0.36 . . . . 0.0 111.633 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 t -69.33 158.24 35.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.922 0.392 . . . . 0.0 111.007 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.576 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.9 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.795 0.331 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.4 t0 40.48 69.81 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.96 -176.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.749 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.641 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 t0 -92.26 107.81 19.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.972 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.843 ' O ' HD11 ' A' ' 14' ' ' LEU . 17.9 mp0 -91.28 -22.81 20.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.086 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 14' ' ' LEU . 41.5 t -78.88 -31.2 45.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.4 ttt85 -64.02 -30.26 71.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.274 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -40.87 -37.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.469 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -164.79 155.78 12.95 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.968 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.33 -21.69 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 0.0 111.477 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -114.41 27.19 9.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.003 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.843 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.47 -59.59 0.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.342 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.0 m -88.95 27.43 1.35 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.641 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.91 22.23 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.908 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 166.04 -59.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.134 0.467 . . . . 0.0 110.993 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 45' ' ' CYS . . . -54.28 -163.69 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.683 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 mm-40 -125.74 109.69 12.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.773 0.321 . . . . 0.0 110.96 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -63.09 125.87 25.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.49 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.4 t -109.05 164.1 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.133 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.559 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.4 t-20 -102.68 148.53 25.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 111.604 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.5 p -155.42 156.45 30.93 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.862 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 12.4 Cg_endo -56.26 117.93 4.66 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.74 2.293 . . . . 0.0 111.904 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . 49.28 44.41 34.83 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.859 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 166.55 -178.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.741 0.305 . . . . 0.0 110.459 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.59 ' CB ' ' HB2' ' A' ' 7' ' ' GLU . 7.1 p90 -155.25 155.08 33.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 pt-20 -123.32 -167.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.034 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.03 -177.38 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 112.193 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 1.1 tmtm? -141.74 79.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.567 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 21.8 m -60.15 -179.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.775 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.3 t70 -90.66 -151.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.415 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.3 mt-10 -33.13 -74.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.732 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -135.4 40.94 1.49 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.057 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -88.43 133.72 34.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.61 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -89.58 121.89 32.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.305 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -89.57 98.2 11.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 110.48 76.14 0.85 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.797 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 65.3 t80 -111.94 -76.69 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.559 ' HB3' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -123.16 -12.84 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.193 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 42' ' ' MET . 13.5 mmm -90.89 -22.57 20.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.697 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.7 mmt 123.27 -43.39 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.402 1.064 . . . . 0.0 110.911 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -158.72 20.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.585 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -67.26 149.86 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.5 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 15.9 m -95.64 102.21 13.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.458 . . . . 0.0 110.34 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 25.5 ptm -127.83 116.59 20.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.087 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 5.1 p-10 -21.36 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.929 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.61 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -46.52 -177.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.441 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.8 t0 -96.8 72.42 2.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.714 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.841 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.6 mp0 -50.86 -22.19 2.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.95 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.4 t -76.01 -8.95 58.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.705 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 3.4 mt-30 -119.12 -24.12 6.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -23.74 9.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 57' ' ' LEU . 2.1 m-20 -124.99 139.45 33.62 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.041 0.448 . . . . 0.0 111.166 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.79 -9.38 15.74 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.029 2.486 . . . . 0.0 112.279 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.632 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -119.13 -6.62 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.95 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.53 112.58 0.67 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.582 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 39.6 m 52.69 22.16 2.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.158 0.504 . . . . 0.0 109.864 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.632 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -38.49 -38.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.51 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.62 24.06 6.2 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.806 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -136.27 -130.88 2.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.531 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.712 HG11 ' NE2' ' A' ' 64' ' ' HIS . 70.0 t -137.82 128.42 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.777 0.322 . . . . 0.0 111.001 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.469 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -98.15 95.02 7.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.712 ' NE2' HG11 ' A' ' 62' ' ' VAL . 41.0 m80 -88.53 60.45 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 8.3 t-20 -45.93 112.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -109.35 -161.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.974 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.66 127.03 34.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 56.81 29.86 59.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 168.2 -172.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.696 ' CE2' HD21 ' A' ' 57' ' ' LEU . 9.6 p90 -156.97 147.56 21.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.71 116.48 31.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.322 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.871 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -98.42 134.91 40.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.305 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.3 tt0 -150.19 126.2 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.518 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -49.65 -45.91 79.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.456 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 3.3 Cg_exo -75.56 -60.21 0.09 OUTLIER 'Cis proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.669 -1.388 . . . . 0.0 113.193 1.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.9 Cg_endo -84.39 -155.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.87 2.38 . . . . 0.0 113.155 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.0 37.44 9.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.874 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.516 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 161.0 -165.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.235 0.54 . . . . 0.0 111.255 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -139.22 78.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.105 179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.871 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -56.98 107.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.463 0.649 . . . . 0.0 111.784 -178.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB2' HD13 ' A' ' 84' ' ' ILE . 55.4 p -52.03 124.62 29.72 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.75 ' O ' HD12 ' A' ' 84' ' ' ILE . 73.6 Cg_endo -76.42 111.75 3.32 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 122.796 2.331 . . . . 0.0 113.221 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 23.4 m120 73.66 13.68 4.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.336 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 82' ' ' PRO . 3.8 mp -101.24 -44.92 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 5.7 p 91.75 79.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.18 102.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -50.27 130.27 22.73 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.864 0.364 . . . . 0.0 110.901 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.516 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 1.1 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.175 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.768 0.318 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.3 t0 41.58 90.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.809 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.87 -165.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.809 ' N ' HG23 ' A' ' 5' ' ' ILE . 9.4 t0 -87.56 -50.1 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 111.103 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.643 ' O ' HD11 ' A' ' 14' ' ' LEU . 9.5 mp0 73.11 -55.49 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' HA ' HD13 ' A' ' 14' ' ' LEU . 91.1 m -63.22 -24.31 67.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.95 -32.58 69.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.52 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 14' ' ' LEU . 11.4 mm -44.04 -39.08 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 110.281 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 41.0 t -163.17 153.28 13.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.712 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_endo -85.54 -19.42 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.169 2.58 . . . . 0.0 111.093 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -112.2 26.89 10.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.994 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.954 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.69 -47.73 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -83.2 11.02 7.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.402 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 60.89 9.95 16.73 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.159 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 162.15 -37.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 110.87 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -68.47 -153.49 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.805 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.05 101.59 5.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 0.0 110.639 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.1 t -57.15 150.16 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 28' ' ' GLU . 7.1 p -132.06 154.0 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' ND2' ' OE1' ' A' ' 7' ' ' GLU . 6.4 t-20 -91.55 142.34 27.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.229 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 28' ' ' GLU . 13.4 p -147.89 151.09 37.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.51 103.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.853 2.368 . . . . 0.0 111.992 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.12 98.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.117 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.2 OUTLIER 178.8 -166.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.954 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.7 p90 -172.45 139.86 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.671 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 23' ' ' THR . 0.1 OUTLIER -105.97 -147.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.684 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.2 m -170.08 159.49 7.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -122.6 71.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.535 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.9 OUTLIER -49.59 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.06 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -125.96 -156.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.109 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER 8.32 -75.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.009 0.818 . . . . 0.0 112.636 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.529 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -157.72 29.61 0.49 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.136 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 22.9 m-85 -79.24 151.15 31.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 2.1 pt-20 -112.02 128.16 56.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -83.42 92.78 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 114.32 56.86 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.553 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 58.4 t80 -77.12 -24.83 51.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.845 0.355 . . . . 0.0 110.787 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.14 -25.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.486 ' HG2' ' HE3' ' A' ' 40' ' ' MET . 42.0 mmm -72.68 -33.36 66.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.415 ' CB ' ' O ' ' A' ' 41' ' ' MET . 1.8 ptm 166.0 -63.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 12.9 tptt -177.01 29.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.451 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 41' ' ' MET . 0.2 OUTLIER -76.91 179.51 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.44 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.4 m -92.16 106.58 18.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' PHE . 2.1 mmt -124.0 101.01 7.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.045 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.3 p-10 -21.83 101.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.984 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -48.42 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.094 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 56.3 t0 -94.69 71.7 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.564 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.886 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -48.3 -24.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.27 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 1.028 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.1 t -76.92 -8.97 58.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.45 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.0 mt-30 -116.38 -21.29 9.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 54' ' ' ASP . 7.8 ttt-85 -58.75 -33.25 70.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -115.89 140.58 26.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.091 0.472 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 90.3 Cg_endo -80.83 -5.03 13.02 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.085 2.523 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -128.37 1.22 5.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.56 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.028 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.41 115.56 1.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.123 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.97 ' SG ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER 49.22 21.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.643 -179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.29 87.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.2 -24.4 0.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.098 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -129.15 -98.16 0.87 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.944 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.591 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 19.2 t -150.32 125.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 111.572 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 25.4 p -89.55 99.27 12.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.591 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 71.2 m80 -89.62 59.79 4.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 1.4 t-20 -46.0 117.98 1.71 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.678 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -117.69 -171.05 1.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.089 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.6 pt-20 -73.25 143.2 47.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.9 32.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.612 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER 164.69 174.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.61 0.243 . . . . 0.0 110.43 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.865 ' CD2' HD21 ' A' ' 57' ' ' LEU . 8.7 p90 -146.8 166.44 26.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.142 0.496 . . . . 0.0 111.783 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.678 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -122.54 108.15 12.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.574 ' HB3' HD21 ' A' ' 80' ' ' LEU . 19.0 m -89.59 116.33 27.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.152 0.501 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -100.75 141.7 33.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.495 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.832 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -78.05 -35.63 1.24 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.026 -178.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.832 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 9.6 Cg_exo -73.74 -168.54 6.18 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.454 0.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 65.0 Cg_exo -40.57 172.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 113.04 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.92 86.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.154 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.592 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -139.74 -136.86 0.12 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.08 84.5 1.39 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.275 0.489 . . . . 0.0 111.254 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.04 123.82 34.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.085 0.469 . . . . 0.0 111.677 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -49.95 122.22 13.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.264 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 73.2 Cg_exo -37.32 -44.98 1.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.869 2.38 . . . . 0.0 112.713 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.586 ' H ' HD12 ' A' ' 84' ' ' ILE . 32.2 m120 -163.24 24.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -86.91 -27.34 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.427 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.686 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.9 p 87.15 87.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.347 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 153.48 84.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.542 ' HA ' HD13 ' A' ' 80' ' ' LEU . 9.6 t -38.34 152.9 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.592 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.28 -0.866 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.898 0.38 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 3' ' ' THR . 2.8 t70 158.66 82.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.782 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.75 159.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.535 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 59.5 t0 -75.21 90.04 2.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 0.0 111.041 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' LEU . 28.1 mp0 -74.08 -21.86 59.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.054 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -46.74 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.511 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.525 ' CG ' ' OD2' ' A' ' 6' ' ' ASP . 1.2 mmt-85 -50.63 -31.95 17.6 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 15.0 mm -53.31 -55.08 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.504 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 14' ' ' LEU . 1.4 t -143.06 121.95 7.43 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.84 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.7 -19.56 47.47 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.756 2.304 . . . . 0.0 110.753 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -118.88 25.57 10.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.717 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.867 HD22 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.53 -44.43 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.862 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -84.37 15.69 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.459 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 61.55 5.83 7.39 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.811 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 174.39 -60.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.758 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 31' ' ' CYS . . . -48.71 164.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.749 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.93 84.53 5.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.81 0.338 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -44.46 148.73 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.161 0.505 . . . . 0.0 111.165 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.3 t -135.52 163.45 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.425 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' N ' HG12 ' A' ' 21' ' ' VAL . 5.5 t-20 -91.41 146.25 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.025 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 27' ' ' PHE . 3.6 p -151.56 156.02 34.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.5 Cg_endo -55.24 107.53 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.239 . . . . 0.0 111.888 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.34 41.79 95.26 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.017 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 173.75 -167.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.867 ' CZ ' HD22 ' A' ' 14' ' ' LEU . 2.5 p90 -164.85 145.27 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 5.9 pt-20 -117.21 -167.41 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 2.9 p -167.52 154.4 8.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.192 0.52 . . . . 0.0 111.718 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -101.58 76.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.266 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.537 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . 60.0 m -41.23 169.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.849 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 0.8 OUTLIER -91.78 -151.23 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.318 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' ASP . 67.1 mm-40 -33.12 -95.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -114.96 36.48 3.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.588 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 1.8 m-85 -89.8 121.59 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.754 0.311 . . . . 0.0 110.429 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.581 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -94.81 128.1 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 110.862 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 7.7 p -84.07 95.05 8.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.59 34.72 0.68 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 2.3 t80 -55.87 -17.36 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.316 . . . . 0.0 110.913 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.65 -22.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.987 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' MET . 29.2 mmm -75.9 -29.68 58.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.593 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.3 mmt 131.69 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.281 0.988 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HG3' ' SG ' ' A' ' 15' ' ' CYS . 7.8 tptt 177.98 104.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 0.0 111.281 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.529 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -166.97 50.52 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.966 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 74.6 m 5.93 100.07 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.154 0.909 . . . . 0.0 112.235 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.484 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.8 mmt -125.95 113.67 17.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.827 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 46' ' ' MET . 9.9 p-10 -20.89 101.61 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 O-C-N 123.667 0.604 . . . . 0.0 112.04 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -42.13 176.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 45.4 t0 -92.97 76.18 4.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.75 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.952 ' O ' HD13 ' A' ' 57' ' ' LEU . 32.2 mp0 -48.8 -25.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.865 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 1.016 ' HA ' HD22 ' A' ' 57' ' ' LEU . 45.2 t -74.69 -8.8 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.71 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -117.98 -26.37 6.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.637 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.11 -30.23 61.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.24 138.05 25.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.98 -4.7 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.99 2.46 . . . . 0.0 112.05 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -119.49 -11.54 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.516 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.016 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -49.49 113.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 75.4 m 51.84 21.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 110.247 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.44 -28.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.649 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.24 -7.83 6.27 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.101 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -113.15 -152.43 11.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 64' ' ' HIS . 47.4 t -112.74 129.87 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.325 . . . . 0.0 111.067 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.481 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 7.3 p -95.41 101.59 13.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.54 ' O ' HG22 ' A' ' 66' ' ' THR . 28.3 m80 -90.19 62.26 5.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.557 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 7.9 t-20 -44.53 109.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -108.51 -178.61 3.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.97 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.3 129.32 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 41.15 29.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -167.72 -169.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.844 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.6 p90 -171.47 139.76 1.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.766 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 1.3 mtp180 -109.83 158.98 17.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.235 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.012 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -131.92 143.93 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.258 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 21.6 tt0 -139.79 118.13 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 111.799 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.93 -32.8 0.93 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.869 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.35 172.38 34.6 Favored 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.594 1.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 49.9 Cg_exo -35.36 -27.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.055 2.503 . . . . 0.0 113.162 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -36.66 -31.08 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.45 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.569 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -89.65 -126.47 0.07 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.19 58.08 1.4 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.012 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -81.99 109.04 15.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.624 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.666 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -43.8 133.63 3.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.44 -68.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.54 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.682 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.4 m120 -127.35 29.54 5.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.689 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.819 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -96.28 -14.76 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.801 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.7 87.74 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.966 178.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 154.36 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.78 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.987 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.569 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.457 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.838 0.351 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -177.34 107.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.819 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.0 OUTLIER -118.33 164.69 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 47.8 t0 -81.23 109.19 15.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.734 ' O ' HD11 ' A' ' 14' ' ' LEU . 14.1 mp0 -92.47 -23.85 19.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.941 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.87 -45.64 64.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.566 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.477 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 3.1 ttt180 -51.9 -35.3 44.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 10.7 mm -41.51 -39.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.338 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.77 150.03 11.11 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.678 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.4 Cg_endo -87.26 -16.64 3.19 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.135 2.556 . . . . 0.0 111.541 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.62 20.21 18.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.919 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.65 -50.58 4.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.206 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -63.86 -10.07 18.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.7 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 62.74 6.93 13.18 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.883 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.638 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 13.9 tpt180 172.58 -44.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.876 0.369 . . . . 0.0 110.706 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.68 -139.05 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.622 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.1 mt-30 -136.69 111.39 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 110.995 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -68.82 155.36 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 36.8 t -140.76 161.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.736 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.3 t-20 -90.63 155.93 18.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.508 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.538 HG23 ' HA ' ' A' ' 27' ' ' PHE . 11.9 p -156.87 155.73 28.8 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.833 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.0 Cg_endo -54.61 110.26 0.5 Allowed 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.71 2.274 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.01 41.92 94.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 168.96 -162.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.536 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.919 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -163.58 141.44 7.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.029 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 pt-20 -101.61 -150.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -165.86 177.43 7.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.148 0.499 . . . . 0.0 111.78 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 5.6 tmtm? -145.43 76.24 1.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.192 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 5.8 m -44.83 177.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.694 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -93.87 -73.44 0.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.313 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.95 -74.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.148 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.968 ' O ' HG23 ' A' ' 48' ' ' ILE . . . -101.09 -0.61 54.65 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.158 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 17' ' ' ARG . 1.9 m-85 -71.05 118.15 13.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.922 ' HB2' HG22 ' A' ' 48' ' ' ILE . 1.4 tp10 -89.96 141.02 29.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.416 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 13.0 p -45.49 81.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.154 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 43' ' ' LYS . . . 82.14 -12.09 45.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.169 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 40' ' ' MET . 0.0 OUTLIER 72.17 4.1 4.9 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.579 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 107.97 -22.41 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.758 0.823 . . . . 0.0 110.97 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' MET . 3.1 ptm -66.63 -32.98 74.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 41' ' ' MET . 21.5 mmt -162.31 -75.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 110.467 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.594 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 12.2 tptt 179.97 -24.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.04 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -46.0 90.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.757 0.313 . . . . 0.0 110.859 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' CYS . 25.2 m -36.15 103.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.393 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.547 ' HA ' ' CD2' ' A' ' 35' ' ' TYR . 3.2 ptp -132.14 135.55 46.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 p-10 -22.39 118.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.34 0.591 . . . . 0.0 111.95 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.968 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.1 pt -58.47 -170.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.475 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 57.4 t0 -97.76 71.98 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.453 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -50.72 -21.51 1.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 9.1 t -77.39 -10.03 59.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.2 mt-30 -117.65 -22.39 8.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HD3' ' OD1' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.45 -24.03 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.095 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -126.57 138.02 31.59 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.965 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.94 -7.88 13.24 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.942 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -115.65 -7.94 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.597 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.954 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -52.07 114.74 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.7 m 52.53 22.29 2.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.223 0.535 . . . . 0.0 109.955 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 3.4 ttt180 -40.25 -30.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.761 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.56 22.22 4.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.021 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -138.76 -131.11 2.83 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.466 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.729 HG11 ' NE2' ' A' ' 64' ' ' HIS . 39.4 t -135.37 129.7 49.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.763 0.316 . . . . 0.0 110.733 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.458 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.8 p -97.99 95.88 7.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.729 ' NE2' HG11 ' A' ' 62' ' ' VAL . 38.6 m80 -88.98 60.41 5.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.679 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.9 t-20 -43.0 117.03 0.98 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.265 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -117.58 -179.65 3.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' N ' ' OG1' ' A' ' 66' ' ' THR . 10.5 pt-20 -64.65 135.4 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.02 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 37.12 31.93 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.594 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 66' ' ' THR . 0.2 OUTLIER 172.9 158.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 4.1 p90 -136.49 147.38 47.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.194 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.565 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.18 119.23 38.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.326 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.068 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -92.07 142.51 27.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.866 179.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -133.55 122.46 23.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.824 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.99 -34.49 2.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.98 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.824 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 13.2 Cg_exo -71.96 -174.07 11.15 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.61 1.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 78.5 Cg_exo -39.94 173.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.028 2.485 . . . . 0.0 113.011 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.37 56.54 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -101.12 -126.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.961 179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.52 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 35.2 tt0 -151.3 64.64 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.383 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.068 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.6 OUTLIER -90.9 109.97 21.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.848 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' CG1' ' A' ' 84' ' ' ILE . 38.7 t -58.44 136.79 85.61 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 4.9 Cg_exo -74.15 109.94 2.99 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 113.809 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 22.0 m120 71.1 -1.18 2.8 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.553 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -77.42 -35.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.239 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 3.9 p 85.03 84.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.373 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.34 96.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 1.029 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -55.56 160.89 2.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.282 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 1.8 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.218 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.783 0.325 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 24' ' ' PRO . 37.4 t70 43.27 73.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.85 165.18 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 14.2 t0 -77.29 92.06 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.063 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.623 ' O ' HD11 ' A' ' 14' ' ' LEU . 31.8 mp0 -73.93 -17.33 61.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.075 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.614 ' HA ' HD13 ' A' ' 14' ' ' LEU . 55.6 m -83.77 -27.58 28.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.14 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -46.11 -44.07 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.295 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -156.2 146.46 15.88 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.586 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.9 Cg_endo -84.48 -15.92 6.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.998 2.465 . . . . 0.0 111.626 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -111.35 19.0 18.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.397 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -39.19 -49.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 18' ' ' GLY . 8.0 t -89.51 36.84 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.654 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . -14.37 80.38 0.0 OUTLIER Glycine 0 C--N 1.335 0.485 0 O-C-N 123.978 0.799 . . . . 0.0 113.771 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.619 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 116.53 13.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 15' ' ' CYS . . . -148.14 -149.65 5.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.11 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -133.72 106.75 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 37.5 t -56.07 155.59 6.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 20.5 t -136.26 164.91 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.597 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.578 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 9.2 t-20 -115.96 141.78 47.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.211 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASP . 9.5 p -146.25 155.46 50.37 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 32.2 Cg_endo -64.06 112.35 1.83 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . 70.52 31.76 68.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.3 OUTLIER 165.31 -169.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.696 0.284 . . . . 0.0 110.472 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 14' ' ' LEU . 5.5 p90 -164.43 -176.01 4.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.038 0.447 . . . . 0.0 111.215 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' A' ' 27' ' ' PHE . 8.3 pt-20 -167.88 -155.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.284 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 6.2 p -168.15 179.15 4.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 111.969 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -117.32 80.35 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.607 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -54.67 163.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.081 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.39 -88.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.088 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 2.1 tt0 -122.61 -80.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.29 -3.92 64.78 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.356 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HA ' ' N ' ' A' ' 47' ' ' ASP . 14.5 m-85 -68.63 123.82 21.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.958 0.408 . . . . 0.0 110.218 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -93.59 136.75 33.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.046 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.54 96.83 10.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.944 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 100.67 44.75 2.06 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' MET . 5.8 t80 -40.03 -30.25 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.074 0.464 . . . . 0.0 110.212 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.47 -38.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.548 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 4.5 ptm -57.64 -47.99 80.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.818 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 41' ' ' MET . 46.9 mmm -163.09 -94.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HZ1' ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -168.47 96.92 0.4 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.474 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -165.21 134.25 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.184 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -42.72 121.91 2.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.355 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -149.77 86.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 7.9 p-10 -15.77 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.744 0.653 . . . . 0.0 112.142 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -45.04 179.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.451 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 61.0 t0 -95.88 73.63 3.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.902 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp0 -50.07 -24.35 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.995 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.961 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.3 t -75.83 -9.43 58.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.721 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -119.34 -23.33 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.986 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -52.86 -34.8 56.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 139.02 28.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.07 0.462 . . . . 0.0 111.019 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.08 -7.91 13.08 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.036 2.49 . . . . 0.0 111.931 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.698 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -108.81 -14.24 14.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.117 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.961 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.52 120.35 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.666 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 74.4 m 47.64 24.98 0.59 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.195 0.521 . . . . 0.0 110.425 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.14 -21.46 3.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.216 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.51 13.02 5.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.049 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.41 -132.46 3.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.628 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.581 HG12 ' CE1' ' A' ' 64' ' ' HIS . 34.0 t -133.16 127.53 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 111.089 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 27.9 p -94.1 106.74 18.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.033 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.581 ' CE1' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.45 67.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.519 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -48.03 110.24 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.047 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.558 HG21 HH11 ' A' ' 71' ' ' ARG . 0.3 OUTLIER -104.93 -170.97 1.83 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.018 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -70.62 126.79 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.803 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.1 28.54 1.94 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.454 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -169.74 -168.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.898 0.38 . . . . 0.0 110.975 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -167.68 140.55 3.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.558 HH11 HG21 ' A' ' 66' ' ' THR . 0.6 OUTLIER -110.98 156.07 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.08 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.54 137.32 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 31.5 tt0 -138.59 116.48 11.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.803 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.806 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -80.67 -30.18 0.56 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.806 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 21.9 Cg_exo -67.95 176.79 25.78 Favored 'Cis proline' 0 C--N 1.357 0.978 0 C-N-CA 123.988 -1.255 . . . . 0.0 112.767 1.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HG3' ' A' ' 73' ' ' GLU . 76.9 Cg_exo -39.86 -24.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.081 2.521 . . . . 0.0 112.908 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -35.58 -31.81 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.337 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -83.39 -121.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.61 ' NE2' HG21 ' A' ' 88' ' ' ILE . 39.5 tt0 -148.73 65.6 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.08 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -90.46 111.51 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.9 -178.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.674 ' OG ' HD13 ' A' ' 84' ' ' ILE . 38.0 t -62.07 137.1 95.55 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.719 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 84' ' ' ILE . 63.6 Cg_endo -76.57 108.88 2.75 Favored 'Trans proline' 0 CA--C 1.526 0.105 0 C-N-CA 123.052 2.501 . . . . 0.0 114.063 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 20.4 m120 72.51 14.25 5.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.259 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.674 HD13 ' OG ' ' A' ' 81' ' ' SER . 2.0 mp -95.75 -19.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 110.201 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.57 86.0 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.11 178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.698 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 147.64 98.77 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.487 0.492 . . . . 0.0 111.428 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 5.9 t -63.77 161.7 14.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.591 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.61 HG21 ' NE2' ' A' ' 79' ' ' GLN . 2.0 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.186 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.71 0.291 . . . . 0.0 111.059 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' THR . 63.4 t0 37.37 69.39 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.616 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -95.06 153.38 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.367 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.533 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 41.1 t0 -69.58 90.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.597 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.4 mp0 -73.85 -20.52 60.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.68 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 45.0 t -79.31 -36.26 39.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.491 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 6' ' ' ASP . 2.0 ttt85 -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mm -52.24 -46.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -162.91 154.14 14.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.2 -18.84 2.61 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.29 2.66 . . . . 0.0 111.722 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -108.12 21.35 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.378 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.736 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -40.06 -51.66 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.981 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 45' ' ' CYS . 12.4 m -95.13 17.26 14.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 67.93 3.34 28.62 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.969 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.513 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 175.09 -52.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.988 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 30' ' ' LYS . . . -48.11 176.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.804 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 10.7 mt-30 -105.96 104.97 14.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.809 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 8' ' ' CYS . 2.9 p -52.27 134.91 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.031 0.443 . . . . 0.0 111.558 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -118.38 164.05 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.21 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.3 t-20 -106.34 142.96 35.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 111.644 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.6 p -149.87 157.06 38.36 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 15.9 Cg_endo -57.61 111.84 0.95 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.256 . . . . 0.0 111.849 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.55 44.28 67.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.695 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' OE2' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 171.11 -175.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.738 0.304 . . . . 0.0 110.516 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.736 ' CE2' HD22 ' A' ' 14' ' ' LEU . 28.0 p90 -160.23 167.38 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.254 0.549 . . . . 0.0 111.716 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.7 pt-20 -143.51 -165.18 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.583 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.8 p -170.7 168.09 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 111.782 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -114.17 82.19 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.16 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -39.03 165.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.252 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 2.7 t70 -77.15 -144.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.17 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 32' ' ' ASP . 1.8 mt-10 -28.15 -93.41 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.859 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -123.51 32.67 4.21 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.22 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 21.2 m-85 -81.6 143.8 31.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.001 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 3.0 pt-20 -117.49 132.96 56.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.64 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -42.31 100.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.353 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . -47.25 -76.64 0.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.485 -0.865 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 87.39 -22.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.663 0.268 . . . . 0.0 111.04 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 mtm -59.5 -32.08 69.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.21 0.529 . . . . 0.0 109.884 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.0 mmm -117.42 -23.23 7.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.516 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 179.31 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.224 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 42' ' ' MET . 1.2 tptt 173.31 34.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.994 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -62.44 -177.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.779 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.585 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -100.39 105.84 17.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.207 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.555 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 2.2 ptp -123.83 99.87 6.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.302 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -9.14 125.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.846 0.716 . . . . 0.0 112.732 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -64.94 -174.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.256 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -100.44 73.54 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.301 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.885 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.2 mp0 -50.09 -21.58 1.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.729 ' HA ' HD22 ' A' ' 57' ' ' LEU . 51.1 m -77.7 -9.83 59.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.663 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.45 -22.27 8.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.637 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' OD1' ' A' ' 54' ' ' ASP . 33.9 ttt-85 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.105 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' OD1' ' NH1' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -100.97 156.12 35.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.027 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 20.8 Cg_endo -90.2 -2.61 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.344 2.696 . . . . 0.0 112.364 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -132.06 14.57 4.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.404 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.885 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -62.81 129.16 39.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' GLY . 1.7 m 45.93 25.89 0.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.351 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -62.31 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.239 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 129.6 0.46 5.73 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.806 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -122.55 -139.06 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.562 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.717 HG11 ' NE2' ' A' ' 64' ' ' HIS . 55.8 t -127.58 117.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.964 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.45 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 6.3 t -84.1 94.33 8.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.717 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.8 m80 -89.43 53.73 2.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 17.6 t-20 -49.66 111.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.718 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.51 ' CG2' ' HD3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -112.7 -161.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.316 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.4 pt-20 -75.53 138.93 41.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.233 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 34.59 46.6 0.58 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.721 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.1 t 157.61 -176.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.731 ' CE2' HD21 ' A' ' 57' ' ' LEU . 1.8 p90 -154.81 156.13 35.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HD3' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -122.92 117.19 24.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.01 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.549 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -100.07 135.37 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' C ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt0 -150.22 120.59 7.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.112 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.754 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -45.68 -47.53 38.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.754 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.4 Cg_exo -76.3 -60.41 0.08 OUTLIER 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.771 -1.345 . . . . 0.0 113.264 0.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.707 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 1.7 Cg_endo -83.38 -154.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.823 2.349 . . . . 0.0 113.111 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 78' ' ' HIS . . . 45.88 39.36 8.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.917 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.564 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.51 -162.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.0 111.041 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -141.78 73.03 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 87' ' ' CYS . 0.2 OUTLIER -63.83 91.6 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.211 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.791 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -46.68 130.7 8.38 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 59.2 Cg_endo -74.51 112.58 3.59 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.965 2.444 . . . . 0.0 113.253 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 75.97 34.26 0.55 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.985 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.791 HD13 ' C ' ' A' ' 81' ' ' SER . 1.1 mp -115.0 -39.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.111 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.7 p 88.74 69.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.041 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.03 116.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.696 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -62.46 128.49 36.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.564 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.713 0.292 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -64.54 63.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.6 tp -89.86 173.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 51.5 t0 -84.49 97.81 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.931 0.396 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.746 ' O ' HD11 ' A' ' 14' ' ' LEU . 28.8 mp0 -76.75 -25.93 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.571 ' HA ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -69.51 -45.43 68.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.353 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -50.5 -35.58 29.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.034 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 11.1 mm -42.37 -40.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -161.94 147.88 10.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.578 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.8 Cg_endo -85.24 -17.05 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.038 2.492 . . . . 0.0 111.256 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -112.13 23.76 13.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.059 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -38.96 -54.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.421 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -77.39 -10.84 59.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.067 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.31 -1.82 48.18 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.775 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 6.8 tpt180 -173.57 -44.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.971 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -71.72 -151.61 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.628 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -133.74 99.3 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 4.7 t -50.77 153.52 1.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.188 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 31.6 t -136.86 161.72 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.724 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 3.7 t-20 -95.69 143.65 26.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.691 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -149.18 155.82 39.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.932 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 11.9 Cg_endo -55.59 105.88 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.717 2.278 . . . . 0.0 111.952 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.43 41.51 97.09 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.906 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 175.57 -168.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.697 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.6 p90 -165.82 148.12 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.0 pt-20 -118.46 -170.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.434 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -147.34 155.78 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 111.531 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -113.36 71.66 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.967 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.0 OUTLIER -50.74 -175.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.856 -178.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.62 -158.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.049 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 32' ' ' ASP . 3.9 mm-40 19.88 -82.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.181 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ASP . . . -152.62 22.45 0.82 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.61 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 28.3 m-85 -79.79 134.38 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 4.6 pt-20 -99.66 134.83 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HG3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -86.49 88.2 7.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.963 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 125.58 79.87 0.37 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.273 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.516 ' O ' ' CB ' ' A' ' 40' ' ' MET . 22.0 t80 -122.18 -3.07 9.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.72 0.295 . . . . 0.0 111.238 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 159.7 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.091 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -89.88 -24.34 21.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.6 OUTLIER 124.26 -19.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.256 0.972 . . . . 0.0 109.988 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HA ' ' N ' ' A' ' 38' ' ' GLY . 1.7 tptt -164.8 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.912 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 21.94 102.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.885 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.3 m -39.21 95.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.18 0.514 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.815 ' HA ' ' HE3' ' A' ' 46' ' ' MET . 0.0 OUTLIER -119.74 91.88 3.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.147 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.5 p30 -5.51 123.24 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.087 0.867 . . . . 0.0 112.958 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -63.2 -171.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.606 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 54.3 t0 -94.83 72.82 3.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.814 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.4 mp0 -51.01 -21.59 1.86 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.954 ' HA ' HD22 ' A' ' 57' ' ' LEU . 18.2 t -78.28 -9.01 59.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.748 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.449 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 5.4 mt-30 -116.74 -22.22 8.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.713 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -59.95 -32.71 71.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.138 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -116.15 137.48 23.47 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.037 0.446 . . . . 0.0 110.979 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.77 -4.16 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.193 2.595 . . . . 0.0 112.147 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.507 HD13 ' HG3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -118.88 -9.43 10.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.285 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.957 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -49.96 114.15 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.575 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 35.5 m 50.78 23.54 1.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.271 0.557 . . . . 0.0 109.959 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HG3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -39.42 -31.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.689 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.38 21.65 5.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -137.99 -129.76 2.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.573 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' NE2' ' A' ' 64' ' ' HIS . 28.3 t -136.19 129.67 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.455 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 24.6 p -97.4 96.33 8.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' NE2' HG11 ' A' ' 62' ' ' VAL . 52.0 m80 -88.67 59.85 5.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.731 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 3.7 t-20 -44.1 119.48 1.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.871 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.647 HG21 ' HD3' ' A' ' 71' ' ' ARG . 1.4 p -119.43 -162.07 0.89 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 69' ' ' SER . 2.7 mt-10 -77.47 142.61 39.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' SER . . . 33.98 34.39 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.753 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 65.1 p 172.89 -169.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.874 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 1.5 p90 -162.1 147.92 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.647 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.1 OUTLIER -109.93 146.39 35.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.963 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.055 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -119.19 138.7 52.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.931 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HG3' ' HD3' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -131.77 123.45 27.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.72 -34.1 1.71 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.989 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 15.1 Cg_exo -70.99 -176.06 13.65 Favored 'Cis proline' 0 C--N 1.356 0.945 0 C-N-CA 124.154 -1.186 . . . . 0.0 112.616 0.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 98.8 Cg_exo -39.29 172.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.015 2.476 . . . . 0.0 112.928 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.77 48.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.575 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.7 t-160 -99.48 -126.12 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.751 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -151.67 64.52 0.86 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.122 0.486 . . . . 0.0 110.011 179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.055 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -88.94 107.52 19.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.247 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.622 ' N ' HD12 ' A' ' 80' ' ' LEU . 31.3 t -55.3 136.77 68.76 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.539 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 73.6 Cg_endo -77.52 110.49 2.98 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.904 2.403 . . . . 0.0 113.845 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 22.3 m120 71.83 -0.61 3.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.344 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.541 ' CG1' ' OG ' ' A' ' 81' ' ' SER . 1.6 mp -79.33 -35.12 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.251 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.714 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 4.4 p 85.98 81.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.181 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.02 101.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.948 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.4 148.95 30.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.319 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.3 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.295 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 28.7 t70 -54.19 113.09 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.875 HD13 ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -120.69 161.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.875 ' N ' HD13 ' A' ' 5' ' ' ILE . 23.9 t0 -42.39 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 14' ' ' LEU . 1.5 mt-10 95.37 -52.79 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.121 0.569 . . . . 0.0 110.805 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 5.5 t -66.68 -36.01 81.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' CB ' ' OD2' ' A' ' 6' ' ' ASP . 0.9 OUTLIER -76.89 -26.24 53.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.77 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ARG . 9.2 mm -38.18 -36.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.74 154.02 8.67 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -89.7 -18.58 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 111.471 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.97 17.5 24.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.065 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -39.84 -55.39 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -85.73 15.19 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 43.72 24.59 0.47 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.381 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER 163.29 -59.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.3 -150.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 2.4 mt-30 -137.92 113.08 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 24.6 p -53.49 155.31 3.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 24.8 t -133.55 163.79 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.525 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.565 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -107.06 142.45 36.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.965 0.412 . . . . 0.0 111.64 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.0 p -152.28 153.59 31.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.55 116.55 2.93 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 111.713 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . 46.42 46.92 17.1 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.576 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 171.41 177.91 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CG ' ' HB3' ' A' ' 7' ' ' GLU . 5.5 p90 -157.98 161.27 38.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.431 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 0.5 OUTLIER -133.57 -172.25 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.471 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 1.1 m -140.83 159.09 42.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.917 0.389 . . . . 0.0 111.341 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 1.6 tmtm? -112.76 75.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.594 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 99.5 m -45.87 155.78 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.334 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 33' ' ' GLU . 30.9 t70 -57.3 -81.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 6.2 mt-10 -145.11 -40.19 0.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.48 17.52 6.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.391 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 3.8 m-30 -89.61 158.16 17.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.665 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -122.08 124.73 44.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.178 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -88.49 105.41 17.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.72 69.83 0.66 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.389 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 91.5 t80 -104.28 -15.02 15.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.445 ' SD ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 168.32 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.198 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.556 ' O ' ' CB ' ' A' ' 42' ' ' MET . 30.7 mmm -75.53 -16.26 60.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.479 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.556 ' CB ' ' O ' ' A' ' 41' ' ' MET . 3.5 mtm 99.17 -15.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.524 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 1.6 mmtp 172.87 99.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.885 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -168.14 72.53 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.347 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 57.1 m -28.65 108.88 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.722 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 8.6 ptm -138.87 113.17 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.5 p-10 0.08 106.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.982 0.802 . . . . 0.0 112.809 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -56.53 -175.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.66 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 50.9 t0 -94.6 76.13 3.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.421 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.867 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.8 mp0 -49.68 -21.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.142 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.959 ' HA ' HD22 ' A' ' 57' ' ' LEU . 44.1 t -77.69 -11.11 59.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -111.59 -23.86 10.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -20.92 40.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.829 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -132.76 142.61 45.41 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.48 -5.63 11.76 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.94 2.427 . . . . 0.0 112.354 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -122.5 -8.37 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.821 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.959 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -53.12 114.35 1.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.7 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . 74.1 m 58.0 16.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.47 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -42.73 -27.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.425 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.23 29.4 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.073 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA3' ' CD2' ' A' ' 80' ' ' LEU . . . -142.59 -132.83 2.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.955 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.677 HG11 ' NE2' ' A' ' 64' ' ' HIS . 52.1 t -132.54 136.15 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 88.4 m -93.01 89.94 6.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.677 ' NE2' HG11 ' A' ' 62' ' ' VAL . 31.7 m80 -89.03 47.78 1.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 110.041 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 19.5 t-20 -44.61 116.06 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.276 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 71' ' ' ARG . 2.4 p -115.39 -162.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLY . 1.3 mt-10 -75.66 135.87 40.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.91 37.83 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.58 168.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.727 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.1 p90 -140.98 149.57 41.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.495 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -111.63 106.25 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.759 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.8 t -90.19 132.85 35.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.741 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.858 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.7 tt0 -145.81 128.09 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.785 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -50.59 -45.49 85.27 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.558 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.785 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 2.7 Cg_exo -75.08 -60.32 0.08 OUTLIER 'Cis proline' 0 C--N 1.352 0.732 0 C-N-CA 123.664 -1.39 . . . . 0.0 113.183 1.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.697 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.8 Cg_endo -85.13 -156.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.884 2.389 . . . . 0.0 113.59 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 78' ' ' HIS . . . 47.05 37.25 9.76 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.0 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.1 OUTLIER 160.52 -165.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 111.342 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.22 86.26 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.637 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -65.73 124.12 21.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.348 0.595 . . . . 0.0 111.932 -178.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.793 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -53.34 123.09 34.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.879 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.28 -44.81 43.72 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.578 2.185 . . . . 0.0 112.032 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.532 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.6 m120 -145.36 13.81 1.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -89.93 -20.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.622 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.34 103.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.0 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.835 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 127.55 106.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.904 0.752 . . . . 0.0 111.276 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.81 139.14 58.73 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 111.328 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.562 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.152 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.562 HG22 ' N ' ' A' ' 4' ' ' ASP . 35.2 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.562 ' N ' HG22 ' A' ' 3' ' ' THR . 23.4 t0 -178.7 51.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.83 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -89.85 165.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.546 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 61.7 t0 -71.9 91.93 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 14' ' ' LEU . 48.9 mp0 -72.56 -24.83 61.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.518 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.664 ' HA ' HD13 ' A' ' 14' ' ' LEU . 20.3 t -70.41 -45.7 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HG2' ' OD2' ' A' ' 6' ' ' ASP . 6.8 mmt180 -55.18 -31.25 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' GLU . 9.5 mm -37.97 -37.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.305 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.86 153.57 8.2 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.642 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.72 -22.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.854 2.37 . . . . 0.0 111.495 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -108.02 18.99 20.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.939 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -29.68 -57.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.516 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -93.29 -18.52 22.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.426 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 84.03 -47.2 3.8 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.033 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG2' ' CD2' ' A' ' 35' ' ' TYR . 31.5 tpt85 -116.68 -9.69 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 0.0 111.268 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -118.46 -171.96 15.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.615 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -118.29 108.9 15.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.796 0.331 . . . . 0.0 110.991 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' CB ' HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -50.58 134.67 23.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.064 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 28' ' ' GLU . 2.1 p -119.43 146.16 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.5 t-20 -84.89 141.25 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.41 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.702 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.6 p -148.6 155.12 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.754 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 9.3 Cg_endo -53.0 104.16 0.1 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 57.79 42.77 94.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.752 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER 178.62 -168.68 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.877 0.37 . . . . 0.0 110.799 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.702 ' HA ' HG23 ' A' ' 23' ' ' THR . 5.9 p90 -173.61 139.5 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.643 ' H ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -106.48 -148.75 0.42 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.284 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 43' ' ' LYS . 1.3 m -163.09 148.35 11.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 0.0 111.493 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 6.6 tmtm? -100.87 67.3 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.098 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 93.4 m -52.52 171.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.842 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 11.1 t70 -68.58 -84.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.522 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' ' C ' ' A' ' 68' ' ' GLY . 1.6 tt0 -128.07 -65.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.506 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.71 5.07 32.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.456 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 2.6 m-85 -69.58 112.64 6.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.023 0.44 . . . . 0.0 110.395 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -89.46 117.07 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.467 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -81.99 103.13 11.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.585 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . . . 126.86 69.47 0.17 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 77.9 t80 -123.61 11.23 9.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.89 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 0.0 111.431 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.597 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.5 mmt -94.96 -27.96 15.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.597 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.5 OUTLIER 127.45 -20.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.443 1.089 . . . . 0.0 110.101 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 37' ' ' SER . 5.6 mptt -148.75 -89.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.772 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 36.27 67.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 27.6 m -29.7 96.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.154 0.502 . . . . 0.0 110.889 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -125.85 115.35 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.868 -178.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.555 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -20.87 138.92 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.584 ' CG2' ' CB ' ' A' ' 36' ' ' GLU . 1.3 pt -82.94 -174.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.134 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.504 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 41.6 t0 -104.07 72.98 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.989 ' O ' HD13 ' A' ' 57' ' ' LEU . 6.0 mp0 -47.34 -26.04 1.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.391 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 1.004 ' HA ' HD22 ' A' ' 57' ' ' LEU . 48.8 t -75.31 -11.93 60.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.038 0.447 . . . . 0.0 110.833 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.0 mt-30 -111.47 -25.3 9.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.353 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HD3' ' OD2' ' A' ' 54' ' ' ASP . 5.0 ttt180 -51.03 -32.89 22.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.594 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 60.2 m-20 -129.78 150.59 76.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.777 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -88.48 -3.89 6.62 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.238 2.625 . . . . 0.0 112.491 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -113.89 -10.59 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.004 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.4 OUTLIER -53.17 119.57 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.793 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 61.7 m 46.8 26.1 0.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.499 . . . . 0.0 109.968 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 1.3 ttt85 -41.4 -28.3 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.535 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.68 21.32 3.4 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.891 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -127.57 -139.98 5.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.716 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 73' ' ' GLU . 79.7 t -121.7 137.13 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 25.9 m -96.08 89.13 5.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.496 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 56.7 m80 -89.99 49.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.447 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 13.2 t-20 -45.73 113.76 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.716 HG21 ' CD ' ' A' ' 71' ' ' ARG . 1.5 p -105.06 -173.82 2.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.956 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ASP . 1.6 mp0 -50.5 -98.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . -88.8 57.71 4.07 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.415 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 70' ' ' TYR . 10.8 t 156.8 -173.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.7 0.285 . . . . 0.0 110.67 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.772 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 7.5 p90 -148.55 149.9 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.716 ' CD ' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -113.62 118.21 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.051 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.025 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.07 142.39 27.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.334 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 76' ' ' PRO . 2.2 tt0 -136.19 122.41 20.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.592 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.81 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.07 -34.55 1.71 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.005 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.81 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 11.8 Cg_exo -72.89 -172.15 9.28 Favored 'Cis proline' 0 C--N 1.356 0.943 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.521 0.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 89.2 Cg_exo -41.0 176.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.943 2.429 . . . . 0.0 113.006 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.57 -19.28 48.76 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.577 ' CD2' ' OXT' ' A' ' 88' ' ' ILE . 9.3 t-160 -101.68 -126.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.506 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 30.2 tt0 -151.22 64.8 0.89 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.113 0.482 . . . . 0.0 109.894 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -90.46 129.22 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.576 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.053 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -58.79 134.29 86.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.563 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 81' ' ' SER . 45.9 Cg_exo -55.83 -50.56 12.08 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.595 2.197 . . . . 0.0 111.953 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.684 ' C ' HD13 ' A' ' 84' ' ' ILE . 9.3 m120 -147.15 28.52 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.447 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.794 ' N ' HD13 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -96.65 -23.65 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.56 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.684 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 74.98 89.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.142 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 151.87 99.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 1.011 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.25 157.15 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.348 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.577 ' OXT' ' CD2' ' A' ' 78' ' ' HIS . 1.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.845 0.355 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -165.8 86.97 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -93.04 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.813 ' N ' HG23 ' A' ' 5' ' ' ILE . 8.0 t0 -84.61 -50.81 7.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 110.958 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 7.0 mp0 73.6 -56.9 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.616 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' HA ' HD13 ' A' ' 14' ' ' LEU . 28.3 t -64.68 -18.18 64.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.62 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -76.89 -34.22 57.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.552 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.3 mt -43.3 -37.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.615 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.9 t -162.25 152.19 13.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.671 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 3.3 Cg_endo -85.53 -17.8 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.114 2.543 . . . . 0.0 111.466 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.53 22.41 15.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.216 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.938 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -43.72 -44.25 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.163 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 1.8 m -83.91 11.47 7.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 52.73 11.1 1.16 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.942 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 tpm_? 172.81 -55.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.338 0.569 . . . . 0.0 110.877 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -64.98 -145.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.969 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 3.6 mt-30 -131.48 124.41 30.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.016 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 2.2 p -75.09 130.43 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 111.252 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' ASN . 41.5 t -117.34 162.02 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.645 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.7 t-20 -93.63 148.54 22.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.499 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 27' ' ' PHE . 6.4 p -152.72 149.12 21.58 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -49.59 111.45 0.5 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.805 2.337 . . . . 0.0 111.953 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.68 43.7 86.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.888 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.459 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 170.01 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.869 0.366 . . . . 0.0 110.671 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.938 ' CE2' HD22 ' A' ' 14' ' ' LEU . 16.2 p90 -166.51 144.41 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.6 pt-20 -109.98 -168.12 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 1.5 m -152.31 165.31 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 111.69 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -124.94 72.26 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.564 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 98.7 m -41.84 170.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.55 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -80.83 -73.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -131.21 -85.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.646 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 33' ' ' GLU . . . -93.33 -7.6 61.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.639 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 19.1 m-30 -68.57 127.15 31.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 1.8 pt-20 -100.24 128.06 46.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -86.94 105.73 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.21 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 117.13 24.17 3.64 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.798 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 40' ' ' MET . 84.9 t80 -44.6 -26.71 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.557 ' CG ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.14 -34.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.601 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.574 ' CG ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -54.14 -44.44 71.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.749 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.75 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 8.8 tptt -167.82 23.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.548 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.574 ' ND2' ' CG ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -76.33 143.26 40.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 86.5 m -85.13 108.84 17.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 22.8 ptm -136.6 113.46 10.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.95 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.524 ' N ' ' HA ' ' A' ' 35' ' ' TYR . 2.0 p30 2.57 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 124.028 0.83 . . . . 0.0 112.973 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -53.31 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.163 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.542 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 46.0 t0 -97.19 73.47 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.937 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.963 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.7 mp0 -49.47 -23.19 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 110.763 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.945 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.3 t -76.38 -11.22 59.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.814 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 2.9 mt-30 -114.45 -23.96 9.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -57.79 -31.44 66.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.02 137.81 23.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.833 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.01 -2.12 10.1 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.061 2.507 . . . . 0.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.599 HD13 ' CG ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -122.93 -5.62 8.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.596 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -53.05 116.67 2.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.957 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 56.1 m 52.08 21.49 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.17 -26.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.272 179.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.57 21.63 6.31 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.95 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 73' ' ' GLU . . . -147.48 -129.83 1.97 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.683 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 64' ' ' HIS . 38.7 t -137.16 133.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.825 0.345 . . . . 0.0 110.569 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.473 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 21.0 p -99.95 96.88 7.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.496 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.57 ' CD2' HG12 ' A' ' 62' ' ' VAL . 16.9 m80 -88.4 61.14 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.4 t-20 -41.96 120.45 1.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.902 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.541 ' CG2' ' HG3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -121.17 172.7 7.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 6.3 pt-20 -59.99 139.19 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 67' ' ' GLU . . . 38.08 33.77 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.48 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 179.3 -166.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.131 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -173.63 144.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.446 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.541 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 0.5 OUTLIER -109.36 152.09 25.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.032 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -132.17 135.55 46.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.089 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG2' ' CD ' ' A' ' 76' ' ' PRO . 6.7 tt0 -142.9 124.97 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.977 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.846 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -63.71 -38.57 39.04 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.846 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.0 Cg_exo -80.16 -172.51 11.19 Favored 'Cis proline' 0 C--N 1.356 0.936 0 C-N-CA 124.291 -1.129 . . . . 0.0 112.587 1.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 8.9 Cg_exo -28.39 152.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.16 2.573 . . . . 0.0 113.56 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.09 -12.77 16.94 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.574 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 1.4 t60 -120.53 -131.93 0.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.522 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.539 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.32 72.42 1.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 110.16 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.032 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -84.16 125.81 32.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.269 0.556 . . . . 0.0 111.861 -179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.94 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.1 p -62.89 132.68 94.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.854 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.29 -48.21 13.65 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.656 2.237 . . . . 0.0 112.395 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 84' ' ' ILE . 13.2 m120 -153.69 33.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.61 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.819 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.9 OUTLIER -101.96 -12.31 8.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.449 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 65.41 86.88 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.305 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 150.73 104.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.2 t -71.21 145.93 49.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.716 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 2.3 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.24 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.807 0.337 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 8.9 t0 173.6 99.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.6 tp -90.5 -165.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.811 ' N ' HG23 ' A' ' 5' ' ' ILE . 17.8 t0 -91.77 -49.27 6.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.997 0.427 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 16.1 mp0 71.71 -55.32 0.66 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 67.4 m -61.37 -27.1 68.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.855 0.359 . . . . 0.0 110.344 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.9 -32.62 73.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.169 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.4 mm -45.51 -39.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.626 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.477 ' OG ' ' HD2' ' A' ' 12' ' ' PRO . 17.7 t -168.13 154.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.205 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 76.1 Cg_endo -89.31 -20.12 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.234 2.623 . . . . 0.0 111.289 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.32 22.0 16.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.6 179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.654 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.87 -46.44 5.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.272 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -82.35 2.4 32.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.364 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 65.19 4.24 15.41 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.668 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER 175.95 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.109 0.455 . . . . 0.0 111.362 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 30' ' ' LYS . . . -65.05 -131.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.163 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 5.1 mt-30 -148.28 122.0 9.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.39 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 36.5 t -67.95 160.85 27.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.7 t -141.43 164.1 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.746 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 6.3 t-20 -105.25 151.21 24.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.7 p -153.77 146.82 17.86 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.876 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.77 111.51 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.904 2.403 . . . . 0.0 112.059 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.8 42.08 96.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.996 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 168.05 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.481 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.654 ' CE2' HD22 ' A' ' 14' ' ' LEU . 4.1 p90 -165.32 171.75 13.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.971 0.415 . . . . 0.0 111.082 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 3.0 pt-20 -142.62 175.14 10.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -139.91 153.35 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.232 0.539 . . . . 0.0 111.379 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.21 162.84 12.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.907 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 1.3 m -139.74 153.66 47.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.071 0.463 . . . . 0.0 111.341 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -89.89 -157.01 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.657 -179.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 32' ' ' ASP . 4.4 mt-10 9.42 -77.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 48' ' ' ILE . . . -154.28 31.02 0.71 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.176 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 21.9 m-85 -81.12 155.58 26.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -132.68 133.41 43.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.539 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -42.96 100.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.607 ' HA2' ' HE3' ' A' ' 46' ' ' MET . . . -51.04 -76.22 0.18 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.39 -0.909 . . . . 0.0 111.695 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 84.48 -12.35 0.77 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.402 ' SD ' ' HE1' ' A' ' 46' ' ' MET . 1.0 OUTLIER -88.85 -16.8 31.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.337 179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -33.15 2.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.22 36.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.246 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HD3' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER 51.17 36.62 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -77.21 -152.45 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' CYS . 1.2 m -115.73 113.68 23.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.351 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.607 ' HE3' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -130.54 103.72 6.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.088 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.0 p-10 -12.57 110.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.062 0.851 . . . . 0.0 112.654 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -48.76 -173.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.116 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 60.5 t0 -101.51 72.92 1.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.378 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.975 ' O ' HD13 ' A' ' 57' ' ' LEU . 5.1 mp0 -51.96 -22.01 3.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 110.149 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.439 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.9 -11.27 60.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -115.27 -29.04 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.643 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -49.35 -38.0 26.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -113.12 130.55 23.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.797 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 56' ' ' LEU . 73.0 Cg_endo -77.52 -5.73 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.829 2.353 . . . . 0.0 112.156 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -126.64 -6.73 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -30.39 134.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 1.3 m 38.49 36.13 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.47 -40.8 0.89 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 21.6 7.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.889 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -136.02 -157.0 7.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.951 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG11 ' NE2' ' A' ' 64' ' ' HIS . 35.3 t -113.96 123.33 69.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.897 0.38 . . . . 0.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.662 ' HB2' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -88.84 98.41 11.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.821 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.689 ' NE2' HG11 ' A' ' 62' ' ' VAL . 47.6 m80 -93.37 61.02 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.252 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 12.9 t-20 -49.04 114.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -116.08 -163.47 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -76.03 144.86 40.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.17 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 33.87 35.03 0.04 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.831 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 166.55 177.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.369 . . . . 0.0 111.263 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.755 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.8 p90 -148.84 147.38 28.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 3.5 mmm180 -109.66 148.73 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -130.17 133.35 46.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.549 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 4.1 tt0 -125.83 119.12 27.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.77 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -64.29 -40.09 48.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 17.4 Cg_exo -69.26 174.21 39.75 Favored 'Cis proline' 0 C--N 1.353 0.788 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.616 1.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.549 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 67.1 Cg_exo -30.85 -32.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.057 2.504 . . . . 0.0 113.096 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.61 -30.62 0.06 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.279 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.539 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 0.4 OUTLIER -103.03 -134.92 0.32 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -137.32 82.61 1.94 Allowed 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 118.323 0.51 . . . . 0.0 110.992 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.699 HD12 ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -90.28 113.48 25.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.699 ' N ' HD12 ' A' ' 80' ' ' LEU . 18.1 t -67.6 135.77 92.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.903 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 Cg_exo -32.96 -115.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.031 3.154 . . . . 0.0 114.157 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.42 39.74 0.96 Allowed 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.957 -0.464 . . . . 0.0 111.062 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -95.93 -31.01 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.377 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER 72.04 89.23 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 179.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 157.37 74.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.0 t -35.89 146.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.585 0.231 . . . . 0.0 110.431 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.537 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.189 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.792 0.33 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 22.0 t0 64.06 97.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.61 155.42 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.508 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 8' ' ' CYS . 50.7 t0 -76.31 67.66 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.639 ' CB ' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 -45.33 -25.02 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.417 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.615 ' HA ' HD13 ' A' ' 14' ' ' LEU . 37.3 m -74.48 -39.24 62.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' ASP . 13.6 ttt-85 -55.41 -34.2 64.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.786 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mm -42.91 -40.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -160.48 145.88 11.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.484 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -83.08 -17.13 6.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.032 2.488 . . . . 0.0 111.279 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -113.57 24.08 12.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.91 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.34 -48.67 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.436 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -81.21 0.28 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.205 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 13' ' ' ASP . . . 82.69 -44.33 3.21 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.507 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' HG2' ' HB2' ' A' ' 32' ' ' ASP . 1.6 tpt180 -142.34 -40.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -63.83 178.46 7.34 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.669 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 6.5 mt-30 -100.76 95.91 6.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.624 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.475 ' CA ' ' SG ' ' A' ' 15' ' ' CYS . 50.9 t -47.42 130.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -116.5 154.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.974 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 23' ' ' THR . 0.6 OUTLIER -107.1 163.4 13.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.145 0.498 . . . . 0.0 112.069 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 22' ' ' ASN . 1.1 p -161.4 158.9 23.5 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.478 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 7.1 Cg_endo -49.84 110.39 0.37 Allowed 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.728 2.285 . . . . 0.0 112.192 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 4' ' ' ASP . . . 56.28 43.09 89.48 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.354 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CA ' ' OE2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 169.53 176.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.797 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.879 ' CE2' HD22 ' A' ' 14' ' ' LEU . 7.1 p90 -155.87 148.99 24.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.331 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 pt-20 -114.46 -144.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.973 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.9 m -167.84 159.86 11.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.468 . . . . 0.0 111.702 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -120.16 72.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.319 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 94.7 m -42.09 171.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.7 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 25.6 t0 -85.66 -92.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.554 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 56.4 mt-10 -111.95 -69.86 0.84 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.374 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.37 -2.03 35.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 13.7 m-85 -69.32 125.31 26.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.721 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -106.05 127.44 53.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 43' ' ' LYS . 1.3 p -91.05 116.5 28.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.92 37.8 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.79 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CG ' ' SD ' ' A' ' 46' ' ' MET . 79.4 t80 -77.79 -20.81 52.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.782 0.325 . . . . 0.0 110.808 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.514 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 160.74 -24.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.588 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -72.6 -23.14 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.588 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 109.67 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.195 0.934 . . . . 0.0 109.953 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 163.25 104.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.766 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -170.01 47.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.396 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m -1.6 116.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.365 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.567 ' SD ' ' CG ' ' A' ' 39' ' ' PHE . 9.8 ptm -143.02 128.93 19.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.244 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 46' ' ' MET . 1.2 p-10 -20.93 113.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -58.48 -173.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.545 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 51' ' ' CYS . 53.9 t0 -101.67 72.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 57' ' ' LEU . 19.9 mp0 -50.22 -22.31 1.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.551 ' HA ' HD22 ' A' ' 57' ' ' LEU . 70.0 m -75.25 -9.63 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.542 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.06 -20.84 9.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.761 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.57 -31.37 70.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.134 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.56 141.49 41.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.561 ' O ' HD12 ' A' ' 56' ' ' LEU . 91.8 Cg_endo -84.82 -5.76 9.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.134 2.556 . . . . 0.0 112.156 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -119.51 0.38 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.007 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -53.65 114.63 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 62' ' ' VAL . 56.7 m 54.4 22.31 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.766 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.19 -35.19 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.458 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.26 18.09 25.95 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.923 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.08 -122.64 1.29 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.76 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 73' ' ' GLU . 19.0 t -150.01 135.36 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 0.0 110.794 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.606 ' HB3' HD23 ' A' ' 57' ' ' LEU . 21.7 p -102.64 100.98 11.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.141 0.496 . . . . 0.0 110.938 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 37.7 m80 -88.98 64.16 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.2 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 16.4 t-20 -46.49 120.15 2.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.181 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.588 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -117.33 -162.96 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.991 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 7.3 mt-10 -80.51 133.88 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 46.01 42.85 12.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.441 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 3.0 p 159.39 -172.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.793 0.33 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.979 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -159.3 150.27 19.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.588 ' HD3' HG21 ' A' ' 66' ' ' THR . 4.2 mmm180 -109.84 146.47 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.009 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.7 t -125.79 127.47 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.318 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.45 127.94 36.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.472 -178.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.85 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.24 -37.73 14.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.85 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 6.3 Cg_exo -80.12 -172.61 11.33 Favored 'Cis proline' 0 C--N 1.357 0.997 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.456 1.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.669 ' HD2' ' CB ' ' A' ' 75' ' ' PRO . 20.8 Cg_exo -28.08 150.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.148 2.565 . . . . 0.0 113.406 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.12 -16.51 11.9 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -115.76 -131.09 0.31 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.105 -0.548 . . . . 0.0 109.686 179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.652 HE22 HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -150.97 71.39 1.02 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.835 0.35 . . . . 0.0 110.277 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.009 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -85.72 105.41 16.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.408 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.722 ' C ' HD13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -61.15 134.42 93.07 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.911 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.518 ' O ' ' CD1' ' A' ' 84' ' ' ILE . 56.1 Cg_endo -72.27 109.34 2.7 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.869 2.379 . . . . 0.0 113.568 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 20.0 m120 73.68 33.29 1.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.533 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -110.82 -32.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 109.741 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.4 OUTLIER 77.4 72.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.793 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.4 99.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.508 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 t -59.76 151.56 25.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 110.7 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.652 HD12 HE22 ' A' ' 79' ' ' GLN . 2.0 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.19 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 3.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.815 0.34 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 3' ' ' THR . 7.2 t0 161.29 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 ' N ' ' A' ' 6' ' ' ASP . 1.2 tp -89.92 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.821 ' N ' HG23 ' A' ' 5' ' ' ILE . 15.1 t0 -88.02 -49.31 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.578 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 9.6 mp0 72.45 -55.46 0.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 66.4 m -62.03 -23.89 66.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.53 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -66.19 -35.5 80.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.153 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.9 mm -41.6 -37.41 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.327 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' CYS . 1.6 t -164.74 153.54 11.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.605 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.1 Cg_endo -83.28 -20.31 5.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.156 2.571 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -114.26 25.89 10.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.146 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.822 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -42.08 -50.16 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.266 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 6.9 t -60.18 -14.06 15.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 74.71 -3.23 44.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.778 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 10.9 tpt180 176.82 -33.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.052 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -85.85 -139.92 5.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.889 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -132.97 106.73 7.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 111.029 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 40.8 t -59.96 152.17 24.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 111.299 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.8 t -138.89 163.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' HG12 ' A' ' 21' ' ' VAL . 7.2 t-20 -100.27 146.78 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.599 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.9 p -150.54 146.31 19.55 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.77 107.89 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.864 2.376 . . . . 0.0 112.008 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.02 40.6 99.12 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.128 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 171.99 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.822 ' CE2' HD22 ' A' ' 14' ' ' LEU . 6.3 p90 -169.15 151.81 4.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.4 pt-20 -131.26 -170.97 2.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.152 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' CB ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -165.49 150.87 9.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 111.681 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -97.23 81.69 3.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.143 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -44.09 174.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.336 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.61 -95.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.377 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 9.6 tt0 -114.21 -77.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -103.91 4.13 45.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.83 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD2' ' HB3' ' A' ' 45' ' ' CYS . 21.8 m-30 -69.94 133.07 46.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.286 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.614 ' CB ' HG22 ' A' ' 48' ' ' ILE . 1.4 pt-20 -89.29 128.52 35.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.521 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 33.5 p -84.1 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 95.64 76.78 1.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.786 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' ' OE2' ' A' ' 36' ' ' GLU . 4.0 t80 -85.64 -18.01 34.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 110.547 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.37 -35.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -60.17 -42.89 95.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.518 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.67 -87.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.013 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -161.2 32.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.25 -174.97 3.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.176 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 1.5 m -111.02 107.82 17.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' C ' ' A' ' 47' ' ' ASP . 18.1 ptm -141.48 110.57 6.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.09 124.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.985 0.803 . . . . 0.0 112.752 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.614 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -78.0 -174.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.209 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 52' ' ' GLN . 60.6 t0 -98.52 72.97 2.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.922 ' O ' HD13 ' A' ' 57' ' ' LEU . 11.8 mp0 -52.74 -21.85 4.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.475 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.612 ' HA ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -74.83 -10.57 59.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.458 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 7.2 mt-30 -119.63 -25.98 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -28.26 14.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.239 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 5.9 m-20 -133.32 144.4 52.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 111.259 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.11 -5.32 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.157 2.571 . . . . 0.0 112.045 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.04 2.45 10.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -56.9 122.69 12.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' GLY . 76.0 m 49.76 25.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.18 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.72 61.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 151.91 -16.82 0.82 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.199 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.51 -120.78 3.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.805 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.55 135.72 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 110.928 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.451 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 0.5 OUTLIER -106.59 92.38 4.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.12 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.805 ' NE2' HG11 ' A' ' 62' ' ' VAL . 37.6 m80 -89.73 60.24 4.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.741 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 22.2 t-20 -51.3 111.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.497 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -108.27 -161.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.042 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 47' ' ' ASP . 4.1 mt-10 -89.75 128.68 36.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 67.01 26.46 73.29 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.646 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 7.0 t 158.14 -176.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.923 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -146.82 147.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.497 ' HD3' HG21 ' A' ' 66' ' ' THR . 1.0 OUTLIER -109.79 121.36 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.019 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -99.58 131.69 45.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.964 179.372 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -130.33 120.13 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 111.884 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -78.0 -31.95 0.85 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.938 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 40.8 Cg_endo -66.47 173.0 32.82 Favored 'Cis proline' 0 C--N 1.356 0.94 0 C-N-CA 123.802 -1.332 . . . . 0.0 112.76 1.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 72.1 Cg_exo -36.74 -29.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.943 2.428 . . . . 0.0 112.88 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.96 -30.45 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.377 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 88' ' ' ILE . 5.6 t-160 -89.74 -129.34 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.572 ' CB ' ' HB ' ' A' ' 88' ' ' ILE . 20.0 mt-30 -138.55 61.16 1.59 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.019 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -87.19 125.55 34.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.408 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.991 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -56.66 134.12 78.08 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.819 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' HD13 ' A' ' 84' ' ' ILE . 75.1 Cg_exo -49.97 -57.1 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.746 2.297 . . . . 0.0 112.338 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.588 ' H ' HD12 ' A' ' 84' ' ' ILE . 9.2 m120 -143.98 27.92 1.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -97.38 -13.31 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.669 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.691 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 67.93 91.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.786 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.53 99.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.993 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -63.65 148.84 47.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 4.1 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.105 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.821 0.343 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -61.8 79.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.528 ' CG2' ' HG3' ' A' ' 7' ' ' GLU . 1.5 tp -89.54 176.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -74.07 -49.0 25.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.289 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 13.3 mp0 72.06 -56.38 0.65 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.62 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HA ' HD13 ' A' ' 14' ' ' LEU . 90.1 m -62.42 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.337 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -69.14 -30.2 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.582 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.5 mm -48.73 -41.68 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -161.65 156.51 19.89 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.125 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 6.3 Cg_endo -87.4 -18.17 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.479 2.786 . . . . 0.0 111.597 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.09 20.94 18.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.309 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.921 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -45.84 -39.44 8.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.014 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 91.5 m -82.23 -3.88 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.263 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 44' ' ' ASN . . . 57.0 13.76 9.18 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.57 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.545 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 2.7 tpt85 173.61 -54.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.69 -151.38 6.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.69 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.0 mt-30 -123.93 121.43 35.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.0 110.968 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.5 t -65.58 154.7 37.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 41.4 t -135.93 160.25 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.918 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.524 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.7 t-20 -93.13 147.84 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.362 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 27' ' ' PHE . 5.2 p -152.68 146.17 17.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.07 111.63 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.889 2.392 . . . . 0.0 111.884 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.47 43.61 90.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.94 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER 169.17 -165.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 0.0 110.602 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.921 ' CE2' HD22 ' A' ' 14' ' ' LEU . 13.3 p90 -164.61 141.72 6.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 6.9 pt-20 -108.72 -172.38 2.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.06 163.67 27.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.085 0.469 . . . . 0.0 111.527 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -121.11 55.5 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.211 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 35' ' ' TYR . 72.8 m -31.66 152.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.634 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 26.6 t70 -61.03 -72.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 7.7 mt-10 -155.78 -34.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.868 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -125.18 6.26 8.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.628 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE2' ' HG2' ' A' ' 17' ' ' ARG . 2.3 m-85 -92.77 141.78 28.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.384 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -129.3 120.19 25.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.379 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.526 ' C ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -8.1 120.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.885 0.741 . . . . 0.0 112.42 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.61 57.74 2.96 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 40' ' ' MET . 2.0 p90 -52.42 -24.02 7.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.177 -0.512 . . . . 0.0 111.154 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.537 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 2.1 mtt -66.96 -24.77 66.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.166 0.508 . . . . 0.0 110.013 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.524 ' HE3' ' O ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -107.6 -35.57 6.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.55 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 166.95 -61.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.7 tptt 172.47 65.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.85 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.538 ' O ' ' C ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -131.88 87.95 2.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.268 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 44' ' ' ASN . 66.9 m -10.61 117.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.997 0.811 . . . . 0.0 111.846 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.498 ' O ' ' C ' ' A' ' 47' ' ' ASP . 21.5 mtp -140.11 104.98 4.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.849 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 4.9 p-10 7.7 112.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.56 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -48.59 -175.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.331 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 57.4 t0 -102.32 72.54 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.46 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.2 mp0 -49.86 -23.05 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.732 ' HA ' HD22 ' A' ' 57' ' ' LEU . 59.8 m -76.21 -10.18 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.649 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.453 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.4 mt-30 -116.87 -23.83 7.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.68 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -54.12 -33.53 58.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.044 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 4.9 m-20 -127.52 141.69 41.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.0 111.001 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.15 -8.35 11.9 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.058 2.506 . . . . 0.0 112.06 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -112.8 -8.71 13.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.507 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -52.23 120.57 5.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 58.9 m 45.98 26.12 0.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.182 0.515 . . . . 0.0 110.086 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -51.78 -30.24 22.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.745 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.28 18.79 7.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.23 -130.32 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 73' ' ' GLU . 48.7 t -134.21 136.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.519 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 50.9 t -106.81 99.08 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.26 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.492 ' NE2' HG11 ' A' ' 62' ' ' VAL . 54.1 m80 -90.81 61.03 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.572 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 8.3 t-20 -47.42 112.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.914 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.527 HG21 ' HD3' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -111.85 -163.68 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 4.2 mt-10 -72.19 134.39 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.73 36.49 0.12 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER 171.52 163.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.744 0.307 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.955 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.0 p90 -138.03 145.41 41.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.7 115.71 30.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.55 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.008 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.68 132.75 35.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.019 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -132.43 120.81 22.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.825 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.779 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.01 -32.42 0.99 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.926 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.779 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 25.8 Cg_exo -65.33 171.84 31.78 Favored 'Cis proline' 0 C--N 1.355 0.916 0 C-N-CA 123.883 -1.299 . . . . 0.0 112.67 1.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 71.0 Cg_exo -36.33 -27.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.939 2.426 . . . . 0.0 112.95 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 75' ' ' PRO . . . -37.33 -30.78 0.06 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.272 -0.965 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -91.03 -128.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -140.42 65.16 1.42 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.194 0.521 . . . . 0.0 109.614 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.046 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.88 130.33 36.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.408 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.046 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -61.05 134.91 93.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.895 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' HD13 ' A' ' 84' ' ' ILE . 74.7 Cg_exo -49.9 -53.8 6.49 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.712 2.275 . . . . 0.0 112.47 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 11.0 m120 -148.06 24.46 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.245 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -91.74 -17.55 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.964 0.411 . . . . 0.0 110.542 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 72.92 89.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.025 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.8 98.85 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.978 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.33 151.61 31.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.154 178.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.26 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 24.1 p . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.86 0.362 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 3' ' ' THR . 23.7 t0 175.55 82.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 6' ' ' ASP . 1.7 mp -104.09 165.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.574 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 62.6 t0 -77.38 97.21 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.959 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HB2' ' CB ' ' A' ' 27' ' ' PHE . 29.0 mp0 -81.68 -21.32 38.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.641 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 4.4 t -70.57 -49.84 43.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.79 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.59 -22.58 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.7 mt -45.5 -40.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.985 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -164.56 140.11 4.7 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -76.02 -17.07 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.571 2.181 . . . . 0.0 111.651 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -110.76 13.93 22.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.559 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.25 -56.36 2.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.3 t -62.56 -11.76 18.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.022 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 74.46 -2.12 47.92 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.63 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' CG ' ' HB2' ' A' ' 32' ' ' ASP . 11.6 tpt180 177.53 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -87.46 -143.88 8.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.948 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -130.45 112.54 13.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.658 0.266 . . . . 0.0 110.961 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 29' ' ' CYS . 21.2 p -53.95 154.17 4.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.039 0.447 . . . . 0.0 111.195 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 14.2 t -134.79 164.62 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.106 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 7.0 t-20 -110.29 139.54 45.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 111.595 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 27' ' ' PHE . 2.1 p -147.36 153.9 44.82 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.752 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.22 119.91 7.31 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.794 2.329 . . . . 0.0 111.846 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.11 43.77 25.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.847 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER 168.41 -169.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.363 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' THR . 20.5 p90 -166.26 176.6 7.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.185 0.517 . . . . 0.0 111.755 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -153.37 -165.47 2.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.892 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' N ' ' OE1' ' A' ' 28' ' ' GLU . 9.3 p -170.32 151.12 3.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.082 0.467 . . . . 0.0 111.576 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' CD ' ' C ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -94.36 78.75 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.267 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -42.29 170.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.493 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' HB2' ' CG ' ' A' ' 17' ' ' ARG . 13.6 t0 -63.87 -96.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.536 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -116.94 -74.55 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -99.77 -6.35 54.51 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.086 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.503 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 17.6 m-30 -69.14 128.84 38.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 0.0 110.631 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CG ' ' HA ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.11 149.56 21.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.686 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 69.3 p -59.64 77.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 39' ' ' PHE . . . 102.73 -64.49 0.42 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.882 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 62.6 t80 97.66 -14.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.075 0.55 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 156.12 -24.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.061 -179.828 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -73.75 -39.32 64.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.309 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 155.02 -59.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.35 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 28' ' ' GLU . 1.8 tptt 179.35 105.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.732 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -161.21 27.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.899 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' CYS . 2.9 m 42.72 106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.589 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' ASP . 10.2 mmm -148.57 103.4 3.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.098 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' MET . 4.1 p-10 0.27 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.809 . . . . 0.0 112.763 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.498 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -65.64 -173.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -91.0 74.24 6.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.939 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.92 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -51.64 -23.83 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.718 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.988 ' HA ' HD22 ' A' ' 57' ' ' LEU . 40.5 t -74.67 -11.87 60.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.52 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 4.4 mt-30 -116.99 -25.66 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -50.82 -37.99 46.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -113.11 137.93 22.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.909 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.02 -5.07 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.075 2.517 . . . . 0.0 111.982 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.69 -6.67 9.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.42 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.078 HD11 ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -52.72 124.71 14.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.912 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 60' ' ' GLY . 71.3 m 45.02 26.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.331 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -64.89 62.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.431 179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . 146.35 -15.43 1.66 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.627 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.52 -116.65 3.6 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.177 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 49.9 t -150.05 130.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 0.0 110.935 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 9.0 p -100.25 100.91 11.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.043 0.449 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 66' ' ' THR . 73.4 m80 -89.93 57.22 3.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -42.28 110.53 0.18 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.345 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.672 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.4 p -114.26 -161.63 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.028 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' SER . 6.7 mt-10 -75.47 139.89 42.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 34.16 32.83 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.795 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER 171.68 177.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 1.078 ' CE2' HD11 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -147.86 148.32 30.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.672 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.89 114.63 28.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.569 -179.37 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.031 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -89.78 136.87 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.007 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 31.3 tt0 -134.48 120.82 20.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.811 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.807 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -81.06 -32.99 0.67 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.856 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.807 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 45.7 Cg_endo -67.74 173.69 35.74 Favored 'Cis proline' 0 C--N 1.354 0.855 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.641 0.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 77.1 Cg_exo -36.26 -30.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.994 2.463 . . . . 0.0 112.723 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.51 -30.93 0.06 OUTLIER Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.262 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.586 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 5.4 t-160 -88.7 -127.62 0.06 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' N ' ' OXT' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.98 62.85 1.43 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.087 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.042 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.76 131.12 35.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.438 -178.901 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.042 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -62.12 134.85 94.65 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.759 179.727 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.47 ' HD2' HD13 ' A' ' 84' ' ' ILE . 58.6 Cg_exo -51.14 -55.39 4.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.567 2.178 . . . . 0.0 112.307 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.523 ' H ' HD12 ' A' ' 84' ' ' ILE . 8.7 m120 -145.51 25.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.347 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -93.42 -17.62 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 110.324 179.454 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.79 90.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.979 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.25 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 1.003 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.72 148.73 50.51 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.292 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.2 t0 61.89 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.8 -179.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.711 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 9' ' ' ARG . 8.2 t0 -90.31 -48.27 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.849 ' O ' HD11 ' A' ' 14' ' ' LEU . 7.2 mp0 67.43 -53.05 0.49 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.907 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 14' ' ' LEU . 78.5 m -67.13 -22.47 65.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.865 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 3.1 ttt85 -72.69 -30.77 64.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.273 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.0 mt -45.29 -40.77 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.483 179.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -159.02 152.93 19.45 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.616 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -83.48 -23.03 3.57 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.119 2.546 . . . . 0.0 111.14 179.519 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -114.85 31.25 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.709 179.382 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -34.89 -54.28 0.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.518 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 77.5 m -88.42 26.61 1.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 32.99 34.68 0.02 OUTLIER Glycine 0 C--O 1.229 -0.18 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.194 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 157.33 -60.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.96 0.409 . . . . 0.0 110.393 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.89 178.27 1.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.097 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.31 102.39 11.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.82 0.343 . . . . 0.0 110.811 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.47 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 38.8 t -57.9 142.46 46.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.5 t -129.22 162.52 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.563 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.5 t-20 -96.81 142.13 29.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.373 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.9 p -146.42 151.79 44.45 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.872 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.69 117.08 2.98 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.9 2.4 . . . . 0.0 111.923 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.35 44.73 44.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.829 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 168.81 -164.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.705 0.288 . . . . 0.0 110.462 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.709 ' HA ' HG23 ' A' ' 23' ' ' THR . 9.6 p90 -164.2 142.83 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.353 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 5.2 pt-20 -111.45 -167.64 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.201 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -153.29 -177.61 6.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.419 0.628 . . . . 0.0 111.76 -179.864 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' O ' ' A' ' 30' ' ' LYS . 4.9 tmtt? -138.42 69.27 1.38 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.797 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 93.8 m -42.41 169.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -64.82 -93.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.257 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.13 -35.47 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.057 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -140.12 27.34 2.54 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.367 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 4.5 m-30 -94.09 139.01 31.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.631 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -90.09 120.44 31.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 43' ' ' LYS . 15.7 p -79.21 91.28 4.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 43' ' ' LYS . . . 103.13 72.56 0.92 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.557 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD2' ' SD ' ' A' ' 46' ' ' MET . 18.4 t80 -87.52 -8.03 56.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.706 0.289 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.93 -32.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.717 -179.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.534 ' O ' ' CB ' ' A' ' 42' ' ' MET . 1.8 mmm -71.8 -36.44 70.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.4 OUTLIER 156.27 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 1.9 mmtm -158.13 22.63 0.25 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -63.62 76.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.174 0.511 . . . . 0.0 111.381 -179.681 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 16.0 m -37.48 100.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.545 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.568 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -126.39 121.72 33.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.086 -179.47 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 46' ' ' MET . 2.7 p-10 -21.2 100.23 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.985 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 36' ' ' GLU . 0.9 OUTLIER -47.55 -176.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.282 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 60.5 t0 -97.62 72.17 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.583 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.804 ' O ' HD13 ' A' ' 57' ' ' LEU . 2.0 mp0 -51.21 -21.61 2.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.941 ' HA ' HD22 ' A' ' 57' ' ' LEU . 7.1 t -77.72 -8.68 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 6.0 mt-30 -118.92 -22.06 7.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -53.66 -23.04 10.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.34 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -124.38 140.64 35.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.058 0.456 . . . . 0.0 110.971 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 76.9 Cg_endo -78.35 -10.3 16.18 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.011 2.474 . . . . 0.0 112.364 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.667 HD22 ' HG3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.69 -2.72 9.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.581 179.702 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -50.9 111.64 0.58 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.691 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.504 ' HA ' HD21 ' A' ' 80' ' ' LEU . 61.3 m 56.3 18.59 3.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.255 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -40.91 -35.98 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.47 179.507 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.7 22.72 8.11 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.957 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 74' ' ' CYS . . . -142.0 -131.16 2.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.827 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.57 HG11 ' NE2' ' A' ' 64' ' ' HIS . 71.6 t -137.14 129.6 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.878 -179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.471 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 26.7 p -98.71 94.22 6.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.57 ' NE2' HG11 ' A' ' 62' ' ' VAL . 18.8 m80 -88.37 60.6 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.266 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 10.3 t-20 -44.58 115.15 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.532 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.3 p -111.38 -161.61 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.901 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -85.72 127.46 34.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 55.52 27.22 47.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.462 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER 168.11 174.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.743 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.826 ' CD2' HD21 ' A' ' 57' ' ' LEU . 29.5 p90 -141.64 151.22 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.7 112.29 24.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.189 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.778 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.5 t -96.45 135.44 38.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.812 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.9 tt0 -150.06 127.52 11.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.388 -178.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.796 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -49.26 -45.36 76.07 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.443 179.569 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.796 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 4.1 Cg_exo -76.07 -61.42 0.05 OUTLIER 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.676 -1.385 . . . . 0.0 113.121 0.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.724 ' HD3' ' CB ' ' A' ' 75' ' ' PRO . 2.7 Cg_endo -85.37 -155.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.932 2.421 . . . . 0.0 113.02 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' A' ' 78' ' ' HIS . . . 51.73 20.48 5.92 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.836 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.59 ' CE1' ' OXT' ' A' ' 88' ' ' ILE . 1.1 m-70 168.43 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.218 0.533 . . . . 0.0 111.499 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.36 95.86 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.823 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -73.23 120.53 18.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.163 0.506 . . . . 0.0 111.526 -178.931 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.844 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -48.4 123.79 11.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.09 -42.0 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.975 2.45 . . . . 0.0 112.881 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.566 ' H ' HD12 ' A' ' 84' ' ' ILE . 22.9 m120 -154.3 19.42 0.49 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -91.28 -11.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.744 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.618 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 63.94 90.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.892 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.63 ' CB ' HD12 ' A' ' 56' ' ' LEU . . . 137.38 112.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.714 0.634 . . . . 0.0 111.252 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -68.11 158.67 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.806 0.336 . . . . 0.0 110.697 179.572 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' OXT' ' CE1' ' A' ' 78' ' ' HIS . 21.0 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.028 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 4.1 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 3' ' ' THR . 10.8 t0 168.01 88.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 5' ' ' ILE . 1.4 tp -89.61 177.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 8.8 t0 -71.88 -48.02 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 21.7 mp0 71.73 -56.01 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.743 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.653 ' HA ' HD13 ' A' ' 14' ' ' LEU . 87.5 m -59.98 -29.09 68.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HD2' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -64.49 -34.77 78.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.678 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 mm -42.24 -39.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.153 0.502 . . . . 0.0 110.25 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -162.28 151.88 13.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.62 -179.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.71 -19.08 3.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.189 2.593 . . . . 0.0 111.041 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -111.97 26.93 10.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.969 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.961 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -41.86 -48.34 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.352 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -84.64 8.58 16.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.312 -179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . 39.66 25.14 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.491 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' CB ' ' HB2' ' A' ' 45' ' ' CYS . 1.1 tpt180 173.24 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -88.4 -156.08 30.42 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.999 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -125.68 110.45 13.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.791 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 12.3 t -60.74 154.13 22.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.324 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 40.6 t -139.9 161.41 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.721 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.537 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 4.2 t-20 -91.51 142.35 27.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.315 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' PHE . 4.7 p -147.5 150.81 38.22 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.932 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.83 109.25 0.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.788 2.325 . . . . 0.0 111.906 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.06 43.18 93.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.909 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.65 -163.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 0.0 110.727 -179.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.961 ' CE2' HD22 ' A' ' 14' ' ' LEU . 11.7 p90 -167.76 139.89 3.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.99 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 12.7 pt-20 -108.18 -172.65 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.638 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 1.4 m -145.57 157.92 43.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.458 . . . . 0.0 111.406 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -109.55 64.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.196 179.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -50.46 154.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.488 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' HG3' ' A' ' 33' ' ' GLU . 22.9 t70 -37.69 -90.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.304 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 32' ' ' ASP . 27.0 mt-10 -140.03 -37.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -132.15 20.07 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.342 -179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 3.7 m-30 -89.23 155.51 19.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 111.212 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.867 ' CB ' HG22 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -112.87 122.41 47.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.656 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -78.47 82.52 4.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 43' ' ' LYS . . . 126.63 49.14 0.18 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.207 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' O ' ' CB ' ' A' ' 40' ' ' MET . 12.1 t80 -66.28 -13.78 60.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.709 0.29 . . . . 0.0 111.26 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 158.8 -31.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.707 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 42' ' ' MET . 8.9 mmt -66.81 -36.24 81.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.613 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER 159.13 -56.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 17.6 tptt -160.68 21.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.992 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.522 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -70.51 129.51 39.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.796 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 55.8 m -65.69 107.08 1.65 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.643 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 47' ' ' ASP . 6.6 mmt -135.24 103.25 5.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.468 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 2.1 p-10 -1.21 105.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.967 0.792 . . . . 0.0 112.897 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.867 HG22 ' CB ' ' A' ' 36' ' ' GLU . 1.8 pt -63.58 176.11 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.157 179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 52' ' ' GLN . 47.6 t0 -91.58 77.36 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.174 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.91 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.1 mp0 -47.97 -30.61 4.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.329 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' HD22 ' A' ' 57' ' ' LEU . 77.9 m -71.11 -10.94 60.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.436 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 8.1 mt-30 -118.48 -16.01 9.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -61.22 -36.68 80.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.377 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -129.09 124.43 22.3 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.402 -179.629 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 23.4 Cg_exo -63.7 -8.27 15.02 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.877 2.385 . . . . 0.0 112.198 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.842 HD23 ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -111.23 -13.05 14.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.071 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -47.66 114.67 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.869 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 64.2 m 51.05 21.58 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.358 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.06 -31.42 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.105 179.45 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 20.8 5.09 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.713 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 74' ' ' CYS . . . -135.33 -143.43 4.75 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.85 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.724 HG11 ' NE2' ' A' ' 64' ' ' HIS . 50.8 t -119.39 128.02 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.317 . . . . 0.0 110.913 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' CD2' ' A' ' 57' ' ' LEU . 16.1 t -99.36 90.84 4.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.382 . . . . 0.0 111.483 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.724 ' NE2' HG11 ' A' ' 62' ' ' VAL . 43.0 m80 -89.63 57.64 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.394 179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HA ' ' HB2' ' A' ' 70' ' ' TYR . 11.5 t-20 -48.64 108.26 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -105.87 -161.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.953 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' N ' ' OG1' ' A' ' 66' ' ' THR . 2.5 mt-10 -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 75.86 23.24 72.74 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 1.3 p 156.52 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 110.703 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.837 ' CD2' HD21 ' A' ' 57' ' ' LEU . 5.9 p90 -148.62 152.82 37.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.039 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 2.5 mmm180 -109.53 106.63 16.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.01 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.942 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -92.56 125.17 37.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.61 ' C ' HD23 ' A' ' 80' ' ' LEU . 4.4 tt0 -143.19 116.5 9.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.649 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -38.2 -65.05 0.4 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.008 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.77 ' HD2' ' HD3' ' A' ' 76' ' ' PRO . 84.9 Cg_endo -104.94 14.63 10.76 Favored 'Cis proline' 0 N--CA 1.441 -1.563 0 C-N-CA 123.775 -1.344 . . . . 0.0 113.126 1.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.77 ' HD3' ' HD2' ' A' ' 75' ' ' PRO . 69.9 Cg_exo -41.7 171.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.357 2.038 . . . . 0.0 112.227 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -54.32 81.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.586 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -153.83 -159.91 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.0 110.861 -178.946 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.59 80.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -68.88 120.19 14.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.569 . . . . 0.0 111.487 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.945 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -46.87 127.95 8.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.089 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.39 -52.43 7.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.763 2.309 . . . . 0.0 112.422 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.6 ' C ' HD13 ' A' ' 84' ' ' ILE . 14.0 m120 -138.45 20.62 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.851 ' N ' HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -91.95 -28.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.781 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.63 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 82.34 100.81 0.05 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.92 179.015 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.842 ' CB ' HD23 ' A' ' 56' ' ' LEU . . . 129.33 133.99 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.898 0.749 . . . . 0.0 111.308 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 40.5 t -73.28 140.53 46.87 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.578 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 5.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.315 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.883 0.373 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 3' ' ' THR . 37.8 t0 179.17 96.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.971 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.792 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -94.99 166.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.761 179.783 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 9' ' ' ARG . 8.5 t0 -72.95 -51.44 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 109.974 179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.592 ' HB3' ' CD1' ' A' ' 27' ' ' PHE . 6.5 mp0 69.69 -53.32 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.512 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 86.3 m -63.82 -27.04 68.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 3.4 mmt180 -68.14 -33.47 74.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 14' ' ' LEU . 28.5 mt -44.42 -39.9 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.092 0.473 . . . . 0.0 110.445 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -162.03 150.83 12.8 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.456 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 2.1 Cg_endo -84.8 -19.72 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.127 2.552 . . . . 0.0 111.342 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -111.91 25.43 11.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.134 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.887 HD22 ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -42.92 -36.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.331 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -85.66 15.63 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.314 -179.435 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 17' ' ' ARG . . . 52.1 16.94 3.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.281 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 153.65 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 15' ' ' CYS . . . -67.77 -162.6 2.03 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.034 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LYS . 2.4 mt-30 -121.02 112.04 18.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.1 t -70.59 149.6 46.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.327 0.584 . . . . 0.0 112.471 -179.298 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 33.8 t -135.35 163.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.343 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 5.5 t-20 -99.63 142.41 31.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.219 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.433 ' CG2' ' HG2' ' A' ' 28' ' ' GLU . 4.3 p -146.05 145.67 25.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.929 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.22 111.75 0.17 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.965 2.443 . . . . 0.0 112.003 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.56 47.47 44.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.919 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' O ' ' CD ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 172.01 -172.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.822 -179.596 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.887 ' CE2' HD22 ' A' ' 14' ' ' LEU . 17.3 p90 -163.05 146.76 10.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 21' ' ' VAL . 15.5 pt-20 -124.16 -177.4 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.155 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 1.3 m -141.41 163.98 31.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' GLN . 1.4 tmtt? -110.83 69.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' LYS . 72.7 m -33.0 144.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.58 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 14.7 t70 -51.59 -71.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 34' ' ' GLY . 4.2 tt0 -153.51 -62.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.575 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' ILE . . . -108.47 28.63 11.26 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.596 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.642 ' C ' HG23 ' A' ' 48' ' ' ILE . 4.8 m-30 -98.08 159.91 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.668 0.275 . . . . 0.0 110.783 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.89 ' HB2' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -119.67 131.23 55.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.564 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -83.0 94.57 7.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.769 179.745 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . 106.58 43.25 1.47 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.432 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' MET . 25.0 t80 -46.04 -32.33 2.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 110.347 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 155.75 -30.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.051 179.67 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.533 ' HG2' ' ND2' ' A' ' 44' ' ' ASN . 4.8 ppp? -55.97 -43.91 77.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.569 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER 171.37 -40.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.0 OUTLIER 156.96 87.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.568 -179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' ' HG2' ' A' ' 41' ' ' MET . 0.0 OUTLIER -149.36 93.99 2.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.227 0.537 . . . . 0.0 110.415 179.651 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 36' ' ' GLU . 40.4 m -36.2 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.073 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 39' ' ' PHE . 3.3 ptm -133.13 131.39 40.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 1.9 p-10 -18.29 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.544 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.7 pt -49.67 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.328 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 58.3 t0 -101.05 72.45 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.375 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.877 ' O ' HD13 ' A' ' 57' ' ' LEU . 3.1 mp0 -48.86 -24.94 1.63 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.223 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.964 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.2 t -75.43 -10.16 59.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 49' ' ' ASP . 2.4 mt-30 -118.77 -23.3 7.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.879 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -21.04 18.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -128.96 139.2 34.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.998 -179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' OD1' ' A' ' 54' ' ' ASP . 92.4 Cg_endo -80.58 -5.32 13.27 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.923 2.415 . . . . 0.0 112.072 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -121.2 -8.37 9.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.614 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -51.78 117.12 2.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.871 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 63' ' ' CYS . 60.7 m 49.28 23.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.041 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 56' ' ' LEU . 2.4 tmt_? -45.91 -33.68 3.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.741 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.31 11.42 10.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.065 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.89 -138.54 4.09 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 73' ' ' GLU . 50.4 t -126.48 135.32 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.869 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 58' ' ' CYS . 14.0 p -103.08 99.48 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 66' ' ' THR . 48.1 m80 -90.01 60.23 4.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 4.3 t-20 -44.5 110.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.352 -179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 71' ' ' ARG . 1.0 OUTLIER -109.69 -178.5 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.667 179.553 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 4.4 pt-20 -79.39 119.35 22.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 69' ' ' SER . . . 73.59 26.54 69.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' GLY . 8.7 t 158.4 177.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 110.727 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.764 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 15.0 p90 -144.35 149.51 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 0.0 OUTLIER -110.73 114.28 27.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.444 -179.508 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.034 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -90.03 135.59 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.918 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' CD ' ' A' ' 76' ' ' PRO . 20.7 tt0 -132.16 117.75 18.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.771 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -77.73 -33.09 0.98 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.822 179.399 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.771 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 24.3 Cg_exo -66.13 171.86 35.47 Favored 'Cis proline' 0 C--N 1.355 0.907 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.634 1.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.521 ' CD ' ' HG3' ' A' ' 73' ' ' GLU . 61.5 Cg_exo -36.61 -29.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.022 2.481 . . . . 0.0 112.833 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -37.8 -30.63 0.07 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.328 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.583 ' CG ' ' OXT' ' A' ' 88' ' ' ILE . 4.8 t-160 -88.45 -127.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -141.47 62.88 1.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.151 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.055 HD12 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -89.6 130.95 35.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.375 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.055 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.38 134.79 93.53 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' HD13 ' A' ' 84' ' ' ILE . 69.0 Cg_exo -50.45 -53.26 7.41 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.674 2.25 . . . . 0.0 112.35 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.535 ' H ' HD12 ' A' ' 84' ' ' ILE . 10.8 m120 -148.75 26.25 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.299 -179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.787 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -94.03 -17.18 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.434 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.706 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.1 OUTLIER 73.6 90.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 179.105 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 156.2 100.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.99 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -64.27 149.26 48.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.101 178.787 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.583 ' OXT' ' CG ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.353 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.81 0.338 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 3' ' ' THR . 13.0 t0 178.08 71.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.639 ' C ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -104.87 153.58 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.905 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.572 ' C ' HD13 ' A' ' 5' ' ' ILE . 44.2 t0 -62.39 74.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 111.068 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 14' ' ' LEU . 37.5 mp0 -56.67 -17.04 7.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 13.8 t -81.35 -35.05 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.676 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HG3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -70.47 -27.75 64.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.523 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -45.57 -41.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.745 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -164.79 127.36 1.57 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.919 -179.65 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' SER . 11.2 Cg_exo -68.19 -18.27 45.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.659 2.239 . . . . 0.0 111.034 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -105.28 11.27 33.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.484 179.633 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -43.24 -47.98 6.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 45' ' ' CYS . 4.2 t -72.9 -14.35 61.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 13' ' ' ASP . . . 76.23 -2.36 57.03 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.522 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 9.1 tpt85 177.35 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.035 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 31' ' ' CYS . . . -82.47 -139.16 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.99 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 7.8 mt-30 -140.3 107.5 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.642 0.258 . . . . 0.0 110.916 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 5.2 p -52.37 149.72 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 25.0 t -131.26 163.99 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 4.7 t-20 -110.27 141.89 42.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.007 0.432 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.734 HG23 ' HA ' ' A' ' 27' ' ' PHE . 1.7 p -148.51 157.01 42.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.652 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 16.2 Cg_endo -57.86 113.03 1.34 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.658 2.239 . . . . 0.0 111.726 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 3' ' ' THR . . . 52.43 44.88 59.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.541 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER 171.58 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.366 -179.502 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.734 ' HA ' HG23 ' A' ' 23' ' ' THR . 27.3 p90 -166.75 175.91 7.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 111.852 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 10.3 pt-20 -153.59 -164.88 2.0 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 10.4 p -170.09 150.4 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 111.638 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -93.93 83.54 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.396 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -48.68 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.418 -179.355 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLU . 3.7 t0 -104.33 -144.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.983 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 32' ' ' ASP . 2.6 mm-40 -29.61 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.83 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 47' ' ' ASP . . . -120.0 25.93 7.32 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.663 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 20.9 m-30 -79.91 135.07 36.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.111 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 48' ' ' ILE . 5.0 pt-20 -108.07 131.89 54.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.845 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.6 99.06 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.914 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.97 44.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.558 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 40' ' ' MET . 17.7 t80 -86.46 -6.6 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.775 0.322 . . . . 0.0 111.035 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER 158.98 -23.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.643 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.4 OUTLIER -90.72 -20.38 22.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.781 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.582 ' CB ' ' O ' ' A' ' 41' ' ' MET . 0.3 OUTLIER 100.51 -13.88 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.917 0.76 . . . . 0.0 110.413 -179.528 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 7.0 tptt 168.35 100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.002 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -166.72 34.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.442 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m 34.66 98.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.429 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.519 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.6 mmt -132.83 102.19 5.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.53 179.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 46' ' ' MET . 0.6 OUTLIER -6.24 123.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.017 0.823 . . . . 0.0 112.796 -179.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -66.84 -173.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.137 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 43.2 t0 -95.13 76.57 3.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.026 179.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.061 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp0 -46.58 -27.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.393 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 1.0 ' HA ' HD22 ' A' ' 57' ' ' LEU . 34.7 t -75.07 -16.83 60.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.003 0.43 . . . . 0.0 110.605 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 6.8 mt-30 -103.02 -23.31 13.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.216 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -43.98 92.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD2' ' OG ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -100.63 155.92 35.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -93.3 3.77 3.26 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.432 2.755 . . . . 0.0 112.733 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -144.01 11.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.335 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -57.33 118.23 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 62' ' ' VAL . 34.6 m 50.2 24.14 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.392 0.615 . . . . 0.0 109.653 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -39.52 -29.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.818 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' CYS . . . -134.18 27.25 3.31 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.961 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.68 -126.36 2.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.83 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 73' ' ' GLU . 43.0 t -137.39 135.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 110.818 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 58' ' ' CYS . 61.9 m -96.92 92.59 6.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 58.2 m80 -88.98 48.84 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.038 0.447 . . . . 0.0 110.27 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 49' ' ' ASP . 9.1 t-20 -42.42 116.93 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.044 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 71' ' ' ARG . 2.5 p -119.53 -176.44 3.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 47' ' ' ASP . 5.2 pt-20 -64.0 134.59 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER . . . 35.45 36.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.489 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER 171.78 156.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.808 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.995 ' CE2' HD11 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -133.57 145.61 50.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.837 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 66' ' ' THR . 0.0 OUTLIER -109.86 114.11 27.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.027 ' SG ' HD21 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -89.78 134.13 34.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.863 179.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' CG ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -131.57 127.06 36.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.064 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.821 ' N ' ' HA ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -74.73 -33.68 1.6 Allowed Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.437 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HA ' ' N ' ' A' ' 74' ' ' CYS . 14.6 Cg_exo -71.25 -173.3 9.44 Favored 'Cis proline' 0 C--N 1.356 0.964 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.568 1.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD3' ' CG ' ' A' ' 73' ' ' GLU . 81.3 Cg_exo -40.92 173.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.938 2.425 . . . . 0.0 112.812 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.52 -19.51 53.25 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 88' ' ' ILE . 1.1 t60 -101.08 -125.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.519 ' CG ' ' HB ' ' A' ' 88' ' ' ILE . 30.4 tt0 -151.05 65.85 0.91 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.001 0.429 . . . . 0.0 110.296 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.027 HD21 ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -90.91 123.08 34.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.225 -179.47 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.895 ' N ' HD12 ' A' ' 80' ' ' LEU . 79.8 p -60.41 136.44 91.9 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.756 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.19 -66.0 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.787 2.325 . . . . 0.0 112.541 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 84' ' ' ILE . 14.6 m120 -137.48 41.07 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.224 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.776 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -106.06 -14.74 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.413 . . . . 0.0 110.47 179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER 66.35 89.12 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.12 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 85' ' ' SER . . . 155.18 93.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.995 ' SG ' HD22 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -54.58 159.93 1.97 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.766 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.576 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 2.2 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_